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Abstract
Selenium (Se) is an essential micronutrient necessary for human health. In humans, Se deficiency has
been associated with inflammatory bowel disease (IBD) and increased risk of certain cancers, including
colorectal cancer. Se has well established antioxidant and anti-inflammatory properties which are medi-
ated, in part, though the actions of the selenoproteins, in which Se is present in the form of the amino acid
selenocysteine (Sec). The cells of the gastrointestinal tract are exposed to stresses from pro-oxidative and
hypoxic conditions, which have been suggested to be involved in the pathogenesis and pathology of IBD.
Further characteristics of IBD are inappropriate immune responses of the gut epithelial cells to the gut
microbiota. Thus, to help explain the roles of Se in IBD, it is important to understand the modulatory
effects of Se on the cell innate immune responses following challenge of intestinal epithelial cells with
pathogen-associated molecular patterns (PAMPs), as well as oxidative and hypoxic stresses. The present
work aimed to assess the roles of Se and the selenoproteins, SelH and TR1, in the responses of Caco-2
cell, modelling the gut epithelium, to hypoxia and infection, the latter replicated by challenge with S.
typhimurium flagellin.
To investigate the responses of gut cells to low Se and PAMPs, undifferentiated Caco-2 cells with either
supplemented with Se (40 nM selenite) or depleted of Se for 72 h before challenging with flagellin (F)
(500 ng/mL). The gene expression of the pro-inflammatory cytokines IL-8 and TNF-α were measured in
addition to the genes encoding the antimicrobial peptides (AMPs) hBD1 and hBD2. Data showed that
Se depletion significantly affected hBD1 expression (0.88-fold increase, P < 0.05), but that Se depletion
plus F significantly increased the induced expression of all genes (IL-8: 1.68-fold, P < 0.001; TNF-α:
0.71-fold, P < 0.001; hBD2: 1.74-fold, P < 0.001) compared with the Se supplemented cells. F and Se
depletion were also associated with a significant increase in expression of TR1 (F: 1.68-fold, P < 0.001;
Se depletion: 0.33-fold, P < 0.01) and GPX2 (F: 3-fold, P < 0.001; Se depletion: 11-fold, P < 0.001),
but a significant decrease due to Se depletion in SelH (62 %, P < 0.001) and GPX1 (47 %, P < 0.001).
The selenoprotein TR1 is an antioxidant enzyme and the primary regulator of the thioredoxin system
(TXN), which has previously been shown to regulate immune responses. Knockdown of TR1 expression
resulted in the reduced flagellin-induced expression of IL-8 (40 %, P < 0.001), TNF-a (45 %, P < 0.01),
hBD1 (40 %, P < 0.01) and hBD2 (45 %, P < 0.001). These data suggested that Se, through TR1, is
involved in regulating the expression of flagellin-induced immune effectors. The selenoprotein SelH has
also been suggested to have antioxidant functions. Knockdown of SelH was associated with the increased
expression of the oxidative stress-associated genes NQO1 (0.41-fold, P < 0.001), and HMOX1 (1.78-fold,
P < 0.001), supporting a role for SelH in the expression of oxidative stress-associated genes. The role of
Se, through SelH and oxidative stress, in regulating the gut responses to flagellin, has been discussed.
The Caco-2 cell model is more representative of intestinal epithelial cells in vivo, when the cells are
differentiated and placed in a gaseous environment reflecting the oxygen gradient of the gut. Thus the
F challenge experiments using differentiated Caco-2 cells were repeated using a dualoxic environment.
Interestingly, no potentiation of gene expression relating to the pro-inflammatory agents IL-8 and TNF-α,
and the defensins hBD1 and hBD2 was observed. These data suggested that the dualoxic environment
completely diminished the effects of Se depletion on the expression of immune effectors IL-8, TNF-α, hBD2
and hBD1, following flagellin challenge. These data suggested the effects of Se in more physiologically
relevant intestinal epithelial cell models, more representative of the in vivo state, are required.
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Chapter 1
Introduction
1.1 Selenium: An essential micronutrient for human
health
Selenium (Se) is an essential micronutrient for both animal and human health [1, 2].
During the first half of the 20th century, the original focus for Se research, in relation to
health and disease, centred around the toxicity of Se compounds in farm animals [3]. The
latter half of that century saw the research focus shift from the harmful effects of Se to
elucidating the roles of Se as a nutrient, which is a requirement for good health, as it was
shown to prevent death from Se deficiency-associated diseases in many animals [4]. In hu-
mans, dietary intake of Se is partly determined by individual dietary habits. However, the
actual Se content of foods derived from vegetables and meats are, in part, determined by
the Se content of the soil on which livestock or crops are raised [5]. Thus, it has been ob-
served that certain regions with low Se soil content exhibit a higher prevalence of endemic
pathologies associated with Se deficiency. For instance, Keshan disease is a cardiomy-
opathy, which is endemic within regions of China that have a low soil Se content. When
individuals in these Se-deficient regions were supplemented with Se, the prevalence of Ke-
shan disease was greatly reduced [6]. Furthermore, a plethora of studies have suggested
an important role for Se-deficiency in a number of various pathologies, including Kaschin-
Beck disease, inflammatory bowel disease (IBD) and a number of different cancers [1, 7].
Such discoveries produce insight into how either Se deficiency or supplementation can
modulate the pathogenesis and treatment of a number of nutritionally-related diseases.
The relationship between Se status and cancer risk has received much attention. Yet
despite a wealth of ecological, cohort, case-controlled studies and randomised controlled
trials, the link between low Se status and increased cancer risk is still uncertain [8]. One
issue with the interpretation of data from such studies is that such studies have used
different biomarkers, such as plasma levels of selenoprotein P (SePP1) or glutathione
peroxidase (GPX), to assess Se status [8].
Two large scale supplementation studies have investigated the effects of Se status and
supplementation on cancer risk: the Nutritional Prevention of Cancer (NPC) trial [9, 10]
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and Selenium and Vitamin E Cancer Prevention Trial (SELECT) [11, 12]. The NPC trial,
performed over a mean of 7.7 years, supplemented 1,312 individuals, of varying baseline
Se status, with 200 µg organic Se per day, in the form of selenised bakers yeast. This
trial indicated a decreased risk of prostate and colorectal cancers in individuals with low
baseline Se status who were supplemented with Se [13, 14]. However, an increased risk of
total non-melanoma skin cancer was reported in supplemented groups [10]. Additionally,
it was reported that individuals that already exhibited higher baseline levels of Se, showed
increased risk of prostate cancer [15]. The SELECT trial also supplemented individuals
with 200 µg organic Se, but in the form of selenomethionine, as well as some receiving an
additional supplementation of Vitamin E. Due to concerns regarding increased risk of the
development of Type II diabetes with Se supplementation, the trial was terminated early
[8]. In contrast to the NPC trial, the SELECT trial provided evidence that suggested that
Se supplementation was associated with a slightly increase risk of colorectal, prostate and
lung cancers [16, 17]. The reason for the contradictory conclusions between the two trials
is not fully understood, but has been reviewed in depth [8]. Briefly, one possibility that has
been argued is that the baseline dietary Se intake in the SELECT trial was already optimal
[18]. Thus, in the Se-adequate population, one would not expect to observe benefits from
additional Se intake, and may instead introduce the possibility of causing harm due to
excessive Se intake. However, it has also been argued that the differences in baseline Se
intake in both of the trials was so small that it could not account for the contradictory
conclusions that the two studies reached [8]. Another fundamental difference between
the two trials may relate to the study populations used in each trial. The NPC trial
used a study population consisting of patients diagnosed with non-melanoma skin cancer,
whereas the SELECT trial used a population of healthy volunteers, albeit restricted to
males. Additionally, a relatively recent study in a large European population reported
that a low baseline Se status was significantly correlated with an increased risk of rectal
cancer in women [19]. Nonetheless, the effects of Se supplementation on cancer risk
remains poorly understood and controversial and more work is needed on understanding
how Se affects the gut epithelium.
1.1.1 Selenium to selenoproteins
One of the main mechanisms by which Se is thought to exert many of its biological func-
tions is via the incorporation into selenoproteins, in the form of the 21st amino acid,
selenocysteine (Sec). The incorporation of Sec into selenoproteins requires a highly con-
served and multi-step mechanism in which Sec is coded for by a UGA stop codon present
in selenoprotein messenger RNA (mRNA) (Figure 1.1) [20]. The synthesis of Sec occurs on
a Sec-specific transfer ribonucleic acid (tRNA), tRNASec, which forms a supramolecular
complex with SECIS-binding protein 2 (SBP2) and Sec-specific elongation factor (EFSec)
[21, 22]. The supramolecular complex then binds to a stem-loop structure, known as the
selenocysteine insertion sequence (SECIS), which is present in the 3’untranslated region
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Figure 1.1. Insertion of the amino acid, selenocysteine (Sec), into selenoproteins. Sec is encoded
by a UGA codon and a SECIS present in the 3’ UTR of the selenoprotein mRNA is necessary (a).
The SECIS element has a unique stem-loop structure to which SBP2 and a complex surrounding
a Sec-specific tRNA can bind. The assembly of all of these factors on selenoprotein mRNA can
permit the decoding of the UGA codon to Sec (b).
(UTR) of selenoprotein mRNAs [23]. Recent data have suggested that, for a number of
selenoproteins, the successful insertion of Sec into selenoproteins can be highly dependent
upon the position of the UGA stop codon but for other selenoproteins, merely possessing
a UGA stop codon and SECIS element is sufficient for successful incorporation of Sec [24].
There are a total of 25 selenoproteins that have found to be expressed in humans but
not all have been relatively well characterised (Table 1.1) [2]. Among the few seleno-
proteins that have been extensively studied are the GPX family of selenoproteins, which
have been identified primarily as antioxidant enzymes [25]. Additionally, the thioredoxin
reductase (TR) family of selenoproteins have been shown to exhibit antioxidant functions
and indicated to be involved in redox signalling [26].
The iodothyronine deiodinase family of selenoproteins have also been well characterised
and found to be involved in thyroid hormone metabolism [25]. The rest of the selenopro-
teome is less well characterised and functions are only starting to be fully understood.
Current research has indicated a range of potential functional roles, including protein
folding at the endoplasmic reticulum (ER) and roles in antioxidant defence [25].
1.1.2 Selenoprotein H (SelH)
Selenoprotein H (SelH) is a 14 kDa selenoprotein that is reported to be moderately ex-
pressed in many tissues. Interestingly, higher expression of SelH in certain cancers includ-
ing lung, stomach and liver cancers [27]. Se status is a strong regulator of SelH expression
in both in vivo and in vitro studies [28–31]. SelH possesses a thioredoxin-like ’CXXU’
motif, as does SelW, SelT, SelM and SelV, thus indicating a possible oxidoreductase role
[27, 32–34]. However, SelH shares no significant homology with any other functionally
characterised proteins [35]. Additionally, a nuclear-localisation signal is present in the
peptide sequence of SelH, which is consistent with reports that SelH protein has been
found to reside in the nucleus and nucleolus [27, 36].
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Selenoprotein Symbol Description
Glutathione peroxidase 1 GPX1 Reduction of cytosolic lipid hydroperoxides
Glutathione peroxidase 2 GPX2 Reduction of cytosolic lipid hydroperoxides in the gut
Glutathione peroxidase 3 GPX3 Reduction of plasma lipid hydroperoxides
Glutathione peroxidase 4 GPX4 Reduction of phospholipid hydroperoxides
Glutathione peroxidase 6 GPX6 Reduction of olfactory lipid hydroperoxides
Iodothyronine deodinase 1 DIO1 Regulation of thyroid hormone activity
Iodothyronine deodinase 2 DIO2 Regulation of tissue-specific thyroid hormone
Iodothyronine deodinase 3 DIO3 Regulation of tissue-specific thyroid hormone
Thioredoxin reductase 1 TR1 Reduction of cytosolic thioredoxin
Thioredoxin reductase 2 TR2 Testis-specific thioredoxin reduction
Thioredoxin reductase 3 TR3 Reduction of mitochondrial thioredoxin and glutaredoxin
Methionine-R-sulphoxide reductase MSRB1 Reduction of oxidized methionine residues
Selenophosphate synthetase 2 SPS2 Involved in synthesis of selenoproteins
Selenoprotein W SelW Redox regulation of 14-3-3 protein
Selenoprotein T SelT Regulation of pancreatic B-cell function and glucose homeostasis
Selenoprotein H SelH Regulation of GSH synthesis and phase II detoxification enzymes
Selenoprotein V SelV Unknown function
Selenoprotein I SelI Unknown function
15 kDa selenoprotein Sep15 Putative role in quality control of protein folding in the ER
Selenoprotein M SelM Rearrangement of disulphide bonds in the ER-localised proteins
Selenoprotein K SelK Putative role in endoplasmic reticulum-associated degradation
Selenoprotein S SelS Putative role in endoplasmic reticulum-associated degradation
Selenoprotein O SelO Unknown function
Selenoprotein N SelN Putative role during muscle development
Selenoprotein P SelP Selenium transport
Table 1.1. List of the 25 known human selenoproteins and their functions. Adapted from Labunskyy and Hatfield, 2014 [40]
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It has also been reported in the literature that SelH is highly responsive to the redox
status of the cell [37, 38]. Additionally, under conditions of oxidative stress, it was found
that overexpression of SelH resulted in enhanced antioxidant capacity of cells. This may
have been facilitated by a potential gene regulatory function of SelH attributed to a
proposed AT-binding hook, which could bind to deoxyribonucleic acid (DNA) and regulate
gene expression [37]. Interestingly, under resting conditions, overexpression of SelH was
reported to have little effect on the antioxidant capacity of cells [37]. However, the
direction of the SelH response to stress is suspected to be dependent upon the nature
of stress. For example, one study reported that mouse embryonic CGR8 cells stressed
with inorganic arsenic resulted in decreased SelH expression [38], while another reported
that SelH expression was negatively regulated by heat stress [39].
SelH expression has been found to be regulated by metals, such as zinc and copper.
This regulation is proposed to be mediated by the presence of a metal response element
(MRE) in the transcribed region of SelH [41, 42]. Interestingly, the effect of zinc treat-
ment has been observed to both increase and decrease SelH expression depending upon
which cell-type is examined. Treatment of HEK-293T kidney cells with zinc resulted in
decreased SelH mRNA expression, whereas zinc treatment of WISH amniotic epithelial
cells resulted in increased expression [41]. MREs also exist within the promoter regions
of the selenoproteins glutathione peroxidase 4 (GPX4) and selenoprotein W (SelW) [43–
45]. A transcription factor involved in the regulation of cell cycle progression, known
as delta-lactoferrin, has also been suggested to regulate the expression of SelH [46, 47].
Furthermore, the activity of this transcription factor was found to be directly responsible
for SelH overexpression in the MDA-MB-231 breast cancer cell line [46]. Additionally,
SelH has been reported to be down-regulated by treatment with lead, but the mechanism
of such regulation is unknown [48].
Relatively little is known about the physiological functional roles of SelH in different
tissues. A number of studies have reported that SelH can promote neuronal cell survival
by ameliorating ultraviolet (UV)-induced damage by limiting the formation of superoxide
[49–52]. Some studies have suggested that the protective effects of SelH may be mediated
by involvement in nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-κB) signalling pathways, as well as
mitochondrial biogenesis and glutathione synthesis [37, 41, 50, 51, 53].
Previous work in the laboratory has explored the potential roles for SelH in Caco-2 cells.
A microarray analysis after knockdown of SelH using SelH-specific small interfering RNA
(siRNA) in the Caco-2 gut epithelial cell model suggested an involvement in a number of
stress response pathways, including the Nrf2 and hypoxia signalling pathways (Gautrey
H, unpublished data).
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1.1.3 Thioredoxin reductase 1 (TR1) and the thioredoxin (TXN)
antioxidant system
The TR family of selenoproteins exist in three isoforms in mammals: the cytoplasmic
thioredoxin reductase 1 (TR1), the mitochondrial thioredoxin reductase 2 (TR2) and
thioredoxin reductase 3 (TR3), an isoform expressed only in specialised tissues [54]. They
each contain a Sec residue, which acts as the functional site for the main activities of the
TR proteins [55, 56]. These TR proteins are homodimeric flavoproteins and an essential
component of the thioredoxin (TXN) antioxidant system, which comprises three compo-
nents: nicotinamide adenine dinucleotide phosphate (NADPH), TR and TXN. Together,
these components form a major disulphide reduction system, which provides free electrons
to a range of enzymes critical for responses to various forms of stress. Indeed, the ac-
tivity of a number of transcription factors, including NF-κB, Nrf2 and hypoxia-inducible
factor-1 alpha (HIF-1α), are modulated by the TXN system [26, 57]. Furthermore, TR1
is the primary regulator of the TXN system by using NADPH to reduce TXN [58, 59].
The TXN system is an essential regulator of the redox system of the cell and contributes
to a number of cellular processes, including cell proliferation and viability [60, 61], protein
folding and signal transduction [62, 63] and defence against oxidative stress [64, 65]. The
reduction of TXN allows it to modulate the activity of a number of pathways by either
directly interacting with redox enzymes or by donating an electron to them [61, 65].
Indeed, the TXN system is an important regulator of redox events within the cell, as
well as being regulated itself by redox events [66–71]. The translocation of TXN to the
nucleus allows it to control gene expression by regulating the activation of a number of
transcription factors, including NF-κB, Nrf2, activator protein-1 (AP-1), HIF-1α and p53
[72–76].
TXN has been suggested to be a regulator of NF-κB activity. One study has reported
activation of NF-κB via redox control of the mitogen-activated protein kinases (MAPK),
mitogen-activated protein kinase kinase 4 (MKK4), by TXN [77]. Additionally it has
been shown that TXN can mediate the S-nitrosylation of the NF-κB subunit, p65, which
inhibits NF-κB DNA binding activity [78]. TXN has previously been suggested to be
important in the reduction of disulphide bonds of antimicrobial peptides to increase their
potency [79–81].
TR1 has also been suggested to be a potent regulator of the Nrf2 antioxidant defence
system. The selenoproteome and Nrf2 have a well documented relationship, as a down-
regulation of the selenoproteome by Se-depletion or by knockout of Sec-specific transfer
RNA (tRNASec) has been reported to induce activation of the Nrf2 signalling pathway
[82–84]. The Nrf2 signalling pathway is up-regulated in response to oxidative stress and is
involved in phase II detoxification and antioxidant defence, and initiates the transcription
of genes containing an antioxidant response element (ARE) in their promoter, as discussed
in further detail in Section 1.3.1. TR1 contains an ARE in its promoter and is thus able to
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be up-regulated in response to oxidative stress by Nrf2 [85]. However, an inter-dependent
relationship between TR1 and Nrf2 has previously been reported in which the activities
of each protein are able to regulate each other [86, 87]. For instance, inhibition or down-
regulation of TR1 has been shown to result in activation of the Nrf2 pathway [82, 88, 89].
As TR1 is a key regulator of the TXN system and thus regulates redox control, TR1
inhibition can result in oxidative stress, which can then activate the Nrf2 system [88].
However, previous studies have also reported that knockout of TR1 had no effect on the
activities of the TXN system and did not induce oxidative stress but still resulted in
activation of the Nrf2 signalling pathway [89–91]. These data suggest that inhibition of
TR1 activity can cause an activation of the Nrf2 pathway via a mechanism independent
of oxidative stress. Additionally, TR1 induction and Nrf2 activation do not always occur
at the same time. For instance, treatment of cells with compounds such as sulforaphane,
isothiocyanates and other Nrf2 activators can activate Nrf2 but inhibit expression and
activity of TR1 [92–96]. Thus, a complex relationship exists between the Nrf2 pathway
and TR1 where the cross-activation of both components appears to be stimulus- and
situation-dependent.
1.2 Innate intestinal immunity, the microbiota and
the modulatory effects of selenium
1.2.1 Innate immunity of the gut and the microbiota
The complex network of the enteric microbiota, mucus, secreted factors, epithelial cells
and signalling receptors cooperate in the intestinal tract to protect the host from enteric
infection. In addition to a physical barrier, they also contribute to maintaining immune
homeostasis of the intestine as well as extra-intestinal tissues. Loss of this barrier function
has been shown to contribute to the pathogenesis and pathology of intestinal inflamma-
tion, and chronic disease states, such as inflammatory bowel disease [97].
The gut microbiota consists of a huge range of species of bacteria, protozoa, fungi and
viruses [98]. Together, the microbiota can assist in digestion, provide nutrients and vi-
tamins to host cells and prevent the colonisation of the intestinal tract by pathogenic
species [99, 100]. The luminal layer of mucus, secreted by Goblet cells, is another com-
ponent of the intestinal barrier. This protective layer also contains a number of different
antimicrobial agents, such as the defensins, mucins and trefoil factors, which help prevent
colonisation of the intestine by pathogens [98]. In addition to their antimicrobial function,
these factors can also act to promote epithelial reconstitution and regulate susceptibility
to colonic inflammation [101, 102].
The gut epithelium plays a critical role in maintaining the intestinal barrier and is com-
posed of a number of different cell types, each of which plays an essential role in main-
taining the barrier and regulating the immune responses of the gut [103]. These cell
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types include enterocytes (or intestinal epithelial cells (IECs)), M cells, Goblet cells and
Paneth cells [98]. The most numerous of these cell types are the enterocytes, through the
formation of tight junctions, prevent the contents of the lumen from accessing the under-
lying tissues [104]. Additionally, the IEC layer expresses a variety of receptors including
the toll-like receptor (TLR), pattern recognition receptor (PRR) and nucleotide-binding
oligomerisation domains (NOD) families. These are able to detect and respond to micro-
bial stimuli to coordinate and regulate the immune cells of the gut accordingly in either a
tolerogenic or immunogenic manner, depending upon the perceived threat of the stimulus
[103]. For instance, IECs can be stimulated by a number of microbial factors, such as
flagellin and lipopolysaccharide (LPS) binding to cell surface receptors, such as TLRs.
This can result in the immediate activation of immune signalling pathways, such as the
NF-κB pathway, which results in the secretion of cytokines, such as Interleukin-8 (IL-8)
and antimicrobial peptides (AMPs), such as the defensins, in order to coordinate local
immune responses to deal with the perceived threat [105–108].
AMPs are small peptides of less than 50 amino acids, which include defensin and cathe-
licidin families, which can kill or inhibit the growth of microorganisms [109]. The AMPs
which have been investigated in the present work are the human β-defensins, human
beta-defensin 1 (hBD1) and human beta-defensin 2 (hBD2) [110]. The defensins are pri-
marily secreted by Paneth cells, epithelial cells and immune cells of the gut. They are
cysteine-rich cationic proteins which can bind to negatively charged phospholipids on the
surface of microorganisms, which results in their antimicrobial pore-forming activity on
cell membranes [110]. hBD1 is a constitutively expressed AMP in the human colonic ep-
ithelium and is regulated by peroxisome proliferator-activated receptor γ (PPARγ) [111].
The potency of the antimicrobial activity of hBD1 is increased after the reduction of three
disulfide bonds, which can occur via the activity of TXN and TR1 [79–81]. Unlike the
constitutively expressed hBD1, hBD2 is an inducible defensin which can be induced by
stimulation with pro-inflammatory cytokines, such as interleukin-17 (IL-17) and Tumour
necrosis factor-α (TNF-α), via the activities of NF-κB and AP-1 pathways [112, 113].
Additionally, hBD2 can be induced by flagellin in a colon carcinoma cell line and its
expression could be significantly reduced by inhibitors of NF-κB, MAPK p38 and c-Jun
N-terminal kinases (JNK) but not ERK1/2 [114]. Previous human studies have reported
higher levels of hBD2 expression in patients with active ulcerative colitis, but not in
patients with Crohn’s disease [115–117]. hBD2 has also been suggested to have a role
in regulating the innate immune response by acting as a chemoattractant for Mast cell
migration [118]. AMPs in humans are thought to play an important role in maintaining
immune homeostasis in the gut during early childhood development of the gut microbiota
[119]. The gut microbiota is also thought to play an important role in the transcriptional
regulation of some AMPs, such as hBD2 [120]. Furthermore, AMPs can be subject to
post-translational regulation and can be activated in response to redox changes in their
environment. For example, conditions of low oxygen have been shown to increase the
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antimicrobial potency of hBD1 [121].
1.2.2 Immunomodulatory effects of selenium and selenoproteins,
with a focus on intestinal inflammation
Se has a well-established, yet poorly understood, role in the modulation of inflammatory
pathways. Generally, the micronutrient has been reported to exhibit anti-inflammatory
properties, both in vitro and in vivo [122, 123]. Moreover, clinical trials investigating the
effects of Se supplementation in critically ill patients with systemic inflammation [124],
and patients suffering from other forms of inflammation [125], report a positive impact
of Se on slowing disease progression. In addition to the reported activities of individual
selenoproteins as mediators of the immunological effects of Se, the metabolites of Se have
previously been suggested to have chemopreventative effects, which may indicate a role for
Se metabolites in immune response pathways [126, 127]. Moreover, Se supplementation
in farm animals has demonstrated a positive role for Se in the development of a healthy
immune system in poultry [128], as well as the recovery of innate and humoral immune
responses following disease in sheep [129]. A study in horses suggested that different im-
munomodulatory effects of Se are observed depending upon whether or not the dietary
source of Se is organic or inorganic [130]. Furthermore, in mice, selenoprotein mRNAs
were differentially expressed in gut-associated lymphoid tissue (GALT) in response to
Se deficiency. The largest decreases in expression were observed in SelW, glutathione
peroxidase 1 (GPX1), SelH and selenoprotein M (SelM) mRNA, which coincided with
a decrease in expression of mRNAs associated with inflammatory responses initiated by
stimulation with TNF-α and interleukin-2 (IL-2) [29]. On the other hand, activation of
immune cell signalling can induce cell-type dependent changes in expression levels of the
selenoproteome. For example, in mouse macrophages stimulated with LPS, increases in
the expression of TR1 mRNA and protein, as well as the ER-localised selenoproteins se-
lenoprotein K (SelK) and selenoprotein S (SelS), have been reported [122, 131]. In humans
neutrophils stimulated with TNF-α, a reactive oxygen species (ROS)-dependent increase
in GPX4 expression has also been reported previously [132]. A Se supplementation study
which followed up supplemented and non-supplemented patients vaccinated against in-
fluenza showed an increase in SelS mRNA in response to vaccination, with higher levels
reported in those supplemented with Se [133].
IBD is a chronic disease, that commonly presents as either Crohn’s disease (CD) or
ulcerative colitis (UC). A phenotype associated with patients with IBD are exacerbated
immune responses to commensal bacteria [134]. It has also been previously suggested
that Se deficiency may be involved in the pathogenesis or pathology of IBD due to the
potential absence of proposed anti-inflammatory effects of Se. The aetiology of IBD and
its subtypes is not very well understood but over 150 genes, microbiome composition
and environmental factors, such as nutrition, have been identified as risk factors [135–
137]. In particular, micronutrients, such as Vitamin D and Se have been investigated
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in human IBD as well as associated animal models [138–140]. Previous studies focusing
on the importance of Se in IBD have reported that low Se status has been associated in
patients with CD [141–143]. However, a further study of CD patients who had undergone
an enterectomy found that the length of small intestine that was resected was inversely
correlated to Se status [144]. Additionally, a study on patients suffering from short bowel
syndrome found a correlation between short bowel length and Se uptake [145]. Thus,
these reports suggest that Se deficiency occurs as a result of CD and not as a cause of
CD. Furthermore, two studies have noted that low Se status occurs early in CD is not
associated with the progression of the disease and hence does not support involvement
of low Se status in the disease pathology [146, 147]. Clinical studies have indicated less
involvement of Se in UC than in CD with one study reporting lower serum Se in UC
patients that that have recently been diagnosed and in remission [148]. However, other
studies have found no significant change in Se in UC patients compared with healthy
controls [142, 149]. This may be attributed to the fact that CD primarily affects the
small intestine and thus inhibits the absorption of Se.
Se supplementation in experimental colitis has found to be beneficial in a number of
different rodent models [140, 143, 150, 151], with Se deficiency associated with worsened
inflammation [150], decreased survival and increased weight loss [140], as well as increased
microscopic and macroscopic colonic damage [143, 151]. Many of the biological activities
of Se are mediated by the expression and activities of selenoproteins. As discussed previ-
ously, the expression levels of different selenoproteins change in response to Se deficiency
- some selenoproteins increase in expression whereas others decrease, depending upon
where they lie in the selenoprotein hierarchy. In the gut, SelH, GPX1, SelM and SelW
are particularly responsive to Se intake [7]. Additionally, Se intake has an effect on a
number of genes involved in the regulation of inflammatory responses [152]. In rodent ex-
perimental colitis models, glutathione peroxidase 2 (GPX2) mRNA is consistently highly
expressed when compared with controls [153]. On the other hand, SePP1 expression in
the colon is down-regulated in experimental colitis, which was suggested to be via the
induction of inducible nitric oxide synthase-2 (iNOS2) [154].
Another mechanism by which Se may affect colitis risk or progression is through interac-
tions with the gut microbiota. A number of dietary and specific nutritional components
have previously been identified to affect to gut microbiome and consequently the immune
response in the gut [136]. In vivo murine studies reported that the Se deficiency had a
greater impact on reducing the expression of selenoproteins in plasma, liver and intestine
in germ-free mice compared with mice with gut microbiota. This effect was not observed
in mice, which were fed adequate levels of Se suggesting that under Se deficiency condi-
tions, the microbiota may be able to compete for limited Se supplies [155]. Another study
reported that Se deficiency reduced the diversity of the gut microbiota and affected the
relative proportion of certain phyla of bacteria in mice [156]. Reduced diversity of the
gut microbiota has previously been associated with inflammatory disorders in the gut and
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there is evidence of involvement of the gut microbiota in the pathogenesis of CD [156].
Evidence suggests that selenoproteins can be regulated in response to activation of the
innate immune system. SelS has been reported to contain a binding site for NF-κB in its
promoter region and can be up-regulated by NF-κB activity [157, 158]. Pro-inflammatory
cytokine, TNF-α, was reported to induce expression of GPX4 in immune cells [159]. On
the other hand, TNF-α treatment was shown to inhibit the mRNA expression in FRTL5
cells [160]. iodothyronine deiodinase type II (DIO2), however, has been reported to be
NF-κB responsive and can be induced by NF-κB activity [161]. As described in Section
1.5, there is a lot of cross-regulatory mechanisms between oxidative stress, hypoxia and
immune signalling. Thus, any selenoproteins which are regulated in response to oxidative
stress and hypoxia transcription factors, such as Nrf2 and hypoxia inducible factor (HIF-
1) transcription factors, for example, may have their expression modulated in response to
NF-κB signalling as a consequence of cross-regulatory mechanisms.
Overall, there is good evidence to indicate that a link exists between inflammation and Se
in the intestine. However, whether or not lower Se status associated with inflammatory
conditions is causative or a consequence of disease remains unknown. The mechanism
by which Se exerts its anti-inflammatory properties is currently not well understood.
However, studies have suggested that Se has a modulatory effect on NF-κB signalling
pathway [31, 162], which is discussed in further detail in Section 1.2.4.
1.2.3 The role of TLR5/flagellin signalling in intestinal epithe-
lial cells
IECs express a range of PRR molecules on the cell surface, as well as intracellularly, in
order to recognise pathogen-associated molecular patterns (PAMPs) and activate down-
stream signalling pathways that lead to the induction of an innate immune response. The
TLR family of receptors are an essential member of PRR family in the gut and are im-
portant in responding to pathogens, helping to coordinate adaptive and innate immune
responses, and maintaining barrier integrity [163]. The present work focused on Toll-
like receptor 5 (TLR5), which has only one known natural agonist, flagellin, a bacterial
monomer component of flagella [164]. TLR5 is expressed predominantly in the colon, but
has also been found to be expressed in the small intestine [163, 165, 166]. In IECs isolated
from patients with IBD, TLR5 expression was found to be lower when compared with
healthy controls [165–168]. The expression levels of TLR5, as well as Toll-like receptor
2 (TLR2), Toll-like receptor 3 (TLR3) and Toll-like receptor 4 (TLR4), have also been
found to be induced by commensal bacteria [169].
TLRs can recruit utilise Toll/interleukin-1 receptor (TIR) domain-containing adaptor
proteins, such as myeloid differentiation primary response gene 88 (MyD88) and TIR-
domain-containing adaptor-inducing interferon-β (TRIF), to induce pro-inflammatory
gene expression (Figure 1.2). All TLRs use MyD88 recruitment to activate NF-κB and
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Figure 1.2. Schematic overview of activation of NF-κB signalling by TLR5 activation. TLR5
bound by flagellin results in activation of NF-κB mediated by MyD88 and TRIF adaptor proteins
associated with the TLR5 receptor. MyD88 forms a complex with IRAK kinases, resulting in
the activation of TRAF6 and TAK1 by IRAK1. TRIF activation also results in the activation of
TRAF6 and TAK1, which subsequently result in dissociation of IκBα from the NF-κB complex.
The NF-κB complex then binds to responsive elements in the promoters of pro-inflammatory
mediators, such as IL-8, TNF-α and hBD2.
MAPKs, and induce pro-inflammatory gene expression [170]. TLR5 recruits and utilises
both the MyD88 and TRIF adaptor proteins to induce pro-inflammatory gene expression
[171, 172]. When a MyD88-recruiting TLR is activated, such as when TLR5 is bound by
flagellin, MyD88 forms a complex with members of the IRAK kinase family, which results
in the release of IRAK1 from the complex [173, 174]. IRAK1 then induces activation of
TRAF6 and subsequently TAK1 [175, 176], which then can result in the activation of the
IKK complex. This results in NF-κB pathway activation and consequently the expression
of pro-inflammatory cytokines. Additionally, TAK1 activation can result in activation of
MAPKs, such as JNK, p38 and ERK1/2. These can, in turn, mediate activation of the
AP-1 pathway which has been shown be required for maximal gene expression of certain
pro-inflammatory cytokines, such as IL-8 [177–186].
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1.2.4 The NF-κB pathway and the modulatory effects of sele-
nium
In addition to mediating immune responses, the NF-κB family of transcription factors
also play an essential role in the cellular proliferation, differentiation and survival [187].
The NF-κB family consists of five monomer subunits in humans: p65/RelA, RelB, c-Rel,
p50 and p52. These subunits can form homodimers or heterodimers which can translocate
to the nucleus to bind to DNA and initiate transcription of target genes [188, 189]. The
NF-κB family of transcription factors are controlled by two regulatory pathways: the
canonical pathway and noncanonical pathway. Both of these pathways control NF-κB
pathway activity by either the degradation of IκB inhibitor proteins, processing NF-κB
precursor proteins or by the expression of NF-κB subunits [190, 191]. NF-κB pathway
activation results in the transcription of pro-inflammatory mediators, such as IL-8, TNF-α
and hBD2 [187, 192]. Previous studies have reported that Se-supplementation suppresses
the activation of NF-κB via the inhibition of MyD88- and TRIF- signalling pathways
[193, 194]. Furthermore, Se-depletion has been reported to increase the luciferase activity
of a reporter gene assay in undifferentiated Caco-2 cells [31]. Additionally, it has been
shown that Se supplementation at pharmacological doses leads to inhibition of NF-κB
binding to DNA and modify the cysteine residues of NF-κB [195–197].
1.3 Oxidative stress in the gut and the effects of se-
lenium
Oxidative stress is the consequence of an inadequate antioxidant capacity to process a cer-
tain level of pro-oxidants, such as ROS or reactive nitrogen species (RNS). The inability
of a cell to deal with pro-oxidants can have a profound impact on the normal function of
a cell via oxidative damage of cell components. Lipid peroxidation, as one example of ox-
idative damage, can initiate a chain reactions, which can result in the generation of more
free radicals [198]. The modulatory effects of lipid peroxidation has been observed in core
cellular processes such as altered gene expression and cell proliferation [198, 199]. Fur-
thermore, excessive lipid peroxidation can result in pathophysiological changes resulting
in increased membrane permeability and inflammation [200]. Additionally, the products
of lipid peroxidation can react with DNA and studies have suggested that these DNA
modifications may contribute to the pathogenesis of certain cancers, including prostate
and colorectal cancers [201, 202]. Proteins can also be subject to oxidative damage which
causes structural changes and subsequent impairment the specificity or activity of en-
zymes, including polymerases involved in DNA repair and replication [203]. Additionally,
proteins with oxidative damage can be poorly targeted for ER degradation and, as a result,
can accumulate inside cells and potentially contribute a variety of pathologies [203–205].
Finally, DNA can also be directly damaged by oxidation, leading to errors in both DNA
transcription and methylation. An example of DNA oxidative damage is the generation
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of 8-oxodG in DNA resulting in G-T transversions during DNA replication [202, 206]. Al-
ternatively, a metabolic product of 8-oxodG, known A 8-oxoGTP can be formed, leading
to A-C transversions [207]. Oxidative damage of DNA can also lead to epigenetic changes
via the oxidation of DNA at CpG sites, causing changes in DNA methyltransferase to
cytosine residues, leading to hypomethylation of DNA and thus altering the regulation of
genes by DNA methylation [206].
Originally, ROS and RNS were investigated in relation to their ability to cause damage
within cells. However, they are increasingly being recognised as having a major regulatory
role as intracellular signalling molecules [208]. For instance, ROS have been implicated
in the regulation of a number of biological pathways, including NF-κB and MAPK sig-
nalling pathways [209–211]. However, in pathophysiological conditions where ROS levels
are in excess against antioxidant enzymes, oxidative damage within the cell can lead to
inflammation, uncontrolled proliferation and apoptosis [208, 212].
Oxidative stress has been suggested to play an important role in the pathogenesis and
pathology of IBD. Activated immune cells produce large amounts of ROS, such as super-
oxide and nitric oxide [213]. Hence, this increase in ROS levels can further exacerbate
inflammation and tissue injury [214]. Thus, it has been suggested that an increase in
ROS or a decrease in antioxidant capacity in the gut may be involved in the pathology
and pathogenesis of IBD [215, 216]. Furthermore, IEC injury as a result of ROS has been
reported in studies on patients with IBD [217, 218]. As discussed earlier, one of the intra-
cellular consequences of increased ROS is oxidative damage to DNA, which can result in
DNA lesions [219]. There is evidence to suggest that oxidative damage to DNA may play
a role in the pathogenesis of IBD and also in the associated increase risk of cancer during
inflammation-associated tumourigenesis [220–222]. Animal models of experimental col-
itis have reported an increase in oxidative stress markers when compared with healthy
controls [223, 224]. Previous studies in patients with IBD have also found increased lev-
els of ROS compared with healthy controls [225]. Furthermore, patients with IBD have
been observed to have decreased antioxidant capacities compared with healthy controls
[218, 226]. In particular, IBD patients have also been found to exhibit increased GPX
activity [227, 228]. This is relevant to Se research as GPX selenoenzymes are induced in
response to oxidative stress [229]. Additionally, patients with IBD have been observed to
have increased levels of oxidative damage to DNA in their blood and mucosa [230].
The GPX and TR family of selenoproteins have very well characterised antioxidant func-
tions [2, 231]. There have also been studies which suggest that SelK, SelM, selenoprotein
N (SelN) and SelH may also possess redox functions [232]. Interestingly, there is also
evidence to suggest that Se-containing compounds may also possess pro-oxidant capaci-
ties within the cell. For example, the excessive production of the metabolic products of
hydrogen selenide and methylselenol has been linked with pro-oxidant effects [233]. Ad-
ditionally, there is evidence that both organic and inorganic Se compounds can enhance
the levels of intracellular oxygen free radicals [234, 235]. The general consensus in the
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literature, however, is that the overall effects of Se at physiological levels is antioxidant
in nature, but the pro-oxidant capacity of Se at higher concentrations requires further
investigation [236].
1.3.1 The Nrf2 pathway in antioxidant defence and the modu-
latory roles of selenium
The Nrf2 pathway is a defence mechanism that is activated in response to specific stim-
uli, such as oxidative stress and xenobiotics [237]. The Nrf2 protein is a member of a
cap ’n’ collar family of transcription factors, which also include nuclear factor (erythroid-
derived 2)-like 1 (Nrf1), nuclear factor (erythroid-derived 2)-like 3 (Nrf3) and p45 NF-E2
[238, 239]. Activation of the Nrf2 pathway initiates transcription of cytoprotective genes
necessary for protection against oxidative stress. Gene transcription is initiated by the
binding of Nrf2 to AREs in the promoter regions of cytoprotective genes. Previous studies
have reported that consistently high expression levels of Nrf2 contributes to chemoresis-
tance and promotes carcinogenesis [240]. Conversely, Nrf2 has also been suggested to have
a role in inhibiting tumourigenesis and chemoresistance [241].
Upon activation, Nrf2 induces transcription of various genes involved in oxidative stress
defence and phase II detoxification [242, 243]. During resting states, cells minimise protein
levels of Nrf2 by sequestering Nrf2 via an inhibitory protein, Keap1, in the cytoplasm.
The Nrf2/Keap1 complex is directed to CUL E3 ligase for ubiquitylation, which then
targets the complex for proteasomal degradation, thus keeping levels of Nrf2 low during
resting conditions [244, 245]. Under conditions of oxidative stress, the cysteine residues of
Keap1 become oxidised and allow dissociation of Nrf2 from the inhibitory complex [246].
The activated Nrf2 protein then translocates to the nucleus where it heterodimerises with
proteins, such as small Maf proteins or complementary JUN (cJUN), to help facilitate
gene transcription [247–250]. This Nrf2 transcriptional complex then binds to AREs, a
cis-acting enhancer, located in the promoter regions of Nrf2 target genes, such as heme
oxygenase 1 (HMOX1) and NAD(P)H dehydrogenase (quinone 1) (NQO1) [237, 251, 252].
Bach1 is an example of a negative regulator of the Nrf2 pathway, which competes with
Nrf2 by also binding to ARE in Nrf2 target genes [253]. A further level of Nrf2 regulation is
by modulation of the nuclear export and proteasomal degradation of negative regulators
of Nrf2. This reduces inhibition of Nrf2 nuclear import and thus has a positive effect
on Nrf2 target gene induction [254–256]. Induction of Nrf2 is thought to be mediated
by a number of kinases that can phosphorylate Nrf2, leading to its dissociation from the
inhibitory complex with Keap1 [257–259]. Additionally, Nrf2 can induce the transcription
of itself via the presence of an ARE in its promoter region, which facilitates the rapid
induction of Nrf2 in response to cellular stress [237].
A number of studies have reported a link between Se status and Nrf2 pathway activity and
in particular, Se deficiency has shown to be linked with up-regulated Nrf2 activity in both
in vitro and in vivo models [82, 261, 262]. Certain selenoproteins have also been reported
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Figure 1.3. Schematic illustration of gene activation by Nrf2 signalling. Nrf2 acts as a transcrip-
tion factor under conditions of oxidative stress by associating with small Maf proteins in the
nucleus and binding to genes containing an antioxidant response element (ARE) in the promoter
region. Under oxidative stress, Keap1 dissociates from Nrf2 in the cytoplasm. allowing Nrf2 to
translocate to the nucleus, associate with small Maf proteins and initiate transcription of target
genes. Adapted from Bhatia, 2013 [260]
to be regulated by Nrf2 pathway activity, including GPX2 and TR1 [263, 264]. Thus, there
is evidence for cross-regulation between selenium, selenoproteins and the Nrf2 pathway,
but the mechanisms are not fully understood and the data are inconsistent. Previous
studies using cells with a deletion of the Trsp gene, which encodes for tRNASec, reported
inconsistent results with regards to the Nrf2 pathway. One study which performed this
deletion in liver cells and mouse macrophages, reported an up-regulation of ARE-regulated
genes [265]. However, another study utilising a Trsp knockdown in mice reported no
induction of ARE-regulated genes [266]. Interestingly, both studies reported a regulation
of HMOX1 which was suggested by both to be independent of Nrf2 activity. In the former
study, HMOX1 was up-regulated in response to Nrf2 knockout in Trsp-null cells, whereas
other ARE-containing genes were down-regulated [265]. In the second study, HMOX1
failed to be induced in response to Trsp knockout despite the other ARE-containing genes
being up-regulated [266]. These data suggest Nrf2-independent regulatory mechanisms
for HMOX1 associated with altered expression levels of selenoproteins.
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1.4 Hypoxia in the gut and the responses of intestinal
epithelial cells
In the gut there exists a steep oxygen gradient across the epithelium, with the oxygen
concentration at the apical IEC surface at less than 2 % and the intestinal tissue with
approximately 8 %, when compared to the partial pressure of O2 (pO2) of arterial blood
[267]. However the luminal pO2 is subject to regular fluctuations. Food intake increases
the pO2 of the intestinal lumen whereas periods of fasting decrease the pO2; these fluctu-
ations in luminal pO2 are physiological and have been referred to as physoxia [268, 269].
It has previously been described that a constant hypoxia-associated low-level of inflamma-
tion is the physiological norm for the gastrointestinal tract, in which the mucosal immune
response is essential in the response to this inflammation [270]. However, conditions in
which there is excessive and uncontrolled inflammation are characteristic of IBDs such
as Crohn’s Disease and Ulcerative Colitis [271]. Thus, the levels of inflammation in the
gut must be carefully controlled and one level of control is suggested to be via cellular
responses to hypoxia and the hypoxia signalling [272].
1.4.1 The role of the HIF-1 transcription factor in the responses
of intestinal epithelial cells to hypoxia
One of the primary responses to hypoxic stress is mediated by the transcription factor,
HIF-1. HIF-1 is able to bind to hypoxia response elements in the promoters of several
genes involved in the cellular response to hypoxic stress [273, 274]. The HIF-1 tran-
scription factor is a heterodimer, which consists of two subunits: an α subunit which is
responsive to oxygen status, and a constitutively expressed β subunit [275]. The HIF-1α
protein is highly regulated by cellular pO2. During normoxia, there are physiological pO2
levels and therefore a hypoxia response is not needed and thus HIF-1α is rapidly targeted
for degradation. During these periods of normoxia, prolyl hydroxylase (PHD) proteins,
which are oxygen- and iron- dependent, hydroxylate two proline residues on HIF-1α [276].
This allows von Hippel–Lindau tumour suppressor (pVHL) to bind to it and targets HIF-
1α for degradation. However, under hypoxic conditions, oxygen-dependent hydroxylation
of HIF-1α by PHD is inhibited and results in the rapid accumulation of HIF-1α inside
the cell [277]. Another layer of HIF-1α regulation is provided for by factor inhibiting
HIF (FIH), which hydroxylates asparaginyl residues in HIF-1α, resulting in protein inter-
actions between HIF-1α transactivation domains and coactivators in the transcriptional
complex being inhibited. This inhibition by FIH is diminished during hypoxia [278].
During periods of hypoxia, PHD and FIH hydroxylation activity is reduced, allowing the
nuclear translocation of the HIF-1 complex, where it can interact with co-activators and
bind hypoxia response element (HRE) in the promoters of target genes [278, 279].
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Figure 1.4. Schematic illustration of the regulation of HIF-α by hypoxia. During periods of
normoxia, the presence of oxygen and iron allows PHD proteins to hydroxylate HIF-1α and target
it for pVHL-mediated degradation. During periods of hypoxia, oxygen-dependent hydroxylation
of HIF-1α is inhibited and allows HIF-1α to accumulate. HIF-1α dimerises with the HIF-1β
subunit, translocates to the nucleus and regulates the transcription of hypoxia-responsive genes.
Adapted from Petousi, 2014 [280]
Inflammation and infection within tissues can increase cellular oxygen demand through
the recruitment of oxygen consuming immune cells, such as neutrophils and macrophages,
which can induce a localised state of hypoxia [270, 281, 282]. IECs obtained from patients
with IBD, were found to have higher expression levels of HIF-1α compared with healthy
controls [283]. The role of HIF-1α has been suggested to be protective within the gut by
improving barrier function and preventing apoptosis of IECs [284, 285]. In murine ep-
ithelial cells, a conditional knockout or reduced expression of HIF-1α diminished barrier
function and exacerbated colitis symptoms [286, 287]. Furthermore, inhibiting the degra-
dation of HIF-1α by use of inhibitors reduces the severity of colitis symptoms [285, 287].
Additionally, treatment of a murine experimental model of colitis with a HIF-1α agonist
resulted in an increase in the innate immune response of the intestinal epithelium [288].
1.4.2 The cross-regulatory mechanisms between selenium and
hypoxia signalling
The literature supports a complex level of cross-regulation between selenium, selenopro-
tein biosynthesis and responses to hypoxia. A number of in vivo studies in a variety of
species have suggested that supplementation with Se, in both inorganic and organic forms,
has a protective effect against hypoxic stress [289–291]. Furthermore, in vitro studies have
suggested that this effect may be due to modulatory effects of Se on mRNA and protein
expression, as well as the transcriptional activity, of HIF-1α [292–300]. However, the ac-
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tual regulation of HIF-1α in vitro appears to be dependent upon the dose of Se supplied.
For instance, high doses of Se supplementation, at 5 µM and greater, have been shown
to have an inhibitory effect on the mRNA and protein levels of HIF-1α [293–295, 297].
In contrast, physiological levels of Se, between 100 and 145 nM, have shown a protective
effect of Se against hypoxic stress and raise the level of HIF-1α protein [296, 298].
Hypoxia has been shown to have a modulatory effect on some of the members of the
selenoprotein biosynthesis machinery, thereby regulating the expression of different se-
lenoproteins [301]. For instance, hypoxia had a suppressive effect on the mRNA and
protein levels of SePP1, TR1 and also the enzyme activities of iodothyronine deiodinase
type I (DIO1) and GPX [290, 301, 302]. However, hypoxia has also been shown to in-
crease the mRNA and protein levels of GPX1, GPX4 and selenium-binding protein 1
(SELENBP1) [301, 303]. Furthermore, previous studies have suggested that SELENBP1
is directly regulated by HIF-1 during hypoxia [303, 304]. Additionally, SELENBP1 has
also been suggested to regulate the expression of HIF-1α but the mechanism is currently
unknown [303, 305]. Interestingly, the regulation of selenoproteins by hypoxia have been
described to occur via a mechanism that is independent of HIF-1 [290, 301].
1.5 Roles for Se in the cross-talk between oxidative
stress, hypoxia and innate immune signalling
1.5.1 Oxidative Stress and innate immune signalling
Evidence indicates that a significant amount of cross-talk exists between inflammatory
and oxidative stress signalling pathways. Caco-2 cells depleted of Se for 72 h have been
reported to have raised levels of intracellular ROS [31], which have been previously been
reported to modulate the activity of the NF-κB pathway by a number of mechanisms.
These include the suppression of protein phosphatase 2A (PP2A) IκB kinase (IKK) de-
phosphorylation [306, 307], and histone deacetylase (HDAC)-mediated down-regulation
of NF-κB transcription of target genes [308, 309]. On the contrary, pre-exposure to ROS
has also been shown to inhibit NF-κB activation [310, 311].
Increased intracellular ROS activates the Nrf2 signalling pathway. Both the Nrf2 and NF-
κB signalling pathways have downstream effectors involved in carcinogenesis and inflam-
mation, and both pathways have been reported to cross-regulate each other [312, 313].
In fact, inducers of the Nrf2 pathway, including Se-depletion, have previously been re-
ported to inhibit NF-κB pathway activation [312, 314–316]. However, the mechanisms
of interaction between the two pathways are unclear and relevant studies have provided
contradictory evidence, suggesting both positive and negative regulation between the two
pathways [317].
Oxidative stress has also been reported to up-regulate the AP-1 pathway, which has been
shown to be mediated through a number of pathways, including JNK, MAPK and p38
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signalling pathways [318]. The AP-1 pathway is a regulator of cell homeostasis, and
is an important modulator of cell proliferation and apoptotic signalling cascades [319–
321]. Se has been reported to be involved in the regulation of AP-1 and cJUN [322–327].
Furthermore, roles for AP-1 and cJUN have previously been reported in the regulation of
the NF-κB pathway [177–186].
Se has been shown to modulate the Nrf2 and AP-1 pathways and both of these pathways
are regulators of each other and the NF-κB pathway [82, 261, 262, 265, 312, 313, 322, 323,
328]. The modulation of the NF-κB response by Se is well documented but the pathways
by which this modulation occurs, is not well understood.
1.5.2 Hypoxia and innate immune signalling
The hypoxia-inducible factor (HIF) family of transcription factors are the main regulators
of the cellular response to hypoxia [329]. A number have studies have shown that HIF-1α
is induced in a number of cell types in response to pathogenic infection by NF-κB [330],
and is also associated with a number of inflammatory diseases [331].
Hypoxia is a well characterised inducer of HIF-1, but is also able to activate the NF-κB
pathway in a TAK1-dependent manner [332]. Additionally, during periods of hypoxia and
inflammation, NF-κB has been reported to directly regulate the expression of HIF-1 [333,
334]. On the other hand, HIF-1 has previously been shown to inhibit the transcriptional
activity of NF-κB [335, 336].
Se has been shown to regulate the activity of both the HIF pathway [296, 298] and the NF-
κB pathway [31, 193, 194]. However, the involvement of Se in the cross-talk mechanisms
between hypoxia and immune signalling pathways has not yet been been investigated.
1.6 Intestinal epithelial cell models
The Human colonic adenocarcinoma cell model, Caco-2, was originally established in
1974 by Jorgen Fogh [337]. The usefulness of this cell line as an intestinal cellular model
was recognised when it was observed that Caco-2 cells spontaneously exhibit enterocytic
differentiation within 20 days of passaging [338, 339]. Caco-2 cells, once differentiated,
become functionally polarised, featuring apically located microvilli and tight junctions
between adjacent cells, as well as expressing characteristic membrane transporters and
enzymes [340, 341]. The differentiation process in Caco-2 cells results in down-regulation
of Squamous cell carcinoma antigen recognized by T-cells 3 (SART3), a Ribonucleic Acid
(RNA) binding protein, which is involved in the splicing of pre-mRNA. Phenotypically,
Caco-2 cells initially exhibit a coloncyte phenotype but upon differentiation, start to
display properties of small intestine enterocytic phenotype with properties more similar
to foetal, rather than adult, ileal enterocytes [339, 342, 343]. Consequently, the Caco-2
cell model has been extensively used for in vitro models to investigate a host of intestinal
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properties, including the study of gut physiology and nutrient absorption in the gut [344,
345].
The Caco-2 cell model, either on its own or in co-cultures with other cell types found
in the intestinal mucosa, has also been used extensively as a model for innate immunity
in the gut [346–350]. Similar to intestinal epithelial cells in vivo, Caco-2 cells also ex-
press receptors for PAMPs, such as TLR5. Accordingly, they also express and secrete
immune mediators such as antimicrobial peptides, such as hBD1 and hBD2, as well as
pro-inflammatory mediators, such as Interleukin-6 (IL-6), IL-8 and TNF-α, in response to
various PAMPs [345, 351, 352]. However, caution must be taken when inferring properties
of undifferentiated Caco-2 cells to differentiated Caco-2 cells, as alluded to above.
1.7 The aim of current research
1.7.1 Gaps in knowledge
Although the anti-inflammatory effects of Se in a number of species have been previously
discussed in Section 1.3, the role of Se in the responses of in vitro models of IECs have
received less attention. One study has reported anti-inflammatory effects of Se in undif-
ferentiated IECs [31], but the effects of Se in differentiated IECs, which are considered
more physiologically relevant, have not been investigated prior to the submission of the
present work.
The effects of low Se status on altered expression of oxidative stress and hypoxia associated
genes have been reported in a number of cell types (Sections 1.3.1 and 1.4). However, the
effects of IEC differentiation on the regulation of oxidative stress and hypoxia associated
genes by Se-depletion has not received much attention. As a significant amount of cross-
talk exists between immune, oxidative stress and hypoxia signalling pathways (Section
1.5), it is important to investigate how the effects of Se on pathways which affect immune
responses in more physiologically relevant IEC models.
In order to more accurately model the conditions of IECs in vivo, it is important to
consider the steep oxygen gradient which exists in the gut, with the apical membranes of
IECs exposed to hypoxic conditions and the basolateral membranes exposed to normoxic
conditions. At the time of submission of the present work, the effects of a steep oxygen
gradient on the responses of IECs in an in vitro IEC model has not yet been investigated.
1.7.2 Research aims and objectives
The aim of the work presented in this thesis was to investigate the effects of Se-depletion,
and the selenoproteins TR1 and SelH, in the Caco-2 model of IECs on responses to flag-
ellin, oxidative stress and hypoxia. Furthermore, changes in the effects of Se-depletion
were investigated in more physiologically relevant conditions, including differentiated
Caco-2 cells and with the presence of a steep oxygen gradient.
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In order to achieve these aims, the following objectives were set:
1. Investigate the effects of Se-depletion, and knockdown of expression of the seleno-
protein TR1, on responses to flagellin in both differentiated and undifferentiated
Caco-2 cells.
2. Investigate the effects of Se-depletion, and knockdown of expression of the seleno-
proteins SelH and TR1, on the expression of oxidative stress-associated genes in
both differentiated and undifferentiated Caco-2 cells.
3. Investigate the effects of Se-depletion, and knockdown of expression of the seleno-
protein SelH, on the expression of hypoxia-associated genes in both differentiated
and undifferentiated Caco-2 cells in response to hypoxia.
4. Investigate the effects of Se-depletion on responses to flagellin, under conditions
of normoxia, hypoxia and a novel dualoxic cell culture chamber, in differentiated
Caco-2 cells.
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Chapter 2
Materials and Methods
2.1 Human intestinal cellular model
2.1.1 Cell culture maintenance, routine passaging and Caco-2
cell polarisation
All cell culture operations were performed in a Envair Bio2+D Microbiological Class
II safety hood. Routine culture of Caco-2 cells (ATCC® HTB-37TM) was performed
in Dulbecco’s modified Eagle’s medium (DMEM) containing 4.5 g/L glucose and 0.58
g/L L-glutamine (D5796, Sigma Aldrich UK). To this basal medium, 10% (v/v) Foetal
Bovine Serum (FBS), 1% (w/v) non-essential amino acids, 100 units/mL penicillin and
100 µg/mL streptomycin was added. All cell culture reagents were obtained from Sigma
Aldrich UK, unless otherwise stated. Cells were grown in an atmosphere of 5% CO2 at
37◦C. Cell media was routinely replenished every 48-72 h.
Cells were passaged when 70-100% confluent. Passaging was performed by washing cells
three times with 1X Phosphate buffered saline (PBS) (D8662, Sigma Aldrich UK), in-
cubating for 10 minutes with 5 mL 1X Trypsin-EDTA (T3924, Sigma Aldrich UK) at
37◦C to detach the cell monolayer from the cell culture flask, inactivating the trypsin by
adding 13 mL DMEM culture medium to the cell suspension, centrifuging at 1500 rpm
for 4 minutes (Centrifuge B 4i, Jouan SA), after which the cell supernatant was decanted
from the cell pellet. The cell pellet was re-suspended in 10 mL of routine DMEM cell
culture medium and 1 mL cell suspension was transferred to a 75 cm2 flask or 2.5 mL to
a 175 cm2 flask.
To culture polarised differentiated Caco-2 cells, 1.5 x 105 cells were seeded on to 6-well
Transwell permeable inserts (Corning UK) for 18 - 21 days in complete DMEM media, as
detailed in Section 2.1.1. The media was changed every 3 - 4 days and prior to changing the
media, the trans-epithelial resistance (TER) between the apical and basal environments
was measured using an epithelial volt-ohmmeter (World Precision Instruments Inc.). The
cells were considered polarised and differentiated when the TER values plateaued after
approximately 18 days. When cell polarisation was confirmed by TER assay, the cells
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Sense Antisense
siSELH1 CCGUUGUUGUUAUCGAGCAUUG CAAUGCUCGAUAACAACGGTC
siSELH2 GAGGCGACCGUUGUUAUCGAGCAUU AAUGCUCGAUAACAACGGUCGCCUC
siTR1 CACGUGCUUGUGGACAUCAUU UGAUGUCCACAAGCACGUGUU
Table 2.1. List of SelH-specific and TR1-specific siRNA sequences for transient transfection
into Caco-2 cells. Three distinct siRNA sequences were used to knockdown SelH and TR1 gene
expression in Caco-2 cells, siSELH1, siSELH2 and siTR1 The sense and antisense sequences are
indicated.
were used for further experiments.
2.1.2 Selenium starvation and supplementation
In Se depletion and supplementation experiments, serum-containing medium was replaced
with serum-free DMEM medium containing 1% (w/v) non-essential amino acids, 100
units/mL penicillin and 100 µg/mL streptomycin, human insulin (I9278, Sigma UK), apo-
Transferrin (T5391, Sigma UK). Where appropritae, this was supplemented with 7 nmol/L
sodium selenite (S9133, Sigma UK), which is equivalent to 40 nM Se in Se-supplemented
media. Caco-2 cells were cultured in Se-deficient (NoSe) or Se-supplemented (Se) medium
for 72 h before their responses to different stimuli were measured.
2.1.3 Transfection of SELH-specific or TR1-specific siRNA into
Caco-2 cells
Knockdown of gene expression using siRNA was performed using Viromer BLUE (Lipoca-
lyx), a polymer-based transfection reagent. The knockdown of SelH and TR1 expression
was performed using two distinct SelH-specific sequences: siSELH1, a HP Custom siRNA
(Qiagen UK); siSELH3, a pre-designed Stealth RNAiTM siRNA (ThermoFisher UK); and
siTR1, a Silencer® siRNA (Ambion UK). The sense and antisense sequences forming the
siRNA duplexes for each sequence are shown in Table 2.1.
Caco-2 cells were plated at a seeding density of 3.5 x 105 cells per well, in a 6-well plate for-
mat in antibiotic-free DMEM media containing 10% FBS, 1% (w/v) non-essential amino
acids, 100 units/mL penicillin and 100 µg/mL streptomycin. Cell media were replaced 24
h later with 2 mL Opti-MEM Reduced Serum Medium (ThermoFisher UK), supplemented
with 5% FBS, 1% (w/v) non-essential amino acids. A cocktail of transfection complexes
with a total volume of 200 µL was prepared consisting of 186 µL Buffer F (Lipocalyx), 2.5
µL Viromer BLUE (Lipocalyx) transfection reagent, 11.5 µL of siRNA duplexes from 20
µM stock. The transfection cocktail was incubated for 10 minutes at room temperature
and added to the Caco-2 cell media. The cell media was changed to the standard DMEM
culture media, as described in Section 2.1.1, at 24 h post-transfection. At 24- and 48-h
post-transfection, cells were lysed for RNA and protein analysis as detailed in Section
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2.2.1 and Section 2.3.2, respectively.
2.1.4 Hypoxic challenge of Caco-2 cells
Caco-2 cells were subjected to a hypoxic environment within a sealed InvivO2 400 (Baker
Ruskinn) hypoxia chamber. The hypoxic environment was maintained at an ambient
temperature of 37 ◦C with a gaseous composition of 1% O2, 5% CO2 and 94% N2.
To ensure the DMEM media had the appropriate hypoxic gaseous composition, it was
left exposed inside the hypoxia chamber overnight. This ensured that the gases dissolved
inside the liquid media had reached equilibrium with the hypoxic environment. Caco-2
cells were left for 3 or 7 h inside the hypoxia chamber. Lysates were collected for RNA
and protein analysis as described in Section 2.2.1 and Section 2.3.1, respectively.
2.1.5 NF-κB activation of Caco-2 cells via TLR5-specific ago-
nist, flagellin
Caco-2 cells, both undifferentiated and differentiated, were challenged with 500 ng/mL S.
typhimurium flagellin (FLA-ST) (Invivogen) for 6 and 16 h. After the challenge period,
cell lysates and media were collected for RNA and protein analysis, respectively.
2.1.6 Use of a novel dual-environment cell culture chamber to
challenge Caco-2 cells with a TLR5 agonist, flagellin, in a
more physiologically relevant environment
Studies that use the differentiated Caco-2 cell culture model use non-physiological 20%
O2 aerobic or 1% anaerobic environments to study immune responses. A novel dual-
environment cell culture chamber was used in order to investigate if Se has a modulatory
role which is dependent upon the levels of oxygen present in the apical and basal culture
media (Figure 2.1).
To assess the effects of culture environment on the modulatory effects of Se, Caco-2 cells
were first grown until polarised and differentiated, as described in Section 2.1.1. Caco-2
cells were incubated at 37 ◦C in either a dual-environment (apical: 0% O2, 10% CO2;
basal: 20% O2, 5% CO2), hypoxic environment (1% O2, 5% CO2) or aerobic environment
(20% O2, 5% CO2) for 4 h, with their media changed to Se or NoSe media (Section
2.1.2), which has been equilibrated to the appropriate environment for 24 h, at the 0 h
time-point. After 4 h, the apical and basal media were treated with flagellin to a final
concentration of 500 ng/mL for 6 h. Cell lysates and apical/basal media samples were
collected for RNA and protein analysis, respectively.
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Figure 2.1. The dual-environment cell culture chamber. The apical pole of the cells were exposed
to an anaerobic environment (0% O2, 10% CO2, 90% N2) maintained by an anaerobic cell culture
hood. The basal pole of the cells were exposed to an aerobic environment (20% O2, 5% CO2,
75% N2), maintained by the air-tight seal of the dual-environment cell culture chamber and the
the tight junctions formed between the Caco-2 cells. Access to the basal media for the treatment
of the Caco-2 cells with flagellin was via a syringe access port.
2.2 Real-time quantitative PCR to quantify gene ex-
pression
Real-time quantitative polymerase chain reaction (RT-qPCR) was performed to quantify
gene mRNA expression.
2.2.1 Total RNA extraction and purification
Total RNA extractions were performed using SV Total RNA Isolation extraction kit
(Promega UK) as per the manufacturer protocol. Briefly, Caco-2 cells were lysed in 0.01
M Tris RLA lysis buffer (Promega UK) containing 4 M guanidine thiocyanate (GTC)
and 0.97% β-mercaptoethanol (BME), and cell lysates passed through a 20-gauge needle.
Proteins present in the lysates were precipitated from solution using RNA Dilution Buffer
(Promega UK) and incubating at 70 ◦C. Cell lysates were diluted with 95% ethanol and
filtered through spin columns containing a silica-membrane based system. Bound RNA
was washed with RNA Wash Solution (Promega UK), containing 162.8 mM potassium
acetate and 27.1 mM Tris-HCl (pH 7.5), treated for 15 minutes with DNase I enzyme
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(Promega UK) followed by a DNA Stop Solution (Promega UK) containing 2 M GTC,
4 mM Tris-HCl and 57% ethanol. Two more washes with RNA Wash Solution were per-
formed and the bound RNA eluted using 100 µL nuclease-free water. The RNA concen-
trations of samples, as well as purities, 260/280 and 260/230 ratios, were measured using
a NanoDrop 1000 (Thermo Scientific USA). Isolated RNA samples were stored at -80 ◦C
until needed for the synthesis of complementary DNA (cDNA) via reverse transcription,
as described in Section 2.2.2.
2.2.2 cDNA synthesis via reverse transcription
cDNA synthesis was performed by incubating 0.5 µg of isolated total RNA with 500 ng
of random hexamers (GE Biosciences) at 65 ◦C for 5 minutes and incubation on ice for
2 minutes to prevent secondary structure formation. The samples were incubated with
0.5 mM of deoxyribose nuclear triphosphates (dNTP) mixture (Promega UK), 1X M-
MLV Buffer (Promega UK), 100 U M-MLV Reverse Transcriptase and 20 U Recombinant
RNasin® Ribonuclease Inhibitor (Promega UK) in a final volume of 20 µL at 42 ◦C
for 120 minutes. Samples underwent a enzyme-inactivation step by incubating at 70 ◦C
for 1 minute. For each batch of reverse transcription reactions, three negative controls
were included: a control including only RNA and water, a control containing the normal
reaction mixture minus reverse transcriptase and a water-only control. cDNA samples
were diluted by a factor of 1 in 10 and stored at -20 ◦C until required.
2.2.3 Primer design for Real-Time qPCR
Primers were designed using the Primer3 search algorithm at the NCBI Primer-BLAST
portal. The search identified primer sequences that spanned exon-exon junctions to pre-
vent amplification of possible contaminant genomic DNA in the RT-qPCR reaction. Ad-
ditionally, the search was constrained to retrieve primer sequences generating a PCR
product size of between 70 bp and 150 bp. Primer sequences used for Real-Time qPCR
are presented in Table 2.2.
The primer pairs for IL-8, TNF-α were bought as a pre-designed primer pair from Prime-
Time Premade qPCR library (Integrated DNA Technologies UK) with the product codes
Hs.PT.56a.38869678.g and Hs.PT.58.45380900, respectively. The housekeeping genes β2-
microglobulin (B2M), eukaryotic initiation factor 4A-II (EIF4A2) and TOP1 were ob-
tained from PrimerDesign as part of the GeNorm package, as detailed in Section 2.2.5.
The optimal annealing temperatures for the geNorm primer pairs were set at 60 ◦C, as
per manufacturer instructions. The optimal annealing temperatures of the primer pairs
which were designed using Primer3, which can be found in Table 2.2, and those ob-
tained from the PrimeTime Premade qPCR library were determined by thermal-gradient
endpoint-polymerase chain reaction (PCR) as discussed in Section 2.2.4.
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Target Forward Primer Reverse Primer Product (bp) Temp◦C
SELH CTTCGAGGTGACGCTGCT CTTGAGGCTCAGGGAATTTG 101 59
HMOX1 CCTTCTTCACCTTCCCCAAC CTCTTCTATCACCCTCTGCC 113 59
HIF1a CCAGCAGACTCAAATACAAGAACC TGTATGTGGGTAGGAGATGGAGAT 138 59
HERPUD1 GGTCCTGGTTTCTCCGGTTAC TGGTTGTGAATAGGGGCTGGA 188 59
cJUN TGCCTCCAAGTGCCGAAAAA TGACTTTCTGTTTAAGCTGTGCC 143 59
NQO1 ATGTATGACAAAGGACCCTTCC TCCCTTGCAGAGAGTACATGG 88 59
TR1 GACAGTTCGTACCAATTAAAGTTGAAC GCCAGCATCACCGTATTATATTC 124 60
GPX1 TATCGAGAATGTGGCGTCCC TCTTGGCGTTCTCCTGATGC 143 60
GPX2 GTCCTTGGCTTCCCTTGC TGTTCAGGATCTCCTCATTCTG 67 60
GPX3 AAGAGCTTGCACCATTCGGT CCTGGTCGGACATACTTGAGG 115 60
GPX4 GCCATCAAGTGGAACTTCACC CCTTCTCTATCACCAGGGGC 119 60
BNIP3 TGGACGGAGTAGCTCCAAGA CTTCCTCAGACTGTGAGCTGT 131 60
PHD3 CTTGGCATCCCAATTCTTGT ATCGACAGGCTGGTCCTCTA 186 60
DEC1 CCTTGAAGCATGTGAAAGCA TTCAGGTCCCGAGTGTTCTC 202 60
GLUT3 CAATGCTCCTGAGAAGATCATAA AAAGCGGTTGACGAAGAGT 172 60
hBD1 GATGGCCTCAGGTGGTAACT CGGGCAGGCAGAATAGAGAC 100 60
hBD2 CAGCCATCAGCCATGAGGGT CCACCAAAAACACCTGGAAGAGG 83 58
Table 2.2. List of primer pairs designed for RT-qPCR. Optimal annealing temperatures (Temp◦C), as determined using gradient endpoint PCR, are
indicated. Primers in this table were designed using Primer 3 from the NCBI Primer BLAST portal as described in Section 2.2.3 and were synthesised
by Eurofins MWG Operon.
28
2.2.4 Determining optimal annealing temperatures by endpoint-
PCR and agarose gel electrophoresis
An TC-5000 thermal cycler (Techne) was used to perform amplification of genome DNA
target sequences by PCR. Each 20 µL PCR reaction mixture consisted of 1.5 µL of an equal
mixture of a primer pair (final concentration 1.0 µM), 5.0 µL of 5X GoTaq® Green PCR
buffer (Promega UK), 2.5 µL of a 10X dNTP mixture (Promega UK), 1.25 U GoTaq®
Polymerase enzyme (Promega UK), 9.8 µL nuclease-free water and 1.0 µL of undiluted
template cDNA, generated as described in Section 2.2.2. A gradient-PCR temperature
program was used for amplification. This included an initial 3 minute activation step at
95 ◦C, followed by 35 cycles of denaturing step at 95 ◦C for 30 seconds, annealing at a
range of temperatures from 50 ◦C to 64 ◦C for 30 seconds and a final extension step at
72 ◦C for 30 seconds. Samples then underwent a final extension cycle for 10 minutes at
72 ◦C before incubation at 4 ◦C.
Electrophoresis of 20 µL of the above-mentioned endpoint-PCR product and 5 µL of
HyperLadder IV (BioLine) was performed on a 2% agarose/1X Tris-borate EDTA (TBE)
gel for 1 h at 5 V per cm of gel length. Products were visualised and imaged on a Bio-
RadTM Gel Doc XR system to ensure that they were of the expected product size as
stated in Table 2.2.
2.2.5 Using GeNorm to determine appropriate housekeeping
genes for Real-Time qPCR
For accurate RT-qPCR, it was necessary to identify suitable housekeeping genes which
were stably expressed in both the cell line used and experimental condition being ma-
nipulated. geNorm is a script which calculates the gene-stability measures of candidate
housekeeping genes in a given set of samples. The script discards the worst-scoring gene
and recalculates the gene-stability measures for the remaining genes until two or more
housekeeping genes with optimal gene-stability measures have been identified. The genes
from the Human geNorm reference gene kit (Primer Design Ltd UK) were analysed for
measures of gene-stability in differentiated Caco-2 cells under the conditions of exposure
to 7 h hypoxic stress and 16 h of hypoxic challenge. The genes examined included β-
actin (ACTB), glyceraldehyde 3-phosphate dehydrogenase (GAPDH), ubiquitin C (UBC),
B2M, tyrosine 3-monooxygenase (YWHAZ), 18S ribosomal RNA (18S), ribosomal protein
L13a (RPL13A), EIF4A2, topoisomerase I (TOP1) and ATP synthase, H+ transporting,
mitochondrial F1 complex, β polypeptide (ATP5B).
2.2.6 RT-qPCR using Roche LightCycler 480
The Roche LightCycler® 480 was used to perform RT-qPCR with SYBR green and the
relative quantification of target gene mRNA expression was calculated using a relative
standard curve method [353]. RT-qPCR reactions were performed in duplicate with a
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total reaction mixture of 10 µL. Each sample comprised out 2.0 µL template cDNA, 5.0
µL of SYBR Green I Master mix (Roche UK), 0.5 µL of a 10 µM mixture of primer pairs
and 2.5 µL of nuclease-free water. The RT-qPCR reaction mixture underwent a thermal
cycling program, first consisting of an initial denaturing step at 95 ◦C for 5 minutes.
This was followed by 45 cycles of a thermal cycling program, which consisted of a further
denaturing step at 95 ◦C for 10 seconds, incubation at the optimal annealing temperature
for the primer pair as shown in Table 2.2 and Section 2.2.3 for 15 seconds, and an extension
step at 72 ◦ for 5 seconds. Finally, this was followed by a melt-curve analysis and cooling
to 4 ◦C. For each RT-qPCR run, three reactions were performed for the three negative
controls described in Section 2.2.2.
2.2.7 Analysis and Normalisation of RT-qPCR data
The binding of the primer pair to the template cDNA forms a double stranded DNA
amplicon with a minor groove to which the SYBR Green I Master mix (Roche UK)
can intercalate with. This intercalation reaction generates fluorescence which increases
exponentially with each cycle of RT-qPCR reaction. The point during thermal cycling at
which this fluorescence reaches a pre-defined threshold of exponential growth is known as
the CT value. As the CT values are proportional to the exponential accumulation of the
DNA amplicon, the relative concentrations of a target gene in the original cDNA template
can be calculated using the standard curve method [353]. Standard curves for every primer
pair were generated using a dilution series of undiluted cDNA to assess amplification
efficiencies at different dilutions. Each RT-qPCR reactions were performed in duplicate
and the standard error of the technical replicates were calculated. If the standard error
of a replicate exceeded 10% then that sample was not used in further analysis. Data are
presented as average or normalised relative concentration of the experimental group ±
standard error of the mean (SEM). All statistical analysis was performed using GraphPad
(Instat USA) and these are detailed in figure legends and results sections.
RT-qPCR data of target genes were normalised against the geometric mean of two ap-
propriate housekeeping genes for the experimental conditions being manipulated. The
method by which these housekeeping genes were identified was discussed in Section 2.2.5.
2.3 Western blotting to quantify protein abundance
in cell lysates
2.3.1 Total protein extraction
Caco-2 cells cultured in 6-well plates were washed twice with PBS and harvested by
scraping into 150 µL of protein lysis buffer (Table 2.3). Protein lysates were sonicated
using a Bioruptor (Diagenode) and stored at -80 ◦C before further analysis by Western
Blotting.
30
Component Concentration
HEPES 60 mM
NaCl 154 mM
KCl 3 mM
EDTA 5 mM
Triton X-100 1 %
SDS 0.1 %
Table 2.3. List of lysis buffer components for use in total protein extraction
2.3.2 Total protein concentration determination by Bradford as-
say
Total protein concentrations of the cell lysates were determined using Bradford assay
(BIO-RAD). The assay was performed in a 96-well plate format (Greiner). The Brad-
ford reagent was diluted 1:4 with deionised water and a standard calibration curve was
generated using bovine serum albumin (BSA) (Promega) concentrations ranging from 1
mg/mL to 16 mg/mL. For each standard, sample or water control, 1 µL of each was
added in duplicate to 200 µL of diluted Bradford reagent . The contents of the wells
were mixed thoroughly by aspiration before the absorbance at 595 nm was read using a
FluoStar Omega Plate Reader (BMG Labtech Germany). The sample concentration for
each lysate was calculated using the calibration curve from the BSA standard curve.
2.3.3 SDS-PAGE electrophoresis
Protein collected from cell lysates were separated using sodium dodecyl sulphate (SDS)-
polyacrylamide gel electrophoresis (PAGE) performed on 4-12 % Novex NuPAGE Bis-Tris
Pre-Cast gels (Life Technologies). Protein samples were incubated at 70 ◦C in a mix of
4X NuPAGE lithium dodecyl sulphate (LDS) Sample Buffer and 10X NuPAGE Reducing
Agent (Life Technologies). The protein samples were loaded onto a gel and electrophoresed
at 200 V for 50 minutes in NuPAGE 2-(N-morpholino)ethanesulfonic acid (MES) SDS
running buffer (50 mM MES, 50 mM Tris Base, 0.1 % SDS, 1 mM EDTA at pH 7.3)
before use in Western Blot analysis.
2.3.4 Western Blot
Proteins separated by SDS-PAGE gel electrophoresis were transferred to nitrocellulose
membrane (Bio-Rad) or PVDF membrane (Immobilon-P Transfer Membrane; IPVH00010)
for 90 minutes by semi-dry transfer, after which, the membrane was blocked in 4%
Marvel/TBS-T (0.1% TWEEN-20) for 1 h at room temperature. Membranes were washed
3 times with TBS-T before overnight incubation at 4 ◦C with the primary antibody anti-
SELH (1:1000, Santa Cruz Biotechnology), anti-HIF1a (1:1000, Cell Signalling) or for
1 h at room temperature with anti-ACTIN (1:2000, Cell Signalling). Membranes were
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washed for a further 3 times in TBS-T and incubated with the appropriate HRP-tagged
secondary antibody (1:1000 in 4% Marvel/TBS-T) for 1 h at room temperature. Mem-
branes were developed using ECL (Thermofisher) as per manufacturer’s instructions on
X-ray film using a X-ray film processor (Xograph Compact X4).
2.4 Enzyme-linked immunosorbent assay to quantify
protein abundance of interleukin-8 in cell media
extracts
Following stimulation of Caco-2 cells with S. typhimurium flagellin for 6 and 16 h, as de-
scribed in Section 2.1.5 and Section 2.1.6, cell media was collected to measure the quantity
of IL-8 present in the media. The enzyme-linked immunosorbent assay (ELISA) was per-
formed using the Human IL-8 ELISA Ready-SET-Go! 2nd Generation (Affymetrix eBio-
science) kit, as per manufacturer protocol. Briefly, 96-well plates (NUNC Maxisorp) were
coated with IL-8 capture antibody overnight. Each well was washed the recommended
number of times with wash buffer and 100 µL of sample, IL-8 standard or negative con-
trol was added to the appropriate wells overnight. Following further washes, 100 µL or
detection antibody, Avidin-HRP, TMB Solution was added sequentially, with washes in
between. Finally, 50 µL of Stop Solution was added to each well before reading the plate
at 450 nm.
2.5 Statistical Analyses
Statistical analyses were performed using GraphPad Prism 6 software (GraphPad Soft-
ware, USA). One-way or two-way ANOVA were performed to compare the means of data
sets, after which, multiple comparisons were performed using Tukey’s post hoc tests to
compare each treatment mean to every other treatment mean.
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Chapter 3
Innate immunity of the gut and the
importance of selenium
3.1 Introduction
3.1.1 The role of the microbiota and intestinal epithelial cells
in host innate immunity
The gastrointestinal tract hosts an epithelium with the largest surface area of the body
and is colonised by more than 100 trillion microorganisms, consisting mostly of bacte-
ria but also includes fungi, viruses and parasites. Collectively, these microorganisms are
commonly referred to as the microbiota. The microbiota have a mutualistic relationship
with the host organism, digesting and fermenting dietary carbohydrates, producing vita-
mins and helping to prevent the colonisation of the gut by pathogens. In return, the host
provides nutrients to the microbiota and a niche in which the microbiota can thrive [354].
Beneath the layer of microbiota is a continuous layer of IECs, which function to absorb
nutrients from the diet, and protect of the host from invasion by potential pathogenic
microorganisms that enter the gastrointestinal tract. The tight barrier of IECs includes a
variety of cell types, including Paneth cells, Goblet cells and enteroendocrine cells, each
possessing a unique distinct function in the gut. The most numerous of the IECs, however,
are the enterocytes that function in nutrient absorption and the local immune responses
that help protect the host from infection [103].
3.1.2 Dysbiosis, oxygen and chronic inflammation - breakdown
of the barrier function and inappropriate immune responses
to commensal microbiota
Although the relationship between the microbiota and host is mutualistic, under certain
conditions, dysbiosis can occur. Dysbiosis occurs when there are imbalances, and hence
changes, in the phyla of the microbiota [354]. Furthermore, changes in the gut microbiota
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have been associated with the pathogenesis of certain inflammatory diseases, such as in
IBD [355]. However, it is currently under debate whether the changes in the microbiota
are a cause or consequence of IBD.
Observations have been made that the phyla of microbiota that colonise a particular
location, either by their proximity to the epithelial cell wall, or longitudinally along the
gut axis, are dependant upon the concentration of oxygen that the microbiota are exposed
to [356–358]. Furthermore, it has been hypothesised that chronic inflammation, such as
seen in IBD, can increase the oxygen concentration of the affected area of the gut and
thus cause dysbiosis [359].
Chronic inflammation of the gut wall results in breakdown of the barrier function of the
IECs, allowing bacterial antigens, such as flagellin, to leak through from the lumen into
the host mucosa and initiate innate and adaptive immune responses [360]. Flagellin is
the only known agonist for the cell-surface receptor, TLR5, which is known to induce a
pro-inflammatory response in IECs [361, 362]. This response to flagellin results in release
of pro-inflammatory cytokines, such as IL-8 and TNF-α, as well as defensins, such as
hBD2. Furthermore, it has previously been reported that flagellin is one of the dominant
antigens in Crohn’s disease, demonstrating its potential importance in the pathogenesis
and pathology of IBD [363, 364].
Se has primarily received much research interest due to its anti-oxidative and anti-inflammatory
functions, in addition to its potential role in cancer prevention [1, 2]. Additionally, it was
reported that low Se status was associated with increased prevalence of Crohn’s disease
[141]. In a number of rodent studies, it has been shown that Se deficiency correlates with
exacerbated disease severity in experimental colitis models [140, 150], and furthermore, it
has been shown that supplementation with Se has provided beneficial effects in a range
of experimental settings of colitis in rodents [140, 143, 150, 151].
The mechanisms by which Se may modulate inflammatory responses are poorly under-
stood. In mice, the composition of the gut microbiota was shown to affect the levels of Se
in the host [155]. Conversely, alterations in the levels of dietary Se have been shown to
affect the composition of the microbiota in mice [156]. A study using murine models of
colitis found consistent up-regulation of GPX2 mRNA. Furthermore, a study in rodents
found that a double knockout of the selenoproteins, GPX1 and GPX2, resulted in ileo-
colitis [365]. Additionally, knockout of glutathione peroxidase 3 (GPX3) expression in
a dextran sulfate sodium (DSS)-induced colitis model was observed to exacerbate colitis
symptoms in mice [366]. In vitro studies in cultured human cells suggest that modulation
of the inflammatory response of IECs may partly be attributed to the regulation of NF-κB
signalling through the activity of GPX selenoproteins [31, 162]. A role for the selenopro-
tein, TR1, in the regulation of the NF-κB-mediated inflammatory response has also been
observed in an epithelial cell line [367]. Thus, there is evidence that the regulation of
inflammation by Se may be mediated through altered expression of selenoproteins in host
cells.
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3.1.3 Research aims
The aim of the research reported in this chapter was to assess the effects of Se sup-
plementation or depletion on the response of differentiated and undifferentiated Caco-2
cells to challenge with S. typhimurium flagellin. Furthermore, the potential roles of the
selenoprotein TR1 in these responses to flagellin were also investigated.
35
3.2 Results
3.2.1 Effect of selenium depletion on the expression of immune
effectors and selenoproteins in response to flagellin chal-
lenge in differentiated Caco-2 cells
Caco-2 cells were grown on Transwell semi-permeable inserts for 18 days to allow polar-
isation and differentiation (Section 2.1.1). The cells were then depleted of Se (NoSe), or
supplemented with Se (Se) for 72 h (Section 2.1.2).
Following the 72 h depletion or supplementation period, the cells were challenged with
bacterial flagellin (Section 2.1.5) and RNA isolated (Section 2.2.1). The mRNA expression
level of the immune effectors IL-8, hBD2, TNF-α and hBD1 were measured after 6 h and
16 h flagellin treatment by RT-qPCR. mRNA levels relative to the geometric mean of
housekeeping genes TOP1 and EIF4A2 are shown in Figure 3.1. After 6 h of flagellin
treatment, mRNA expression of all of the immune effectors IL-8, hBD2, TNF-α and
hBD1 was induced due to flagellin treatment compared with unchallenged controls (P <
0.01). There was a 0.21-fold increase in the flagellin-induced expression levels of hBD2
in the Se-depleted cells (NoSe) compared with those that were supplemented with Se (P
< 0.01) (Figure 3.1B). After 16 h of flagellin treatment, there was an induction in the
mRNA expression of IL-8 (P < 0.001), hBD2 (P < 0.01) and TNF-α (P < 0.01) but this
induction was reduced compared to values observed for these targets after 6 h of flagellin
treatment. At the 16 h time-point, there was a 0.7-fold increase in the flagellin-induced
mRNA expression of hBD2 (P < 0.001; Figure 3.1B), as well as a 0.42-fold increase
in induced TNF-α expression (P < 0.05; Figure 3.1C). There was no effect due to Se-
depletion or flagellin on hBD1 expression at the 16 h time-point (Figure 3.1D) and no
effect of Se-depletion on IL-8 expression in the flagellin challenged cells (Figure 3.1A).
The level of secreted IL-8 protein was measured by ELISA in spent media from Caco-2
cells after 6 and 16 h of flagellin challenge (Figure 3.2). At both the 6 h and 16 h time-
points, flagellin challenge was found to induce the secretion of IL-8 into both the apical
and basolateral media by differentiated Caco-2 cells. After 6 h of flagellin challenge, there
was a 0.1-fold increase in the amount of flagellin-induced IL-8 secreted basolaterally by
differentiated Caco-2 cell that were depleted of Se (NoSe), compared with those that were
supplemented with Se (P < 0.05; Figure 3.2A-ii). There was no statistically significant
changes observed in the IL-8 levels detected in the apical media after 6 h (Figure 3.2A-ii).
After 16 h of flagellin challenge, there was a 0.2-fold increase in the flagellin-induced IL-8
secreted apically by differentiated Caco-2 cells depleted of Se (NoSe) (Figure 3.2B-i; P <
0.01). In the basolateral media, there was no significant change in flagellin-induced IL-8
secretion in Se-depleted cells (Figure 3.2B-ii).
The mRNA expression of the selenoproteins of TR1, SelH, GPX1 and GPX2 was measured
in response to Se depletion and stimulation with S. typhimurium flagellin for 6 and 16
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Figure 3.1. Effect of 72 h Se supplementation (Se) or selenium depletion (NoSe) on the mRNA
expression of the innate immune effectors IL-8 (A), hBD2 (B), TNF-α (C) and hBD1 (D) in
response to 6 and 16 h flagellin (+F) treatment in differentiated Caco-2 cells. All data were
normalised to the housekeeping genes TOP1 and EIF4A2. Data were expressed as a proportion
of the mean of the NoSe flagellin treated cells in order to combine 3 distinct biological replicates,
each consisting of 3 technical replicates (n = 9). Data were analysed statistically using two-way
ANOVA with a Tukey post-test for multiple comparisons. The data are displayed as mean ±
standard error of the mean (SEM). * P < 0.05; ** P < 0.01; *** P < 0.001.
h in differentiated Caco-2 cells (Figure 3.3). After 6 h of flagellin stimulation, there was
an induction in the mRNA expression of TR1 in both the Se-supplemented (Se) and
Se-depleted differentiated Caco-2 cells (Figure 3.3A; P < 0.001). After 16 h of flagellin
treatment, there was no induction of TR1 mRNA but a 67 % and 58 % decrease in
expression from the 6 h time-point was observed in the Se-supplemented and Se-depleted
cells challenged with flagellin, respectively (P < 0.001). After 6 h of flagellin stimulation,
there was a 41 % reduction in SelH mRNA expression in the Se-depleted differentiated
Caco-2 cells (Figure 3.3B; P < 0.05), but not in the Se-supplemented cells. There was
no effect of Se treatment or flagellin treatment on SelH mRNA expression at the 16 h
time-point.
At the 6 h time-point, there was a decrease in GPX1 mRNA expression in both the
flagellin-treated and untreated cells due to Se depletion by 50 % and 54 %, respectively
(Figure 3.3C; P < 0.001). At the 16 h time-point, there was a decrease of 49 % observed in
the mRNA expression of GPX1 in the untreated cells (P < 0.01), but not in the flagellin-
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Figure 3.2. Effect of 72 h Se supplementation (Se) or selenium depletion (NoSe) on the secretion
of IL-8 by Caco-2 cells in response to 6 and 16 h flagellin (+F) treatment in differentiated Caco-2
cells. The figures denoted by the letters A and B represent data from 6 h and 16 h, respectively,
from both the apical (i) and basolateral (ii) secreted media. Data from the 16 h time point were
expressed as a proportion of the mean of the NoSe flagellin treated cells in order to combine
2 distinct biological replicates, with each data point consisting of 4 technical replicates (n =
8). Data were analysed statistically using two-way ANOVA with a Tukey post-test for multiple
comparisons. The data are displayed as mean ± standard error of the mean (SEM). * P < 0.05;
** P < 0.01.
treated cells. There were no significant changes in GPX2 mRNA as a result of any of
the experimental conditions (Figure 3.3D). However, there was a trend towards increased
GPX2 observed as a result of flagellin treatment.
3.2.2 Effect of selenium depletion on the expression of immune
effectors and selenoproteins in response to flagellin chal-
lenge in undifferentiated Caco-2 cells
Caco-2 cells were grown on 6-well plates to confluency (Section 2.1.1) before being depleted
(NoSe) of Se, or supplemented with Se (Se) for 72 h (Section 2.1.2).
Following 72 h depletion (NoSe) or supplementation (Se) of confluent but undifferentiated
Caco-2 cells, the mRNA expression of the immune effectors IL-8, hBD2, TNF-α and hBD1
were measured in response to 6 h and 16 h flagellin treatment (Figure 3.4). At the 6 h
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Figure 3.3. Effect of 72 h Se supplementation (Se) or selenium depletion (NoSe) on the mRNA
expression of the selenoproteins TR1 (A), SelH (B), GPX1 (C) and GPX2 (D) in response to 6
and 16 h flagellin (+F) treatment in differentiated Caco-2 cells. All data were normalised to the
housekeeping genes TOP1 and EIF4A2. Data were expressed as a proportion of the mean of the
NoSe flagellin treated cells in order to combine 3 distinct biological replicates, each consisting
of 3 technical replicates (n = 9). Data were analysed statistically using two-way ANOVA with
a Tukey post-test for multiple comparisons. The data are displayed as mean ± standard error
of the mean (SEM). * P < 0.05; ** P < 0.01; *** P < 0.001.
time-point, there was flagellin-induced expression of IL-8 (Se: P < 0.01; NoSe: P < 0.001),
hBD2 (Se: P < 0.05; NoSe < 0.001) and TNF-α (P < 0.001) in both the Se-supplemented
and Se-depleted cells was observed. However, there was only induction of hBD1 mRNA
at the 6 h time-point in the Se-depleted cells (NoSe: P < 0.01). The cells which were
Se-depleted and challenged with flagellin for 6 h increased the flagellin-induced mRNA
expression of IL-8 by 1.68-fold (Figure 3.4A; P < 0.001), hBD2 by 1.74-fold (Figure 3.4B;
P < 0.001), TNF-α by 0.71-fold (Figure 3.4C; P < 0.001) and hBD1 by 0.88-fold (Figure
3.4D; P < 0.001), compared with those that were supplemented with Se and challenged
with flagellin. At the 16 h time-point there was no detected induction of mRNA of any
target gene due to flagellin challenge. Se-depletion resulted in an increase in expression
of hBD1 in the cells treated with flagellin (Figure 3.4D; P < 0.001) and the untreated
cells (Figure 3.4D; P < 0.05). When compared with flagellin challenged cells at the 6 h
time-point there was markedly lower expression of IL-8 (Se: P < 0.05; NoSe: P < 0.001)
and TNF-α (P < 0.001). Interestingly, there was an increase in hBD2 mRNA in the
untreated Se-depleted cells from 6 h to 16 h (P < 0.01).
ELISAs were performed on spent media from undifferentiated Caco-2 cells after 6 and
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Figure 3.4. Effect of 72 h Se supplementation (Se) or selenium depletion (NoSe) on the mRNA
expression of the innate immune effectors IL-8 (A), hBD2 (B), TNF-α (C) and hBD1 (D) in
response to flagellin (+F) treatment after 6 and 16 h in undifferentiated Caco-2 cells. All
data were normalised to the housekeeping genes TOP1 and EIF4A2. Data were expressed as a
proportion of the mean of the NoSe flagellin treated cells in order to combine 3 distinct biological
replicates, each consisting of 3 technical replicates (n = 9). Data were analysed statistically using
two-way ANOVA with a Tukey post-test for multiple comparisons. The data are displayed as
mean ± standard error of the mean (SEM). * P < 0.05; ** P < 0.01; *** P < 0.001.
16 h of flagellin challenge in two distinct biological replicates (Figure 3.5). At the 6 h
time-point (Figure 3.5A), there was induction of IL-8 in the cells treated with flagellin
(P < 0.001). In the flagellin-treated cells which were depleted of Se (NoSe), there was
a 0.4-fold increase in the amount of IL-8 detected in the media (P < 0.001) compared
with Se-supplemented cells. At the 16 h time-point (Figure 3.5A), there was induction of
IL-8 in the cells treated with flagellin (P < 0.001). In the flagellin-treated cells that were
depleted of Se (NoSe), there was an 1.01-fold increase in the amount of IL-8 detected (P
< 0.001) compared with Se-supplemented cells.
The mRNA expression of the selenoproteins of TR1, SelH, GPX1 and GPX2 was measured
in response to Se depletion and stimulation with S. typhimurium flagellin for 6 and 16 h
in undifferentiated Caco-2 cells is presented in Figure 3.6. The mRNA expression of TR1
(Figure 3.6A) was increased following flagellin challenge at the 6 h time-point in both the
Se-supplemented cells (1.68-fold; P < 0.001) and Se-depleted cells (0.41-fold; P < 0.01).
Furthermore, Se-depletion caused a reduction in flagellin-induced mRNA expression by
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Figure 3.5. Effect of 72 h Se-supplementation (Se) or Se-depletion (NoSe) on the secretion of
IL-8 into the media by undifferentiated Caco-2 cells as detected by ELISA. A: 6 h flagellin
treatment. B: 16 h flagellin treatment. The data shown represents two biological replicate with
4 repeats (n = 8) for each time-point. Data were analysed statistically using two-way ANOVA
with a Tukey post-test for multiple comparisons. The data are displayed as mean ± standard
error of the mean (SEM). *** P < 0.001.
18 %, compared with that of the flagellin-induced mRNA in the Se-supplemented cells (P
< 0.05). In the unchallenged cells, however, there was a 0.33-fold increase in TR1 mRNA
compared with the Se-supplemented cells (P < 0.01). There was no induction due to
flagellin challenge observed for TR1 at the 16 h time-point. However, an increase due to
Se-depletion was observed in both the challenged and unchallenged cells by 0.29-fold (P
< 0.05) and 0.53-fold (P < 0.01). TR1 mRNA expression levels were decreased at the 16
h time-point in the challenged Se-supplemented cells and the unchallenged Se-depleted
cells when compared with their counterparts at the 6 h time-point (P < 0.001).
At the 6 h time-point, there was no induction of SelH mRNA observed following flagellin
challenge (Figure 3.6B). However, there was a decrease due to Se-depletion observed in
both the challenged and unchallenged cells by 62 % and 53 %, respectively (P < 0.001).
There was also no induction due to flagellin challenge observed for SelH at the 16 h
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time-point. A decrease in expression of 51 % due to Se-depletion was observed for the
challenged cells (P < 0.01), but not for the unchallenged cells.
At the 6 h time-point, GPX1 showed a 0.48-fold induction in mRNA expression in the
Se-supplemented cells (P < 0.01), but not in the Se-depleted cells (Figure 3.6C). A de-
crease in GPX1 mRNA expression due to Se-depletion was observed in the challenged and
unchallenged cells by 47 % and 38 %, respectively (P < 0.001 and P <0.05, respectively).
There was no induction of GPX1 mRNA due to flagellin observed at the 16 h time-point
but a decrease due to Se-depletion was observed in both the challenged and unchallenged
cells by 70 % and 67 %, respectively (P < 0.01). There was also an increase in GPX1
mRNA detected at the 16 h time-point in both the challenged and unchallenged cells
compared with their counterparts at 6 h (P < 0.05 and P¡< 0.001, respectively).
At the 6 h time-point, there was an induction of GPX2 mRNA due to flagellin in both the
Se-supplemented and Se-depleted cells by 3-fold and 0.44-fold, respectively (P < 0.01 and
P < 0.001, respectively). Se-depletion resulted in increased GPX2 mRNA expression in
both challenged and unchallenged cells by 3.4-fold and 11-fold, respectively (Figure 3.6D;
P < 0.001). At the 16 h time-point there was a 0.6-fold induction due to flagellin challenge
in the Se-depleted cells (P < 0.001), but no induction observed in the Se-supplemented
cells. There was also an increase in GPX2 mRNA detected in the Se-depleted cells that
were both challenged and unchallenged (P < 0.001) but these expression levels were
reduced compared to their counterparts at the 6 h time-point (P < 0.05).
3.2.3 Effects of TR1 knockdown in undifferentiated Caco-2 cells
on the expression of immune effectors in response to flag-
ellin challenge
As there was consistent flagellin-induced expression of the selenoprotein TR1 in both the
differentiated and undifferentiated Caco-2 cells, the gene was selected for further study.
Knockdown of TR1 mRNA expression, as described in Section 2.1.3, was achieved using
a TR1-specific siRNA in undifferentiated Caco-2 cells to assess the effect of reduced TR1
expression on the ability of Caco-2 cells to respond to challenge with S. typhimurium
flagellin for 6 h. Following transfection with TR1-specific siRNA, the level of TR1 mRNA
measured 48 h post-transfection and showed an 85% reduction in TR1 mRNA expression
compared with cells transfected with negative control (NC) siRNA (Figure 3.7). There
was no effect of flagellin challenge on the expression level of TR1 in either the cells
transfected with TR1-specific siRNA or negative control siRNA.
After 6 h of flagellin challenge, the expression of IL-8 mRNA increased in the cells trans-
fected with TR1-specific and negative control (NC) siRNA (P < 0.001) (Figure 3.8). How-
ever, the cells transfected with TR1-specific siRNA exhibited a flagellin-induced increase
of IL-8 mRNA but this was 40% reduced compared with cells transfected with negative
control siRNA (P < 0.001). This effect was also observed in the concentration of secreted
IL-8 protein, with a 32 % reduction in IL-8 secreted IL-8 protein (Figure 3.9). After 6 h of
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Figure 3.6. Effect of 72 h Se-supplementation (Se) or Se-depletion (NoSe) on the mRNA expres-
sion of the selenoproteins TR1 (A), SelH (B), GPX1 (C) and GPX2 (D) in response to 6 and
16 h flagellin (F) treatment in undifferentiated Caco-2 cells. All data were normalised to the
housekeeping genes TOP1 and EIF4A2. Data were expressed as a proportion of the mean of the
NoSe flagellin treated cells in order to combine 3 distinct biological replicates, each consisting
of 3 technical replicates (n = 9). Data were analysed statistically using two-way ANOVA with
a Tukey post-test for multiple comparisons. The data are displayed as mean ± standard error
of the mean (SEM). * P < 0.05; ** P < 0.01; *** P < 0.001.
flagellin challenge, the expression of hBD2 mRNA increased in the cells transfected with
TR1-specific and negative control (NC) siRNA (P < 0.01 and P < 0.001, respectively).
However, this was 45% reduced in the siTR1 transfected cells compared with the control
(P < 0.001). After 6 h of flagellin challenge, the expression of TNF-α mRNA increased in
the cells transfected with TR1-specific and negative control (NC) siRNAs (P < 0.05 and
P < 0.001, respectively). However, this was 45% reduced in the siTR1 transfected cells
compared with the control (P < 0.01). After 6 h of flagellin challenge, the expression of
hBD1 mRNA increased in the cells transfected with negative control (NC) siRNA (P <
0.05), but not in the cells transfected with TR1-specific siRNA. However, the cells trans-
fected with TR1-specific siRNA exhibited a increase in the challenged and unchallenged
cells of hBD1 mRNA which was approximately 40% smaller than that of cells transfected
with negative control siRNA (P < 0.01 and P < 0.05, respectively).
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Figure 3.7. TR1 mRNA expression level 48 h post-transfection with TR1-specific siRNA or
negative control (NC) siRNA, followed by 6 h challenge with S. typhimurium flagellin (+F) or
water negative control (-F). All data were normalised to the housekeeping genes TOP1 and B2M.
Data were expressed as a proportion of the mean of the NC siRNA transfected cells challenged
with flagellin in order to combine 2 distinct biological replicates, each consisting of 3 technical
replicates (n = 6). Data were analysed statistically using two-way ANOVA with a Tukey post-
test for multiple comparisons. The data are displayed as mean ± standard error of the mean
(SEM). *** P < 0.001.
3.3 Discussion
The roles of Se in the innate defences of the gut are conflicting but the anti-inflammatory
effects of Se have been well-documented in a number of in vivo models as well as a
range of different cell types in in vitro models [193, 368–371]. In this chapter, the anti-
inflammatory effects of Se were investigated in Caco-2 cells after stimulation with S.
typhimurium flagellin. These in vitro experiments were performed to assess the effects of
Se supplementation or depletion on the responses of differentiated and undifferentiated
Caco-2 cells, modelling the gut epithelium, to the bacterial PAMP flagellin. Effectors
measured are involved in innate immunity and focused on the pro-inflammatory cytokines
IL-8 and TNF-α, and the antimicrobial killing agents, hBD1 and hBD2.
Se-depletion was found to stimulate the expression of the immune effectors IL-8, hBD2,
TNF-α and hBD1, induced by stimulation with S. typhimurium flagellin in Caco-2 cells.
The effect of Se-depletion on the induction of immune effectors was much larger in undif-
ferentiated Caco-2 cells (Figure 3.4). Differentiated Caco-2 cells were more resistant to
the effects of Se-depletion and, in response to flagellin treatment, exhibited a higher-fold
induction of target mRNA (Figure 3.1) and secreted IL-8 protein (Figure 3.2). The ef-
fect of flagellin treatment on selenoprotein mRNA expression was measured and showed
a consistent induction of TR1 mRNA expression by flagellin in both the differentiated
and undifferentiated Caco-2 cell models. Therefore, a knockdown of TR1 was performed
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Figure 3.8. Effects of TR1 knockdown on the expression of the inflammatory mediators IL-8
(A), hBD2 (B), TNF-α (C) and hBD1 (D) at 48 h post-transfection with TR1-specific siRNA
or negative control (NC) siRNA, and 6 h challenge with S. typhimurium flagellin (+F) or water
negative control (-F). All data were normalised to the housekeeping genes TOP1 and B2M.
Data were expressed as a proportion of the mean of the NC siRNA transfected cells challenged
with flagellin in order to combine 2 distinct biological replicates, each consisting of 3 technical
replicates (n = 6). Data were analysed statistically using two-way ANOVA with a Tukey post-
test for multiple comparisons. The data are displayed as mean ± standard error of the mean
(SEM). * P < 0.05; ** P < 0.01; *** P < 0.001.
(Figure 3.7) which indicated that reduced expression of TR1 mRNA resulted in a decrease
in the induction of immune effectors by flagellin in undifferentiated Caco-2 cells (Figure
3.8).
The Caco-2 cell line has extensively been used as an in vitro model of IECs to study
the effects of Se on various pathways and morphologies under a variety of experimental
conditions. Some of these studies were performed in undifferentiated Caco-2 cells [31,
229, 372–389], whereas others were performed in Caco-2 cells that had been polarised
and fully differentiated [154, 390–397]. Caco-2 cell polarisation and differentiation have
previously been shown to result in changes in a number of cellular processes, including
cell cycle regulation and apoptosis [398–400], inflammatory responses and signalling [400,
401], cell metabolism [402], nutrient uptake [403–406], responses to oxidative stress [407,
408], global transcriptomic and proteomic changes [398, 405, 409], as well as changes in
which reference genes can be used for analysis of RT-qPCR [410]. The work mentioned
above indicates that the polarisation and differentiation of Caco-2 cells represent the
phenotypic change of the cell line from a tumorigenic phenotype to a one more similar to
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Figure 3.9. Effects of treatment of Caco-2 cells with TR1-specific siRNA (siTR1) or negative
control (NC) siRNA, and 6 h treatment with S. typhimurium flagellin (+F) or water nega-
tive control (-F) on secreted IL-8 concentration by undifferentiated Caco-2 cells as detected
by ELISA. The data shown represents 2 biological replicate with 3 repeats (n = 6) for each
time-point. Data were analysed statistically using two-way ANOVA with a Tukey post-test for
multiple comparisons. The data are displayed as mean ± standard error of the mean (SEM).
*** P < 0.001.
that of a differentiated enterocytic intestinal cell. Therefore, it was important to study
the responses of differentiated and undifferentiated Caco-2 cells to changes in Se when
faced with various stressors.
The effect of selenium on the induction of immune effectors by flagellin stim-
ulation in undifferentiated and differentiated Caco-2 cells
An induction in the immune targets IL-8, hBD2, TNF-α and hBD1 was observed in re-
sponse to the challenge of Caco-2 cells with S. typhimurium flagellin in both differentiated
and undifferentiated cells (Figure 3.1 and Figure 3.4, respectively).
In the undifferentiated Caco-2 cells, Se-depletion resulted in an increase in the induction
of IL-8 mRNA after 6 h of flagellin treatment (Figure 3.4), and secreted IL-8 protein
after 6 and 16 h of flagellin treatment (Figure 3.5). Previous research that assessed the
effects of Se supplementation on undifferentiated Caco-2 cells to immune stressors found
no effect of Se on responses to flagellin challenge, but did find it modulated responses to
challenge with TNF-α [31]. There was no effect of Se-depletion on the mRNA levels of IL-
8 in differentiated Caco-2 cells (Figure 3.1). However, Se-depletion resulted in increased
induction of secreted IL-8 protein in the basolateral media after 6 h, and apical and
basolateral media after 16 h of flagellin challenge (Figure 3.2). Interestingly, there was
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a decrease in IL-8 basolaterally-secreted protein observed in one biological replicate after
16 h due in differentiated Caco-2 cells which were Se-depleted. The effects of Se-depletion
on the induction of IL-8 has not been reported in differentiated Caco-2 cells prior to the
work described in this thesis.
There are a number of potential mechanisms by which Se may repress the expression of
the IL-8 gene, CXCL8, at the transcriptional level. The gene CXCL8 contains a 200
nucleotide promoter region that contains various motifs and response elements necessary
for transcriptional regulation of IL-8 [411]. The binding of NF-κB to its response element,
and CXCL8 promoter activity in general, can be repressed by the deacetylation of his-
tones. Previous studies have found that the inhibition of histone deacetylase-1 (HDAC-1)
caused the derepression of CXCL8, leading to the hyperacetylation of histones and chro-
matin remodelling, which led to the reduced repression of CXCL8 [412, 413]. Inhibition
of histone deacetylation has also been reported to prevent the activation of NF-κB in
undifferentiated Caco-2 cells [414]. With regards to the effects of Se, one study reported
that treatment of prostate cancer cells with 1.5 µM selenite resulted in a significant inhi-
bition of histone deacetylase activity [415]. Although this study did not focus specifically
on NF-κB activation, the results suggest that Se treatment may enhance expression of
IL-8 via inhibition of histone deacetylation. However, this does not agree with the data
presented in this chapter. The dose of selenite used in Xiang et al [415] was over 35-fold
higher and hence a pharmacological dose, compared with what is generally considered
physiological or nutritionally-relevant concentrations from 10 nM to 100 nM [397, 416].
The importance of histone deacetylation in the differentiation of intestinal cells, including
Caco-2 cells, is well documented in the literature [417–421]. Although the role of histone
deacetylation in the context of Se is poorly understood, changes in histone deacetylation
due to differentiation could offer a potential explanation as to why Se-depletion resulted
in exacerbation of IL-8 induction in undifferentiated, but not differentiated Caco-2 cells.
Other mechanisms by which the CXCL8 promoter is known to be repressed is via the
binding of Oct-1 and NF-κB repressing factor (NRF) to regulatory elements in the CXCL8
promoter [177, 422]. It is not currently known whether Se has a regulatory role in those
mechanisms of transcriptional repression.
A key transcription factor in terms of inducing transcription of CXCL8 in response to
challenge with S. typhimurium flagellin is NF-κB, which has been reported to be essential
for the transcription of CXCL8 [423–425]. However, there are a number of binding sites
in the promoter of CXCL8 to which a number of different transcription factors can bind
that act to enhance the expression of IL-8 [426], including the AP-1 binding site. AP-1 is a
homodimer or heterodimer which is composed of the subunits cJUN, Jun-B, Jun-D, Atf-2,
Fra-1, Fra-2 and c-Fos [427, 428]. The AP-1 pathway is activated by MAPK in response a
variety of stimuli, including growth factors, chemokines and environmental stressors [429]
and all three MAPK pathways, extracellular signal–regulated kinase (ERK), JNK and
p38 MAPK, have been shown to regulate CXCL8 gene expression [423]. Although not
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essential for CXCL8 expression, the AP-1 pathway has been suggested to be required for
maximal gene expression [177–186]. Additionally, much like NF-κB, JNK is essential for
CXCL8 gene expression, most likely through activation of cJUN [430]. Interestingly, AP-
1 regulation of hBD2 [192, 431, 432] and TNF-α [433] expression in response to microbial
challenge has also been reported.
There is no consensus in the literature on the direction of the regulation of AP-1 pathway
and the AP-1 subunit cJUN by Se. In the data presented in this thesis, both differentiated
and undifferentiated Caco-2 cells observed raised levels of cJUN mRNA under conditions
of Se-deficiency (Figure 4.5 and Figure 4.2). A study in rats indicated that Se deficiency
resulted in a decrease in NF-κB activity that was accompanied with a increase in AP-1
pathway activity [322]. In a human breast cancer cell line, it was observed that selenite
treatment in the dose range of 250 nM to 2.5 µM reduced AP-1 binding to DNA. Further-
more, one study reported that human whole blood treated with 100 µM of Se-containing
compounds resulted in reduced NF-κB and AP-1 pathway activity [323]. Interestingly,
in a study using physiologically relevant concentrations of selenite, in the ranges of 10
nM to 100 nM, it was found that NF-κB binding to DNA was inhibited in a human T
cell line supplemented with Se, but it was accompanied by an increase in AP-1 transac-
tivation [324]. In agreement with the data presented here, a study in human HEK-293
cells reported that Se supplementation at 100 nM resulted in decreased cJUN luciferase
reporter activity, as well as an inhibition of JNK in response to UV stress [434]. Addi-
tionally, a study also found that Se-supplementation of rat neurons, at a concentration
of 700 nM, resulted in a reduction in cJUN mRNA and protein. However, there have
been three studies from Shalini et al, that have reported that Se-deficiency resulted in
a decrease in cJUN mRNA [325–327]. The direction of regulation of AP-1 and cJUN is
poorly understood and seems to vary in different cell types and at different concentrations
of Se treatment. However, there is a strong indication for a role for Se in the regulation of
AP-1 and cJUN and this role needs further study in intestinal cell lines, such as Caco-2.
Given that there is a well documented regulation of NF-κB by AP-1 and cJUN, there is a
possibility that the effect of Se on the responses to flagellin presented in this chapter may
be occurring through modulation of AP-1 and cJUN. This is supported by the data ob-
served in undifferentiated Caco-2 cells where there was a significant affect of Se-depletion
on all immune targets tested (Figure 3.4) accompanied by an increase in the level of cJUN
mRNA detected (Figure 4.5).
hBD2 is an AMP which can form pores in the membranes of pathogens in order to
neutralise them. Along with hBD1 and human beta-defensin 3 (hBD3), hBD2 has been
found to be expressed in the gastrointestinal tract [435]. Previous studies have indicated
that hBD2 can be induced by probiotic bacteria and increase the barrier function of the gut
[436, 437]. However, increased expression of hBD2 has been associated with inflammation
in CD and UC [116, 438]. hBD2 has been induced in vitro in response to challenge with
a number of PAMPs, including flagellin, in various cell types including IECs [114, 432].
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The promoter region of hBD2 contains two NF-κB binding sites [436] and it has previ-
ously been suggested that intact function of NF-κB is required for hBD2 expression [439].
Furthermore, hBD2 expression has previously been suggested to be regulated by a number
of pathways in IECs, including PI3K/Akt, p38 MAPK, JNK, AP-1, nucleotide-binding
oligomerisation domain-containing protein 1 (NOD1) and nucleotide-binding oligomeri-
sation domain-containing protein 2 (NOD2) [114, 440–443]. Much like IL-8, hBD2 is a
pro-inflammatory mediator which often is co-expressed in response to microbial challenge.
However, previous studies have reported that hBD2 can be differentially regulated to IL-
8. One study infected undifferentiated Caco-2 cells with P. aeruginosa and reported an
inhibition of IL-8 expression, but an induction of hBD2 [442]. Another study using an
IEC model reported that supplementation of cells with vitamin D resulted in a down-
regulation of IL-8, but an up-regulation of hBD2 [440], which is consistent with previous
reports that vitamin D receptor (VDR) signalling plays and important role in defensin
regulation [444, 445]. The present work reports that Se-depletion results in an increase
in flagellin-induced hBD2 expression in both differentiated and undifferentiated Caco-2
cells (Figure 3.1B and Figure 3.4B, respectively). This consistent effect of Se-depletion on
hBD2 in both the differentiated and undifferentiated Caco-2 cells, which was not observed
for the other immune effectors, may reflect the involvement of pathways other than NF-κB
that hBD2 may be more responsive to during Se-depletion. Nonetheless, the present work
reports that hBD2 expression is responsive to Se status in IECs. Thus, further study is
warranted to investigate a role for altered hBD2 expression in the pathogenesis of UC in
patients with low Se status [116, 142, 149, 438].
TNF-α plays an essential role in both the innate and adaptive immune responses and is
widely expressed in a number of different cell types [446, 447]. The present work sug-
gests that flagellin-induced TNF-α mRNA is up-regulated in response to Se-depletion in
differentiated Caco-2 cells after 16 h flagellin challenge (Figure 3.1C), and undifferenti-
ated Caco-2 cells after 6 h flagellin challenge (Figure 3.4C). These data indicated that
TNF-α may be modulated by Se status at a transcriptional level. Transcription of TNF-α
can be induced by a number of different stimuli, including hypoxia [448], oxidative stress
[449] and PAMPs, including flagellin [450, 451]. The TNF-α promoter contains a cAMP
responsive element (CRE) [452, 453] to which transcription regulators, such as activat-
ing transcription factor 2 (ATF2) and cJUN can bind [454–456]. This suggests that Se
modulation of TNF-α may occur via changes in cJUN transcriptional activity, which is
supported by a previous study which found that de novo expression of cJUN and ATF2 in
Drosophila cells resulted in activation of a TNF-α reporter gene [454]. Data reported later
in this thesis found that Se modulated cJUN expression levels in differentiated and un-
differentiated Caco-2 cells (Figure 4.2 and Figure 4.5, respectively), which supports that
altered TNF-α expression may occur as a result of increased cJUN transcriptional activity.
Additionally, the TNF-α promoter contains a number of NF-κB binding sites to which
NF-κB is known to bind following TLR5 stimulation by flagellin [457–459]. As discussed
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in Section 1.2.4, Se modulates NF-κB signalling, thus providing a possible mechanism by
which TNF-α expression may have increased in response to Se-depletion.
hBD1 is an AMP which, similarly to hBD2, is able to form pores in the membranes of
pathogens in order to kill them [460]. Unlike hBD2, hBD1 has been reported to be consti-
tutively expressed in a number of different cell types, including the IEC cell lines, Caco-2
and HT29 [461, 462]. However, hBD1 has been found to be inducible by LPS and TNF-α
in monocytes [463], as well as TLR3 agonists in uterine epithelial cells [464]. A previous
study using undifferentiated Caco-2 cells reported that hBD2, but not hBD1, mRNA was
inducible by Interleukin-1α (IL-1α), interferon-γ (IFN-γ), LPS and Salmonella dublin in-
fection [461], while flagellin has only been reported to induce hBD1 mRNA in vivo when
applied to the corneal epithelial cells of mice [465]. Interestingly, the data presented in
the present work indicated that hBD1 gene expression is inducible in both differentiated
and undifferentiated Caco-2 cells (Figure 3.1D and Figure 3.4D, respectively). This is
surprising as a previous study in undifferentiated Caco-2 cells was unable to induce hBD1
mRNA in response to a number of microbial challenges, including live infection with
enteroinvasive and flagellated bacteria which would normally induce a TLR5 response
[461]. However, the concentration of flagellin used in the present work was relatively high
and would only bind TLR5, whereas live infection with flagellated bacteria would trigger
responses from a number of different PAMP receptors. This indicates that the hBD1
response of Caco-2 cells to flagellin was specific to TLR5. In the undifferentiated Caco-2
cells, Se-depletion increased the expression of hBD1 in the challenged and unchallenged
cells at both time-points (Figure 3.4D). The mechanism of hBD1 regulation by Se is not
currently known but operates within 6 h and is thus fast-acting. Previous studies have
suggested that HDAC-1 is able to regulate the expression of hBD1 in lung epithelial cells
[462]. Inhibition of histone deacetylation has also been reported to prevent the activation
of NF-κB in undifferentiated Caco-2 cells [414]. With regards to the effects of Se, one
study reported that treatment of prostate cancer cells with 1.5 µM selenite resulted in
a significant inhibition of histone deacetylase activity [415]. Although this study wasn’t
looking specifically at NF-κB activation, the results would suggest that selenite treatment
may enhance expression of hBD1 via inhibition of histone deacetylation, which would not
agree with the data presented in this chapter. However, the dose of selenite used in that
study was over 35-fold higher and would be considered a pharmacological dose, compared
with what is generally considered physiological or nutritionally-relevant concentrations
[397, 416]. Additionally, it has been reported that the NF-κB pathway inhibitors, per-
oxisome proliferator-activated receptor α (PPARα) and PPARγ inhibit the expression
of hBD1 after LPS stimulation [466]. Previous studies have suggested that Se-depletion
exerts pro-inflammatory effects by suppressing PPARγ and thereby increasing NF-κB
signalling [467, 468]. Hence, the modulation of PPARγ activity by Se may be a potential
mechanism by which Se regulates the expression of hBD1.
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The effect of selenium on the expression of selenoproteins after flagellin stim-
ulation in undifferentiated and differentiated Caco-2 cells
The data presented in this chapter indicated that Se-depletion and flagellin treatment,
both on their own and in combination, had different effects on the expression of the
selenoproteins TR1, SelH, GPX1 and GPX2 depending on the differentiation status of
the Caco-2 cells.
Thioredoxin reductase 1 (TR1)
TR1 is a selenoprotein which plays an essential role in the TXN antioxidant system, which
comprises of three components: NADPH, TR and TXN. Together, these components form
a major disulfide reduction system, which provides free electrons to a range of enzymes
critical for responses to various forms of stress. Indeed, the activity of a number of tran-
scription factors, including NF-κB, Nrf2 and HIF-1α, are modulated by the TXN system
[26, 57]. TR exists in three isoforms which consist of the cytoplasmic TR1, mitochondrial
TR2 and testis-specific thioredoxin glutathione reductase (TGR) [65].
In the differentiated Caco-2 cells, the mRNA expression of TR1 increased approximately
two-fold in response to treatment with S. typhimurium flagellin after 6 h but exhibited
no change in expression in response to Se-depletion (Figure 3.3). In the undifferentiated
Caco-2 cells, there was still an induction of TR1 mRNA due to flagellin after 6 h, but
the induction was significantly lower in the Se-depleted cells. Additionally, Se-depletion
resulted in a greater expression level of TR1 in unchallenged cells at the 6 h time-point,
and in both the challenged and unchallenged cells at the 16 h time-point (Figure 3.6).
These data suggested a regulation of TR1 mRNA by both flagellin and Se-depletion, which
is dependent upon the differentiation status of the Caco-2 cell. Interestingly, the majority
of studies in rodent and human in vivo and in vitro models report decreases in thioredoxin
reductase activity accompanied by decreased TR1 mRNA due to Se-depletion, although
the increase in mRNA tend to be small or has no change [229, 469–475]. However, there
is one in vivo study in chickens that reported a decrease in thioredoxin activity due to
Se-deficiency but an increase in TR1 mRNA. Furthermore, the down-regulation of TR1 by
siRNA or inhibitor, has previously been reported to not change thioredoxin redox status
[476–478]. Instead, it has been suggested that the glutathione (GSH) system serves as a
backup system to reduce thioredoxin [65]. The role of flagellin in the induction of TR1
mRNA has not previously been investigated.
TR1 was the only selenoprotein observed to be consistently up-regulated in response to
treatment with S. typhimurium flagellin in both differentiated and undifferentiated Caco-
2 cells. Therefore, it was decided that TR1 was most suitable for further investigation
into its role in the modulation of the responses to flagellin challenge. Undifferentiated
Caco-2 cells were treated with a TR1-specific siRNA for 48 h in order to knockdown
expression of TR1 and this was successful with 80 % knockdown achieved (Figure 3.7).
The cells which were pre-treated with TR1-specific siRNA exhibited an approximately
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40 - 50% reduction in the flagellin-induced mRNA expression of IL-8, hBD2, TNF-α
and hBD1 (Figure 3.8), as well as a significant decrease in the secretion of IL-8 protein
into the media in response to flagellin challenge (Figure 3.9). Studies investigating the
involvement of TR1 in the NF-κB pathway have reported a regulatory role for TR1 in the
binding of NF-κB to DNA, most likely through changes in the TXN system as a whole
[479–481]. It is well documented that TXN is a known regulator of NF-κB activity by
reducing a cysteine residue in NF-κB DNA binding domain [482, 483]. Additionally, TXN
has been suggested to be an important factor in the potency of antimicrobial activity of
the defensin AMP family [79–81]. Thus, the regulation of TXN activity by TR1 may serve
as a potential explanation for how decreased expression levels of TR1 mRNA attenuated
the flagellin-induced expression of IL-8, hBD2, TNF-α and hBD1.
Selenoprotein H (SelH)
SelH is a small 14 kDa selenoprotein expressed in many tissues, with elevated expression
in certain cancers, including colorectal cancer [27]. Se status has been reported to regulate
SelH expression both in vivo and in vitro [28–31]. SelH possesses a TXN-like ’CXXU’
motif, thus indicating a possible oxidoreductase role [27, 32–34]. However, SelH shares no
significant homology with any other functionally characterised proteins [35]. Additionally,
a nuclear-localisation signal is present in the peptide sequence of SelH, which is consistent
with reports that the protein resides in the nucleus and nucleolus [27, 36]. Relatively
little is known about the physiological roles of SelH, but studies have suggested that the
potential protective effects of SelH are mediated through its roles in the Nrf2 and NF-κB
pathways, mitochondrial biogenesis, and GSH synthesis [41, 50, 51, 53].
In the differentiated Caco-2 cells, SelH mRNA expression was found to be down-regulated
in response to flagellin treatment under conditions of Se depletion (Figure 3.3) but there
was no response to flagellin in the undifferentiated Caco-2 cells (Figure 3.6). Interestingly,
SelH was found to be unresponsive to Se status in the differentiated Caco-2 cells, but de-
creased more than 2-fold in response to Se-depletion in undifferentiated Caco-2 cells. The
effects of Se-depletion on SelH expression have never been investigated in differentiated
Caco-2 cells but similar results have been observed in undifferentiated Caco-2 cells previ-
ously [31]. This may be to compensate for redistribution of scarcer supplies of Se during
Se-depletion.
Glutathione peroxidase 1 (GPX1)
GPX1 is the most abundantly expressed member of the glutathione peroxidase family and
is present in cytoplasmic, mitochondrial and peroxisomal compartments. It is a seleno-
protein that has the essential antioxidant function of preventing harmful accumulation
of intracellular hydrogen peroxide [484]. In vitro studies have demonstrated potential
regulatory roles for GPX1 in NF-κB pathway activation. Overexpression of GPX1 in
a breast cancer cell line resulted in inhibition of IκBα degradation and reduced NF-κB
(p50) translocation to the nucleus, the effects of which have been reversed by Se-depletion
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[162, 485]. GPX1 has also been found to be very responsive to Se status in in vitro cell
models, including in undifferentiated Caco-2 cells [31, 376].
In the present work, the mRNA expression of GPX1 was found to be unresponsive to
challenge with S. typhimurium flagellin in differentiated Caco-2 cells (Figure 3.3). How-
ever, an induction by flagellin treatment was observed in undifferentiated Caco-2 cells,
which were supplemented with Se (Figure 3.6). As described previously, a potential reg-
ulatory role has been suggested between GPX1 and NF-κB activation [162, 485]. Given
that GPX1 expression is highly regulated by Se status [31, 376], these data may indicate
that GPX1 may have a regulatory role but only if there is adequate levels of intracellular
Se.
Glutathione peroxidase 2 (GPX2)
GPX2 has similar peroxidase activity as GPX1, but its expression is mainly limited to
IECs and thus is it is thought to be important in protection against gut pathogens and
inflammation [365, 486, 487]. It has previously been shown that GPX2 knockout mice
are prone to severe intestinal inflammation [150, 365, 486]. Furthermore, it has been
suggested that GPX2 may suppress intestinal inflammation by inhibition of the expression
or activity of a pro-inflammatory cytokine, COX-2 [488, 489]. Similar to GPX1, GPX2 is
a selenoprotein, but it responds differently to Se-depletion. In fact, expression of GPX2
mRNA has been reported in increase in response to Se-depletion [373]. In undifferentiated
Caco-2 cells, it has been reported that GPX2 mRNA is unresponsive to Se-depletion but
protein levels of GPX2 decrease with Se-depletion [229], and that GPX2 mRNA levels
increased with Se-depletion. Thus, the link between Se status and GPX2 expression level
is contradictory and not completely understood.
There was no consistent induction of GPX2 due to S. typhimurium flagellin treatment
in differentiated Caco-2 cells (Figure 3.3). In undifferentiated Caco-2 cells, induction
was observed in both Se groups at the 6 h time-point and interestingly, only in the Se-
depleted Caco-2 cells at the 16 h time-point (Figure 3.4). In fact, GPX2 was the only
selenoprotein mRNA induced by flagellin treatment at the 16-h time point. These data
suggest a potential role for GPX2 in the later phases of the Caco-2 cell response to
flagellin. Se-depletion had no effect on GPX2 mRNA in differentiated Caco-2 cells, but
resulted in approximately 4-fold increases in mRNA expression in undifferentiated Caco-2
cells. These data suggest that the selenoprotein hierarchy may change as the Caco-2 cell
differentiates or that Caco-2 cells may become less sensitive to shortages in Se supply as
they differentiate.
Summary
Se-depletion exacerbated the mRNA expression of pro-inflammatory cytokines and de-
fensins in response to flagellin challenge in Caco-2 cells, with Se observed to have a greater
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effect in undifferentiated Caco-2 cells. Both Se-depletion and flagellin challenge modu-
lated the expression of selenoproteins that have been previously described to be involved
in responses to oxidative stress, as discussed further in Section 4. Thus, it is important to
determine the effect of Se-depletion on oxidative stress to determine if Se-depletion has
similar effects on both immune and oxidative stress targets.
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Chapter 4
Selenium, selenoproteins and
oxidative stress
4.1 Introduction
4.1.1 Oxidative stress, damage and the cellular defences against
it
Oxidative stress is the consequence of an inadequate antioxidant capacity to process a
certain level of pro-oxidants, such as ROS or RNS. The inability of a cell to deal with
pro-oxidants can have a profound impact on the physiological functions of the cell via
the oxidation of a variety of compounds within the cell, including lipids, proteins and
DNA [198, 202, 203]. Although ROS and RNS are considered harmful in excess, they are
essential in cell signalling and act as second messengers for many physiological processes
[490]. As such, ROS have been implicated in the regulation of a number of biological
pathways, including the NF-κB, PI3K/Akt and MAPK pathways [209–211]. However, in
pathophysiological conditions where ROS levels are in excess, the oxidative damage within
the cell can lead to inflammation, uncontrolled proliferation or apoptosis [208, 212].
There are a number of multiple defence mechanisms within the cell to ensure that the
levels of ROS are kept within the physiological range. Firstly, the level of oxidative stress
in the cell can be modulated by altering either the level of oxygen transport, or by the
expression of iron-binding proteins [208, 491]. The secondary response to oxidative stress
involves the induction of antioxidant defence enzymes via a number of pathways, such
as the Nrf2, AP-1 and HIF-1 [492, 493]. Antioxidant defence enzymes neutralise ROS
and RNS and contain a number of selenoproteins. Finally, repair enzymes can be used to
repair oxidative damage to lipids, proteins and nucleic acids [208].
4.1.2 The antioxidant properties of selenium and selenoproteins
Se-containing compounds have been found to be essential in multiple antioxidant defence
systems. It has previously been reported that Se treatment improves oxidative stress
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status in rodent with sepsis and ovalbumin-induced asthma [370, 494, 495]. There is also
evidence to suggest that Se-containing amino acids, such as Sec and selenomethionine,
are able to scavenge both single and double electron oxidants [496, 497], as well as repair
or recycle oxidised Se species [498, 499]. Additionally, a role for Se-containing compounds
have been reported in binding metal ions involved in oxidative stress homeostasis [500,
501].
Se has also been shown to be involved in the response to oxidative express through its
incorporation into a number of selenoproteins in the form of the amino acid, Sec. Sec,
catalytically active residue in the redox-active selenoproteins. The families of selenopro-
teins, which have very well characterised antioxidant functions are the GPXs the the
TRs [2, 231]. Additionally, potential antioxidant roles for other selenoproteins, including
methionine-R-sulfoxide reductase 1 (MsrB1) [502], 15 kDa selenoprotein (Sep15) [503],
SelM [504], selenoprotein O (SelO) [35], selenoprotein T (SelT) [505] and SelH [35] have
previously been suggested.
4.1.3 The cross-talk between oxidative stress, the Nrf2 and AP-
1 pathways and the NF-κB pathway
Evidence suggests a significant amount of cross-talk and inter-dependence between in-
flammatory and oxidative stress signalling pathways. Se-depletion of Caco-2 cells for 72 h
has previously been shown to significantly increase the amount of ROS present in the cell
[31]. ROS have been shown to have a modulatory role on the NF-κB pathway in either a
positive or negative direction via mechanisms which are not yet fully understood. It has
been reported, for instance, that pre-exposure to ROS prolongs the activation of the NF-
κB pathway through mechanisms, including suppression of PP2A IKK dephosphorylation
[306, 307] and HDAC-mediated down-regulation of NF-κB gene transcription [308, 309].
However, ROS pre-exposure has also been shown to inhibit NF-κB activation [310, 311].
The Nrf2 pathway is also up-regulated in response to ROS. Furthermore, the Nrf2 and
NF-κB signalling pathways, which both have downstream effectors that are involved in
carcinogenesis and inflammation, show cross-talk between each other [312, 313]. In fact,
inducers of the Nrf2 pathways include Se-depletion, have previously been shown to have
an inhibitory effect on the activation of the NF-κB pathway [312, 314–316]. However,
the mechanisms of interaction between the two pathways are unclear and relevant studies
have provided contradictory evidence, suggesting both positive and negative regulation
between the two pathways [317].
The AP-1 pathway is also up-regulated in response to an imbalance of ROS. This up-
regulation of the AP-1 pathway has been shown to be mediated through a number of
pathways, including JNK, MAPK and p38 signalling pathways [318]. The AP-1 pathway
is a regulator of cell homeostasis, and is an important modulator of cell proliferation and
apoptotic signalling cascades [319–321]. Previous studies have described potential roles
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for Se in the regulation of AP-1 and cJUN [322–327]. Furthermore, roles for AP-1 and
cJUN have previously been reported in the regulation of the NF-κB pathway [177–186].
Se has been shown to modulate the Nrf2 and AP-1 pathways and both of these pathways
are regulators of each other and the NF-κB pathway [82, 261, 262, 265, 312, 313, 322, 323,
328]. The modulation of the NF-κB response by Se is well documented but the pathways
by which this modulation occurs, is not well understood.
4.1.4 Research aims
The aim of the experiments reported in this chapter was to assess the effects of Se sup-
plementation or depletion on the expression of oxidative stress-associated target genes
in differentiated and undifferentiated Caco-2 cells. Furthermore, using gene knockdown
techniques, the potential roles of the selenoproteins SelH and TR1 in the expression of
these oxidative stress-associated target genes was also investigated.
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4.2 Results
4.2.1 Effects of selenium depletion on mRNA expression of ox-
idative stress-associated targets in differentiated Caco-2
cells
Differentiated Caco-2 cells were grown on Transwell semi-permeable inserts for 18 days,
as described in Section 2.1.1, and were depleted of Se (NoSe), or supplemented with
Se (Se), for 72 h as described in Section 2.1.2. Following this 72 h Se depletion or
supplementation period, RNA was extracted from the cells and the mRNA expression
levels of Nrf2 downstream effectors were analysed.
After 72 h of either Se-depletion or Se-supplementation, the mRNA levels of downstream
effector genes known to be involved in responses to oxidative stress and including NQO1,
HMOX1, superoxide dismutase 2 (SOD2), peroxiredoxin 1 (PRDX1) and glutathione
S-transferase P 1 (GSTP1) were measured by RT-qPCR and expressed relative to house-
keeping genes, as described in Section 2.2 (Figure 4.1). Se-depletion resulted in a 0.12-fold
increase in expression of NQO1 (P < 0.05) but there was no change in mRNA expres-
sion levels of either HMOX1, SOD2, PRDX1 or GSTP1. Additionally, the levels of the
upstream target cJUN, involved in the transcriptional regulation of genes involved in ox-
idative stress, was analysed. Se-depletion resulted in a 0.38-fold increase in cJUN mRNA
expression (Figure 4.2; P < 0.001).
The levels of expression of selenoproteins are presented in Figure 4.3. Se-depletion for
72 h resulted in a reduction in GPX1 and SePP1 mRNA by 50 % (P < 0.001) and 32
% (P < 0.01), respectively. Additionally, a trend towards a decreased response to Se-
depletion was observed for SelH mRNA, but this was not statistically significant (P =
0.057). Se-depletion resulted in a 0.38-fold increase in GPX2 mRNA (P < 0.001). No
effect of Se-depletion was observed for the selenoproteins GPX4 and TR1.
4.2.2 Effect of selenium depletion on oxidative stress-associated
targets in undifferentiated Caco-2 cells
Undifferentiated Caco-2 cells were grown on 6-well plates to confluency, as described in
Section 2.1.1 and were depleted of Se (NoSe), or supplemented with Se (Se), for 72 h as
described in Section 2.1.2.
The mRNA expression levels of the downstream effector genes known to be involved in
responses to oxidative stress and including NQO1, HMOX1, SOD2, PRDX1 and GSTP1
were measured (Figure 4.4). Se-depletion resulted in a 1.09-fold increase in the mRNA
expression of NQO1 (P < 0.001); a 0.44-fold increase of SOD2 (P < 0.01); a 0.25-fold
increase of PRDX1 (P < 0.001) and a 0.45-fold increase of GSTP1 (P < 0.001). Addi-
tionally, the levels of an upstream target, cJUN, involved in the transcriptional regulation
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Figure 4.1. Effect of 72 h selenium starvation or supplementation on the mRNA expression of
Nrf2 targets in differentiated Caco-2 cells. All data were normalised to the housekeeping genes
TOP1 and EIF4A2. Data were expressed as a proportion of the mean of the NoSe in order to
combine 3 distinct biological replicates, each consisting of 4 technical replicates (n = 12). Data
were analysed statistically using a two-tailed unpaired t-test. The data are displayed as mean
± standard error of the mean (SEM). * P < 0.05.
of genes involved in oxidative stress, increased by 2-fold after Se-depletion (Figure 4.5; P
< 0.001).
Selenoprotein mRNAs were also examined in response to Se-depletion or Se-supplementation
for 72 h was examined in undifferentiated Caco-2 cells (Figure 4.6). Se-depletion for 72
h resulted in a reduction in the mRNA expression of GPX1 by 62 % (P < 0.001), GPX4
by 21 %, SePP1 by 30 % (P < 0.001) and SelH by 61 % (P < 0.001). Additionally,
Se-depletion resulted in an increase in the mRNA of GPX2 by 10.6-fold (P < 0.001) and
TR1 by 0.45-fold (P < 0.001).
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Figure 4.2. Effect of 72 h selenium starvation or supplementation on the mRNA expression of
cJUN mRNA in differentiated Caco-2 cells. All data were normalised to the housekeeping genes
TOP1 and EIF4A2. Data were expressed as a proportion of the mean of the NoSe in order to
combine 3 distinct biological replicates, each consisting of 4 technical replicates (n = 12). Data
were analysed statistically using a two-tailed unpaired t-test. The data are displayed as mean
± standard error of the mean (SEM). *** P < 0.001.
4.2.3 Effects of SelH knockdown on the mRNA expression of
oxidative stress-associated genes in undifferentiated Caco-
2 cells
The data presented in Figure 3.6B suggested that SelH expression was regulated at the
mRNA level by Se status. Additionally, previous microarray data from the laboratory
indicated that reduced expression of SelH in Caco-2 cells by siRNA modulated the ex-
pression of oxidative stress-associated genes via the Nrf2 pathway (Gautrey, Hall, Hesketh
unpublished data). Thus, the effect of a knockdown of SelH expression on expression of
specific oxidative stress-associated genes was assessed at 48 h and 72 h post-transfection.
The transfection of two SelH-specific siRNAs, siSELH1 and siSELH2, into undifferentiated
Caco-2 cells, the level of SelH mRNA expression was measured after 48 h and 72 h post-
transfection in order to assess the efficiency of knockdown. At 48 h post-transfection, the
mRNA expression of SelH was reduced by 79 % in cells transfected with siSELH1 (P <
0.001) and by 71 % in cells transfected with siSELH2 (P < 0.001), compared with the
expression levels of their respective negative controls. There was no statistically significant
difference detected between the extent of knockdown with the two siRNAs at 48 h post-
transfection. At 72 h post transfection, the mRNA expression of SelH was reduced by 93
60
N
o
rm
a
li
s
e
d
G
P
X
1
m
R
N
A
Se NoSe
0.0
0.5
1.0
1.5
2.0
2.5
***
N
o
rm
a
li
s
e
d
G
P
X
2
m
R
N
A
Se NoSe
0.0
0.5
1.0
1.5
***
N
o
rm
a
li
s
e
d
G
P
X
4
m
R
N
A
Se NoSe
0.0
0.5
1.0
1.5
N
o
rm
a
li
s
e
d
T
R
1
m
R
N
A
Se NoSe
0.0
0.5
1.0
1.5
N
o
r
m
a
li
s
e
d
S
e
P
P
1
m
R
N
A
Se NoSe
0.0
0.5
1.0
1.5
2.0
**
N
o
r
m
a
li
s
e
d
S
E
L
H
m
R
N
A
Se NoSe
0.0
0.5
1.0
1.5 (ns; P = 0.057)
A B
C D
E F
Figure 4.3. Effect of 72 h Se-supplementation or Se-depletion (NoSe) on the mRNA expression
of the selenoproteins GPX1, GPX2, GPX4, TR1, SePP1 and SelH in differentiated Caco-2 cells.
All data were normalised to the housekeeping genes TOP1 and EIF4A2. Data were expressed as
a proportion of the mean of the NoSe in order to combine 3 distinct biological replicates, each
consisting of 4 technical replicates (n = 12). Data were analysed statistically using a two-tailed
unpaired t-test. The data are displayed as mean ± standard error of the mean (SEM). ** P <
0.01; *** P < 0.001.
% in cells transfected with siSELH1 (P < 0.001) and by 88 % in cells transfected with
siSELH2 (P < 0.001). There was no statistically significant difference detected between
the level of SelH knockdown by either of the SelH-specific siRNAs.
At 48 h post-transfection, the mRNA expression level of NQO1 was increased by 0.41-
fold when transfected with siSELH1 (P < 0.001), and by 0.24-fold when transfected with
siSELH2 (P < 0.05) compared with treatment with their negative control siRNA. There
was no difference between siSELH1 and siSELH2 treatment in the expression levels of
NQO1 at 48 h post-transfection. However, at 72 h post-transfection, siSELH1 or siSELH2
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Figure 4.4. Effect of 72 h Se-supplementation or Se-depletion (NoSe) on the mRNA expression of
the oxidative stress-associated genes NQO1, HMOX1, SOD2, PRDX1 and GSTP1. All data were
normalised to the housekeeping genes TOP1 and EIF4A2. Data were expressed as a proportion
of the mean of the NoSe in order to combine 3 distinct biological replicates, each consisting of 4
technical replicates (n = 12). Data were analysed statistically using a two-tailed unpaired t-test.
The data are displayed as mean ± standard error of the mean (SEM). ** P < 0.01; *** P <
0.001.
treatment resulted in no change in NQO1 mRNA and there was no difference detected in
the expression of NQO1 between siSELH1 and siSELH2.
After 48 h post-transfection there was an increase in HMOX1 mRNA by 1.78-fold when
treated with siSELH1 (P < 0.001) and by 0.95-fold when treated with siSELH2 (P < 0.01),
relative to the cells treated with negative control siRNA. Additionally, the induction of
HMOX1 mRNA by siSELH1 treatment was significantly greater than the induction by
siSELH2 (P < 0.01). At 72 h post-transfection, there was an increase in HMOX1 mRNA
of 1.97-fold in cells transfected with siSELH1 (P < 0.001) but no significant change in
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Figure 4.5. Effect of 72 h selenium starvation or supplementation on the mRNA expression of
cJUN mRNA in undifferentiated Caco-2 cells. All data were normalised to the housekeeping
genes TOP1 and EIF4A2. Data were expressed as a proportion of the mean of the NoSe in
order to combine 3 distinct biological replicates, each consisting of 4 technical replicates (n =
12). Data were analysed statistically using a two-tailed unpaired t-test. The data are displayed
as mean ± standard error of the mean (SEM). *** P < 0.001.
cells treated with siSELH2.
mRNA expression of selenoproteins, GPX1, GPX2, GPX4 and TR1 were also measured
to assess their responses to SelH knockdown. Treatment with either siSELH1 or siSELH2
resulted in no significant change of GPX1 mRNA at either 48 or 72 h post-transfection.
Transfection with siSELH1 resulted in increases in GPX2 mRNA by 0.93-fold at 48 h
post-transfection (P < 0.001), and by 0.38-fold at 72 h post-transfection, but no change
in GPX2 mRNA was observed due to treatment with siSELH2. There was no change
in GPX4 mRNA due to either siRNA at 48 h post-transfection but an increase of 0.17-
fold was detected at 72 h post-transfection with siSELH1 compared with the negative
control (P < 0.05). Similarly, there was no change observed in TR1 mRNA at 48 h post-
transfection, but an increase of 0.49-fold was observed after 72 h post-transfection with
siSELH2 compared with negative control (P < 0.01).
4.2.4 Effects of TR1 knockdown on the expression of oxidative
stress-associated genes in undifferentiated Caco-2 cells
TR1 was shown to have an effect on the mRNA expression of immune effectors in response
to flagellin challenge (Section 3.2.3). Additionally, previous studies have suggested a role
for TR1 in the regulation of oxidative stress-associated genes[60, 63, 506]. There exists a
63
N
o
rm
a
li
s
e
d
G
P
X
1
m
R
N
A
Se NoSe
0
1
2
3
4
***
N
o
rm
a
li
s
e
d
G
P
X
2
m
R
N
A
Se NoSe
0.0
0.5
1.0
1.5
***
N
o
rm
a
li
s
e
d
G
P
X
4
m
R
N
A
Se NoSe
0.0
0.5
1.0
1.5
***
N
o
rm
a
li
s
e
d
T
R
1
m
R
N
A
Se NoSe
0.0
0.5
1.0
1.5
***
N
o
r
m
a
li
s
e
d
S
e
P
P
1
m
R
N
A
Se NoSe
0.0
0.5
1.0
1.5
2.0 ***
N
o
r
m
a
li
s
e
d
S
E
L
H
m
R
N
A
Se NoSe
0
1
2
3
4
***
A B
C D
E F
Figure 4.6. Effects of 72 h Se-supplementation or Se-depletion (NoSe) on the mRNA expression
of the selenoproteins GPX1, GPX2, GPX4, TR1, SePP1 and SelH in undifferentiated Caco-
2 cells. Data were expressed as a proportion of the mean of the NoSe in order to combine
3 distinct biological replicates, each consisting of 4 technical replicates (n = 12). Data were
analysed statistically using a two-tailed unpaired t-test. The data are displayed as mean ±
standard error of the mean (SEM). *** P < 0.001.
wealth of evidence in the literature of cross-talk between immune response and oxidative
stress pathways [82, 261, 262, 265, 312, 313, 322, 323, 328]. Thus, it was hypothesised
that TR1 may exert the immunomodulatory effects observed in Section 3 by modulation
of oxidative stress-associated genes. To test this a knockdown of TR1 mRNA expression
was carried out in undifferentiated Caco-2 cells and gene expression of NQO1, HMOX1,
GPX2 and SelH assessed.
Following the transfection of a TR1-specific siRNA, siTR1, into undifferentiated Caco-2
cells, the level of TR1 mRNA expression was measured 48 h post-transfection to assess
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Figure 4.7. Effects of treatment of undifferentiated Caco-2 cells with SelH-specific siRNAs on
mRNA expression of SelH at 48 h and 72 h post-transfection. All data were normalised to the
housekeeping genes B2M and TOP1. Data were expressed as a proportion of the mean of the
NoSe in order to combine 2 distinct biological replicates, each consisting of 4 technical replicates
(n = 8). Data were analysed statistically using two-way ANOVA with a Tukey post-test for
multiple comparisons. The data are displayed as mean ± standard error of the mean (SEM).
*** P < 0.001.
the efficiency of knockdown (Figure 4.10). mRNA expression of TR1 was reduced by 83 %
in cells transfected with siTR1 (P < 0.001), compared with cells transfected with negative
control siRNA.
mRNA expression data relating to the oxidative stress-associated genes NQO1 and HMOX1
are shown in Figure 4.11. Transfection of Caco-2 cells with siTR1 resulted in no statis-
tically significant change in the expression of NQO1. However, Caco-2 cells treated with
siTR1 exhibited a 0.63-fold increase in HMOX1 mRNA compared with cells treated with
negative control siRNA (P < 0.001).
Treatment of Caco-2 cells with siTR1 resulted in no statistically significant change in the
expression of GPX2 compared with cells treated with negative control siRNA, while an 8
% decrease in SelH mRNA was detected (Figure 4.12; P < 0.05).
4.3 Discussion
The data presented in this chapter suggest that Se-depletion increases the expression of
oxidative stress-associated genes in undifferentiated Caco-2 cells but not in differentiated
Caco-2 cells, while cJUN expression was affected by Se-depletion in both differentiated
and undifferentiated Caco-2 cells. Knockdown of SelH and TR1 expression also resulted in
modulation of oxidative stress-associated gene expression but not in a manner consistent
with the effects of Se-depletion.
Se-depletion was found to increase the mRNA expression of oxidative stress-associated
targets in undifferentiated Caco-2 cells, although HMOX1, a target which is highly asso-
ciated with Nrf2 activation, exhibited no change in expression. Interestingly, Se-depletion
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Figure 4.8. Effects of treatment of undifferentiated Caco-2 cells with SelH-specific siRNAs on
mRNA expression of oxidative-stress associated targets, NQO1 and HMOX1 at 48 h and 72 h
post-transfection. All data were normalised to the housekeeping genes B2M and TOP1. Data
were expressed as a proportion of the mean of the NoSe in order to combine 2 distinct biological
replicates, each consisting of 4 technical replicates (n = 8). Data were analysed statistically using
two-way ANOVA with a Tukey post-test for multiple comparisons. The data are displayed as
mean ± standard error of the mean (SEM). * P < 0.05; ** P < 0.01; *** P < 0.001.
resulted in the increased expression of the AP-1 and Nrf2 transcription factor subunit,
cJUN, suggesting a potential role for cJUN in the regulation of the oxidative stress-
associated targets.
Knockdown of SelH was performed in undifferentiated Caco-2 cells, which resulted in the
increase in expression of NQO1 and HMOX1. Additionally, a knockdown of TR1 was
performed which resulted in the increase in expression of HMOX1, but not NQO1. Thus,
these data indicated that, in undifferentiated Caco-2 cells, Se-depletion increases the ex-
pression of oxidative stress-associated genes and the expression of some of these targets is
modulated by knockdown of either SelH or TR1. However, the link between these seleno-
proteins and that the expression of oxidative stress targets is not clear. Importantly, the
response of oxidative stress targets to Se-depletion was markedly different in differentiated
Caco-2 cells, with there only being a relatively small increase in NQO1 observed and no
changes measured in the other targets.
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Figure 4.9. Effects of treatment of undifferentiated Caco-2 cells with SelH-specific siRNAs on
mRNA expression of selenoproteins, GPX1, GPX2, GPX4 and TR1 at 48 h and 72 h post-
transfection. All data were normalised to the housekeeping genes B2M and TOP1. Data were
expressed as a proportion of the mean of the NoSe in order to combine 2 distinct biological
replicates, each consisting of 4 technical replicates (n = 8). Data were analysed statistically
using two-way ANOVA with a Tukey post-test for multiple comparisons. The data are displayed
as mean ± standard error of the mean (SEM). * P < 0.05; ** P < 0.01.
4.3.1 The effect of selenium depletion on the expression of ox-
idative stress-associated genes and selenoprotein mRNAs
in undifferentiated Caco-2 cells
NAD(P)H dehydrogenase quinone 1 (NQO1)
NQO1 is a homodimeric flavoprotein that catalyses the reduction reaction of quinones
to hydroquinones and is a key antioxidant enzyme in the oxidative stress defence system
[507, 508]. It has previously been reported that NQO1 is involved in cellular senescence
[508, 509] and exhibits increased expression in a number of cancers, including colon cancer
[510–512]. NQO1 has also been suggested to have a protective effect against excessive pro-
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Figure 4.10. Effects of treatment of undifferentiated Caco-2 cells with TR1-specific siRNA
(siTR1) on mRNA expression of TR1 at 48 h post-transfection. All data were normalised to
the housekeeping genes B2M and TOP1. Data were expressed as a proportion of the mean
of the NoSe in order to combine 2 distinct biological replicates, each consisting of 3 technical
replicates (n = 6). Data were analysed statistically using a two-tailed unpaired t-test. The data
are displayed as mean ± standard error of the mean (SEM). *** P < 0.001.
inflammatory responses by suppressing NF-κB induction of pro-inflammatory cytokines
[513, 514].
The induction of NQO1 expression is primarily controlled via the binding of Nrf2/small
Maf protein heterodimers to ARE in the promoter region of NQO1 [259]. However,
the ARE of NQO1 also contains AP-1 recognition elements to which other transcription
factors, such as Nrf1, Nrf2, c-Fos, cJUN, BTB Domain and CNC Homolog 1 (Bach1)
and small Maf proteins can bind [259]. Thus, the transcriptional regulation of NQO1 in
response to oxidative stress has the potential to be controlled by a number of different
transcription factor complexes. The transcription of NQO1 can also be repressed. A
previous study has found that c-Fos is able to repress the transcription of NQO1 by binding
to the ARE in the NQO1 promoter [515]. Furthermore, overexpression of c-Fos has been
shown to downregulate the transcription of ARE-containing genes, NQO1 and glutathione
S-transferase (GST) genes, such as GSTP1 [516]. It is not currently understood if c-Fos
forms a complex to repress ARE-mediated gene transcription. However, there is evidence
that suggests cJUN protects c-Fos from degradation as overexpression of cJUN results in
accumulation of phosphorylated c-Fos [517].
The effects of Se status on the expression of NQO1 is not currently well understood.
Three clinical trials in humans have reported that low Se or supplementation with Se had
68
N
o
rm
a
li
s
e
d
N
Q
O
1
m
R
N
A
siTR1 siNC
0.0
0.5
1.0
1.5
N
o
rm
a
li
s
e
d
H
M
O
X
1
m
R
N
A
siTR1 siNC
0.0
0.5
1.0
1.5
2.0 ***
siTR1
siNC
A B
Figure 4.11. Effects of treatment of undifferentiated Caco-2 cells with TR1-specific siRNA on
mRNA expression of oxidative stress-associated targets, NQO1 and HMOX1, at 48 h post-
transfection. All data were normalised to the housekeeping genes B2M and TOP1. Data were
expressed as a proportion of the mean of the NoSe in order to combine 2 distinct biological
replicates, each consisting of 3 technical replicates (n = 6). Data were analysed statistically
using a two-tailed unpaired t-test. The data are displayed as mean ± standard error of the
mean (SEM). *** P < 0.001.
no effect on NQO1 gene expression [518–520] but toxic levels of Se were found to increase
the levels of NQO1 protein in one study [521]. A number of rodent studies have found
that Se deficiency resulted in an up-regulation of NQO1 mRNA expression [328, 522, 523].
On the other hand, some rodent studies have found no correlation between Se status and
NQO1 gene expression or activity [524, 525]. Surprisingly, there is a distinct lack of in
vitro studies that have investigated both Se status and NQO1 gene expression.
The data presented in this chapter indicated that 72 h Se-depletion in both differentiated
and undifferentiated Caco-2 cells induced the expression of NQO1 mRNA, with a much
larger effect of Se-depletion observed in undifferentiated Caco-2 cells (Figure 4.1 and
Figure 4.4, respectively). Interestingly, NQO1 was the only oxidative stress-associated
target, which increased in expression due to Se-depletion in the differentiated Caco-2 cells
(Figure 4.1). As NQO1 exhibited the largest increase in expression due to Se-depletion in
the undifferentiated cells (Figure 4.4), this suggests that NQO1 is particularly sensitive
to changes in Se status and hence why it was the only oxidative stress-associated target
to increase in expression in differentiated Caco-2 cells. There are no previous reports
examining the effect of Se status on NQO1 expression in Caco-2 cells. However, NQO1
was found to be inducible in undifferentiated Caco-2 cells by oxidative stress and Nrf2
pathway activators [526, 527]. Interestingly, basal NQO1 protein levels and activity have
previously found to be undetectable in undifferentiated Caco-2 cells but the mRNA levels
of NQO1 were not tested [528]. In differentiated Caco-2 cells, NQO1 has been found to
be induced by homogenised broccoli, possibly via phytochemical-induced Nrf2 activation
[529]. There is lack of agreement between the present data and in vivo studies in humans,
which showed no increase in NQO1 expression in response to reduced Se status [518–521].
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Figure 4.12. Effects of treatment of undifferentiated Caco-2 cells with TR1-specific siRNA on
mRNA expression of selenoproteins, GPX2 and SELH, at 48 h post-transfection. All data were
normalised to the housekeeping genes B2M and TOP1. Data were expressed as a proportion of
the mean of the NoSe in order to combine 2 distinct biological replicates, each consisting of 3
technical replicates (n = 6). Data were analysed statistically using a two-tailed unpaired t-test.
The data are displayed as mean ± standard error of the mean (SEM). * P < 0.05.
NQO1 is inducible in both differentiated and undifferentiated Caco-2 cells, but the effect
of Se-depletion is greater in undifferentiated Caco-2 cells (Figure 4.1A and Figure 4.4A,
respectively). One explanation for the lack of observed effect of Se status in vivo, may be
the fact that the effect of Se-depletion is more pronounced in vitro.
To dissect the mechanisms by which Se-depletion may be inducing oxidative stress-
associated target genes, knockdown of the siRNA of the selenoprotein SelH was performed.
SelH was chosen because it showed a decrease in both differentiated and undifferentiated
Caco-2 cells (Figure 4.3 and Figure 4.6, respectively). Additionally, previous microarray
data from the laboratory showed that SelH knockdown in Caco-2 cells had a modulatory
effect on genes involved in the Nrf2 pathway (unpublished data). Moreover, SelH has been
suggested to have a protective role with in the cell during stress, which may be mediated
by Nrf2 and NF-κB pathway activity [37, 41, 50, 51]. At the time of publication, there
are no other studies known to have studied the effects of SelH on the expression of NQO1.
Rodent studies have reported a down-regulation of SelH mRNA due to Se deficiency with
a concurrent up-regulation of NQO1 mRNA [328, 522, 523], although one rodent study
has observed a decrease in SelH mRNA with no change in NQO1 activity [525]. Despite
no evidence for the direct effects of SelH on the expression of NQO1, these rodent studies
provide some correlative evidence that further supports an association between SelH ex-
pression levels and NQO1 expression or activity. The present data indicates an increase
in NQO1 mRNA as a result of SelH knockdown at only 48 h but, unlike HMOX1, there
was no increase at 72 h. The reason behind this result is unclear. One explanation is
that HMOX1 is more sensitive to the effects of SelH knockdown than NQO1. However, if
SelH mediates the modulatory effects of Se on the expression of oxidative stress-associated
targets, SelH knockdown would be expected to affect NQO1 expression, but not HMOX1
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expression.
As previously discussed in Chapter 3, the data suggest that TR1 is a mediator of the
modulatory effects of Se-depletion on the responses of Caco-2 cells to flagellin. TR1 is
a key enzyme in one of the prominent redox regulatory systems in mammalian cells, the
TXN system, which is important for cellular defences against oxidative stress and signal
transduction [60, 63, 506]. Several studies have shown that knockdown or inhibition of
TR1 leads to activation of the Nrf2 signalling pathway, leading to the hypothesis that
TR1 is a potent regulator of the Nrf2 signalling pathway [506]. Additionally, there is also
evidence that suggests that TR1 itself is regulated by the Nrf2 signalling pathway as it
contains an ARE in its promoter [530]. Interestingly, TR1 knockdown did not result in any
change in NQO1 mRNA which is surprising because a previous study has reported that
inhibition of TR1 resulted in increased levels of NQO1 mRNA. In future work, it would
be important to verify that TR1 protein levels and activity were reduced in response to
TR1 knockdown.
Haem oxygenase-1 (HMOX1)
HMOX1 is an enzyme which catabolises haem into carbon monoxide, biliverdin and iron
[531], and has also been reported to possess antioxidant functions [532–535]. The induc-
tion of HMOX1 is important in the protection against a diverse variety of states of cellular
stress, including hypoxia and oxidative stress [536]. Additionally, it has been reported to
be a potent anti-inflammatory enzyme, which is an inhibitor of NF-κB pathway activity
[537]. There is also evidence that HMOX1 plays a role in the pathogenesis of a number
of different malignancies [538].
The expression of HMOX1 is controlled at the transcriptional level [539–542] and it has
been shown to be induced by a variety of stimuli, including haem, hypoxia, UV radiation,
hydrogen peroxide and LPS [543–548]. Transcriptional control of HMOX1 has been shown
to be mediated by binding of a number of transcription factors, including AP-1 and Nrf2
[549–560]. AP-1 and Nrf2 have been shown to be able to regulate the expression of
HMOX1 by the binding of their transcription factor complexes to an AP-1 binding site
and a core ARE in the HMOX1 promoter sequence, where both binding sites can overlap
and both transcription factors can bind [253]. Although Nrf2 is commonly described as
the major transcription factor which binds to AREs to induce HMOX1 expression [561],
there is also evidence that HMOX1 can be induced in Caco-2 cells in a manner which is
independent of Nrf2 activity [562].
It is well documented that Se deficiency activates the Nrf2 pathway, and induces the
expression of Nrf2 target genes [82, 261, 328, 520, 563–565]. One well-characterised Nrf2
target is HMOX1, which is induced by Nrf2 pathway activation [566, 567]. Therefore,
it was expected that the activation of the Nrf2 pathway by Se deficiency would induce
HMOX1 expression. A number of studies on the effects of Se deficiency in a number of
species have found a mixture of results. For instance, Se deficiency in chickens has been
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linked to an increase in HMOX1 kidney protein [568], but no change in HMOX1 mRNA
in either kidney cells [568, 569] or lymphocytes [570]. In rodent studies, Se deficiency was
observed to increase HMOX1 mRNA in the gut and, as well as both mRNA and protein in
the liver [83, 328]. However, it has also been reported that there was no change in HMOX1
mRNA due to Se deficiency in rat liver cells [571]. The effects of Se deficiency on the
expression of HMOX1 in humans is sparse. However, one study reported that individuals
in China with excessively high Se status exhibited high levels of HMOX1 mRNA and
protein, compared with individuals with normal Se status [572].
The data presented in this chapter found no induction of HMOX1 mRNA in response to
Se-depletion in either differentiated (Figure 4.1) or undifferentiated (Figure 4.4) Caco-2
cells. Interestingly, HMOX1 was the only oxidative stress-associated target tested that
was not up-regulated due to Se-depletion in undifferentiated Caco-2 cells. These data
agree with a previous study which has described no effect of Se on HMOX1 mRNA in
undifferentiated Caco-2 cells. However, depleting cells of Se for 24 h may not be long
enough to induce a stress response in Caco-2 cells [389]. As all targets tested contain
an ARE and have been previously reported to be induced by Nrf2 activation, this might
indicate a repressive mechanism of transcriptional regulation of HMOX1, which acts in
addition to ARE-mediated transcriptional activation.
To dissect the mechanisms by which Se-depletion induced oxidative stress-associated tar-
get genes, knockdown of the siRNA of the selenoprotein SelH was performed. SelH was
chosen because 1) it showed a decrease in both differentiated and undifferentiated Caco-2
cells (Figure 4.3 and Figure 4.6, respectively) 2) as discussed above, previous unpublished
microarray data indicate that SelH knockdown in Caco-2 cells had a modulatory effect on
genes involved in the Nrf2 pathway (unpublished data), and 3) SelH has previously been
suggested to have a protective role with during stress, which may be mediated by Nrf2
and NF-κB pathway activity [37, 41, 50, 51].
The present work suggested that SelH is involved in the transcriptional regulation of
HMOX1 as knockdown of SelH siRNA resulted in an increase in HMOX1 mRNA at 48
h and 72 h post-transfection in undifferentiated Caco-2 cells(Figure 4.8). However, SelH
was not the mediator of HMOX1 transcription regulation following Se-depletion as Se-
depletion did not result in any change in HMOX1 mRNA in undifferentiated Caco-2 cells
(Figure 4.6). There are a number of possible explanations for this result. One possibility is
that the level of SelH knockdown, which was 90 % (Figure 4.7), was much lower than the 61
% reduction in SelH mRNA observed in response to Se-depletion. Hence the modulatory
effects of SelH on HMOX1 transcription may be more pronounced at lower levels of SelH
expression. However, it is not known how the protein levels of SelH correspond to changes
in mRNA levels and therefore it would be useful to determine the protein levels of SelH
by Western blotting, after both Se-depletion and SelH knockdown.
A selenoprotein hierarchy also exists in the cell, by which each selenoprotein is differen-
tially up-regulated or down-regulated in response to Se-deficiency, depending on where
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they lie in the hierarchy [382, 469], and many of the 25 selenoproteins in humans are
suggested to exhibit antioxidant functions [40]. Therefore, as Nrf2 and MAPK activity
can be directly activated by oxidative stress [573, 574], it is feasible that the differential
expression of the selenoproteome contributes to the transcriptional regulation of HMOX1
and that it cannot be attributed to the expression level of SelH alone.
The data presented in Section 3 suggest that TR1 was a mediator of the modulatory
effects of Se-depletion on the responses of Caco-2 cells to flagellin. In undifferentiated
Caco-2 cells, Se-depletion resulted in a 0.45-fold increase in TR1 mRNA (Figure4.6A),
which occurred simultaneously to an increase in oxidative stress-associated targets, but
not HMOX1 (Figure 4.4). An 83 % knockdown of TR1 siRNA in undifferentiated Caco-2
cells (Figure 4.10) resulted in a 0.63-fold increase in HMOX1 mRNA, but not NQO1
mRNA (Figure 4.11). Thus, much like with SelH, there were no modulatory effects of Se-
depletion on the expression of HMOX1, but there were effects of TR1 knockdown. Thus,
the effects of Se-depletion of oxidative stress-associated genes are probably not mediated
through TR1 alone, but through a complex interaction between many members of the
selenoproteome.
Superoxide dismutase 2 (SOD2)
The superoxide dismutase family of antioxidant enzymes catalyse the dismutation of oxy-
gen free radicals to hydrogen peroxide, which is then further detoxified by catalase to
oxygen and water [575]. There exists three isoforms of the superoxide dismutase family
- superoxide dismutase 1 (SOD1), SOD2 and SOD3. SOD1 is primarily localised to the
cytosol and peroxisomes, and is dependent upon incorporated copper (Cu) and zinc (Zn)
for its redox activities. SOD2, which will be discussed further in this section, is localised
to the mitochondrial matrix and is dependent upon manganese (Mn). Finally, superoxide
dismutase 3 (SOD3) is an extracellular isoform that relies on Cu and Zn for its redox
activities [576]. The expression of each isoform correlates with levels of intracellular ROS
[577]. SOD2, in particular, has been reported to be responsive to oxidative stress and has
been suggested to be pivotal in the protection against oxidative stress [578–580].
The transcriptional regulation of the SOD2 promoter can be modulated by a number
of different redox-sensitive transcription factors, including NF-κB, AP-1 and Nrf2 [581].
Members of the NF-κB family are able to bind to a confirmed NF-κB binding site in
the SOD2 [582]. Previous studies have shown that NF-κB is able to induce SOD2 gene
expression in response to oxidative stress [583–585]. However, the p50 subunit of the NF-
κB family has previously been suggested to negatively regulate the transcription of SOD2
[586]. SOD2 has also been shown to contain an AP-1 binding site in its promoter region
by which SOD2 can be regulated in response to oxidative stress [581] via two signalling
pathways involving JNK and p38 MAPK via AP-1 [587]. Additionally, the SOD2 promoter
also contains an ARE to which Nrf2 can modulate its expression in response to oxidative
stress [581].
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In vivo studies in rats and humans reported that Se supplementation resulted in increased
SOD2 expression [588, 589], whereas one study in chickens reported no increase [590]. A
study in humans reported an inverse correlation between SOD2 expression and Se status
[520]. On the contrary, one in vitro study in macrophages reported that Se supplemen-
tation caused a decrease in SOD2 gene expression [591]. However, caution is needed as
none of the studies mentioned here compared the effects of Se deficiency or depletion,
whereas the data reported in the present chapter present a direct comparison between Se
supplemented and depleted status.
The data presented in this chapter suggested no effect of Se-depletion on SOD2 expression
in differentiated Caco-2 cells (Figure 4.1). However, Se-depletion resulted in a 0.43-fold
increase in SOD2 mRNA in undifferentiated Caco-2 cells (Figure 4.6). These data do not
agree with the previously mentioned studies that found an increase in SOD2 expression
with Se supplementation [588, 589]. However, these studies did not examine the effects of
Se deficiency and only the effects of Se supplementation, and furthermore were carried out
in a cell type (macrophages) in which ROS have a specialised function. Additionally, at
high concentrations, Se has been reported to have pro-oxidant effects which may explain
the increase in SOD2 expression in these studies [233]. These data do agree, however,
with one study looking at the effect of Se status, both low and high, which reported that
low Se status correlates with increased expression of SOD2. However, further study is
needed to elucidate the mechanisms of transcriptional regulation that occurs in the SOD2
promoter at varying levels of Se.
Peroxiredoxin 1 (PRDX1)
Peroxiredoxins are a family of TXN-dependent antioxidant peroxidase enzymes, of which
PRDX1 is a major member. PRDX1 has been reported to play a role in defence against
oxidative stress, cell proliferation and apoptosis [592]. Additionally, PRDX1 has been
reported to regulate of the NF-κB pathway [593, 594].
The transcriptional regulation of PRDX1 can occur via the action of a number of tran-
scription factors. It has previously been reported that accumulation of ROS induced by
hypoxia resulted in increased expression of PRDX1 via the Nrf2 pathway [595, 596]. Fur-
thermore, it has been suggested that PRDX1 regulated the expression of HMOX1 via the
activation of the NF-κB pathway [595]. However, the role of NF-κB in the transcriptional
regulation of HMOX1 is currently debated [597–600]. An in vivo study performed in
rodents and a study in humans have reported that Se deficiency is associated with an
increase in expression of PRDX1 [328, 520]. The data presented in this chapter using
undifferentiated Caco-2 cells agrees with the results from these studies as PRDX1 mRNA
expression was found to be increased in response to Se-depletion (Figure 4.4D). However,
Se-depletion in differentiated Caco-2 cells do not agree with the results from these in
vivo studies as no change in PRDX1 expression was observed in response to Se-depletion
(Figure 4.1D).
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Glutathione S-transferase P 1 (GSTP1)
GSTP1 belongs to the GST family of phase II detoxification enzymes, which are involved
in the neutralisation of free radicals [601]. GSTP1 in particular has been suggested to be
involved in cell proliferation and has been observed to be highly expressed in proliferating
epithelial cells [602]. Basal and inducible expression of GSTP1 has been suggested to be
partly mediated by AP-1 transcription factors [603–605]. GSTP1 mRNA expression has
also been shown to be up-regulated directly by NF-κB in response to hydrogen peroxide
treatment [606]. As Se-depletion has been associated with increased NF-κB activity, the
increase in expression of GSTP1 observed in undifferentiated Caco-2 cells in the present
work (Figure 4.4D) may be mediated by the NF-κB pathway.
However, the GSTP1 promoter contains a number of AREs, to which Nrf2 can bind and
initiate gene transcription [607, 608]. A study in human epidermal cells reported that
AREs play no role in the transcriptional regulation of GSTP1 but it is not currently
known if this ARE silencing is cell-type specific [609]. A previous study observed that
undifferentiated Caco-2 cells exhibit higher mRNA and protein expression of GSTP1 com-
pared with differentiated Caco-2 cells [407]. Although absolute quantification of mRNA
was not measured in the present work, Se-depletion resulted in increased expression of
GSTP1 in the undifferentiated Caco-2 cells but not the differentiated Caco-2 cells (Figure
4.4D and Figure 4.1D, respectively). Thus, an increase of GSTP1 expression in undiffer-
entiated Caco-2 cells relative to differentiated Caco-2 cells may contribute to the increased
responsiveness of GSTP1 to Se-depletion in undifferentiated Caco-2 cells in the present
work. Consistent with the present work, low Se status has also correlated with higher
GSTP1 mRNA expression in peripheral blood leukocytes in a previous study [520].
4.3.2 The effect of Caco-2 cell differentiation on the modula-
tory effects of selenium on the expression of selenoprotein
mRNAs
Glutathione peroxidase 1 (GPX1)
In both the differentiated and undifferentiated Caco-2 cells, Se-depletion resulted in a
decrease in GPX1 mRNA (Figure 4.3 and Figure 4.6, respectively). These data agree with
previous studies that have also shown that GPX1 is particularly sensitive to Se status as it
is particularly low on the selenoprotein hierarchy [31, 376]. In addition to being regulated
in response to Se, GPX1 mRNA expression can be up-regulated in response to oxidative
stress. Previous reports have indicated that GPX1 expression can be induced via the
binding of p53 to a p53 binding site in the GPX1 promoter [610, 611]. Additionally, GPX1
has previously been shown to be upregulated in response to oxidative stress via the NF-
κB and AP-1 transcription factors binding to their respective binding sites in the GPX1
promoter [612]. The Nrf2 or Nrf1 transcription factors have not previously been reported
to directly induce the expression of GPX1, but GPX1 expression has been reported to
correlate with Nrf1 activity [613]. The data from these studies show a decrease in GPX1
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mRNA expression in response to Se-depletion in both differentiated and undifferentiated
Caco-2 cells (Figure 4.3 and Figure 4.6, respectively). As described in Section 1.3.1, Se-
depletion has been observed to exacerbate oxidative stress and up-regulate antioxidant
enzymes. However, despite GPX1 being well characterised as an antioxidant enzyme,
Se-depletion resulted in a down-regulation of GPX1 expression. As the selenoproteins
GPX2 and TR1 were up-regulated, this may indicate a common method of transcriptional
regulation between GPX2 and TR1, discussed below, that GPX1 does not possess.
Glutathione peroxidase 2 (GPX2)
GPX2 has similar peroxidase activity as GPX1, but has a widely different tissue distribu-
tion as it is mainly expressed in IECs and is thought to be important in protection against
gut pathogens and inflammation [365, 486, 487]. Previous studies have reported that
GPX2 knockout mice are viable, but exhibit severe intestinal inflammation [150, 365, 486].
Furthermore, it has been suggested that GPX2 is able to help suppress intestinal inflam-
mation by inhibiting the expression or activity of cyclooxygenase-2 (COX-2) [488, 489].
Unlike GPX1, GPX2 mRNA was upregulated in the present work in response to Se-
depletion in both differentiated and undifferentiated Caco-2 cells (Figure 4.3 and Figure
4.6, respectively). This is consistent with a previous study in undifferentiated Caco-2
cells, which found an increase of GPX2 mRNA in response to Se-depletion [376]. An-
other study in undifferentiated Caco-2 cells found no change in GPX2 mRNA in response
to Se-depletion, but did report an increase in protein levels [229]. One mechanism by
which GPX2, but not GPX1, may be upregulated in response to Se-depletion is via the
up-regulation of GPX2 by the Nrf2 transcription factor. Unlike GPX1, GPX2 mRNA
has been shown to directly regulated by Nrf2 [229, 264, 614], which may act using a core
ARE in the GPX2 promoter [252, 615].
Glutathione peroxidase 4 (GPX4)
GPX4, much like GPX1 and GPX2, exhibits peroxidase activity and has been suggested
to play an important role in the reduction of lipid peroxides and the protection of cells
from lipid hydroperoxides [616]. The GPX4 gene consists of seven exons and is alter-
nately spliced into cytoplasmic, mitochondrial and sperm nuclear-specific isoforms [617].
GPX4 has been reported to be up-regulated in response to hydrogen peroxide treatment,
although the transcriptional regulatory mechanisms for GPX4 are not currently well un-
derstood [470, 618]. GPX4 was down-regulated in response Se-depletion, but only in
the undifferentiated Caco-2 cells (Figure 4.6C). This is consistent with previous studies
which have reported that GPX4 is regulated by Se status, but is less sensitive than GPX1
[619, 620].
Thioredoxin reductase 1 (TR1)
TR1 is an important antioxidant defence enzyme which is a regulator of the TXN system,
as discussed in further detail in Section 1.1.3. There is a well documented relationship
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between TR1 and the Nrf2 antioxidant defence pathway, where TR1 and Nrf2 have been
reported to regulate the expression and activity of the other [82–84]. TR1 contains an
ARE in its promoter, which means that its expression can be induced by Nrf2 directly. Se-
depletion is associated with increased oxidative stress, which activates the Nrf2 pathway.
As TR1 contains an ARE in its promoter, this may act as a mechanism by which TR1 is
upregulated in response to Se-depletion [85]. The present work observed an upregulation
of TR1 in response to Se-depletion, but only in the undifferentiated Caco-2 cells (Figure
4.3D). Other studies in undifferentiated Caco-2 cells have not reported any responsiveness
of TR1 to Se [229, 389, 621]. One potential explanation for the differences between results
is that the above mentioned studies did not starve Caco-2 cells of Se for as long as 72 h.
Selenoprotein P (SePP1)
SePP1 is a unique selenoprotein containing ten Sec residues, rather than the single Sec
residue that most selenoproteins possess [622]. Due to the high number of Se-containing
Sec residues and the observation that SePP1 is secreted extracellularly into the blood
stream, SePP1 has been suggested to be primary form of Se transport around the body
[622]. However, SePP1 has also been reported to have antioxidant functions via an N-
terminal Sec that is involved in catalysing the oxidation of GSH by hydrogen peroxide
[623, 624]. SePP1 has also been suggested to be important in the pathogenesis of colitis
as rodent experimental colitis models with a macrophage-specific SePP1 knockout exhibit
worsened inflammatory injury [625]. Additionally, one study observed that SePP1 was
the most highly induced gene in pro-inflammatory and tumour-conditioned macrophages,
indicating an important role for SePP1 in macrophage activity [626]. The present work
observed a decrease in SePP1 mRNA in both the differentiated and undifferentiated Caco-
2 cells (Figure 4.3E and Figure 4.6E, respectively). This agrees with a previous study
in differentiated Caco-2 cells, which found that SePP1 protein levels are responsive to Se
status [397].
Selenoprotein H (SelH)
SelH is a nuclear-localised selenoprotein which exhibits oxidoreductase activity, as dis-
cussed in further detail in Section 1.1.2. The present work observed a trend towards
decreased SelH expression in the differentiated Caco-2 cells (Figure 4.3F) and a signifi-
cant reduction in SelH expression in the undifferentiated Caco-2 cells (Figure 4.6F). This
was consistent with previous studies, which have reported that SelH expression was highly
regulated by Se status, in a number of cell types including undifferentiated Caco-2 cells
[28–31]. Se-depletion is associated with increased oxidative stress [82, 261, 262, 265, 328].
SelH has previously been suggested to mediate cytoprotective functions via modulation
of pathways involved in protection against oxidative stress [37, 41, 50, 51, 53]. The down-
regulation of the nuclear-localised SelH by Se-depletion coupled with the up-regulation
of Nrf2 target genes in the present work indicates that SelH exerts some cytoprotective
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function by associating with transcription factors in the nucleus to help facilitate the
transcription of target genes.
4.3.3 Summary
Similarly to the effects of Se-depletion observed the responses of Caco-2 cells to flagellin
(Section 3), Se-depletion resulted in the induction of oxidative-stress associated targets
but only in the undifferentiated Caco-2 cells, with NQO1 being the exception. This
indicates that the effects of Se-depletion on oxidative stress and responses to flagellin
may have a common mechanism, as differentiation of Caco-2 cells diminishes the effects
of Se in both cases. Knockdown of SelH and TR1 also had an effect on the expression
of oxidative-stress associated genes but the effects were not in line with the effects of
Se-depletion. This suggests that the effects of Se-depletion may be mediated through the
actions of SelH and TR1 but other mechanisms of modulation are likely to be involved.
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Chapter 5
Selenium as an important factor
affecting the response of gut cells to
hypoxic stress
5.1 Introduction
A tissue is described as hypoxic when the pO2 falls below levels that are considered
physiological and which lead to hypoxic stress [627]. Hypoxia has both physiological and
pathological roles, with roles ranging from angiogenesis to the pathogenesis of several
diseases, such as several cancers and gastrointestinal disorders [329].
5.1.1 Physiological and pathological hypoxia in the gut
In the gut there exists a steep oxygen gradient across the epithelium, with the oxygen
concentration at the apical IEC surface at less than 2 %, and the intestinal tissue with
approximately 8 %, as a percentage of the pO2 of arterial blood [267]. However the
luminal pO2 is subject to regular fluctuations in pO2. Food intake increases the pO2 of
the intestinal lumen whereas periods of fasting decreases the pO2 of the intestinal lumen;
these fluctuations in luminal pO2 are physiological and have been referred to as physoxia
[268, 269].
It has previously been described that a constant hypoxia-associated low-level of inflamma-
tion is the physiological norm for the gastrointestinal tract, in which the mucosal immune
response of IECs are essential in the response to this inflammation [270]. However, condi-
tions in which there is excessive and uncontrolled inflammation are characteristic of IBDs
such as Crohn’s Disease and Ulcerative Colitis [271]. Thus, the levels of inflammation in
the gut must be carefully controlled and one level of control is suggested to be via cellular
responses to hypoxia and the hypoxia signalling [272].
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5.1.2 The role for HIF-1a in the hypoxia signalling pathway
One of the primary responses to hypoxic stress is mediated by the transcription factor,
HIF-1. HIF-1 is able to bind to hypoxia response elements in the promoters of several
genes involved in the cellular response to hypoxic stress [273, 274]. The HIF-1 tran-
scription factor is a heterodimer which consists of two subunits: an α subunit which is
responsive to oxygen status, and a constitutively expressed β subunit [275]. Thus, it is
HIF-1α which is recognised as the primary modulator of the cellular responses to hypoxic
stress.
The HIF-1α protein is highly regulated by cellular pO2. During normoxia, there are
physiological pO2 levels and therefore a hypoxia response is not needed. Thus, the HIF-
1α protein is rapidly targeted for degradation. During these periods of normoxia, PHD
proteins, which are oxygen- and iron- dependent, hydroxylate two proline residues on HIF-
1α [276]. This allows pVHL to bind to it and targets HIF-1α for degradation. However,
under hypoxic conditions, oxygen-dependent hydroxylation of HIF-1α by PHD is inhibited
and results in the rapid accumulation of HIF-1α inside the cell [277]. Thus, this allows
the heterodimerisation of HIF-1α and hypoxia-inducible factor-1 beta (HIF-1β) which
can then go on to regulate the transcription of genes involved in the cellular response to
hypoxia.
5.1.3 The link between selenium and cellular responses to hy-
poxia
The literature suggests that a complex level of cross-regulation between selenium, seleno-
protein biosynthesis and responses to hypoxia exists. A number of in vivo studies in a
variety of species have suggested that supplementation with Se, in both inorganic and
organic forms, has a protective effect against hypoxic stress [289–291]. Furthermore, in
vitro studies have suggested that this effect may be due to modulatory effects of Se on
the mRNA and protein expression, as well as the transcriptional activity, of HIF-1α [292–
300]. However, the specific direction of the regulation of HIF-1α in vitro appears to be
dependent upon the dose of Se supplied. For instance, high doses of Se supplementation,
at 5 µM and greater, have been shown to have an inhibitory effect on the mRNA and
protein levels of HIF-1α [293–295, 297]. On the other hand, levels of Se closer to phys-
iological levels, between 100 and 145 nM, have shown a protective effect of Se against
hypoxic stress and raises the level of HIF-1α protein [296, 298].
Hypoxia has been shown to have a modulatory effect on some of the members of the
selenoprotein biosynthesis machinery, thereby regulating the expression of different se-
lenoproteins [301]. For instance, previous studies have shown that hypoxia has a sup-
pressive effect on the mRNA and protein levels of SePP1, TR1 and also a suppressive
effect on the enzyme activities of DIO1 and GPX [290, 301, 302]. On the contrary, hy-
poxia has been shown to increase the mRNA and protein levels of GPX1, GPX4 and
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SELENBP1 [301, 303]. Furthermore, previous studies have suggested that SELENBP1
is directly regulated by HIF-1 during hypoxia [303, 304]. Additionally, SELENBP1 has
also been suggested to regulate the expression of HIF-1α but the mechanism is currently
unknown [303, 305]. Interestingly, the regulation of some selenoproteins by hypoxia have
been described to occur via a mechanism which is independent of HIF-1 [290, 301].
5.1.4 Research aims
As introduced above, a modulatory role of HIF-1 signalling in the NF-κB pathway has
been well described in the literature. As there is evidence that suggests Se is able to
regulate cellular responses to hypoxia, this may present a possible mechanism by which
Se may modulate Caco-2 cell responses to flagellin, as reported in Section 3, via changes
in HIF-1 signalling.
The aim of the research reported in this chapter is to assess the effects of Se supple-
mentation or depletion on the expression of genes downstream of HIF-1 signalling in
differentiated and undifferentiated Caco-2 cells. Furthermore, the potential role for SelH
on the expression of these hypoxia-associated genes is also investigated.
5.2 Results
5.2.1 Effect of selenium depletion on responses to hypoxia in
differentiated Caco-2 cells
Caco-2 cells were grown on Transwell semi-permeable inserts for 18 days in order to
for them to completely polarise and differentiate, as described in Section 2.1.1. They
were then depleted (NoSe) of Se, or supplemented with Se (Se), for 72 h as described
in Section 2.1.2. Following this 72 h Se-depletion or supplementation period, cells were
exposed to hypoxia or normoxia for 7 h and then mRNA was extracted and the expression
of hypoxia-associated target genes analysed in response to 7h hypoxia or normoxia. The
levels of HIF-1α mRNA are shown in Figure 5.1. Treatment of differentiated Caco-2 cells
with hypoxia for 7 h resulted in no change in the mRNA expression of HIF-1α in either
the Se-supplemented or Se-depleted groups. Se-depletion for 72 h (NoSe) resulted in no
change in HIF-1α mRNA expression in either the normoxic or hypoxic treatment groups.
However, when data from normoxic and hypoxic treatment groups were combined, there
was an overall effect of Se depletion in reducing the expression of HIF-1α (P < 0.05).
After 72 h of either Se-depletion or Se-supplementation, the mRNA levels of the HIF-1
downstream effectors, BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3)
and prolyl hydroxylase 3 (PHD3) were measured in response to 7 h normoxia or hypoxia
(Figure 5.2). Treatment of Se-supplemented differentiated Caco-2 cells with hypoxia for
7 h resulted in a 13-fold increase in BNIP3 mRNA (P < 0.001) and a 2.8-fold increase
in PHD3 mRNA (P < 0.05), compared with the mean for Se-supplemented cells during
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Figure 5.1. Effect of 72 h Se-depletion or supplementation on the mRNA expression of HIF-1α
after treating differentiated Caco-2 cells with 7 h hypoxia. All data were normalised to the
housekeeping genes TOP1 and EIF4A2. Data were expressed as a proportion of the mean of the
Se-depleted cells treated with hypoxia in order to combine 3 distinct biological replicates, each
consisting of 4 technical replicates (n = 12). Data were analysed statistically using two-way
ANOVA with a Tukey post-test for multiple comparisons. The data are displayed as mean ±
standard error of the mean (SEM). * P < 0.05; ** P < 0.01; *** P < 0.001.
normoxia. There was no significant increase in the expression of BNIP3 or PHD3 in the
Se-depleted cells due to hypoxia. There was no change in BNIP3 or PHD3 mRNA expres-
sion in the normoxic cells due to Se-depletion. In the differentiated Caco-2 cells treated
with hypoxia, however, Se-depletion resulted in a decrease in the expression of BNIP3
and PHD3 by 58 % and 69 %, respectively (P < 0.05).
After 72 h of either Se-depletion or Se-supplementation, the mRNA levels of the seleno-
proteins GPX1, GPX2, TR1 and SelH, were measured in response to 7h normoxia or
hypoxia (Figure 5.3). Treatment of Se-supplemented differentiated Caco-2 cells with hy-
poxia for 7 h resulted in a 35 % decrease in GPX1 mRNA (P < 0.05) but not change in
the expression of other targets, compared with the mean for Se-supplemented cells during
normoxia. There was no significant change in the expression of GPX1, GPX2, TR1 or
SelH in the Se-depleted cells due to hypoxia. In the differentiated Caco-2 cells treated
with normoxia, Se-depletion resulted in a 64 % decrease in GPX1 mRNA (P < 0.001), a
68 % decrease in SelH mRNA (P < 0.01) and a 0.57-fold increase in GPX2 mRNA (P <
0.05). In the differentiated Caco-2 cells treated with hypoxia, Se-depletion resulted in a
57 % decrease in GPX1 mRNA (P < 0.01) and a 0.75-fold increase in GPX2 mRNA (P <
0.01). There was no effect of Se-depletion or hypoxia treatment on the expression levels
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Figure 5.2. Effect of 72 h selenium starvation or supplementation on the mRNA expression of
HIF-1 target genes, BNIP3 and PHD3 after treating differentiated Caco-2 cells with 7 h hypoxia
or normoxia. All data were normalised to the housekeeping genes TOP1 and EIF4A2. Data
were expressed as a proportion of the mean of the Se-depleted cells treated with hypoxia in
order to combine 3 distinct biological replicates, each consisting of 4 technical replicates (n =
12). Data were analysed statistically using two-way ANOVA with a Tukey post-test for multiple
comparisons. The data are displayed as mean ± standard error of the mean (SEM). * P < 0.05;
*** P < 0.001.
of TR1.
5.2.2 Effect of selenium depletion on responses to hypoxia in
undifferentiated Caco-2 cells
Caco-2 cells were grown on 6-well plates to confluency, as described in Section 2.1.1 before
being depleted (NoSe) of Se, or supplemented with Se (Se), for 72 h as described in Section
2.1.2. Following this 72 h Se-depletion or supplementation period, mRNA was extracted
from cells and the expression levels of hypoxia-associated target genes were analysed in
response to 7h hypoxia or normoxia.
After 72 h of either Se-depletion or Se-supplementation, the mRNA levels of HIF-1α were
measured after 7 h of normoxia or hypoxia (Figure 5.4). Treatment of undifferentiated
Caco-2 cells with hypoxia for 7 h resulted in no change in the mRNA expression of HIF-
1α in either the Se-supplemented or Se-depleted groups. Se-depletion for 72 h (NoSe)
resulted in no change in HIF-1α mRNA expression in either the normoxic or hypoxic
treatment groups, although a trend towards decreased expression was observed in the
hypoxic group (P = 0.08). However, in the context of both the normoxic and hypoxic
treatment groups, there was an overall effect of Se-depletion in reducing the expression
of HIF-1α (P < 0.01).
After 72 h of either Se-depletion or Se-supplementation, the mRNA levels of the HIF-1
downstream effectors, BNIP3 and PHD3 were measured in response to 7 h normoxia or
hypoxia (Figure 5.5). Treatment of Se-supplemented undifferentiated Caco-2 cells with
hypoxia for 7 h resulted in a 27-fold increase in BNIP3 mRNA (P < 0.001) and a 2.3-fold
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Figure 5.3. Effect of 72 h selenium starvation or supplementation on the mRNA expression of
the selenoproteins GPX1, GPX2, TR1 and SelH after treating differentiated Caco-2 cells with 7
h hypoxia or normoxia. All data were normalised to the housekeeping genes TOP1 and EIF4A2.
Data were expressed as a proportion of the mean of the Se-depleted cells treated with hypoxia
in order to combine 3 distinct biological replicates, each consisting of 4 technical replicates (n =
12). Data were analysed statistically using two-way ANOVA with a Tukey post-test for multiple
comparisons. The data are displayed as mean ± standard error of the mean (SEM). * P < 0.05;
** P < 0.01; *** P < 0.001.
increase in PHD3 mRNA (P < 0.01), compared with the mean for Se-supplemented cells
during normoxia. There was no significant increase in the expression of BNIP3 or PHD3
in the Se-depleted cells due to hypoxia. In the undifferentiated Caco-2 cells treated with
hypoxia, Se-depletion resulted in a decrease in the expression of BNIP3 and PHD3 by 86
% and 84 %, respectively (P < 0.05).
After 72 h of either Se-depletion or Se-supplementation, the mRNA levels of the seleno-
proteins GPX1, GPX2, TR1 and SelH, were measured in response to 7h normoxia or
hypoxia (Figure 5.6). Treatment of Se-supplemented undifferentiated Caco-2 cells with
hypoxia for 7 h resulted in no change in the expression of any targets, compared with
the mean for Se-supplemented cells during normoxia or hypoxia. In the undifferentiated
Caco-2 cells treated with normoxia, Se-depletion resulted in a 69 % decrease in GPX1
mRNA (P < 0.001), an 80 % decrease in SelH mRNA (P < 0.001) and a 7.6-fold increase
in GPX2 mRNA (P < 0.001). In the undifferentiated Caco-2 cells treated with hypoxia,
Se-depletion resulted in a 71 % decrease in GPX1 mRNA (P < 0.01), a 77 % decrease in
SelH mRNA (P < 0.01) and a 7.3-fold increase in GPX2 mRNA (P < 0.01).
84
N
o
rm
a
li
s
e
d
H
IF
1
a
m
R
N
A
Normoxia Hypoxia
0.0
0.5
1.0
1.5
2.0
Se
NoSe
Figure 5.4. Effect of 72 h selenium starvation or supplementation on the mRNA expression of
HIF-1α after treating undifferentiated Caco-2 cells with 7 h hypoxia. All data were normalised
to the housekeeping genes TOP1 and EIF4A2. Data were expressed as a proportion of the mean
of the Se-depleted cells. Data were analysed statistically using two-way ANOVA with a Tukey
post-test for multiple comparisons. The data are displayed as mean ± standard error of the
mean (SEM).
5.2.3 Effect of SelH knockdown on responses to hypoxia in un-
differentiated Caco-2 cells
The data presented in this chapter suggest that SelH are regulated by Se status (Figure
5.3 and Figure 5.6). Additionally, previous unpublished data from the laboratory by
Hannah Gautrey, where the expression SelH was reduced by knockdown in Caco-2 cells,
indicated a potential role for SelH in the expression of hypoxia-associated genes. Therefore
experiments were carried out to investigate the effects of SelH gene silencing under hypoxic
conditions. Knockdown of SelH expression was performed by transfection of SelH-specific
siRNAs into undifferentiated Caco-2 cells, as described in Section 2.1.3, and the mRNA
expression of hypoxia-associated genes was measured at 72 h post-transfection, after 7 h
of treatment with normoxia or hypoxia.
Following the transfection of either of two SelH-specific siRNAs, siSELH1 and siSELH2,
into undifferentiated Caco-2 cells separately, the level of SelH mRNA expression was
measured after 72 h post-transfection in order to assess the efficiency of knockdown, as
discussed in Section 4.7. The cells were then treated with 7 h normoxia or hypoxia and
the mRNA expression of HIF-1α was then measured (Figure 5.7A). Knockdown of SelH
expression using siSELH1 resulted in a 40 % decrease in HIF-1α mRNA (P < 0.001) and
treatment with siSELH2 resulted in a 0.27-fold increase in HIF-1α mRNA (P < 0.05),
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Figure 5.5. Effect of 72 h selenium starvation or supplementation on the mRNA expression
of HIF-1 target genes, BNIP3 and PHD3 after treating undifferentiated Caco-2 cells with 7 h
hypoxia or normoxia. All data were normalised to the housekeeping genes TOP1 and EIF4A2.
Data were expressed as a proportion of the mean of the Se-depleted cells treated with hypoxia.
Data were analysed statistically using two-way ANOVA with a Tukey post-test for multiple
comparisons. The data are displayed as mean ± standard error of the mean (SEM). ** P <
0.01; *** P < 0.001.
compared with cells treated with negative control siRNA. There was a significant differ-
ence detected between the level of HIF-1α expression after treatment with siSELH1 and
siSELH2 (P < 0.001). Additionally, the level of HIF-1α protein was measured following
treatment with 3 h and 7 h hypoxia, after 72 h post-transfection with siSELH1 (Figure
5.7B). Treatment with siSELH1 resulted in an approximate 45 % reduction in band in-
tensity of HIF-1α protein after 3 h and 7 h hypoxia after normalisation against β-actin
band intensity.
At 72 h post-transfection with the SelH-specific siRNAs, siSELH1 and siSELH2, the
cells were then treated with 7 h normoxia or hypoxia and the mRNA expression of HIF-
1 targets, BNIP3 and PHD3, were then measured (Figure 5.8). Knockdown of SelH
expression using siSELH1 resulted in a 50 % decrease in BNIP3 mRNA (P < 0.001) but
treatment with siSELH2 resulted in no change in BNIP3 mRNA (P < 0.05), compared
with cells treated with negative control siRNA. There was a significant difference detected
between the level of BNIP3 expression after treatment with siSELH1 and siSELH2 (P <
0.01). Knockdown of SelH expression with siSELH1 or siSELH2 resulted in no change in
PHD3 expression in undifferentiated Caco-2 cells treated with 7 h hypoxia.
5.3 Discussion
Se-depletion was found to have a significant inhibitory effect on the expression of down-
stream HIF-1α targets in both differentiated and undifferentiated Caco-2 cells (Figure
5.2 and Figure 5.4, respectively). Interestingly, Se-depletion had no effect on the mRNA
expression of HIF-1α in either the differentiated or undifferentiated Caco-2 cells within
each hypoxic or normoxic treatment group but Se-depletion did reduce the level of HIF-
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Figure 5.6. Effect of 72 h selenium starvation or supplementation on the mRNA expression
of the selenoproteins GPX1, GPX2, TR1 and SelH after treating undifferentiated Caco-2 cells
with 7 h hypoxia or normoxia. All data were normalised to the housekeeping genes TOP1 and
EIF4A2. Data were expressed as a proportion of the mean of the Se-depleted cells treated with
hypoxia. Data were analysed statistically using two-way ANOVA with a Tukey post-test for
multiple comparisons. The data are displayed as mean ± standard error of the mean (SEM). **
P < 0.01; *** P < 0.001.
1α mRNA in the context of both treatment groups combined (Figure 5.1 and Figure
5.4). Hypoxia itself did not appear to modulate the mRNA expression of many seleno-
proteins, with only GPX1 being down-regulated in the differentiated Caco-2 cells (Figure
5.3). Previous microarray data from the laboratory suggested a role for SelH in hypoxia
signalling and thus SelH knockdowns were performed using two different SelH-specific
siRNAs, siSELH1 and siSELH2, but the effects on HIF-1α expression and HIF-1 target
genes were found to be inconsistent between the two siRNAs (Figure 5.7 and Figure 5.8,
respectively). Thus, the present work suggests a role for selenium in hypoxia signalling
in Caco-2 cells but the role for SelH remains poorly understood.
5.3.1 The effect of Caco-2 cell differentiation on the modulatory
effects of selenium on Caco-2 cell responses to hypoxia and
potential roles for SelH
HIF-1α is the hypoxia-regulated subunit of the heterodimeric transcription factor, HIF-
1, which is one of the primary regulators of cellular responses to hypoxia [275]. HIF-1
activation induced by hypoxia has previously been demonstrated in both differentiated
and undifferentiated Caco-2 cells [628, 629]. HIF-1α is regulated post-translationally by
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Figure 5.7. A: Effect of 72 h treatment with SelH-specific siRNAs, siSELH1 and siSELH2, or
negative control siRNA on the mRNA expression of HIF-1α after treating undifferentiated Caco-
2 cells with 7 h hypoxia. All mRNA data were normalised to the housekeeping genes TOP1 and
EIF4A2. Data were expressed as a proportion of the mean of the Se-depleted cells. Data were
analysed statistically using one-way ANOVA with a Tukey post-test for multiple comparisons.
The data are displayed as mean ± standard error of the mean (SEM). * P < 0.05; *** P <
0.001.
hypoxia and thus the mRNA expression level of HIF-1α does not necessarily change when
placed in hypoxia [630], although it has been previously demonstrated that HIF-1α mRNA
expression can decrease in Caco-2 cells over long periods of hypoxia due to the action of
miRNA-155 [631]. The present results are consistent with these findings as there was an
induction of hypoxia targets as a result of hypoxia but there was no change in HIF-1α
mRNA in either the differentiated or undifferentiated Caco-2 cells (Figure 5.1 and Figure
5.4, respectively).
Although no significant effect of Se-depletion on the mRNA expression of HIF-1α was
detected within normoxic and hypoxic groups, a global effect Se-depletion on reducing
HIF-1α mRNA expression was detected in both differentiated and undifferentiated Caco-2
cells. These data agree with previous studies that used physiological levels of Se and found
Se-depletion to result in lower levels of HIF-1α protein [296, 298]. However, other studies
that have treated cells with concentrations of Se greater than 5 µM, which are regarded
as inducing apoptosis [632, 633], have found that Se has an inhibitory effect of HIF-1α
mRNA and protein [293–295, 297]. Although HIF-1α protein levels were not measured in
the present experiments on Se-depleted cells, HIF-1α protein was measured in response
to knockdown of SelH expression using a SelH-specific siRNA (Figure 5.7). The results
here suggest that a decrease in HIF-1α mRNA by 30 % resulted in an approximate 45 %
reduction in HIF-1α protein. Thus, Se may be able to regulate the level of HIF-1α protein
via changes in transcription or mRNA stability. In any future studies, the protein levels
of HIF-1α should be measured in order to assess whether or not the decrease in mRNA
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Figure 5.8. Effect of 72 h treatment with SelH-specific siRNAs, siSELH1 and siSELH2, or
negative control siRNA on the mRNA expression of HIF-1 target genes, BNIP3 and PHD3,
after treating undifferentiated Caco-2 cells with 7 h hypoxia. All mRNA data were normalised
to the housekeeping genes TOP1 and EIF4A2. Data were expressed as a proportion of the mean
of the Se-depleted cells. Data were analysed statistically using one-way ANOVA with a Tukey
post-test for multiple comparisons. The data are displayed as mean ± standard error of the
mean (SEM). ** P < 0.01; *** P < 0.001.
of HIF-1α results in a significantly decreased protein level of HIF-1α. However, it is not
currently known to what extent the effect of SelH knockdown had on the transcriptional
regulation of HIF-1α.
The mechanism by which Se modulates the expression level of HIF-1α is currently not well
understood. One study has reported that high doses of Se, the in form of methylseleninic
acid (MeSA), inhibited the expression and activity of HIF-1α and does not affect the
expression of HIF-1β in prostate cancer cells [295]. HIF-1α has also been shown to be
induced by the phosphoinositide 3-kinase (PI3K) pathway in a number of cell types [634–
636]. The PI3K pathway has also been reported to be modulated by Se [637, 638]. Thus,
this may be a potential mechanism by which Se can modulate responses to hypoxia.
However, further study is required to determine how signal transduction of the PI3K
pathway during hypoxia is modulated by Se. Additionally in this earlier study, treatment
of prostate cancer cells with MeSA resulted in decreased DNA binding of HIF-1α and
down-regulation of HIF-1 target genes. On the other hand, treatment with high doses
of selenite was not reported to result in any significant changes in HRE transcriptional
activity. In another study, treatment of a renal cancer cell line with high doses of Se in
the form of methylselenocysteine resulted in inhibition of HIF-1α protein synthesis via a
post-translational mechanism dependent upon the action of prolyl hydroxylase 2 (PHD2)
[297].
In the present work, in order to assess whether Se-depletion had an effect of the expression
of downstream HIF-1 targets, the expression levels of BNIP3 and PHD3 were measured.
BNIP3 is a hypoxia-inducible gene which can be regulated at the transcriptional level
by HIF-1α by the binding of it to a HRE in the promoter of BNIP3 [639, 640]. Inter-
89
estingly, the NF-κB subunit, p65, has previously been reported to bind to the BNIP3
promoter and repress its transcription [641]. The down-regulation of BNIP3 by NF-κB
signalling is discussed in Chapter 6. PHD3, along with prolyl hydroxylase 1 (PHD1) and
PHD2, functions as an oxygen-sensor which is able to hydroxylate HIF-1α and target
it for pVHL-mediated proteasomal degradation [642]. compared with PHD1 and PHD2,
PHD3 has comparatively better hydroxylating activity during hypoxia and is more highly
induced by hypoxia [643–647]. In Caco-2 cells and IECs, PHD3 has also been reported
to have a protective effect on barrier function by stabilising occludin [648]. The PHD3
promoter region has been found to contain a HRE to which HIF-1α can bind and induce
expression of PHD3 in response to hypoxia [649]. PHD3 has also been reported to be a
negative regulator of NF-κB transcriptional activity in a hydroxylase-dependent manner
[650, 651]. The data presented in this chapter suggest that Se-depletion represses the
mRNA expression of BNIP3 and PHD3 in both differentiated and undifferentiated Caco-
2 cells (Figure 5.2 and Figure 5.5, respectively). This may be due to the down-regulation
of HIF-1α mRNA by Se-depletion (Figure 5.1 and Figure 5.4), resulting in lower HIF-1α
protein levels and thus lower transcription of hypoxia-responsive genes with a HRE in
their promoter.
5.3.2 A potential role for SelH in the regulation of the responses
to hypoxia
Treatment of Caco-2 cells with siSELH1 and siSELH2 had opposite effects on HIF-1α
mRNA levels (Figure 5.7A), despite resulting in similar size knockdown of SelH mRNA
(Figure 4.7). This inconsistent effect on SelH mRNA knockdown between the two siRNAs
could be explained due to an off-target effect by one or both siRNA sequences. However,
the probability of both distinct sequences observing an off-target effect that affected HIF-
1α mRNA is unlikely. As SelH has previously been suggested to be able to bind directly
to DNA [37], it may be possible that differences in the protein level of SelH, which were
not assessed in the present work, may account for the differences in regulation of HIF-1α
mRNA. Furthermore, if SelH has a modulatory role in the transcriptional regulation of
HIF-1α, the relationship between SelH protein levels and transcriptional regulation may
not exhibit a non-linear behaviour, an effect which has been described for some other
transcription factors [652, 653].
The present data showed an effect of SelH knockdown using siSELH1, but not siSELH2, on
the expression level of BNIP3. As siSELH1 treatment reduced both HIF-1α mRNA and
protein, the effect of knockdown of SelH on BNIP3 may be due to decreased transcriptional
activity of HIF-1α on the promoter of BNIP3. Furthermore, SelH has previously been
suggested to have redox functions [37, 38] which can affect the ability of HIF-1α to bind to
DNA and thus affect its ability to regulate the transcription of target genes [654]. However,
there was no effect of SelH knockdown on the mRNA expression of PHD3 which may
suggest that SelH modulation of hypoxia-associated targets may not be through altered
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expression of HIF-1α. Instead, it may be possible that SelH is able to bind to a select
group of HIF-1 targets using its AT-binding hook and regulate gene expression directly.
On the other hand, it may also be possible that hypoxia-induced expression PHD3 reaches
a maximum at low levels of HIF-1α and thus is less sensitive to changes in HIF-1α protein
levels. This is supported by previous studies which have reported that PHD3 is highly
responsive to hypoxia relative to the other prolyl hydroxylases [643–647].
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Chapter 6
The effect of different gaseous
environments on the modulatory
effects of selenium of differentiated
Caco-2 cell responses to flagellin
6.1 Introduction
The responses of IECs to microbial challenges have previously been reported to be altered
by the pO2 of the environment within which the cells are present [284]. Most studies,
however, are performed in a normoxic environment containing 20 % oxygen or hypoxic
environment containing 1 % oxygen.
The situation in vivo is quite different as the cells are exposed to a steep oxygen gradient
- from a relatively normoxic (aerobic) basolateral side to an anoxic (anaerobic) apical
side, but this is a technically challenging system to model in vitro. A novel cell culture
chamber system has been developed, which allows the cells to be treated in a dualoxic
environment where the apical membrane of cells is exposed to an anoxic environment and
the basolateral membrane of cells are exposed to a normoxic environment (Figure 2.1), as
described in Section 2.1.6.
Both in vitro and in vivo studies have indicated that hypoxia activates the NF-κB sig-
nalling pathway [655]. However, during inflammation, hypoxia signalling via HIF-1 was
found to be able to repress NF-κB activity [331]. Thus, it has been suggested that there
are a number of complex interactions between hypoxia and the inflammatory responses
[656].
In particular, HIF-1α has been suggested to have a protective role in the defence against
intestinal pathogens via the promotion of IEC barrier function and inhibiting IEC apop-
tosis [285, 656]. In a murine colitis model, knockout of HIF-1α in IECs was found to
exacerbate symptoms and reduce barrier function of the intestinal epithelium [286]. In
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contrast,, HIF-1α has been found to be highly expressed in IECs in patients with IBD
[283], and the use of inhibitors to inhibit the degradation of HIF-1α reduced the mu-
cosal damage caused by inflammation [285, 287]. Thus, a very complex cross-talk exists
between cellular responses to hypoxia, HIF-1 signalling and NF-κB activation.
6.1.1 Research aims
The data reported in Chapter 3 and Chapter 5, have suggested that Se modulates the
responses of Caco-2 cells to both flagellin and hypoxia when cells are grown under nor-
moxic or hypoxic conditions. However in vivo, IECs form a barrier across a steep oxygen
gradient in the gut and therefore it is important to explore the modulation of Caco-2 cell
responses to Se when the cells are grown in a more physiological dualoxic environment.
Experiments were performed to investigate the modulatory role of Se in the responses of
Caco-2 cells to flagellin in differentiated cells grown under conditions where the apical
surface was in anoxic conditions, and the basolateral surface was in normoxic gaseous
conditions.
6.2 Results
6.2.1 Effect of a different gaseous environments and a novel du-
aloxic cell culture chamber on the modulatory effects of
selenium on the induction of immune effectors by flagellin
in differentiated Caco-2 cells
Differentiated Caco-2 cells were grown on Transwell semi-permeable inserts for 18 days,
as described in Section 2.1.1. They were then depleted of Se (NoSe), or supplemented
with Se (Se), for 72 h as described in Section 2.1.2.
Following the 72 h depletion (NoSe) or supplementation (Se) period, the cells were placed
in either a normoxic, hypoxic or dualoxic environment for 6 h, followed by a 6 h challenge
with or without flagellin, after which the mRNA expression level of the immune effectors
IL-8, hBD2, TNF-α and hBD1 were measured Additionally, the protein level of secreted
IL-8 was measured in spent culture medium.
After 6 h treatment with or without flagellin, the level of IL-8 mRNA expression was
measured in differentiated Caco-2 cells under conditions of normoxia, hypoxia and du-
aloxia (Figure 6.1A). In a normoxic environment, flagellin treatment induced a 23-fold
increase in IL-8 mRNA expression in the Se-supplemented cells (P < 0.001) and a 28-fold
increase in the Se-depleted cells (P < 0.001). Additionally, the Se-depleted cells exhibited
a 2.4-fold increased level of induced IL-8 mRNA compared with the Se-supplemented cells
(P < 0.01).
In the Caco-2 cells treated in a hypoxic environment, flagellin treatment induced a 13-
fold increase in IL-8 mRNA expression in the Se-supplemented cells (P < 0.01) and a
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42-fold increase in the Se-depleted cells (P < 0.01). There was no statistically significant
difference in induced IL-8 mRNA levels detected due to Se-depletion in the hypoxic cells.
In the Caco-2 cells treated in a dualoxic environment, flagellin treatment induced an
increase in IL-8 mRNA expression of 14-fold in the Se-supplemented cells (P < 0.001)
and of 8.9-fold in the Se-depleted cells (P < 0.001). There were no statistically significant
differences in induced IL-8 mRNA levels detected due to Se-depletion in the dualoxic
cells. The Se-depleted cells treated with flagellin in dualoxia had reduced expression of
IL-8 when compared with the Se-depleted cells treated with flagellin in hypoxia (P <
0.01).
Secreted IL-8 protein induced by flagellin was also measured from differentiated Caco-2
cells under conditions of normoxia, hypoxia and dualoxia (Figure 6.1B). In the Caco-
2 cells treated in a normoxic environment, flagellin treatment induced an increase in
secreted IL-8 protein of 97-fold in the Se-supplemented cells (P < 0.001) and of 79-fold in
the Se-depleted cells (P < 0.001). Additionally, the Se-depleted cells exhibited a 0.14-fold
increased level of induced IL-8 protein compared with the Se-supplemented cells (P <
0.05).
In the Caco-2 cells treated in a hypoxic environment, flagellin treatment induced an
increase in secreted IL-8 protein of 89-fold in the Se-supplemented cells (P < 0.001) and
of 13-fold in the Se-depleted cells (P < 0.001). There was no change in induced IL-8
protein detected due to Se-depletion.
In the Caco-2 cells treated in a dualoxic environment, flagellin treatment induced an in-
crease in secreted IL-8 protein of 21-fold in the Se-supplemented cells (P < 0.01) and of
21-fold in the Se-depleted cells (P < 0.05). There was no change in induced IL-8 pro-
tein levels detected due to Se-depletion. The dualoxic environment resulted in decreased
secreted IL-8 protein for both the Se-supplemented and Se-depleted cells compared with
the cells treated in normoxia (P < 0.05 and P < 0.001, respectively). When compared
with Se-depleted cells treated in hypoxia, the dualoxic environment Se-depleted cells ex-
hibited decreased secreted IL-8 protein levels (P < 0.001). Additionally, the normoxic
Se-supplemented cells exhibited an increased induced IL-8 protein level compared with
the challenged Se-supplemented cells in hypoxia (P < 0.05).
After 6 h treatment with or without flagellin, the level of hBD2 mRNA expression was
measured in the differentiated Caco-2 cells under conditions of normoxia, hypoxia and du-
aloxia (Figure 6.2). In the Caco-2 cells treated in a normoxic environment, flagellin treat-
ment induced a increase in hBD2 mRNA expression of 8.4-fold in the Se-supplemented
cells (P < 0.001) and of 4.6-fold in the Se-depleted cells (P < 0.001). The Se-depleted
cells showed a similar level of induced hBD2 mRNA compared with the Se-supplemented
cells (P = 0.21).
In the hypoxic environment, flagellin treatment induced a increase in hBD2 mRNA expres-
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Figure 6.1. Effect of 72 h Se supplementation (Se) or selenium depletion (NoSe) on the mRNA
(A) and protein (B) expression of IL-8 in response to 6 h flagellin (+F) treatment differentiated
Caco-2 cells. All mRNA data were normalised the housekeeping genes TOP1 and EIF4A2. Data
were expressed as a proportion of the mean of the NoSe flagellin treated cells in order to combine
2 distinct biological replicates, each consisting of 3 technical replicates (n = 6) for cells treated
with normoxia and hypoxia. Caco-2 cells under dualoxia consisted of 1 biological replicate with
5 technical replicates (n = 5). Data were analysed statistically using two-way ANOVA with a
Tukey post-test for multiple comparisons. The data are displayed as mean ± standard error of
the mean (SEM). * P < 0.05; ** P < 0.01; *** P < 0.001.
sion of 13-fold in the Se-supplemented cells (P < 0.001) and of 14-fold in the Se-depleted
cells (P < 0.001). The Se-depleted cells were found to have a similar level of induced
hBD2 mRNA compared with the Se-supplemented cells.
In the dualoxic environment, flagellin treatment did not induce an increase in hBD2
mRNA expression. The normoxic Se-supplemented and Se-depleted Caco-2 cells chal-
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lenged with flagellin exhibited increased hBD2 mRNA when compared with their counter-
parts in the dualoxic environment (P < 0.001). Additionally, the hypoxic Se-supplemented
and Se-depleted Caco-2 cells challenged with flagellin exhibited increased hBD2 mRNA
when compared with their counterparts in the dualoxic environment (P < 0.001 and P<
0.05, respectively).
Figure 6.2 the level of TNF-α mRNA expression in differentiated Caco-2 cells under condi-
tions of normoxia, hypoxia and dualoxia. In a normoxic environment, flagellin treatment
induced a increase in TNF-α mRNA expression of 9.2-fold in the Se-supplemented cells
(P < 0.001) and of 8.9-fold in the Se-depleted cells (P < 0.001). The Se-depleted cells
showed no significant increase in level of induced TNF-α mRNA compared with the Se-
supplemented cells. In a hypoxic environment, flagellin treatment induced a increase in
TNF-α mRNA expression of 11.2-fold in the Se-supplemented cells (P < 0.001) and of
9.2-fold in the Se-depleted cells (P < 0.001). The Se-depleted cells showed no significant
increase in level of induced TNF-α mRNA compared with the Se-supplemented cells. In
a dualoxic environment, flagellin treatment induced an increase in TNF-α mRNA expres-
sion of 1.9-fold in the Se-supplemented cells (P < 0.001) and of 1.7-fold in the Se-depleted
cells (P < 0.001). The Se-depleted cells treated in dualoxia exhibited a greater level of
induced TNF-α mRNA expression compared with Se-supplemented cells (P < 0.05). The
normoxic Se-supplemented Caco-2 cells challenged with flagellin exhibited increased TNF-
α mRNA when compared with their counterparts in the hypoxic environment (P < 0.01).
Additionally, the normoxic Se-supplemented and Se-depleted Caco-2 cells challenged with
flagellin exhibited increased TNF-α mRNA when compared with their counterparts in the
dualoxic environment (P < 0.01 and P < 0.001, respectively). Furthermore, the hypoxic
Se-supplemented and Se-depleted Caco-2 cells challenged with flagellin exhibited increased
TNF-α mRNA when compared with their counterparts in the dualoxic environment (P
< 0.001).
In a normoxic environment, flagellin treatment induced a increase in hBD1 mRNA ex-
pression of 0.41-fold in the Se-supplemented cells (P < 0.01) and of 0.56-fold in the
Se-depleted cells (Figure 6.2; P < 0.001). The Se-depleted cells showed no significant in-
crease in level of induced hBD1 mRNA compared with the Se-supplemented cells. In the
hypoxic environment, flagellin treatment induced a increase in hBD1 mRNA expression
of 2.3-fold in the Se-supplemented cells (P < 0.001) and of 1.9-fold in the Se-depleted
cells (P < 0.01). The Se-depleted cells showed no significant increase in level of induced
hBD1 mRNA compared with the Se-supplemented cells. In the Caco-2 cells treated in a
dualoxic environment, flagellin treatment induced a increase in hBD1 mRNA expression
of 0.72-fold in the Se-supplemented cells (P < 0.05) and of 0.51-fold in the Se-depleted
cells (P < 0.05). The Se-depleted cells showed no significant increase in level of induced
hBD1 mRNA compared with the Se-supplemented cells. The normoxic Se-supplemented
Caco-2 cells that were not challenged with flagellin exhibited an increased level of hBD1
mRNA compared with the cells in hypoxia (P < 0.05).
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Figure 6.2. Effects of 72 h Se supplementation (Se) or selenium depletion (NoSe) on the mRNA
expression of hBD2 (A), TNF-α (B) and hBD1 (C) mRNA in response to challenge with or
without flagellin (+F or -F, respectively) for 6 h in differentiated Caco-2 cells. All mRNA data
were normalised the housekeeping genes TOP1 and EIF4A2. Data were expressed as a proportion
of the mean of the NoSe flagellin treated cells in order to combine 2 distinct biological replicates,
each consisting of 3 technical replicates (n = 6) for cells treated with normoxia and hypoxia.
Caco-2 cells under dualoxia consisted of 1 biological replicate with 5 technical replicates (n =
5). Data were analysed statistically using two-way ANOVA with a Tukey post-test for multiple
comparisons. The data are displayed as mean ± standard error of the mean (SEM). * P < 0.05;
** P < 0.01; *** P < 0.001.
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6.2.2 Effect of a different gaseous environments and a novel du-
aloxic cell culture chamber on the modulatory effects of
selenium on the induction of selenoproteins by flagellin in
differentiated Caco-2 cells
After 6 h treatment with or without flagellin, SelH, TR1 and SePP1 mRNA expression
were also measured in differentiated Caco-2 cells following normoxia, hypoxia and dualoxia
(Figure 6.3). In the normoxic environment, flagellin treatment resulted in a 21 % decrease
in SelH mRNA expression in the Se-supplemented cells. The normoxic Se-depleted cells
treated with and without flagellin resulted in decreased SelH mRNA expression compared
with Se-supplemented cells (P < 0.001). In the hypoxic environment, flagellin treatment
had no effect on the mRNA expression of SelH, but Se-depletion cells resulted in decreased
SelH mRNA expression in both the flagellin-challenged and unchallenged cells (P < 0.001).
In the Caco-2 cells treated in a dualoxic environment, neither Se nor flagellin treatments
affected the mRNA expression of SelH. The normoxic Se-supplemented cells that were
treated with flagellin exhibited an increased SelH mRNA expression level when compared
with their dualoxic counterparts (P < 0.001). The normoxic Se-supplemented cells that
were not treated with flagellin exhibited an increased SelH mRNA expression level when
compared with their counterparts in hypoxia and dualoxia (P < 0.01 and P < 0.001,
respectively). The normoxic Se-depleted cells that were not treated with flagellin exhibited
an increased SelH mRNA expression level when compared with their counterparts dualoxia
(P < 0.05). The normoxic Se-supplemented cells, both treated and untreated, exhibited
an increased SelH mRNA expression when compared with their dualoxic counterparts (P
< 0.05 and P < 0.001, respectively).
As shown in Figure 6.3B, treatment of Caco-2 cells with flagellin in a normoxic environ-
ment resulted in an increase in TR1 mRNA expression of 0.84-fold in the Se-supplemented
cells (P < 0.001). The normoxic Se-depleted cells treated with flagellin resulted in de-
creased TR1 mRNA expression compared with its Se-supplemented counterpart (P <
0.05). On the contrary, the normoxic Se-depleted cells that were not treated with flag-
ellin exhibited increased TR1 mRNA when compared with the Se-supplemented cells (P
< 0.05). In the hypoxic environment, flagellin treatment resulted an increase in TR1
mRNA expression of 0.74-fold in the Se-supplemented cells (P < 0.001) and of 0.9-fold
in the Se-depleted cells. The hypoxic cells exhibited no change in TR1 mRNA due to
Se-depletion. In the dualoxic environment, there were no effects detected due to treat-
ment with flagellin. However, Se-depletion resulted in decreased TR1 mRNA in the cells
treated with flagellin (P < 0.05). The normoxic Se-supplemented cells that were treated
with flagellin exhibited an increased TR1 mRNA expression level when compared with
their counterparts in a dualoxic environment (P < 0.001). The normoxic Se-supplemented
cells, treated with and without flagellin, exhibited increased TR1 mRNA expression when
compared with their counterparts in dualoxia (P < 0.001 and P < 0.01, respectively). The
hypoxic Se-supplemented cells that were treated with flagellin exhibited increased TR1
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Figure 6.3. Effects of 72 h Se supplementation (Se) or selenium depletion (NoSe) on the mRNA
expression of hBD2 (A), TNF-α (B) and hBD1 (C) mRNA in response to challenge with or
without flagellin (+F or -F, respectively) for 6 h in differentiated Caco-2 cells. All mRNA data
were normalised the housekeeping genes TOP1 and EIF4A2. Data were expressed as a proportion
of the mean of the NoSe flagellin treated cells in order to combine 2 distinct biological replicates,
each consisting of 3 technical replicates (n = 6) for cells treated with normoxia and hypoxia.
Caco-2 cells under dualoxia consisted of 1 biological replicate with 5 technical replicates (n =
5). Data were analysed statistically using two-way ANOVA with a Tukey post-test for multiple
comparisons. The data are displayed as mean ± standard error of the mean (SEM). * P < 0.05;
** P < 0.01; *** P < 0.001.
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mRNA expression compared with their counterparts in dualoxia (P < 0.01). Additionally,
the hypoxic Se-depleted cells that were treated with flagellin exhibited an increased TR1
mRNA expression level when compared with their counterparts in dualoxia (P < 0.01).
After 6 h treatment with or without flagellin, SePP1 mRNA expression was measured in
differentiated Caco-2 cells under conditions of normoxia, hypoxia and dualoxia (Figure
6.3C). In the normoxic environment, flagellin treatment resulted a 43 % decrease in SePP1
mRNA expression in the Se-supplemented cells (P < 0.001) and 45 % in the Se-depleted
cells (P < 0.001). The normoxic Se-depleted cells treated without flagellin resulted in
decreased SePP1 mRNA expression compared with its Se-supplemented counterpart (P
< 0.05). In the hypoxic environment, flagellin treatment resulted a 42 % decrease in
SePP1 mRNA expression in the Se-supplemented cells (P < 0.001) and 44 % in the Se-
depleted cells (P < 0.05). The hypoxic Se-depleted cells in absence of flagellin resulted in
decreased SePP1 mRNA expression compared with its Se-supplemented counterpart (P <
0.01). In the dualoxic environment, there were no effects detected due to treatment with
flagellin. However, the Se-depleted cells, both with and without flagellin, exhibited de-
creased SePP1 mRNA compared with the Se-supplemented counterparts (P < 0.05 and P
< 0.01, respectively). The normoxic Se-supplemented and Se-depleted cells that were not
treated with flagellin exhibited increased SePP1 mRNA expression when compared with
their counterparts in dualoxia (P < 0.001). The hypoxic Se-supplemented cells, treated
with flagellin, exhibited an increased SePP1 mRNA expression level when compared with
their counterparts in dualoxia (P < 0.05). The hypoxic Se-supplemented and Se-depleted
cells treated without flagellin, exhibited an increased SePP1 mRNA expression level when
compared with their counterparts in dualoxia (P < 0.001).
100
6.3 Discussion
The data presented in previous chapters suggest that Se-depletion has modulatory effects
in Caco-2 cell responses to flagellin, oxidative stress and hypoxia. As discussed previously,
these pathways have been reported to be highly inter-dependent and cross-regulate each
other. Thus, it is important to determine how Se modulates the Caco-2 cell responses to
flagellin in traditional cell culture environments, compared with a more physiologically
relevant, dualoxic environment. The data presented in this chapter suggest that a Caco-2
cells treated in a physiologically-relevant dualoxic environment (anoxic apical membrane
surface conditions and normoxic basolateral membrane conditions) respond differently to
flagellin compared with their responses in normoxic and hypoxic environments. Addi-
tionally, selenoprotein mRNA changed when placed in a dualoxic environment as well as
selenoprotein expression levels in response to flagellin may change in different gaseous
environments.
However, the results described in this chapter need to be interpreted and compared with
the results from Chapter 3 with caution as working with the dualoxic environment re-
quired a fundamental change to the experimental protocol when adding flagellin to the
media. In Chapter 3, the media was changed once after 72 h Se supplementation or de-
pletion to add the media with or without flagellin. In contast, the use of the dualoxic
environment required cells to be placed in dualoxia for 4 h prior to flagellin treatment and
as replenishment of the basolateral media was not possible in the dualoxic environment
due to technical constraints, flagellin was added directly to the basolateral, and apical
media after 4 h dualoxia. In order for the experiments within the present chapter to be
comparable, the experiments performed in normoxia and hypoxia followed the same media
replenishment and flagellin treatment protocols as were performed in dualoxia. A previ-
ous study in retinal pigment epithelial cells reported that changing the media can induce
gene expression of a number of genes including HMOX1, JunB and FosB, all of which
can modulate the NF-κB pathway [657]. The results from the present chapter should be
compared tentatively with results from Chapter 3 as there is evidence to suggest that the
change in protocol may change the responses of Caco-2 cells to Se and flagellin challenge.
Additionally, caution must be observed as the dualoxic data consists of only a single bi-
ological replicate, thus more biological replicates are needed to increase the validity of
results.
In Chapter 3, IL-8 mRNA expression and secreted protein were increased in response
to treatment with flagellin under conditions of normoxia, hypoxia and dualoxia (Figure
6.1). However, in the analyses reported in this chapter, the level of flagellin-induced IL-8
mRNA was up-regulated in response to Se-depletion in the normoxic environment. This
anomaly may be due a difference in the methodology, as discussed above, which may have
induced gene expression of a number of genes including HMOX1, JunB and FosB, all of
which can have modulatory effects on the NF-κB pathway [657]. The mRNA levels of IL-8
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were unchanged between hypoxic and normoxic cells. However, IL-8 mRNA expression
and secreted protein levels of IL-8 were decreased in the Se-depleted cells treated with
flagellin, compared with relevant cells in hypoxia. Additionally, IL-8 secreted protein
concentrations were decreased from normoxia, to hypoxia and then on to dualoxia (Figure
6.1B). This agrees with findings from a previous study showing that during inflammation,
hypoxia signalling via HIF-1 was found to be able to repress NF-κB activity [331].
hBD2, TNF-α and hBD1 all showed similar responses to Se-depletion after Se-depletion
(Figure 6.2). However, TNF-α exhibited an increase in flagellin-induced mRNA expres-
sion in the dualoxic environment, but not the normoxic and hypoxic environments. hBD2
expression in the flagellin-challenged was significantly diminished compared with counter-
parts in normoxia and hypoxia. Additionally, there was no induced hBD2 expression in
dualoxia. These observations may be due to the altered TLR5 signalling resulting from
the steep oxygen-gradient across the epithelium. Although hBD2 expression has never
been measured in a dualoxic environment, hypoxia was found to induce hBD2 expression
in human macrophage cells [658]. In contrast, the data from present work showed no
effect of hypoxia on the expression of hBD2 compared with experiments performed in
normoxia.
Interestingly, hBD1 expression remained relatively constant for all treatment groups be-
tween the different gaseous environments (Figure 6.2C). However, there was a significant
decrease in expression in the hypoxic unchallenged Se-supplemented cells compared with
the normoxic counterparts, as well as a similar trend observed towards a decrease in the
Se-depleted cells. Both TNF-α and hBD2 expression were diminished in the dualoxic
environment compared with the normoxic and hypoxic environments. However, as hBD1
expression was unaffected by dualoxia, this indicated that hBD2 and TNF-α may have
a common regulatory pathway by which dualoxia diminishes their expression. As hBD1
is constitutively expressed and is not as readily as inducible as hBD2 by PAMPs via the
NF-κB pathway [114]. This may suggest that the NF-κB pathway may be mediating the
diminished expression of TNF-α and hBD2 in the dualoxic environment.
Interestingly, in the dualoxic environment Se-depletion had no effect on SelH mRNA
expression, which has previously been reported to be very responsive to Se status [28–
31]. Hypoxia has been suggested to have modulatory effects on selenoprotein biosynthesis
machinery [659]. However, the effects of hypoxia on SelH expression in response to Se-
depletion was similar to that in normoxia. Thus, the steep oxygen gradient that exists in
the dualoxic environment may have a greater effect on selenoprotein biosynthesis than the
hypoxic environment. Furthermore, the changes of TR1 and SePP1 observed in normoxia
are different than in dualoxia. However, the dualoxia experiment needs to be repeated as
a single biological replicate is insufficient for reliable conclusions.
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6.3.1 Summary
The data presented in this chapter suggest that a dualoxic environment reduces the expres-
sion of the immune mediators, IL-8, hBD2 and TNF-α and that the modulatory effects
of Se of IL-8 and hBD2 in particular, are diminished in a dualoxic environment. Fur-
thermore, a dualoxic environment down-regulated expression of the selenoprotein mRNA
for SelH and TR1 and Se-depletion had no effect on the expression of SelH in dualoxia.
However, as the data obtained from dualoxia in this chapter are from only one biological
replicate, the experiment needs to be repeated to increase the reliability of the conclusions
drawn in this chapter.
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Chapter 7
Final Discussion
The data presented in this thesis suggest a model for how Se status modulates the pro-
inflammatory response of undifferentiated Caco-2 cells to flagellin, a PAMP involved in
gut infection and inflammation (Figure 7.1). This model integrates Se modulation of
oxidative stress-associated genes (Chapter 4) and hypoxia signalling (Chapter 5), and
directs a putative model by which Se modulates the response of undifferentiated Caco-2
cells to flagellin (Chapter 3). Each chapter is discussed separately below, followed by a
discussion of how they are linked. Overall, however, the data presented in this thesis
has shown that the effects of Se-depletion in differentiated Caco-2 cells, as well as in the
physiological dualoxic environment, suggest that the effects of Se on cell stress pathways
are reduced in more physiologically-relevant IEC models. These data therefore support
further investigation on how Se status affects the responses of differentiated Caco-2 to
cellular stress.
7.1 Se and pro-inflammatory responses to flagellin
The anti-inflammatory properties of Se have been previously well documented [122, 123],
and low Se status has also been indicated to play a role in the pathogenesis of IBD, which
is a condition characterised by exaggerated immune responses to the microbiota [141–143].
However, the role of Se in the responses of in vitro models of IECs to microbial challenge
has received less attention. One study reported the effects of Se on the responses of undif-
ferentiated Caco-2 cells to microbial challenge [31], but there are no data in differentiated
Caco-2 cells, which are considered a more realistic model of IECs [339, 342, 343]. The
work presented in Chapter 3 reported that Se-depletion resulted in a higher expression
of the pro-inflammatory mediators, IL-8, hBD2, TNF-α and hBD1, in undifferentiated
Caco-2 cells (Figure 3.4), suggesting that Se, functioning through the selenoprotein, TR1,
modulates the expression of pro-inflammatory mediators.
Previous studies have reported that Se can reduce the activity of the TLR5 adaptor pro-
teins, MyD88 and TRIF, and also inhibit the binding of NF-κB to the DNA of target genes
[193, 194], but this has not been verified in Caco-2 cells. In this research, knockdown of
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the selenoprotein TR1 was found to reduce to expression of pro-inflammatory mediators
in flagellin-challenged Caco-2 cells (Figure 3.8). These data imply that increased expres-
sion of TR1 is associated with increased expression of pro-inflammatory mediators, which
agrees with data from undifferentiated Caco-2 cells that shows that TR1 expression is
elevated following Se-depletion (Figures 3.6 and 4.6). Hence, work presented in this the-
sis provides a putative mechanism with TR1 involved in mediating the pro-inflammatory
effects of low Se status, possibly through the TXN system.
7.2 Se and oxidative stress
Oxidative stress in the gut has been associated with the pathology of IBD, as well as
the pathogenesis of cancers, such as colorectal cancer [208, 660]. Se has been very well
characterised due to its antioxidant properties [2], which may explain the association
between low Se status and increased risk of cancer, including colorectal cancer [19].
The results presented in Chapter 4 showed that low Se status resulted in increased ex-
pression of genes associated with oxidative stress, which is in agreement with previous
studies [82, 261, 262]. As the genes affected by Se-depletion in Figure 4.4 all contained
an ARE, this indicated that the Nrf2 transcription factor is involved in mediating the
induction of these genes, which agrees with previous studies that link low Se status with
increased Nrf2 activity [82, 261, 262]. Interestingly, the expression of HMOX1, which is
well characterised as a Nrf2 downstream effector [661], was unaffected (Figure 4.4). This
indicated that HMOX1 is either regulated independently of Nrf2 in Se-depleted Caco-2
cells or that alternate mechanisms of regulation, such the AP-1 pathway, are involved.
In fact, the increased expression of cJUN, a member of the AP-1 family, in response to
Se-depletion (Figures 4.2 and 4.5), also supported the potential involvement of AP-1 in
the regulation of oxidative stress-associated genes in response to Se-depletion.
Knockdown of SelH and TR1 expression in undifferentiated Caco-2 cells modulated the
expression of the oxidative stress-associated targets, NQO1 and HMOX1 (Figures 4.8 and
4.11), but this was inconsistent with data from Se-depletion in undifferentiated Caco-2
cells as HMOX1 was unaffected by Se status (Figure 4.4). However, knockdown data
for both SelH and TR1 were consistent with previous studies that have reported the
regulation of oxidative stress-associated genes by these two selenoproteins [53, 82, 88, 89].
As Se-depletion impacts on the expression of all 25 selenoproteins according to their place
in the selenoprotein hierarchy, and as many have antioxidant functions [2], it is likely
that the effects of Se-depletion on the expression of oxidative stress-associated genes is a
consequence of the altered expression of a number of different selenoproteins. Thus, it is
not surprising that the knockdown of the individual selenoproteins, SelH and TR1, did
not mirror the effects of Se-depletion. These data do, however, support the hypothesis
proposed in present work that altered SelH and TR1 expression contributes to the effects
of Se-depletion on the expression of oxidative stress-associated genes.
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Figure 7.1. Schematic overview of the mechanism of action of Se-depletion on pro-inflammatory gene expression in a flagellin-challenged cell. Low Se
status results in a decrease in SelH expression and an increase in ROS associated with oxidative stress, leading to an amplification of pro-inflammatory
gene expression through increased NF-κB activity. Additionally, low Se increased expression of TR1 and subsequently and increase in TXN activity, which
is associated with increased NF-κB transcriptional activity of pro-inflammatory genes. Finally, low Se is associated with a decrease in HIF-1 signalling,
which is associated with an increase in the activity of NF-κB and thus, increased pro-inflammatory gene expression.
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7.3 Se and responses to hypoxia
The gut has a constant hypoxia-associated low-level of inflammation [270]. However,
conditions in which there is excessive and uncontrolled inflammation are characteristic of
IBDs such as Crohn’s Disease and Ulcerative Colitis [271], thus making the transcription
factor associated with hypoxia, HIF-1, a potential therapeutic target in IBD [662].
The literature suggests the existence of a complex level of cross-regulation between sele-
nium, selenoprotein biosynthesis and responses to hypoxia. The data presented in Chapter
5 agreed with previous studies that also used physiological levels of Se-supplementation,
and which reported raised HIF-1α expression following supplementation [296, 298]. Fur-
thermore, this regulation of HIF-1 signalling by Se was supported by Se-depletion being
followed by decreased expression of the downstream effectors, BNIP3 and PHD3, in both
differentiated and undifferentiated Caco-2 cells. This indicated a down-regulation of HIF-
1 transcriptional activity.
Hypoxia has been shown to have a modulatory effect on members of the selenoprotein
biosynthesis machinery, thereby regulating the expression of different selenoproteins [301].
However, the work reported in this thesis indicated that hypoxia had little effect on the
expression on selenoproteins in both the differentiated and undifferentiated Caco-2 cells
(Figures 5.3 and 5.6, respectively). Interestingly, Se-depletion had similar effects in both
the differentiated and undifferentiated Caco-2 cells on the response of downstream effector
expression to hypoxia. Further work is needed to confirm that protein synthesis of the
HIF-1 downstream effectors actually reflects changes in mRNA for both cell types. Given
the previously discussed links between HIF-1 signalling and IBD, the effects of Se on HIF-
1 pathway activity in the present work shows promise as a potential route of investigating
Se as a therapeutic target in IBD.
Previous work in the laboratory has explored potential roles for SelH in Caco-2 cells.
Microarray analysis following knockdown of SelH using SelH-specific siRNA in the Caco-
2 gut epithelial cell model suggested its involvement in the hypoxia signalling pathway
(Gautrey H, unpublished data). Based on these data, SelH was selected and experiments
performed to elucidate if SelH mediated the modulation of HIF-1 signalling by Se. Knock-
down of SelH expression using two independent siRNAs was followed by modulation of
HIF-1α mRNA expression and protein synthesis (Figure 5.7). However, the data were
conflicting as each siRNA regulated the mRNA differently. The reason for these contra-
dictory data is not clear, however, it may have been due to the differences in the size of the
knockdown of mRNA achieved by each siRNA (Figure 4.7). Hence, it would be important
in future work to perform Western blotting to assess the protein abundance of SelH after
transfection with each siRNA. As SelH has been suggested to bind to DNA, possibly in
association with transcription factors [37], the level of SelH protein might be an important
determinant of the direction of regulation of target genes. Overall, further work is needed
to characterise the actual mechanisms by which SelH regulates the transcription of HIF-1
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target genes.
7.4 Proposed mechanism of Se modulation of pro-
inflammatory gene expression in Caco-2 cells
Figure 7.1 shows a schematic overview of the proposed mechanism by which Se helps
modulate the expression of pro-inflammatory mediators. As discussed in Section 1.5,
oxidative stress, hypoxia and immune signalling have been reported to cross-regulate the
activities of one another, and each have been reported in the present work to be affected
by Se-depletion and hence, regulated by Se.
Firstly, Se has been shown to directly affect the signal transduction of NF-κB signalling
via the inhibition of MyD88 and TRIF signalling [193, 194], as well as Se supplementation
at pharmacological doses inhibiting NF-κB binding to DNA [195–197]. Furthermore, the
increase in expression of pro-inflammatory mediators following Se-depletion observed in
the present work (Figure 3.4) agrees with data in a previous study using undifferentiated
Caco-2 cells that reported that Se-depletion increased NF-κB transcriptional activity and
ROS levels [31]. Although there is evidence that suggests Se directly modulates the tran-
scription factor activity of NF-κB, the cross-talk observed between oxidative stress and
NF-κB signalling may offer an additional level of pro-inflammatory mediator regulation
by Se-depletion.
An indirect mechanism by which Se-depletion exacerbated the pro-inflammatory response
to flagellin was by increasing ROS. As shown in Figure 7.1, a decrease in Se status was
followed by an increase in the expression of oxidative stress-associated genes in unpolarised
Caco-2 cells (Figure 4.4). This followed an increase in the levels of intracellular ROS, which
was reported in a previous study investigating Se-depletion in undifferentiated Caco-2 cells
[31]. Additionally, a decrease in Se was followed by a decreased expression of SelH (Figure
4.6). SelH has previously been suggested to have a protective effect on cells and to be
involved in antioxidant defence [49–52]. Thus, decreased SelH expression may impair the
ability of cells to reduce ROS levels during oxidative stress. As discussed in Chapter 4,
oxidative stress and associated pathways can amplify pro-inflammatory gene expression
through mechanisms which are not fully understood, but may involve the Nrf2 and AP-1
pathways [177–180, 312, 313]. Thus, as a consequence, the combination of oxidative stress
and decreased SelH expression may have contributed to the increased pro-inflammatory
gene expression in flagellin-challenged Caco-2 cells observed in the present work.
Se-depletion also resulted in increased expression of TR1 (Figure 4.6), previously reported
to increase the activity of TXN. Additionally, decreased expression of TR1 by knockdown
was followed by the reduced expression of pro-inflammatory mediators in response to
flagellin challenge (Figure 3.8). Interestingly, the majority of studies in rodent and human
in vivo and in vitro models report decreases in thioredoxin reductase activity accompanied
by decreased TR1 mRNA due to Se-depletion, although the increase in mRNA tend to be
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small or has no change [229, 469–475]. However, there is one in vivo study in chickens that
reported a decrease in thioredoxin activity due to Se-deficiency but an increase in TR1
mRNA. Furthermore, the down-regulation of TR1 by siRNA or inhibitor, has previously
been reported to not change thioredoxin redox status [476–478]. Increased TXN activity
has been reported to activate the NF-κB pathway via redox control of MAPKs [77]. Thus,
TR1 may be a potential therapeutic target in IBD as it is the primary regulator of TXN,
which has been reported to be involved in experimental models of IBD [663].
Finally, Se-depletion down-regulated the expression of downstream effectors of HIF-1α
signalling in both differentiated and undifferentiated Caco-2 cells (Figures 5.2 and 5.5),
which may be explained by a decrease in HIF-1α transcription factor activity. Previous
studies have reported that HIF-1α activity inhibits the NF-κB pathway [664], thus it is
possible that the inhibition of pro-inflammatory gene expression by Se-depletion may be
mediated by decreased HIF-1 signalling.
7.5 The effects of Se in more physiological models of
intestinal epithelial cells
The data obtained from undifferentiated Caco-2 cells in the present work indicated that
Se is a modulator of the responses to flagellin, oxidative stress and hypoxia. However,
when the same experiments were performed in differentiated Caco-2 cells, which are con-
sidered to be a more physiologically relevant model [339, 342, 343], there were no observed
effects of Se on responses to flagellin and expression of genes associated with oxidative
stress. The model of Se-depletion that was used in the experiments performed in the
present work was developed in rat hepatoma cells [665] and further validated undifferen-
tiated Caco-2 cells [376]. At the time of submission, this model of Se-depletion has not
been used previously in differentiated IECs. As the effects of Se-depletion were almost
negligible in differentiated Caco-2 cells, then previous work using Se-depletion in undiffer-
entiated IEC models, which are less representative of IECs in vivo, should be interpreted
with caution. Moreover, further work is required to understand how the effects of Se-
depletion are muted in differentiated Caco-2 cells. The differentiated Caco-2 cells may be
more resistant to Se-depletion for a number of reasons, including: 1) increased stores of
intracellular Se; 2) extracellularly secreted Se, possibly incorporated into SePP1 [397]; 3)
altered selenoprotein hierarchy; 4) increased resistance to oxidative stress [407, 408].
Additionally, a dualoxic environment was used to grow differentiated Caco-2 cells in a
gaseous environment that better represents the steep oxygen gradient observed in vivo
(Figure 2.1 and Chapter 6). Interestingly, the dualoxic environment resulted in the re-
duced expression of pro-inflammatory mediators and were resistant to the effects of Se-
depletion (Figure 6.2). These data may reflect what occurs in vivo, as the immune re-
sponse may need to be suppressed to prevent the immune system over-reacting to bacteria
present in food, as well as the microbiota, as seen in IBD. Thus, future studies using in
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vitro models of the gut should take into consideration the effects of the gaseous environ-
ment of the in vivo situation that is being modelled as the present work suggests that
a dualoxic environment modulates the responses to flagellin and Se-depletion. This is
important for studies using in vitro IEC models to investigate the immunomodulatory
effects of factors, such as diet and pharmacological compounds, on the responses of IECs,
which may be considered relevant to IBD.
7.6 Summary
The overall aims of this thesis was to investigate the effects of Se-depletion, and the
selenoproteins TR1 and SelH, in the Caco-2 model of IECs on responses to flagellin,
oxidative stress and hypoxia. This aim was to be achieved by fulfilling four objectives for
both differentiated and undifferentiated Caco-2 cells. However, data were not consistent
between the two differentiation states and thus, the success of objective completion will
initially be discussed for the undifferentiated Caco-2 cells for the first three objectives.
The first objective was to investigate the effects of Se-depletion and knockdown of the ex-
pression of the selenoprotein TR1, on responses to flagellin. In the undifferentiated Caco-2
cells, Se-depletion exacerbated the mRNA expression of pro-inflammatory cytokines in re-
sponse to challenge with flagellin. TR1 mRNA was found to be induced by both flagellin
and Se-depletion and was thus considered to be an important selenoprotein in the response
of undifferentiated Caco-2 cells to flagellin. Therefore, a knockdown of TR1 mRNA by
siRNA was performed. In the Caco-2 cells that had reduced TR1 expression, there was
a significant reduction in the mRNA expression of pro-inflammatory cytokines. In sum-
mary, TR1 was suggested to have an important role in the pro-inflammatory effect of
Se-depletion on target mRNA.
The second objective was to investigate the effects of Se-depletion, and knockdown of
expression of the selenoproteins SelH and TR1, on the expression of oxidative stress-
associated genes. In the undifferentiated Caco-2 cells, Se-depletion resulted in increased
mRNA expression of genes associated with oxidative stress. The knockdown of mRNA
expression of SelH in Caco-2 cells resulted in increased expression of oxidative stress-
associated genes that had been observed to change with Se-depletion. This was not
observed when TR1 expression was reduced by knockdown. Thus, SelH was suggested
to play an important role in the effect of Se-depletion on oxidative stress-associated gene
expression.
The third objective was to investigate the effects of Se-depletion, and knockdown of
expression of the selenoprotein SelH, on the expression of hypoxia-associated genes in
response to hypoxia. In the undifferentiated Caco-2 cells, Se-depletion reduced the ex-
pression of hypoxia-associated genes in response to hypoxic stress. However, knockdown
of SelH did not result in consistent changes in hypoxia-associated gene expression. Thus,
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Se-depletion was suggested to reduce the ability of Caco-2 cells to express the mRNA of
genes associated with responses to hypoxic stress.
Interestingly, when the first three objectives were investigated in differentiated Caco-2
cells, there was no change in the majority of the stress-associated targets that were in-
vestigated. This suggested that the differentiated Caco-2 cells were more resistant to the
effects of Se-depletion than the undifferentiated Caco-2 cells. As differentiated Caco-2
cells have been considered to be more physiologically representative of IECs than un-
differentiated Caco-2 cells, this suggested that further investigation is required into IEC
models of Se deficiency.
The fourth and final objective was to investigate the effects of Se-depletion on responses to
flagellin, under conditions of normoxia, hypoxia and a novel dualoxic cell culture chamber
in differentiated Caco-2 cells. The Caco-2 cell responses to flagellin were similarly not
affected by Se-depletion in either gaseous environment. Interestingly, the expression of
the inducible pro-inflammatory cytokines were diminished in the more physiologically
relevant dualoxic environment. Thus, further work is required to investigate the effects
the Se-depletion under conditions in vitro, that are more representative of the in vivo
conditions.
Thus, in summary, the data presented in this thesis suggest that, in undifferentiated Caco-
2 cells, Se-depletion exacerbated the mRNA expression of pro-inflammatory cytokines in
response to challenge with flagellin, as well as genes associated with responses to oxida-
tive stress. Additionally, the data suggested that Se-depletion down-regulated the mRNA
expression of genes associated with responses to hypoxia. However, the data were not
consistent when the experiments were performed in differentiated Caco-2 cells, which
suggested that differentiation of Caco-2 cells may have increased their resistance to Se-
depletion. Additionally, the data were not consistent when experiments were performed
on Caco-2 cells that were cultured in a more physiologically-representative, dualoxic envi-
ronment. This outlined the requirement for further work to verify that the common IEC
model for Se-depletion is representative of how IECs respond to Se-depletion when under
stress in vivo.
7.7 Future Work
The data presented in this thesis provided a hypothetical mechanism by which Se modu-
lated the expression of genes associated with inflammation, oxidative stress and hypoxia.
However, on the whole, the current work was limited to mRNA expression levels of target
genes which, for upstream targets, was not confirmed at the protein level.
TR1 mRNA was found to be downregulated in response to Se-supplementation and was
suggested to play an important role in the response of Caco-2 cells to flagellin (Chapter 3).
However, previous work has found increased TR1 mRNA and protein levels following Se-
supplementation [229, 469–475]. Thus, it would be useful for future work to measure the
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protein level of TR1 following supplementation and depletion of Se by Western blotting.
If, for instance, the protein level of TR1 decreased in response to Se-supplementation,
this would agree with the decrease in mRNA expression of TR1 observed in the present
work, as well as fit the proposed mechanism of action in Section 7.4.
The changes in the mRNA expression of the 25 members of the selenoproteome were
limited to just measuring GPX1, GPX2, GPX4, TR1, SePP1 and SelH. Previous stud-
ies have shown that altering Se supply differentially affects the expression of the entire
selenoproteome. Additionally, the treatment of Caco-2 cells with flagellin and hypoxia
are also likely to affect other members of the selenoproteome, and multiple selenoproteins
may also be involved in coordinating responses to flagellin and hypoxia. Thus, future
work could involve examining an array of selenoprotein mRNA expression, so that all
selenoproteins are analysed in response to stress. Furthermore, it would also be useful to
measure the protein concentrations of selenoproteins, in order to investigate that changes
on the mRNA level reflect the changes in protein concentrations. Selenoproteome analyses
could be performed using laser ablation-inductively coupled plasma mass spectrometry
(LA-ICP MS), which is a semi-quantitative method for measuring the protein levels of all
25 selenoproteins [666]. This would provide insight into how the selenoproteome changes
as a whole in response to Se-depletion and other challenges.
The use of a novel dualoxic cell culture chamber allowed differentiated Caco-2 cells to be
cultured in a more physiologically-relevant environment. Although it was considered more
physiological, there is little evidence that this novel in vitro model is more representative of
IECs than undifferentiated or differentiated Caco-2 cells cultured using normal cell culture
protocols. In addition to repeating the experiments performed in Chapter 6, future work
should involve performing the same experiments in other IEC cell lines, such as HT-29
cells, in order to verify the effects of Se in other human immortalised differentiated cell
lines in a dualoxic environment. If the data are consistent, then in vivo experiments could
be performed in a rodent experimental model.
112
Chapter 8
References
[1] Margaret P Rayman. Selenium and human health. Lancet, 379(9822):1256–68, mar
2012.
[2] Susan J Fairweather-Tait, Yongping Bao, Martin R Broadley, Rachel Collings, Di-
anne Ford, John E Hesketh, and Rachel Hurst. Selenium in human health and
disease. Antioxidants & redox signaling, 14(7):1337–83, apr 2011.
[3] Douglas V Frost and Oscar E Olson. The Two Faces of Selenium - Can Selenophobia
Be Cured? CRC Critical Reviews in Toxicology, 1(4):467–514, jan 1972.
[4] Michael Scott. The Selenium Dilemma. The Journal of Nutrition, 103(6):803–810,
jun 1973.
[5] Fiona M. Fordyce. Selenium Deficiency and Toxicity in the Environment. In Olle
Selinus, editor, Essentials of Medical Geology, pages 375–416. Springer Netherlands,
Dordrecht, aug 2013.
[6] Junshi Chen. An original discovery: selenium deficiency and Keshan disease (an
endemic heart disease). Asia Pacific journal of clinical nutrition, 21(3):320–6, jan
2012.
[7] Bodo Speckmann and Holger Steinbrenner. Selenium and selenoproteins in in-
flammatory bowel diseases and experimental colitis. Inflammatory bowel diseases,
20(6):1110–9, apr 2014.
[8] Marco Vinceti. Friend or foe? The current epidemiologic evidence on selenium and
human cancer risk. Journal of environmental science and health. Part C, Environ-
mental carcinogenesis & ecotoxicology reviews, 31(4):305–41, jan 2013.
[9] Larry C. Clark. Effects of Selenium Supplementation for Cancer Prevention in
Patients With Carcinoma of the Skin. JAMA, 276(24):1957, dec 1996.
113
[10] Anna J Duffield-lillico. Selenium Supplementation and Secondary Prevention of
Nonmelanoma Skin Cancer in a Randomized Trial. CancerSpectrum Knowledge
Environment, 95(19):1477–1481, oct 2003.
[11] Yair Lotan, Phyllis J Goodman, Ramy F Youssef, Robert S Svatek, Shahrokh F
Shariat, Catherine M Tangen, Ian M Thompson, and Eric a Klein. Evaluation of
vitamin E and selenium supplementation for the prevention of bladder cancer in
SWOG coordinated SELECT. The Journal of urology, 187(6):2005–10, jun 2012.
[12] Eric A Klein, Ian M Thompson Jr, Catherine M Tangen, John J Crowley, M Scott
Lucia, Phyllis J Goodman, Lori M Minasian, Leslie G Ford, Howard L Parnes,
J Michael Gaziano, Daniel D Karp, Michael M Lieber, Philip J Walther, Laurence
Klotz, J Kellogg Parsons, Joseph L Chin, Amy K Darke, Scott M Lippman, Gary E
Goodman, and Laurence H Baker. Vitamin E and the Risk of Prostate Cancer.
306(14):1549–1556, 2014.
[13] Anna J Duffield-lillico, Mary E Reid, Bruce W Turnbull, Gerald F Combs, Eliza-
beth H Slate, Lori A Fischbach, James R Marshall, and Larry C Clark. Baseline
characteristics and the effect of selenium supplementation on cancer incidence in a
randomized clinical trial: a summary report of the Nutritional Prevention of Can-
cer Trial. Cancer epidemiology, biomarkers & prevention : a publication of the
American Association for Cancer Research, cosponsored by the American Society of
Preventive Oncology, 11(7):630–9, jul 2002.
[14] Mary E Reid, Anna J Duffield-lillico, Linda Garland, Bruce W Turnbull, Larry C
Clark, and James R Marshall. Selenium Supplementation and Lung Cancer Inci-
dence : An Update of the Nutritional Prevention of Cancer Trial Selenium Supple-
mentation and Lung Cancer Incidence : An Update of the Nutritional Prevention
of Cancer Trial 1. pages 1285–1291, 2002.
[15] A.J. Duffield-Lillico, B.L. Dalkin, M.E. Reid, B.W. Turnbull, E.H. Slate, E.T. Ja-
cobs, J.R. Marshall, and L.C. Clark. Selenium supplementation, baseline plasma
selenium status and incidence of prostate cancer: an analysis of the complete treat-
ment period of the Nutritional Prevention of Cancer Trial. BJU International,
91(7):608–612, apr 2003.
[16] Klein EA, Thompson IM, Tangen CM, and et Al. Vitamin e and the risk of
prostate cancer: The selenium and vitamin e cancer prevention trial (select). JAMA,
306(14):1549–1556, oct 2011.
[17] Mark a Moyad. Heart healthy=prostate healthy: SELECT, the symbolic end of
preventing prostate cancer via heart unhealthy and over anti-oxidation mechanisms?
Asian journal of andrology, 14(2):243–4, mar 2012.
114
[18] John Hesketh. Selenium and Cancer: A Story that Should not be Forgotten -
Insights from Genomics. Advances in Nutrition and Cancer, 159:145–166, 2014.
[19] David J Hughes, Veronika Fedirko, Mazda Jenab, Lutz Schomburg, Catherine
Me´plan, Heinz Freisling, H B As Bueno-de Mesquita, Sandra Hybsier, Niels-Peter
Becker, Magdalena Czuban, Anne Tjønneland, Malene Outzen, Marie-Christine
Boutron-Ruault, Antoine Racine, Nadia Bastide, Tilman Ku¨hn, Rudolf Kaaks,
Dimitrios Trichopoulos, Antonia Trichopoulou, Pagona Lagiou, Salvatore Panico,
Petra H Peeters, Elisabete Weiderpass, Guri Skeie, Engeset Dagrun, Maria-Dolores
Chirlaque, Maria-Jose Sa´nchez, Eva Ardanaz, Ingrid Ljuslinder, Maria Wennberg,
Kathryn E Bradbury, Paolo Vineis, Alessio Naccarati, Domenico Palli, Heiner Boe-
ing, Kim Overvad, Miren Dorronsoro, Paula Jakszyn, Amanda J Cross, Jose Ramo´n
Quiro´s, Magdalena Stepien, So Yeon Kong, Talita Duarte-Salles, Elio Riboli, and
John E Hesketh. Selenium status is associated with colorectal cancer risk in the
European prospective investigation of cancer and nutrition cohort. International
journal of cancer. Journal international du cancer, 00:1–13, jul 2014.
[20] Marina V Kasaikina, Dolph L Hatfield, and Vadim N Gladyshev. Understanding
selenoprotein function and regulation through the use of rodent models. Biochimica
et biophysica acta, 1823(9):1633–42, sep 2012.
[21] Jesse Donovan and Paul R Copeland. Threading the needle: getting selenocysteine
into proteins. Antioxidants & redox signaling, 12(7):881–892, mar 2010.
[22] Sotiria Palioura, R Lynn Sherrer, Thomas A Steitz, Dieter So¨ll, and Miljan Si-
monovic. The human SepSecS-tRNASec complex reveals the mechanism of seleno-
cysteine formation. Science (New York, N.Y.), 325(5938):321–5, jul 2009.
[23] Laura V Papp, Jun Lu, Frank Striebel, Derek Kennedy, Arne Holmgren, and
Kum Kum Khanna. The redox state of SECIS binding protein 2 controls its local-
ization and selenocysteine incorporation function. Molecular and cellular biology,
26(13):4895–910, jul 2006.
[24] Anton A. Turanov, Alexei V. Lobanov, Dolph L. Hatfield, and Vadim N. Gladyshev.
UGA codon position-dependent incorporation of selenocysteine into mammalian
selenoproteins. Nucleic Acids Research, 41:6952–6959, may 2013.
[25] Edyta Reszka, Ewa Jablonska, Jolanta Gromadzinska, and Wojciech Wasowicz.
Relevance of selenoprotein transcripts for selenium status in humans. Genes &
nutrition, 7(2):127–37, apr 2012.
[26] Arne Holmgren and Jun Lu. Thioredoxin and thioredoxin reductase: current re-
search with special reference to human disease. Biochemical and biophysical research
communications, 396(1):120–4, may 2010.
115
[27] Sergey V Novoselov, Gregory V Kryukov, Xue-Ming Xu, Bradley A Carlson,
Dolph L Hatfield, and Vadim N Gladyshev. Selenoprotein H is a nucleolar
thioredoxin-like protein with a unique expression pattern. The Journal of biological
chemistry, 282(16):11960–8, apr 2007.
[28] Roger A Sunde, Anna M Raines, Kimberly M Barnes, and Jacqueline K Evenson.
Selenium status highly regulates selenoprotein mRNA levels for only a subset of the
selenoproteins in the selenoproteome. Bioscience reports, 29(5):329–38, oct 2009.
[29] Anna Kipp, Antje Banning, Evert M van Schothorst, Catherine Me´plan, Lutz
Schomburg, Chris Evelo, Susan Coort, Stan Gaj, Jaap Keijer, John Hesketh, and
Regina Brigelius-Flohe´. Four selenoproteins, protein biosynthesis, and Wnt sig-
nalling are particularly sensitive to limited selenium intake in mouse colon. Molec-
ular nutrition & food research, 53(12):1561–72, dec 2009.
[30] Jidong Yan, Yuewen Zheng, Zixin Min, Qilan Ning, and Shemin Lu. Selenium
effect on selenoprotein transcriptome in chondrocytes. Biometals : an international
journal on the role of metal ions in biology, biochemistry, and medicine, 26(2):285–
96, apr 2013.
[31] G Gong, C Me´plan, H Gautrey, J Hall, and J E Hesketh. Differential effects of
selenium and knock-down of glutathione peroxidases on TNFα and flagellin inflam-
matory responses in gut epithelial cells. Genes & nutrition, 7(2):167–78, apr 2012.
[32] Alexander Dikiy, Sergey V Novoselov, Dmitri E Fomenko, Aniruddha Sengupta,
Bradley a Carlson, Ronald L Cerny, Krzysztof Ginalski, Nick V Grishin, Dolph L
Hatfield, and Vadim N Gladyshev. SelT, SelW, SelH, and Rdx12: genomics and
molecular insights into the functions of selenoproteins of a novel thioredoxin-like
family. Biochemistry, 46(23):6871–82, jun 2007.
[33] J L Martin. Thioredoxin–a fold for all reasons. Structure (London, England : 1993),
3(3):245–50, mar 1995.
[34] Lisa N Kinch, David Baker, and Nick V Grishin. Deciphering a novel thioredoxin-
like fold family. Proteins, 52(3):323–31, aug 2003.
[35] Gregory V Kryukov, Sergi Castellano, Sergey V Novoselov, Alexey V Lobanov,
Omid Zehtab, Roderic Guigo´, and Vadim N Gladyshev. Characterization of mam-
malian selenoproteomes. Science (New York, N.Y.), 300(5624):1439–43, may 2003.
[36] G R Hicks and N V Raikhel. Protein import into the nucleus: an integrated view.
Annual review of cell and developmental biology, 11:155–88, jan 1995.
[37] Jun Panee, Zoia R Stoytcheva, Wanyu Liu, and Marla J Berry. Selenoprotein H is
a redox-sensing high mobility group family DNA-binding protein that up-regulates
116
genes involved in glutathione synthesis and phase II detoxification. The Journal of
biological chemistry, 282(33):23759–65, aug 2007.
[38] Zhi Huang, Jun Li, Sichun Zhang, and Xinrong Zhang. Inorganic arsenic modulates
the expression of selenoproteins in mouse embryonic stem cell. Toxicology letters,
187(2):69–76, jun 2009.
[39] Lei Cao, Jiayong Tang, Qiang Li, Jingyang Xu, Gang Jia, Guangmang Liu, Xiaoling
Chen, Haiying Shang, Jingyi Cai, and Hua Zhao. Expression of Selenoprotein Genes
Is Affected by Heat Stress in IPEC-J2 Cells. Biological Trace Element Research,
(211):354–360, 2015.
[40] Vyacheslav M Labunskyy, Dolph L Hatfield, and Vadim N Gladyshev. Seleno-
proteins: Molecular Pathways and Physiological Roles. Physiological reviews,
94(3):739–777, jul 2014.
[41] Zoia R Stoytcheva, Vladimir Vladimirov, Vanessa Douet, Ilko Stoychev, and Marla J
Berry. Metal transcription factor-1 regulation via MREs in the transcribed regions
of selenoprotein H and other metal-responsive genes. Biochimica et biophysica acta,
1800(3):416–24, mar 2010.
[42] Jason L Burkhead, Martina Ralle, Phillip Wilmarth, Larry David, and Svetlana
Lutsenko. Elevated copper remodels hepatic RNA processing machinery in the
mouse model of Wilson’s disease. Journal of molecular biology, 406(1):44–58, feb
2011.
[43] Amanda Amantana and Wolff R Vorachek. Effect of copper, zinc and cadmium on
the promoter of selenoprotein W in glial and myoblast cells. Journal of Inorganic
Biochemistry, 91(2):356–362, aug 2002.
[44] Ursula Wimmer, Ying Wang, Oleg Georgiev, and Walter Schaffner. Two major
branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glu-
tathione. Nucleic acids research, 33(18):5715–27, jan 2005.
[45] Charlene Bierl, Barbara Voetsch, Richard C Jin, Diane E Handy, and Joseph
Loscalzo. Determinants of human plasma glutathione peroxidase (GPx-3) expres-
sion. The Journal of biological chemistry, 279(26):26839–45, jun 2004.
[46] Christophe Mariller, Stephan Hardiville´, Esthelle Hoedt, Isabelle Huvent, Socorro
Pina-Canseco, and Annick Pierce. Delta-lactoferrin, an intracellular lactoferrin iso-
form that acts as a transcription factor. Biochemistry and cell biology = Biochimie
et biologie cellulaire, 90(3):307–19, jun 2012.
[47] Mathilde Breton, Christophe Mariller, Monique Bena¨ıssa, Katia Caillaux, Edith
Browaeys, Maryse Masson, Jean-Pierre Vilain, Joe¨l Mazurier, and Annick Pierce.
117
Expression of delta-lactoferrin induces cell cycle arrest. BioMetals, 17(3):325–329,
jun 2004.
[48] Huajian Gao and Chen Liu. Effects of Dietary Selenium Against Lead Toxicity on
mRNA Levels of 25 Selenoprotein Genes in the Cartilage Tissue of Broiler Chicken.
Biological Trace Element Research, 172(1):234–241, jul 2016.
[49] Kamel E Ben Jilani, Jun Panee, Qingping He, Marla J Berry, and Ping-An Li.
Overexpression of selenoprotein H reduces Ht22 neuronal cell death after UVB ir-
radiation by preventing superoxide formation. International journal of biological
sciences, 3(4):198–204, jan 2007.
[50] Natalia Mendelev, Suresh L Mehta, Sam Witherspoon, Qingping He, Jonathan Z
Sexton, and P Andy Li. Upregulation of human selenoprotein H in murine hip-
pocampal neuronal cells promotes mitochondrial biogenesis and functional perfor-
mance. Mitochondrion, 11(1):76–82, jan 2011.
[51] Suresh L Mehta, Natalia Mendelev, Santosh Kumari, and P Andy Li. Overexpres-
sion of human selenoprotein H in neuronal cells enhances mitochondrial biogenesis
and function through activation of protein kinase A, protein kinase B, and cyclic
adenosine monophosphate response element-binding protein pathway. The interna-
tional journal of biochemistry & cell biology, 45(3):604–11, mar 2013.
[52] Natalia Mendelev, Sam Witherspoon, and P Andy Li. Overexpression of human
selenoprotein H in neuronal cells ameliorates ultraviolet irradiation-induced damage
by modulating cell signaling pathways. Experimental neurology, 220(2):328–34, dec
2009.
[53] Ryan T Y Wu, Lei Cao, Benjamin P C Chen, and Wen-Hsing Cheng. Selenopro-
tein H Suppresses Cellular Senescence through Genome Maintenance and Redox
Regulation. The Journal of biological chemistry, 289(49):34378–88, dec 2014.
[54] Elias S J Arne´r. Focus on mammalian thioredoxin reductases - Important seleno-
proteins with versatile functions. Biochimica et Biophysica Acta - General Subjects,
1790(6):495–526, 2009.
[55] S R Lee, S Bar-Noy, J Kwon, R L Levine, T C Stadtman, and S G Rhee. Mammalian
thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active
site forms a thioselenide, and replacement of selenium with sulfur markedly reduces
catalytic activity. Proceedings of the National Academy of Sciences of the United
States of America, 97(6):2521–6, mar 2000.
[56] Adam P. Lothrop, Gregg W. Snider, Erik L. Ruggles, and Robert J. Hondal. Why
is mammalian thioredoxin reductase 1 so dependent upon the use of selenium?
Biochemistry, 53(3):554–565, 2014.
118
[57] S R Lee, K S Kwon, S R Kim, and S G Rhee. Reversible inactivation of protein-
tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. The
Journal of biological chemistry, 273(25):15366–72, 1998.
[58] Arne Holmgren. Thioredoxin. Annual review of biochemistry, 54:237–71, 1985.
[59] Mikaela Luthman and Arne Holmgren. Rat liver thioredoxin and thioredoxin re-
ductase: purification and characterization. Biochemistry, 21(26):6628–6633, 1982.
[60] Elias S J Arne´r and Arne Holmgren. The thioredoxin system in cancer. Seminars
in Cancer Biology, 16(6):420–426, 2006.
[61] Dler Faieeq Darweesh Mahmood, Amna Abderrazak, Khadija El Hadri, Thomas
Simmet, and Mustapha Rouis. The thioredoxin system as a therapeutic target in
human health and disease. Antioxidants & redox signaling, 19(11):1266–303, 2013.
[62] Christopher Horst Lillig and Arne Holmgren. Thioredoxin and related molecules–
from biology to health and disease. Antioxidants & Redox Signaling, 9(1):25–47,
2007.
[63] Atsushi Matsuzawa and Hidenori Ichijo. Redox control of cell fate by MAP kinase:
physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochimica et
biophysica acta, 1780(11):1325–1336, 2008.
[64] Stephan Gromer, Sabine Urig, and Katja Becker. The thioredoxin system—From
science to clinic. Medicinal Research Reviews, 24(1):40–89, 2004.
[65] Jun Lu and Arne Holmgren. The thioredoxin antioxidant system. Free radical
biology & medicine, 66:75–87, jan 2014.
[66] Yatao Du, Huihui Zhang, Xu Zhang, Jun Lu, and Arne Holmgren. Thioredoxin
1 is inactivated due to oxidation induced by peroxiredoxin under oxidative stress
and reactivated by the glutaredoxin system. Journal of Biological Chemistry,
288(45):32241–32247, 2013.
[67] Seyed Isaac Hashemy and Arne Holmgren. Regulation of the catalytic activity
and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine
residues. The Journal of biological chemistry, 283(32):21890–8, aug 2008.
[68] A Holmgren. Antioxidant function of thioredoxin and glutaredoxin systems. An-
tioxidants & redox signaling, 2(4):811–20, 2000.
[69] Jun Lu and Arne Holmgren. Thioredoxin System in Cell Death Progression. An-
tioxidants & Redox Signaling, 17(12):1738–1747, 2012.
119
[70] Walter H Watson, Jan Pohl, William R Montfort, Olga Stuchlik, Matthew S Reed,
Garth Powis, and Dean P Jones. Redox potential of human thioredoxin 1 and
identification of a second dithiol/disulfide motif. The Journal of biological chemistry,
278(35):33408–15, aug 2003.
[71] Changgong Wu, Andrew M Parrott, Cexiong Fu, Tong Liu, Stefano M Marino,
Vadim N Gladyshev, Mohit R Jain, Ahmet T Baykal, Qing Li, Shinichi Oka, Ju-
nichi Sadoshima, Annie Beuve, William J Simmons, and Hong Li. Thioredoxin
1-mediated post-translational modifications: reduction, transnitrosylation, denitro-
sylation, and related proteomics methodologies. Antioxidants & redox signaling,
15(9):2565–604, 2011.
[72] Young-Mi Go and Dean P Jones. Redox control systems in the nucleus: mechanisms
and functions. Antioxidants & redox signaling, 13(4):489–509, 2010.
[73] Jason M Hansen, Walter H Watson, and Dean P Jones. Compartmentation of
Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA
binding by thioredoxin-1. Toxicological sciences : an official journal of the Society
of Toxicology, 82(1):308–17, nov 2004.
[74] Kiichi Hirota, M Matsui, S Iwata, A Nishiyama, K Mori, and J Yodoi. AP-1
transcriptional activity is regulated by a direct association between thioredoxin and
Ref-1. Proceedings of the National Academy of Sciences of the United States of
America, 94(April):3633–3638, 1997.
[75] K Hirota, M Murata, Y Sachi, H Nakamura, J Takeuchi, K Mori, and J Yodoi. Dis-
tinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism
of redox regulation of transcription factor NF-kappaB. The Journal of biological
chemistry, 274(39):27891–7, sep 1999.
[76] Masaya Ueno, Hiroshi Masutani, Roberto Jun Arai, Akira Yamauchi, Kiichi Hi-
rota, Toshiyuki Sakai, Takashi Inamoto, Yoshio Yamaoka, Junji Yodoi, and Toshio
Nikaido. Thioredoxin-dependent redox regulation of p53-mediated p21 activation.
Journal of Biological Chemistry, 274(50):35809–35815, 1999.
[77] Venkatesh Kundumani-Sridharan, Jaganathan Subramani, and Kumuda C. Das.
Thioredoxin activates MKK4-NFκB pathway in a redox-dependent manner to con-
trol manganese superoxide dismutase gene expression in endothelial cells. Journal
of Biological Chemistry, 290(28):17505–17519, 2015.
[78] Zachary T. Kelleher, Yonggang Sha, Matthew W Foster, W. Michael Foster,
Michael T. Forrester, and Harvey E. Marshall. Thioredoxin-mediated denitrosyla-
tion regulates cytokine-induced nuclear factor κB (NF-κB) activation. The Journal
of biological chemistry, 289(5):3066–72, jan 2014.
120
[79] S U Jaeger, B O Schroeder, U Meyer-Hoffert, L Courth, S N Fehr, M Gersemann,
E F Stange, and J Wehkamp. Cell-mediated reduction of human β-defensin 1: a
major role for mucosal thioredoxin. Mucosal Immunology, 6(6):1179–90, apr 2013.
[80] Bjoern O Schroeder, Zhihong Wu, Sabine Nuding, Sandra Groscurth, Moritz Mar-
cinowski, Julia Beisner, Johannes Buchner, Martin Schaller, Eduard F Stange, and
Jan Wehkamp. Reduction of disulphide bonds unmasks potent antimicrobial activ-
ity of human β-defensin 1. Nature, 469(7330):419–423, 2011.
[81] Cheng Wang, Mingqiang Shen, Naixin Zhang, Song Wang, Yang Xu, Shilei Chen,
Fang Chen, Ke Yang, Ting He, Aiping Wang, Yongping Su, Tianmin Cheng,
Jinghong Zhao, and Junping Wang. Reduction Impairs the Antibacterial Activity
but Benefits the LPS Neutralization Ability of Human Enteric Defensin 5. Scientific
Reports, 6(February):22875, mar 2016.
[82] Raymond F Burk, Kristina E Hill, Akihiro Nakayama, Volker Mostert, Ximena A
Levander, Amy K Motley, Delinda A Johnson, Jeffrey A Johnson, Michael L Free-
man, and Lori M Austin. Selenium deficiency activates mouse liver Nrf2-ARE but
vitamin E deficiency does not. Free radical biology & medicine, 44(8):1617–23, apr
2008.
[83] Volker Mostert, Kristina E. Hill, Christopher D. Ferris, and Raymond F. Burk.
Selective induction of liver parenchymal cell heme oxygenase-1 in selenium-deficient
rats. Biological Chemistry, 384(4):681–687, 2003.
[84] Takafumi Suzuki, Vincent P Kelly, Hozumi Motohashi, Osamu Nakajima, Satoru
Takahashi, Susumu Nishimura, and Masayuki Yamamoto. Deletion of the selenocys-
teine tRNA gene in macrophages and liver results in compensatory gene induction of
cytoprotective enzymes by Nrf2. The Journal of biological chemistry, 283(4):2021–
30, jan 2008.
[85] Atsuko Sakurai, Michie Nishimoto, Seiichiro Himeno, Nobumasa Imura, Masafumi
Tsujimoto, Manabu Kunimoto, and Shuntaro Hara. Transcriptional regulation of
thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: Role
of NF-E2-related factor-2. Journal of Cellular Physiology, 203(3):529–537, 2005.
[86] Volker Mostert, Kristina E Hill, and Raymond F Burk. Loss of activity of the
selenoenzyme thioredoxin reductase causes induction of hepatic heme oxygenase-1.
FEBS letters, 541(1-3):85–8, apr 2003.
[87] Wendy L Trigona, Isis K Mullarky, Yuzhang Cao, and Lorraine M Sordillo. Thiore-
doxin reductase regulates the induction of haem oxygenase-1 expression in aortic
endothelial cells. The Biochemical journal, 394(Pt 1):207–16, feb 2006.
121
[88] Morgan L. Locy, Lynette K. Rogers, Justin R. Prigge, Edward E. Schmidt, Elias S.J.
Arne´r, and Trent E. Tipple. Thioredoxin Reductase Inhibition Elicits Nrf2-Mediated
Responses in Clara Cells: Implications for Oxidant-Induced Lung Injury. Antioxi-
dants & Redox Signaling, 17(10):1407–1416, 2012.
[89] Elena S. Suvorova, Olivier Lucas, Carla M. Weisend, Mary Clare F Rollins, Gary F.
Merrill, Mario R. Capecchi, and Edward E. Schmidt. Cytoprotective Nrf2 pathway
is induced in chronically Txnrd 1-deficient hepatocytes. PLoS ONE, 4(7), 2009.
[90] Sonya V. Iverson, Sofi Eriksson, Jianqiang Xu, Justin R. Prigge, Emily A. Talago,
Tesia A. Meade, Erin S. Meade, Mario R. Capecchi, Elias S.J. Arne´r, and Edward E.
Schmidt. A Txnrd1-dependent metabolic switch alters hepatic lipogenesis, glycogen
storage, and detoxification. Free Radical Biology and Medicine, 63:369–380, oct
2013.
[91] X Peng, P K Mandal, V O Kaminskyy, A Lindqvist, M Conrad, and E S J Arne´r.
Sec-containing TrxR1 is essential for self-sufficiency of cells by control of glucose-
derived H2O2. Cell death & disease, 5:e1235, 2014.
[92] Albena T. Dinkova-Kostova and Paul Talalay. Relation of structure of curcumin
analogs to their potencies as inducers of Phase 2 detoxification enzymes. Carcino-
genesis, 20(5):911–914, 1999.
[93] Sadagopan Magesh, Yu Chen, and Longqin Hu. Small Molecule Modulators of
Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents. Medic-
inal Research Reviews, 32(4):687–726, jul 2012.
[94] Constance Lay Lay Saw, Yue Guo, Anne Yuqing Yang, Ximena Paredes-Gonzalez,
Christina Ramirez, Douglas Pung, and Ah Ng Tony Kong. The berry constituents
quercetin, kaempferol, and pterostilbene synergistically attenuate reactive oxygen
species: Involvement of the Nrf2-ARE signaling pathway. Food and Chemical Toxi-
cology, 72:303–311, 2014.
[95] Hyunjeong Kim, Wooseong Kim, Soohwan Yum, Sungchae Hong, Jeong-Eun Oh,
Ji-Woo Lee, Mi-Kyoung Kwak, Eun Ji Park, Dong Hee Na, and Yunjin Jung. Caffeic
acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state:
structural analysis and potential as a pathologically targeted therapeutic agent in
treatment of colonic inflammation. Free radical biology & medicine, 65:552–62, dec
2013.
[96] Chenqi Hu, Aimee L. Eggler, Andrew D. Mesecar, and Richard B. Van Breemen.
Modification of Keap1 cysteine residues by sulforaphane. Chemical Research in
Toxicology, 24(4):515–521, 2011.
122
[97] Joachim Mankertz and Jo¨rg-Dieter Schulzke. Altered permeability in inflamma-
tory bowel disease: pathophysiology and clinical implications. Current opinion in
gastroenterology, 23:379–383, 2007.
[98] Navkiran Gill, Marta Wlodarska, and B. Brett Finlay. Roadblocks in the gut:
barriers to enteric infection. Cellular microbiology, 13(5):660–9, may 2011.
[99] Arthur Ouwehand, Erika Isolauri, and Seppo Salminen. The role of the intestinal
microflora for the development of the immune system in early childhood. European
journal of nutrition, 41 Suppl 1:I32–I37, 2002.
[100] Inna Sekirov, Shannon L Russell, L Caetano M Antunes, and B Brett Finlay. Gut
microbiota in health and disease. Physiological reviews, 90:859–904, 2010.
[101] Simon P. Hogan, Luqman Seidu, Carine Blanchard, Katherine Groschwitz, Anil
Mishra, Margaret L. Karow, Richard Ahrens, David Artis, Andrew J. Murphy,
David M. Valenzuela, George D. Yancopoulos, and Marc E. Rothenberg. Resistin-
like molecule beta regulates innate colonic function: barrier integrity and inflamma-
tion susceptibility. The Journal of allergy and clinical immunology, 118(1):257–68,
jul 2006.
[102] Douglas Taupin and Daniel K Podolsky. Trefoil factors: initiators of mucosal heal-
ing. Nature reviews. Molecular cell biology, 4:721–732, 2003.
[103] Lance W Peterson and David Artis. Intestinal epithelial cells: regulators of barrier
function and immune homeostasis. Nature reviews. Immunology, 14(3):141–53, feb
2014.
[104] Guido Rindi, Andrew B. Leiter, Alan S. Kopin, Cesare Bordi, and Enrico Solcia.
The ”normal” endocrine cell of the gut: Changing concepts and new evidences.
Annals of the New York Academy of Sciences, 1014:1–12, 2004.
[105] Jorge-Tonatiuh Ayala-Sumuano, Victor M Te´llez-Lo´pez, M Del Carmen Domı´nguez-
Robles, Mineko Shibayama-Salas, and Isaura Meza. Toll-like receptor signaling acti-
vation by Entamoeba histolytica induces beta defensin 2 in human colonic epithelial
cells: its possible role as an element of the innate immune response. PLoS neglected
tropical diseases, 7:e2083, 2013.
[106] Nan Li, Maria C. Quidgley, Firas H. Kobeissy, Jessica Joseph, and Josef Neu. Micro-
bial cell components induced tolerance to flagellin-stimulated inflammation through
Toll-like receptor pathways in intestinal epithelial cells. Cytokine, 60(3):806–11, dec
2012.
[107] Yusuke Yoshino, Takatoshi Kitazawa, Mahoko Ikeda, Keita Tatsuno, Shintaro
Yanagimoto, Shu Okugawa, Hiroshi Yotsuyanagi, and Yasuo Ota. Clostridium dif-
123
ficile flagellin stimulates toll-like receptor 5, and toxin B promotes flagellin-induced
chemokine production via TLR5. Life sciences, 92(3):211–7, mar 2013.
[108] Fu-Chen Chen Huang. Regulation of Salmonella flagellin-induced interleukin-8 in
intestinal epithelial cells by muramyl dipeptide. Cellular immunology, 278(1-2):1–9,
2012.
[109] Jung Mogg Kim. Antimicrobial proteins in intestine and inflammatory bowel dis-
eases. Intestinal research, 12(1):20–33, 2014.
[110] Andreas Cederlund, Gudmundur H. Gudmundsson, and Birgitta Agerberth. An-
timicrobial peptides important in innate immunity. In FEBS Journal, volume 278,
pages 3942–3951, 2011.
[111] Federico Balzola, Charles Bernstein, Gwo Tzer Ho, and Charlie Lees. Peroxisome
proliferator-activated receptor gamma activation is required for maintenance of in-
nate antimicrobial immunity in the colon: Commentary. Inflammatory Bowel Dis-
ease Monitor, 11(2):77, 2010.
[112] Sarah L Gaffen. Structure and signalling in the IL-17 receptor family. Nature
reviews. Immunology, 9(8):556–67, 2009.
[113] Jan Wehkamp, Ju¨rgen Harder, Kai Wehkamp, Birte Wehkamp-von Meissner,
Miriam Schlee, Corinne Enders, Ulrich Sonnenborn, Sabine Nuding, Stig Bengmark,
Klaus Fellermann, Jens Michael Schro¨der, and Eduard F Stange. NF-kappaB- and
AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by
Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infection and
immunity, 72(10):5750–8, oct 2004.
[114] Steven B. Lewis, Alison Prior, Samuel J. Ellis, Vivienne Cook, Simon S. M. Chan,
William Gelson, and Stephanie Schu¨ller. Flagellin Induces β-Defensin 2 in Human
Colonic Ex vivo Infection with Enterohemorrhagic Escherichia coli. Frontiers in
Cellular and Infection Microbiology, 6(June):1–12, 2016.
[115] Maria Tollin, Peter Bergman, Torgny Svenberg, Hans Jo¨rnvall, Gudmundur Hrafn
Gudmundsson, and Birgitta Agerberth. Antimicrobial peptides in the first line
defence of human colon mucosa. Peptides, 24(4):523–530, 2003.
[116] Jan Wehkamp, Juergen Harder, Michael Weichenthal, Oliver Mueller, Klaus R Her-
rlinger, Klaus Fellermann, Jens M Schroeder, and Eduard F Stange. Inducible
and constitutive beta-defensins are differentially expressed in Crohn’s disease and
ulcerative colitis. Inflammatory bowel diseases, 9(4):215–223, 2003.
[117] Marian C Aldhous, Colin L Noble, and Jack Satsangi. Dysregulation of human
beta-defensin-2 protein in inflammatory bowel disease. PloS one, 4(7):e6285, 2009.
124
[118] Franc¸ois Niyonsaba, Kazuhisa Iwabuchi, Akimasa Someya, Michimasa Hirata, Hi-
roshi Matsuda, Hideoki Ogawa, and Isao Nagaoka. A cathelicidin family of human
antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology, 106(1):20–
26, 2002.
[119] Richard L. Gallo and Lora V. Hooper. Epithelial antimicrobial defence of the skin
and intestine. Nature Reviews Immunology, 12(7):503–516, 2012.
[120] D a O’Neil, E M Porter, D Elewaut, G M Anderson, L Eckmann, T Ganz, and
M F Kagnoff. Expression and regulation of the human beta-defensins hBD-1 and
hBD-2 in intestinal epithelium. Journal of immunology (Baltimore, Md. : 1950),
163:6718–6724, 1999.
[121] Simon Ja¨ger, Eduard F. Stange, and Jan Wehkamp. Inflammatory bowel disease:
An impaired barrier disease. Langenbeck’s Archives of Surgery, 398(1):1–12, 2013.
[122] Zhi Huang, Aaron H Rose, and Peter R Hoffmann. The role of selenium in inflam-
mation and immunity: from molecular mechanisms to therapeutic opportunities.
Antioxidants & redox signaling, 16(7):705–43, apr 2012.
[123] Wayne Chris Hawkes, Diane Richter, and Zeynep Alkan. Dietary selenium sup-
plementation and whole blood gene expression in healthy North American men.
Biological Trace Element Research, 155(2):201–208, 2013.
[124] William Manzanares, Alberto Biestro, Mar´ıa H Torre, Federico Galusso, Gianella
Facchin, and Gil Hardy. High-dose selenium reduces ventilator-associated pneumo-
nia and illness severity in critically ill patients with systemic inflammation. Intensive
care medicine, 37(7):1120–7, jul 2011.
[125] Giuseppe Morgia, Sebastiano Cimino, Vincenzo Favilla, Giorgio Ivan Russo,
Francesco Squadrito, Giuseppe Mucciardi, Lorenzo Masieri, Letteria Minutoli,
Giuseppe Grosso, and Tommaso Castelli. Effects of Serenoa repens, selenium and
lycopene (Profluss®) on chronic inflammation associated with benign prostatic
hyperplasia: results of ”FLOG” (Flogosis and Profluss in Prostatic and Genital
Disease), a multicentre Italian study. International braz j urol : official journal of
the Brazilian Society of Urology, 39(2):214–21, 2013.
[126] Clement Ip, Henry J Thompson, Zongjian Zhu, and Howard E Ganther. In vitro and
in vivo studies of methylseleninic acid: evidence that a monomethylated selenium
metabolite is critical for cancer chemoprevention. Cancer research, 60(11):2882–6,
jun 2000.
[127] Huawei Zeng, Wen-Hsing Cheng, and Luann K Johnson. Methylselenol, a sele-
nium metabolite, modulates p53 pathway and inhibits the growth of colon cancer
125
xenografts in Balb/c mice. The Journal of nutritional biochemistry, 24(5):776–80,
may 2013.
[128] Kejie Chen, Xi Peng, Jing Fang, Hengmin Cui, Zhicai Zuo, Junliang Deng, Zhengli
Chen, Yi Geng, Weimin Lai, Li Tang, and Qingqiu Yang. Effects of dietary selenium
on histopathological changes and T cells of spleen in broilers exposed to aflatoxin
B1. International Journal of Environmental Research and Public Health, 11(2):1904–
1913, 2014.
[129] Jean A Hall, William R Vorachek, Whitney C Stewart, M Elena Gorman, Wayne D
Mosher, Gene J Pirelli, and Gerd Bobe. Selenium Supplementation Restores In-
nate and Humoral Immune Responses in Footrot-Affected Sheep. PLoS ONE,
8(12):e82572, dec 2013.
[130] Julia B Montgomery, Jeffrey J. Wichtel, Maureen G Wichtel, Mary A. McNiven,
J. T. McClure, Fred Markham, and David W Horohov. Effects of selenium source
on measures of selenium status and immune function in horses. Canadian Journal
of Veterinary Research, 76(4):281–291, 2012.
[131] Mette Stoedter, Kostja Renko, Antonia Ho¨g, and Lutz Schomburg. Selenium con-
trols the sex-specific immune response and selenoprotein expression during the
acute-phase response in mice. The Biochemical journal, 429(1):43–51, jul 2010.
[132] Hiroyuki Hattori, Hirotaka Imai, Kazuhisa Furuhama, Osamu Sato, and Yasuhito
Nakagawa. Induction of phospholipid hydroperoxide glutathione peroxidase in hu-
man polymorphonuclear neutrophils and HL60 cells stimulated with TNF-alpha.
Biochemical and biophysical research communications, 337(2):464–73, nov 2005.
[133] Andrew J Goldson, Susan J Fairweather-Tait, Charlotte N Armah, Yongping Bao,
Martin R Broadley, Jack R Dainty, Caroline Furniss, David J Hart, Birgit Teucher,
and Rachel Hurst. Effects of selenium supplementation on selenoprotein gene ex-
pression and response to influenza vaccine challenge: a randomised controlled trial.
PloS one, 6(3):e14771, jan 2011.
[134] Katsuyoshi Matsuoka and Takanori Kanai. The gut microbiota and inflammatory
bowel disease. Seminars in Immunopathology, 37(1):47–55, jan 2015.
[135] Iurii Koboziev, Cynthia Reinoso Webb, Kathryn L Furr, and Matthew B Grisham.
Role of the enteric microbiota in intestinal homeostasis and inflammation. Free
radical biology & medicine, 68:122–33, mar 2014.
[136] Liljana Gentschew and Lynnette R. Ferguson. Role of nutrition and microbiota in
susceptibility to inflammatory bowel diseases. Molecular nutrition & food research,
56(4):524–35, apr 2012.
126
[137] Bernard Khor, Agne`s Gardet, and Ramnik J Xavier. Genetics and pathogenesis of
inflammatory bowel disease. Nature, 474(7351):307–17, 2011.
[138] Caroline Hwang, Viveca Ross, and Uma Mahadevan. Micronutrient deficiencies
in inflammatory bowel disease: From A to zinc. Inflammatory Bowel Diseases,
18(10):1961–1981, 2012.
[139] Weicheng Liu, Yunzi Chen, Maya Aharoni Golan, Maria L Annunziata, Jie Du,
Urszula Dougherty, Juan Kong, Mark Musch, Yong Huang, Joel Pekow, Changqing
Zheng, Marc Bissonnette, Stephen B Hanauer, and Yan Chun Li. Intestinal ep-
ithelial vitamin D receptor signaling inhibits experimental colitis. The Journal of
clinical investigation, 123(9):3983–96, 2013.
[140] Caitlyn W. Barrett, Kshipra Singh, Amy K. Motley, Mary K. Lintel, Elena Mata-
fonova, Amber M. Bradley, Wei Ning, Shenika V. Poindexter, Bobak Parang,
Vishruth K. Reddy, Rupesh Chaturvedi, Barbara M. Fingleton, Mary K. Wash-
ington, Keith T. Wilson, Sean S. Davies, Kristina E. Hill, Raymond F. Burk, and
Christopher S. Williams. Dietary Selenium Deficiency Exacerbates DSS-Induced
Epithelial Injury and AOM/DSS-Induced Tumorigenesis. PLoS ONE, 8(7):1–11,
2013.
[141] Liljana Gentschew, Karen S Bishop, Dug Yeo Han, Angharad R Morgan, Alan G
Fraser, Wen Jiun Lam, Nishi Karunasinghe, Bobbi Campbell, and Lynnette R Fer-
guson. Selenium, selenoprotein genes and Crohn’s disease in a case-control popula-
tion from Auckland, New Zealand. Nutrients, 4(9):1247–59, oct 2012.
[142] Akira Andoh, Masaki Hirashima, Hiroaki Maeda, Kazunori Hata, Osamu Inatomi,
Tomoyuki Tsujikawa, Masaya Sasaki, Kazuhiko Takahashi, and Yoshihide Fujiyama.
Serum selenoprotein-P levels in patients with inflammatory bowel disease. Nutrition,
21(5):574–579, 2005.
[143] Amir Ebrahim Miroliaee, Hadi Esmaily, Amanollah Vaziri-Bami, Maryam Baeeri,
Ahmad Reza Shahverdi, and Mohammad Abdollahi. Amelioration of experimen-
tal colitis by a novel nanoselenium-silymarin mixture. Toxicology mechanisms and
methods, 21(3):200–8, 2011.
[144] T Rannem, K Ladefoged, E Hylander, J Hegnhøj, and S Jarnum. Selenium status in
patients with Crohn’s disease. The American journal of clinical nutrition, 56(5):933–
937, 1992.
[145] T Rannem, E Hylander, K Ladefoged, M Staun, L Tjellesen, and S Jarnum. The
metabolism of [75Se]selenite in patients with short bowel syndrome. JPEN. Journal
of parenteral and enteral nutrition, 20(6):412–416, 1996.
127
[146] K. Hammond. Comprehensive Nutritional Status in Patients With Long-Standing
Crohn’s Disease Currently in Remission. Nutrition in Clinical Practice, 14(2):78–78,
apr 1999.
[147] B J Geerling, A Badart-Smook, C van Deursen, A C van Houwelingen, M G Russel,
R W Stockbrugger, and R J Brummer. Nutritional supplementation with N-3 fatty
acids and antioxidants in patients with Crohn’s disease in remission: effects on
antioxidant status and fatty acid profile. Inflammatory bowel diseases, 6(2):77–84,
2000.
[148] B J Geerling, a Badart-Smook, R W Stockbru¨gger, and R J Brummer. Compre-
hensive nutritional status in recently diagnosed patients with inflammatory bowel
disease compared with population controls. European journal of clinical nutrition,
54(6):514–21, 2000.
[149] J Ringstad, S Kildebo, and Y Thomassen. Serum selenium, copper, and zinc con-
centrations in Crohn’s disease and ulcerative colitis. Scandinavian journal of gas-
troenterology, 28(7):605–8, 1993.
[150] Susanne Krehl, Maria Loewinger, Simone Florian, Anna P. Kipp, Antje Ban-
ning, Ludger a. Wessjohann, Martin N. Brauer, Renato Iori, Robert S. Esworthy,
Fong Fong Chu, and Regina Brigelius-Flohe´. Glutathione peroxidase-2 and selenium
decreased inflammation and tumors in a mouse model of inflammation-associated
carcinogenesis whereas sulforaphane effects differed with selenium supply. Carcino-
genesis, 33(3):620–628, 2012.
[151] Oren Tirosh, Eran Levy, and Ram Reifen. High selenium diet protects against
TNBS-induced acute inflammation, mitochondrial dysfunction, and secondary
necrosis in rat colon. Nutrition, 23(11-12):878–886, 2007.
[152] Anna P Kipp, Antje Banning, Evert M van Schothorst, Catherine Me´plan, Su-
san L Coort, Chris T Evelo, Jaap Keijer, John Hesketh, and Regina Brigelius-Flohe´.
Marginal selenium deficiency down-regulates inflammation-related genes in splenic
leukocytes of the mouse. The Journal of nutritional biochemistry, 23(9):1170–7, sep
2012.
[153] Anje A te Velde, Inge Pronk, Floor de Kort, and Pieter C F Stokkers. Glutathione
peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimen-
tal colitis and inflammatory bowel diseases: an important role for H2O2? European
Journal of Gastroenterology & Hepatology, 20(6), 2008.
[154] Bodo Speckmann, Antonio Pinto, Meike Winter, Irmgard Fo¨rster, Helmut Sies, and
Holger Steinbrenner. Proinflammatory cytokines down-regulate intestinal seleno-
protein P biosynthesis via NOS2 induction. Free Radical Biology and Medicine,
49(5):777–785, sep 2010.
128
[155] Juliane Hrdina, Antje Banning, Anna Kipp, Gunnar Loh, Michael Blaut, and Regina
Brigelius-Flohe´. The gastrointestinal microbiota affects the selenium status and se-
lenoprotein expression in mice. The Journal of Nutritional Biochemistry, 20(8):638–
648, aug 2009.
[156] Marina V Kasaikina, Marina a Kravtsova, Byung Cheon Lee, Javier Seravalli,
Daniel a Peterson, Jens Walter, Ryan Legge, Andrew K Benson, Dolph L Hatfield,
and Vadim N Gladyshev. Dietary selenium affects host selenoproteome expression
by influencing the gut microbiota. The FASEB journal : official publication of the
Federation of American Societies for Experimental Biology, 25(7):2492–2499, 2011.
[157] Ningbo Zhang, Wenqian Jing, Jiayue Cheng, Wentao Cui, Yulian Mu, Kui Li, and
Xingen Lei. Molecular characterization and NF-κB-regulated transcription of se-
lenoprotein S from the Bama mini-pig. Molecular Biology Reports, 38(7):4281–4286,
oct 2011.
[158] Yuan Gao, Nicholas R F Hannan, Stephen Wanyonyi, Nicky Konstantopolous,
Joanne Pagnon, Helen C Feng, Jeremy B M Jowett, Kee-Hong Kim, Ken Walder,
and Greg R Collier. Activation of the selenoprotein SEPS1 gene expression by
pro-inflammatory cytokines in HepG2 cells. Cytokine, 33(5):246–51, mar 2006.
[159] Hiroyuki Hattori, Hirotaka Imai, Kazuhisa Furuhama, Osamu Sato, and Yasuhito
Nakagawa. Induction of phospholipid hydroperoxide glutathione peroxidase in hu-
man polymorphonuclear neutrophils and HL60 cells stimulated with TNF-alpha.
Biochemical and biophysical research communications, 337(2):464–73, nov 2005.
[160] A E Pekary, L Berg, F Santini, I Chopra, and J M Hershman. Cytokines modulate
type I iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat
thyroid cells. Molecular and cellular endocrinology, 101(1-2):R31–5, may 1994.
[161] Aniko´ Zeo¨ld, Ma´rton Doleschall, Michael C. Haffner, Luciane P. Capelo, Judit
Menyhe´rt, Zsolt Liposits, Wagner S. da Silva, Antonio C. Bianco, Imre Kacskovics,
Csaba Fekete, and Bala´zs Gereben. Characterization of the Nuclear Factor-κB Re-
sponsiveness of the Human dio 2 Gene. Endocrinology, 147(9):4419–4429, sep 2006.
[162] C Kretz-Remy, P Mehlen, M E Mirault, and a P Arrigo. Inhibition of I kappa
B-alpha phosphorylation and degradation and subsequent NF-kappa B activation
by glutathione peroxidase overexpression. The Journal of cell biology, 133(5):1083–
1093, 1996.
[163] Maria T Abreu. Toll-like receptor signalling in the intestinal epithelium: how bacte-
rial recognition shapes intestinal function. Nature reviews. Immunology, 10(2):131–
44, 2010.
129
[164] Shizuo Akira, Shizuo Akira, Satoshi Uematsu, Satoshi Uematsu, Osamu Takeuchi,
and Osamu Takeuchi. Pathogen recognition and innate immunity. Cell, 124:783–
801, 2006.
[165] E Cario and D K Podolsky. Differential alteration in intestinal epithelial cell ex-
pression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease.
Infection and immunity, 68(12):7010–7017, 2000.
[166] Jan Michel Otte, Elke Cario, and Daniel K. Podolsky. Mechanisms of Cross Hypore-
sponsiveness to Toll-Like Receptor Bacterial Ligands in Intestinal Epithelial Cells.
Gastroenterology, 126(4):1054–1070, 2004.
[167] Arunan S Vamadevan, Masayuki Fukata, Elizabeth T Arnold, Lisa S Thomas, David
Hsu, and Maria T Abreu. Regulation of TLR4-associated MD-2 in intestinal ep-
ithelial cells: a comprehensive analysis. Innate Immunity, 16(2):93–103, 2010.
[168] G Pedersen, L Andresen, M W Matthiessen, J Rask-Madsen, and J Brynskov. Ex-
pression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides
in human intestinal epithelium. Clinical and experimental immunology, 141(2):298–
306, 2005.
[169] Annelie Lundin, Chek Mei Bok, Linda Aronsson, Britta Bjo¨rkholm, Jan-A˚ke
Gustafsson, Sebastian Pott, Velmurugesan Arulampalam, Martin Hibberd, Joseph
Rafter, and Sven Pettersson. Gut flora, Toll-like receptors and nuclear receptors:
a tripartite communication that tunes innate immunity in large intestine. Cellular
Microbiology, 10(5):1093–1103, may 2008.
[170] Takumi Kawasaki and Taro Kawai. Toll-like receptor signaling pathways. Frontiers
in Immunology, 5(SEP):1–8, 2014.
[171] S H Rhee, E Im, and C Pothoulakis. Toll-like receptor 5 engagement modulates
tumor development and growth in a mouse xenograft model of human colon cancer.
Gastroenterology, 135(2):518–528, 2008.
[172] Yoon Jeong Choi, Eunok Im, Hyo Kyun Chung, Charalabos Pothoulakis, and
Sang Hoon Rhee. TRIF mediates toll-like receptor 5-induced signaling in intestinal
epithelial cells. Journal of Biological Chemistry, 285(48):37570–37578, 2010.
[173] Christian Kollewe, Anne Christin Mackensen, Detlef Neumann, Johannes Knop,
Ping Cao, Shyun Li, Holger Wesche, and Michael U. Martin. Sequential Autophos-
phorylation Steps in the Interleukin-1 Receptor-associated Kinase-1 Regulate its
Availability as an Adapter in Interleukin-1 Signaling. Journal of Biological Chem-
istry, 279(7):5227–5236, 2004.
130
[174] Zhengfan Jiang, Jun Ninomiya-Tsuji, Youcun Qian, Kunihiro Matsumoto, and Xi-
aoxia Li. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced
signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and
activate TAK1 in the cytosol. Molecular and cellular biology, 22(20):7158–67, 2002.
[175] Zhijian J Chen. Ubiquitination in signaling to and activation of IKK. Immunological
reviews, 246(1):95–106, mar 2012.
[176] Adebusola A. Ajibade, Helen Y. Wang, and Rong-Fu Wang. Cell type-specific
function of TAK1 in innate immune signaling. Trends in Immunology, 34(7):307–
316, jul 2013.
[177] Gary D Wu, Edwin J Lai, Ning Huang, and Xiaoming Wen. Oct-1 and CCAAT
/ Enhancer-binding Protein ( C / EBP ) Bind to Overlapping Elements within
the Interleukin-8 Promoter. The Journal of biological chemistry, 272(4):2396–2403,
1997.
[178] Pornngarm Limtrakul, Supachai Yodkeeree, Pornsiri Pitchakarn, and Wanisa Punfa.
Anti-inflammatory effects of proanthocyanidin-rich red rice extract via suppression
of MAPK, AP-1 and NF-κB pathways in Raw 264.7 macrophages. Nutrition Re-
search and Practice, 10(3):251, 2016.
[179] Magdy El-Salhy and Kazuo Umezawa. Anti-inflammatory effects of novel AP-1 and
NF-κB inhibitors in dextran-sulfate-sodium-induced colitis in rats. International
journal of molecular medicine, 37(6):1457–64, jun 2016.
[180] Longfei Xia, Hongxiang Xie, Yinjing Yu, Hong Zhou, Ting Wang, and Jinchuan
Yan. The Effects of NF-κB and c-Jun/AP-1 on the Expression of Prothrombotic
and Proinflammatory Molecules Induced by Anti-β2GPI in Mouse. PLOS ONE,
11(2):e0147958, feb 2016.
[181] N. Mukaida and K. Matsushima. Molecular mechanism of interleukin-8 gene ex-
pression. Biotherapy, 9(8):993–1000, 1995.
[182] H Holtmann, R Winzen, P Holland, S Eickemeier, E Hoffmann, D Wallach, N L
Malinin, J A Cooper, K Resch, and M Kracht. Induction of interleukin-8 synthe-
sis integrates effects on transcription and mRNA degradation from at least three
different cytokine- or stress-activated signal transduction pathways. Molecular and
cellular biology, 19(10):6742–53, 1999.
[183] T Murayama, Y Ohara, M Obuchi, K S Khabar, H Higashi, N Mukaida, and K Mat-
sushima. Human cytomegalovirus induces interleukin-8 production by a human
monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-
binding sites of the interleukin-8 gene. Journal of virology, 71(7):5692–5, 1997.
131
[184] Shiny Nair, Akhilesh Datt Pandey, and S. Mukhopadhyay. The PPE18 Protein
of Mycobacterium tuberculosis Inhibits NF- B/rel-Mediated Proinflammatory Cy-
tokine Production by Upregulating and Phosphorylating Suppressor of Cytokine
Signaling 3 Protein. The Journal of Immunology, 186(9):5413–5424, may 2011.
[185] M Aihara, D Tsuchimoto, H Takizawa, A Azuma, H Wakebe, Y Ohmoto, K Ima-
gawa, M Kikuchi, N Mukaida, and K Matsushima. Mechanisms involved in He-
licobacter pylori-induced interleukin-8 production by a gastric cancer cell line,
MKN45. Infection and immunity, 65(8):3218–24, 1997.
[186] Allan R Brasier, M Jamaluddin, A Casola, W Duan, Q Shen, and R P Garo-
falo. A promoter recruitment mechanism for tumor necrosis factor-alpha-induced
interleukin-8 transcription in type II pulmonary epithelial cells. Dependence on nu-
clear abundance of Rel A, NF-kappaB1, and c-Rel transcription factors. The Journal
of biological chemistry, 273(6):3551–61, feb 1998.
[187] Simon Mitchell, Jesse Vargas, and Alexander Hoffmann. Signaling via the NFκB
system. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 8(3):227–
241, may 2016.
[188] Alexander Hoffmann, Thomas H Leung, and David Baltimore. Genetic analysis of
NF-kappaB/Rel transcription factors defines functional specificities. The EMBO
journal, 22(20):5530–5539, 2003.
[189] Thomas H. Leung, Alexander Hoffmann, and David Baltimore. One nucleotide in a
κB site can determine cofactor specificity for NF-κB dimers. Cell, 118(4):453–464,
2004.
[190] Ellen O’Dea and Alexander Hoffmann. The regulatory logic of the NF-kappaB
signaling system. Cold Spring Harbor perspectives in biology, 2(1):a000216, jan
2010.
[191] Tom Huxford, Alexander Hoffmann, and Gourisankar Ghosh. Understanding the
logic of IκB:NF-κB regulation in structural terms. Current topics in microbiology
and immunology, 349:1–24, 2011.
[192] Jan Wehkamp, J. Harder, K. Wehkamp, Birte W.-v. Meissner, Miriam Schlee,
Corinne Enders, Ulrich Sonnenborn, Sabine Nuding, Stig Bengmark, Klaus Feller-
mann, J. M. Schroder, and Eduard F Stange. NF- B- and AP-1-Mediated Induction
of Human Beta Defensin-2 in Intestinal Epithelial Cells by Escherichia coli Nissle
1917: a Novel Effect of a Probiotic Bacterium. Infection and Immunity, 72(10):5750–
5758, oct 2004.
[193] Hyung-Sun Youn, Hyo Jin Lim, Yong Joon Choi, Joo Young Lee, Mi-Young Lee, and
Jae-Ha Ryu. Selenium suppresses the activation of transcription factor NF-kappa B
132
and IRF3 induced by TLR3 or TLR4 agonists. International immunopharmacology,
8(3):495–501, mar 2008.
[194] Alexander V Gasparian, Ya Juan Yao, Junxuan Lu¨, Alexander Y Yemelyanov,
Lyudmila A Lyakh, Thomas J Slaga, and Irina V Budunova. Selenium Compounds
Inhibit IκB Kinase (IKK) and Nuclear Factor-κB (NF-κB) in Prostate Cancer
Cells 1 Supported by Department of Defense Prostate Cancer Research Program
DAMD17-01-1-0015. 1. Molecular Cancer Therapeutics, 1(12):1079–1087, 2002.
[195] H E Ganther. Selenium metabolism, selenoproteins and mechanisms of cancer pre-
vention: complexities with thioredoxin reductase. Carcinogenesis, 20(9):1657–66,
sep 1999.
[196] I Y Kim and T C Stadtman. Inhibition of NF-kappaB DNA binding and nitric oxide
induction in human T cells and lung adenocarcinoma cells by selenite treatment.
Proceedings of the National Academy of Sciences of the United States of America,
94(24):12904–7, nov 1997.
[197] Usha Gundimeda, Jason Eric Schiffman, Divya Chhabra, Jourdan Wong, Adela Wu,
and Rayudu Gopalakrishna. Locally generated methylseleninic acid induces specific
inactivation of protein kinase C isoenzymes: relevance to selenium-induced apopto-
sis in prostate cancer cells. The Journal of biological chemistry, 283(50):34519–31,
dec 2008.
[198] Paloma Cejas, Enrique Casado, Cristobal Belda-Iniesta, Javier De Castro, Enrique
Espinosa, Andre´s Redondo, Mar´ıa Sereno, Miguel a Garc´ıa-Cabezas, Juan a F Vara,
Aurora Domı´nguez-Ca´ceres, Rosario Perona, and Manuel Gonza´lez-Baro´n. Impli-
cations of oxidative stress and cell membrane lipid peroxidation in human cancer
(Spain). Cancer causes & control : CCC, 15(7):707–19, sep 2004.
[199] Lawrence J Marnett. Oxy radicals, lipid peroxidation and DNA damage. Toxicology,
181-182:219–22, dec 2002.
[200] Julien Finaud, Ge´rard Lac, and Edith Filaire. Oxidative stress : relationship with
exercise and training. Sports medicine (Auckland, N.Z.), 36:327–358, 2006.
[201] Fang Cai, Yves Marc Dupertuis, and Claude Pichard. Role of polyunsaturated
fatty acids and lipid peroxidation on colorectal cancer risk and treatments. Current
opinion in clinical nutrition and metabolic care, 15(2):99–106, mar 2012.
[202] Alicja Winczura, Daria Zdz˙alik, and Barbara Tudek. Damage of DNA and proteins
by major lipid peroxidation products in genome stability. Free radical research,
46(4):442–59, apr 2012.
[203] Reshma Shringarpure and Kelvin J A Davies. Protein turnover by the proteasome
in aging and disease. Free radical biology & medicine, 32(11):1084–9, jun 2002.
133
[204] Tilman Grune, Katrin Merker, Grit Sandig, and Kelvin J.a. Davies. Selective degra-
dation of oxidatively modified protein substrates by the proteasome. Biochemical
and Biophysical Research Communications, 305(3):709–718, jun 2003.
[205] Bertrand Friguet. Oxidized protein degradation and repair in ageing and oxidative
stress. FEBS letters, 580(12):2910–6, may 2006.
[206] Svein Bjelland and Erling Seeberg. Mutagenicity, toxicity and repair of DNA base
damage induced by oxidation. In Mutation Research - Fundamental and Molecular
Mechanisms of Mutagenesis, volume 531, pages 37–80, 2003.
[207] Paul T. Henderson, Mark D. Evans, and Marcus S. Cooke. Salvage of oxidized
guanine derivatives in the (2’-deoxy)ribonucleotide pool as source of mutations in
DNA. Mutation research, 703(1):11–7, nov 2010.
[208] Martina Persˇe. Oxidative stress in the pathogenesis of colorectal cancer: cause or
consequence? BioMed research international, 2013:725710, jan 2013.
[209] Yong Son, Sangduck Kim, Hun-Taeg Chung, and Hyun-Ock Pae. Reactive oxygen
species in the activation of MAP kinases. Methods in enzymology, 528:27–48, 2013.
[210] Yuhui Yang, Alexandr V Bazhin, Jens Werner, and Svetlana Karakhanova. Reac-
tive oxygen species in the immune system. International reviews of immunology,
32(3):249–70, jun 2013.
[211] Michael Wrzaczek, Mikael Brosche´, and Jaakko Kangasja¨rvi. ROS signaling loops -
production, perception, regulation. Current opinion in plant biology, 16(5):575–82,
oct 2013.
[212] Marian Valko, Dieter Leibfritz, Jan Moncol, Mark T D Cronin, Milan Mazur, and
Joshua Telser. Free radicals and antioxidants in normal physiological functions and
human disease. The international journal of biochemistry & cell biology, 39(1):44–
84, jan 2007.
[213] H. Zhu and Y. R. Li. Oxidative stress and redox signaling mechanisms of inflam-
matory bowel disease: updated experimental and clinical evidence. Experimental
Biology and Medicine, 237(5):474–480, may 2012.
[214] Cristiana Pereira, Daniela Gra´cio, Joa˜o P. Teixeira, and Fernando Magro. Oxidative
Stress and DNA Damage. Inflammatory Bowel Diseases, 21(10):1, 2015.
[215] Mohammed a Alzoghaibi. Concepts of oxidative stress and antioxidant defense in
Crohn’s disease. World journal of gastroenterology : WJG, 19(39):6540–7, oct 2013.
134
[216] Rame Taha, Ernest Seidman, Genevieve Mailhot, Franc¸ois Boudreau, Fernand-
Pierre Gendron, Jean-Franc¸ois Beaulieu, Daniel Me´nard, Edgard Delvin, Deven-
dra Amre, and Emile Levy. Oxidative stress and mitochondrial functions in the
intestinal Caco-2/15 cell line. PloS one, 5(7):e11817, jul 2010.
[217] A D’Odorico, S Bortolan, R Cardin, R D’Inca, D Martines, A Ferronato, and G C
Sturniolo. Reduced Plasma Antioxidant Concentrations and Increased Oxidative
DNA Damage in Inflammatory Bowel Disease. Scandinavian Journal of Gastroen-
terology, 36(12):1289–1294, 2001.
[218] Ioannis E. Koutroubakis, Niki Malliaraki, Philippos D. Dimoulios, Konstantinos
Karmiris, Elias Castanas, and Elias A. Kouroumalis. Decreased total and corrected
antioxidant capacity in patients with inflammatory bowel disease. Digestive Diseases
and Sciences, 49(9):1433–1437, 2004.
[219] Olga A. Sedelnikova, Christophe E. Redon, Jennifer S. Dickey, Asako J. Nakamura,
Alexandros G. Georgakilas, and William M. Bonner. Role of oxidatively induced
DNA lesions in human pathogenesis. Mutation research, 704(1-3):152–9, 2010.
[220] H Wiseman and B Halliwell. Damage to DNA by reactive oxygen and nitrogen
species: role in inflammatory disease and progression to cancer. The Biochemical
journal, 313 ( Pt 1(2):17–29, 1996.
[221] Helmut Bartsch and Jagadeesan Nair. Chronic inflammation and oxidative stress
in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage,
and repair. Langenbeck’s archives of surgery / Deutsche Gesellschaft fu¨r Chirurgie,
391(5):499–510, 2006.
[222] Thomas B Kryston, Anastassiya B Georgiev, Polycarpos Pissis, and Alexandros G
Georgakilas. Role of oxidative stress and DNA damage in human carcinogenesis.
Mutation research, 711(1-2):193–201, 2011.
[223] Doris M. Tham, John C. Whitin, and Harvey J. Cohen. Increased expression of
extracellular glutathione peroxidase in mice with dextran sodium sulfate-induced
experimental colitis. Pediatric Research, 51(5):641–646, 2002.
[224] Helieh S Oz, Theresa S Chen, Craig J McClain, and Willem J S de Villiers. An-
tioxidants as novel therapy in a murine model of colitis. The Journal of nutritional
biochemistry, 16(5):297–304, 2005.
[225] Rima Ramonaite, Jurgita Skieceviciene, Gediminas Kiudelis, Laimas Jonaitis, Algi-
mantas Tamelis, Paulius Cizas, Vilmante Borutaite, and Limas Kupcinskas. Influ-
ence of NADPH oxidase on inflammatory response in primary intestinal epithelial
cells in patients with ulcerative colitis. BMC gastroenterology, 13:159, 2013.
135
[226] I E Koutroubakis, P Antoniou, M Tzardi, and E A Kouroumalis. The spectrum of
segmental colitis associated with diverticulosis. International Journal of Colorectal
Disease, 20(1):28–32, jan 2005.
[227] Malgorzata Krzystek-Korpacka, Katarzyna Neubauer, Izabela Berdowska, Bogdan
Zielinski, Leszek Paradowski, and Andrzej Gamian. Impaired erythrocyte antioxi-
dant defense in active inflammatory bowel disease: Impact of anemia and treatment.
Inflammatory Bowel Diseases, 16(9):1467–1475, 2010.
[228] Tulay Akman, Mesut Akarsu, Hale Akpinar, Halil Resmi, and Ebru Sezer. Erythro-
cyte deformability and oxidative stress in inflammatory bowel disease. Digestive
Diseases and Sciences, 57(2):458–464, 2012.
[229] Lawrence N. Barrera, Aedin Cassidy, Wei Wang, Taotao Wei, Nigel J. Belshaw,
Ian T. Johnson, Regina Brigelius-Flohe´, and Yongping Bao. TrxR1 and GPx2 are
potently induced by isothiocyanates and selenium, and mutually cooperate to pro-
tect Caco-2 cells against free radical-mediated cell death. Biochimica et Biophysica
Acta - Molecular Cell Research, 1823(10):1914–1924, 2012.
[230] Bele´n Beltra´n, Pilar Nos, Francisco Das´ı, Marisa Iborra, Guillermo Bastida, Marcial
Mart´ınez, Jose´-Enrique O’Connor, Guillermo Sa´ez, Ine´s Moret, and Julio Ponce.
Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in
immune cells of na¨ıve and treated Crohn’s disease. Inflammatory bowel diseases,
16(1):76–86, jan 2010.
[231] Rogerio Margis, Christophe Dunand, Felipe K Teixeira, and Marcia Margis-
Pinheiro. Glutathione peroxidase family - an evolutionary overview. The FEBS
journal, 275(15):3959–70, aug 2008.
[232] Hussain Ahmad, Jinke Tian, Jianjun Wang, Muhammad Ammar Khan, Yuanxiao
Wang, Lili Zhang, and Tian Wang. Effects of dietary sodium selenite and selenium
yeast on antioxidant enzyme activities and oxidative stability of chicken breast meat.
Journal of agricultural and food chemistry, 60(29):7111–20, jul 2012.
[233] Jela Brozmanova´, Dominika Ma´nikova´, Viera Vlcˇkova´, and Miroslav Chovanec.
Selenium: a double-edged sword for defense and offence in cancer. Archives of
toxicology, 84(12):919–38, dec 2010.
[234] Tae Soo Kim, Byung Yup Yun, and Ick Young Kim. Induction of the mitochondrial
permeability transition by selenium compounds mediated by oxidation of the protein
thiol groups and generation of the superoxide. Biochemical Pharmacology, 66:2301–
2311, 2003.
[235] Julian E. Spallholz, Vince P. Palace, and Ted W. Reid. Methioninase and selenome-
thionine but not Se-methylselenocysteine generate methylselenol and superoxide in
136
an in vitro chemiluminescent assay: Implications for the nutritional carcinostatic
activity of selenoamino acids. Biochemical Pharmacology, 67:547–554, 2004.
[236] Aldwin Suryo Rahmanto and Michael J Davies. Selenium-containing amino acids
as direct and indirect antioxidants. IUBMB life, 64(11):863–71, nov 2012.
[237] Emilie E Vomhof-Dekrey and Matthew J Picklo. The Nrf2-antioxidant response
element pathway: a target for regulating energy metabolism. The Journal of nutri-
tional biochemistry, 23(10):1201–6, oct 2012.
[238] Claudia Geismann, Alexander Arlt, Susanne Sebens, and Heiner Scha¨fer. Cyto-
protection ”gone astray”: Nrf2 and its role in cancer. OncoTargets and therapy,
7:1497–518, jan 2014.
[239] Hadi Digaleh, Mahmoud Kiaei, and Fariba Khodagholi. Nrf2 and Nrf1 signaling
and ER stress crosstalk: implication for proteasomal degradation and autophagy.
Cellular and molecular life sciences : CMLS, pages 4681–4694, jun 2013.
[240] Thomas W. Kensler and Nobunao Wakabayashi. Nrf2: friend or foe for chemopre-
vention? Carcinogenesis, 31(1):90–9, jan 2010.
[241] Ka Lung Cheung, Jong Hun Lee, Tin Oo Khor, Tien Yuan Wu, Guang Xun Li,
Jefferson Chan, Chung S. Yang, and Ah Ng Tony Kong. Nrf2 knockout enhances
intestinal tumorigenesis in Apcmin/+ mice due to attenuation of anti-oxidative
stress pathway while potentiates inflammation. Molecular Carcinogenesis, 53:77–
84, 2014.
[242] Aruna Kode, Saravanan Rajendrasozhan, Samuel Caito, Se-Ran Yang, Ian L Meg-
son, and Irfan Rahman. Resveratrol induces glutathione synthesis by activation
of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human
lung epithelial cells. American journal of physiology. Lung cellular and molecular
physiology, 294(3):L478–88, mar 2008.
[243] Chu-Yue Chen, Jung-Hee Jang, Mei-Hua Li, and Young-Joon Surh. Resveratrol
upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2
in PC12 cells. Biochemical and biophysical research communications, 331(4):993–
1000, jun 2005.
[244] Yasutake Katoh, Katsuyuki Iida, Moon-Il Kang, Akira Kobayashi, Mio Mizukami,
Kit I Tong, Michael McMahon, John D Hayes, Ken Itoh, and Masayuki Yamamoto.
Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-
mediated degradation of the protein by proteasome. Archives of biochemistry and
biophysics, 433(2):342–50, jan 2005.
137
[245] K Itoh, N Wakabayashi, Y Katoh, T Ishii, K Igarashi, J D Engel, and M Ya-
mamoto. Keap1 represses nuclear activation of antioxidant responsive elements by
Nrf2 through binding to the amino-terminal Neh2 domain. Genes & development,
13(1):76–86, jan 1999.
[246] Barak Rotblat, Gerry Melino, and Richard A Knight. NRF2 and p53: Januses in
cancer? Oncotarget, 3(11):1272–83, nov 2012.
[247] R Venugopal and a K Jaiswal. Nrf2 and Nrf1 in association with Jun proteins reg-
ulate antioxidant response element-mediated expression and coordinated induction
of genes encoding detoxifying enzymes. Oncogene, 17(24):3145–56, dec 1998.
[248] Janet Jeyapaul and Anil K. Jaiswal. Nrf2 and c-Jun regulation of antiox-
idant response element (ARE)-mediated expression and induction of gamma-
glutamylcysteine synthetase heavy subunit gene. Biochemical pharmacology,
59(11):1433–9, jun 2000.
[249] Ken Itoh, Tomoki Chiba, Satoru Takahashi, Tetsuro Ishii, Kazuhiko Igarashi, Ya-
sutake Katoh, Tatsuya Oyake, Norio Hayashi, Kimihiko Satoh, Ichiro Hatayama,
Masayuki Yamamoto, and Yo-ichi Nabeshima. An Nrf2/Small Maf Heterodimer
Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxi-
dant Response Elements. Biochemical and Biophysical Research Communications,
236(2):313–322, jul 1997.
[250] Holly K Bryan, Adedamola Olayanju, Christopher E Goldring, and B Kevin Park.
The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of
regulation. Biochemical pharmacology, 85(6):705–17, mar 2013.
[251] Truyen Nguyen, Philip J Sherratt, and Cecil B Pickett. Regulatory mechanisms
controlling gene expression mediated by the antioxidant response element. Annual
review of pharmacology and toxicology, 43:233–60, jan 2003.
[252] Donald E Nerland. The antioxidant/electrophile response element motif. Drug
metabolism reviews, 39(1):235–48, jan 2007.
[253] Saravanakumar Dhakshinamoorthy, Abhinav K Jain, David A Bloom, and Anil K
Jaiswal. Bach1 competes with Nrf2 leading to negative regulation of the antioxidant
response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expres-
sion and induction in response to antioxidants. The Journal of biological chemistry,
280:16891–16900, 2005.
[254] James W Kaspar and Anil K Jaiswal. Antioxidant-induced phosphorylation of
tyrosine 486 leads to rapid nuclear export of Bach1 that allows Nrf2 to bind to the
antioxidant response element and activate defensive gene expression. The Journal
of biological chemistry, 285:153–162, 2010.
138
[255] James W Kaspar and Anil K Jaiswal. Tyrosine phosphorylation controls nuclear
export of Fyn, allowing Nrf2 activation of cytoprotective gene expression. The
FASEB journal : official publication of the Federation of American Societies for
Experimental Biology, 25:1076–1087, 2011.
[256] James W. Kaspar, Suryakant K. Niture, and Anil K. Jaiswal. Antioxidant-induced
INrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degrada-
tion of the INrf2-Cul3-Rbx1 complex to allow normal Nrf2 activation and repression.
Journal of cell science, 125(Pt 4):1027–38, feb 2012.
[257] Sara B Cullinan, Donna Zhang, Mark Hannink, Edward Arvisais, Randal J Kauf-
man, and J Alan Diehl. Nrf2 is a direct PERK substrate and effector of PERK-
dependent cell survival. Molecular and cellular biology, 23(20):7198–209, oct 2003.
[258] E Bobrovnikova-Marjon, C Grigoriadou, D Pytel, F Zhang, J Ye, C Koumenis,
D Cavener, and J A Diehl. PERK promotes cancer cell proliferation and tumor
growth by limiting oxidative DNA damage. Oncogene, 29(27):3881–95, jul 2010.
[259] Anil K. Jaiswal. Nrf2 signaling in coordinated activation of antioxidant gene ex-
pression. Free Radical Biology and Medicine, 36(10):1199–207, may 2004.
[260] Maneet Bhatia, Therese C. Karlenius, Giovanna Di Trapani Tonissen, and Kathryn
F. Carcinogenesis. InTech, jan 2013.
[261] Yukie Kawatani, Takafumi Suzuki, Ritsuko Shimizu, Vincent P Kelly, and Masayuki
Yamamoto. Nrf2 and selenoproteins are essential for maintaining oxidative home-
ostasis in erythrocytes and protecting against hemolytic anemia. Blood, 117(3):986–
96, jan 2011.
[262] Nicole M Blum, Kristin Mueller, Doris Lippmann, Cornelia C Metges, Thomas Linn,
Josef Pallauf, and Andreas S Mueller. Feeding of selenium alone or in combination
with glucoraphanin differentially affects intestinal and hepatic antioxidant and phase
II enzymes in growing rats. Biological trace element research, 151(3):384–99, mar
2013.
[263] Andrew D. Patterson, Bradley a. Carlson, Fei Li, Jessica a. Bonzo, Min Hyuk
Yoo, Kristopher W. Krausz, Marcus Conrad, Chi Chen, Frank J. Gonzalez, and
Dolph L. Hatfield. Disruption of thioredoxin reductase 1 protects mice from acute
acetaminophen-induced hepatotoxicity through enhanced NRF2 activity. Chemical
Research in Toxicology, 26:1088–1096, 2013.
[264] Antje Banning, Stefanie Deubel, Dirk Kluth, Zewen Zhou, and R. Brigelius-Flohe.
The GI-GPx Gene Is a Target for Nrf2. Molecular and Cellular Biology, 25(12):4914–
4923, jun 2005.
139
[265] Takafumi Suzuki, Vincent P Kelly, Hozumi Motohashi, Osamu Nakajima, Satoru
Takahashi, Susumu Nishimura, and Masayuki Yamamoto. Deletion of the selenocys-
teine tRNA gene in macrophages and liver results in compensatory gene induction of
cytoprotective enzymes by Nrf2. The Journal of biological chemistry, 283(4):2021–
30, jan 2008.
[266] Vincent P Kelly, Takafumi Suzuki, Osamu Nakajima, Tsuyoshi Arai, Yoshitaka
Tamai, Satoru Takahashi, Susumu Nishimura, and Masayuki Yamamoto. The distal
sequence element of the selenocysteine tRNA gene is a tissue-dependent enhancer
essential for mouse embryogenesis. Molecular and cellular biology, 25(9):3658–69,
may 2005.
[267] Elaine M. Fisher, Mahmood Khan, Ronald Salisbury, and Periannan Kuppusamy.
Noninvasive Monitoring of Small Intestinal Oxygen in a Rat Model of Chronic
Mesenteric Ischemia. Cell Biochemistry and Biophysics, 67(2):451–459, nov 2013.
[268] Cormac T. Taylor and Sean P. Colgan. Hypoxia and gastrointestinal disease. Journal
of Molecular Medicine, 85(12):1295–1300, dec 2007.
[269] Robert D. Guzy and Paul T. Schumacker. Oxygen sensing by mitochondria at
complex III: the paradox of increased reactive oxygen species during hypoxia. Ex-
perimental Physiology, 91(5):807–819, sep 2006.
[270] Sean P. Colgan, Valerie F. Curtis, and Eric L. Campbell. The Inflammatory Tissue
Microenvironment in IBD. Inflammatory Bowel Diseases, 19(10):2238–2244, sep
2013.
[271] Eoin P Cummins, Glen A Doherty, and Cormac T Taylor. Hydroxylases as therapeu-
tic targets in inflammatory bowel disease. Laboratory Investigation, 93(4):378–383,
apr 2013.
[272] Cormac T. Taylor and Eoin P. Cummins. The Role of NF-κB in Hypoxia-Induced
Gene Expression. Annals of the New York Academy of Sciences, 1177(1):178–184,
oct 2009.
[273] G. L. Wang and G. L. Semenza. General involvement of hypoxia-inducible factor
1 in transcriptional response to hypoxia. Proceedings of the National Academy of
Sciences, 90(9):4304–4308, may 1993.
[274] AE Greijer, P van der Groep, D Kemming, A Shvarts, GL Semenza, GA Meijer,
MA van de Wiel, JAM Belien, PJ van Diest, and E van der Wall. Up-regulation of
gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor
1 (HIF-1). The Journal of Pathology, 206(3):291–304, jul 2005.
140
[275] G L Semenza and G L Wang. A nuclear factor induced by hypoxia via de novo
protein synthesis binds to the human erythropoietin gene enhancer at a site required
for transcriptional activation. Molecular and Cellular Biology, 12(12):5447–5454, dec
1992.
[276] Ji-Won Lee, Seong-Hui Bae, Joo-Won Jeong, Se-Hee Kim, and Kyu-Won Kim.
Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions.
Experimental & Molecular Medicine, 36(1):1–12, feb 2004.
[277] Peter J. Ratcliffe, Patrick H. Maxwell, Michael S. Wiesener, Gin-Wen Chang,
Steven C. Clifford, Emma C. Vaux, Matthew E. Cockman, Charles C. Wykoff,
Christopher W. Pugh, and Eamonn R. Maher. The tumour suppressor protein
VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature,
399(6733):271–275, may 1999.
[278] Gregg L Semenza. Oxygen sensing, hypoxia-inducible factors, and disease patho-
physiology. Annual review of pathology, 9:47–71, 2014.
[279] L E Huang, Z Arany, D M Livingston, and H F Bunn. Activation of hypoxia-
inducible transcription factor depends primarily upon redox-sensitive stabilization
of its alpha subunit. The Journal of biological chemistry, 271(50):32253–9, dec 1996.
[280] N. Petousi and P. A. Robbins. Human adaptation to the hypoxia of high altitude:
the Tibetan paradigm from the pregenomic to the postgenomic era. Journal of
Applied Physiology, 116(7):875–884, apr 2014.
[281] Eric L. Campbell, Walter J. Bruyninckx, Caleb J. Kelly, Louise E. Glover, Eo´in N.
McNamee, Brittelle E. Bowers, Amanda J. Bayless, Melanie Scully, Bejan J. Saeedi,
Lucy Golden-Mason, Stefan F. Ehrentraut, Valerie F. Curtis, Adrianne Burgess,
John F. Garvey, Amber Sorensen, Raphael Nemenoff, Paul Jedlicka, Cormac T.
Taylor, Douglas J. Kominsky, and Sean P. Colgan. Transmigrating neutrophils
shape the mucosal microenvironment through localized oxygen depletion to influence
resolution of inflammation. Immunity, 40(1):66–77, jan 2014.
[282] Keira Melican, Jorrit Boekel, Lisa E Ma˚nsson, Ruben M. Sandoval, George A.
Tanner, Orjan Ka¨llskog, Fredrik Palm, Bruce A. Molitoris, and Agneta Richter-
Dahlfors. Bacterial infection-mediated mucosal signalling induces local renal is-
chaemia as a defence against sepsis. Cellular microbiology, 10(10):1987–98, oct
2008.
[283] A Giatromanolaki, E Sivridis, E Maltezos, D Papazoglou, C Simopoulos, K C Gat-
ter, A L Harris, and M I Koukourakis. Hypoxia inducible factor 1alpha and 2al-
pha overexpression in inflammatory bowel disease. Journal of clinical pathology,
56(3):209–13, mar 2003.
141
[284] John Biddlestone, Daniel Bandarra, and Sonia Rocha. The role of hypoxia in in-
flammatory disease (Review). International Journal of Molecular Medicine, pages
859–869, 2015.
[285] Eoin P. Cummins, Fergal Seeballuck, Stephen J. Keely, Niamh E. Mangan, John J.
Callanan, Padraic G. Fallon, and Cormac T. Taylor. The Hydroxylase Inhibitor
Dimethyloxalylglycine Is Protective in a Murine Model of Colitis. Gastroenterology,
134(1):156–165.e1, jan 2008.
[286] Jo¨rn Karhausen, Glenn T. Furuta, John E. Tomaszewski, Randall S. Johnson,
Sean P. Colgan, and Volker H. Haase. Epithelial hypoxia-inducible factor-1 is protec-
tive in murine experimental colitis. Journal of Clinical Investigation, 114(8):1098–
1106, oct 2004.
[287] Simon A. Hirota, Kyla Fines, Jeffrey Ng, Danya Traboulsi, Josh Lee, Eikichi Ihara,
Yan Li, William G. Willmore, Daniel Chung, Melanie M. Scully, Thomas Louie,
Shaun Medlicott, Manigandan Lejeune, Kris Chadee, Glen Armstrong, Sean P. Col-
gan, Daniel A. Muruve, Justin A. MacDonald, and Paul L. Beck. Hypoxia-Inducible
Factor Signaling Provides Protection in Clostridium difficile-Induced Intestinal In-
jury. Gastroenterology, 139(1):259–269.e3, jul 2010.
[288] Andreas Robinson, Simon Keely, Jo¨rn Karhausen, Mark E. Gerich, Glenn T. Fu-
ruta, and Sean P. Colgan. Mucosal protection by hypoxia-inducible factor prolyl
hydroxylase inhibition. Gastroenterology, 134(1):145–55, jan 2008.
[289] Fenju Qin, Miaomiao Shi, Hongxia Yuan, Linxi Yuan, Wenhao Lu, Jie Zhang, Jian
Tong, and Xuehong Song. Dietary nano-selenium relieves hypoxia stress and, im-
proves immunity and disease resistance in the Chinese mitten crab (Eriocheir sinen-
sis). Fish & Shellfish Immunology, 54:481–488, 2016.
[290] Salvador Naranjo-Suarez, Bradley A. Carlson, Petra A. Tsuji, Min Hyuk Yoo,
Vadim N. Gladyshev, and Dolph L. Hatfield. HIF-independent regulation of thiore-
doxin reductase 1 contributes to the high levels of reactive oxygen species induced
by hypoxia. PLoS ONE, 7(2):1–10, 2012.
[291] S. K S Sarada, M. Sairam, P. Dipti, B. Anju, T. Pauline, A. K. Kain, S. K. Sharma,
S. Bagawat, G. Ilavazhagan, and D. Kumar. Role of selenium in reducing hypoxia-
induced oxidative stress: An in vivo study. Biomedicine and Pharmacotherapy,
56:173–178, 2002.
[292] S. Kaur and Mohinder P. Bansal. Protective role of dietary-supplemented sele-
nium and vitamin E in heat-induced apoptosis and oxidative stress in mice testes.
Andrologia, 47(10):1109–1119, 2015.
142
[293] Yuzhi Liu, Wenyu Li, Mengyao Guo, Chengye Li, and Changwei Qiu. Protective
Role of Selenium Compounds on the Proliferation, Apoptosis, and Angiogenesis of
a Canine Breast Cancer Cell Line. Biological trace element research, pages 86–93,
2015.
[294] Ping Chen, Lixiang Wang, Na Li, Qiong Liu, and Jiazuan Ni. Comparative pro-
teomics analysis of sodium selenite-induced apoptosis in human prostate cancer
cells. Metallomics : integrated biometal science, 5(5):541–50, 2013.
[295] Indu Sinha, Kevin Null, William Wolter, Mark a. Suckow, Tonya King, John T.
Pinto, and Raghu Sinha. Methylseleninic acid downregulates hypoxia-inducible
factor-1a in invasive prostate cancer. International Journal of Cancer, 130(6):1430–
1439, 2012.
[296] Suresh L Mehta, Santosh Kumari, Natalia Mendelev, and P Andy Li. Selenium
preserves mitochondrial function, stimulates mitochondrial biogenesis, and reduces
infarct volume after focal cerebral ischemia. BMC neuroscience, 13:79, 2012.
[297] Sreenivasulu Chintala, Tanbir Najrana, Karoly Toth, Shousong Cao, Farukh a Dur-
rani, Roberto Pili, and Youcef M Rustum. Prolyl hydroxylase 2 dependent and
Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2
alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibi-
tion. BMC Cancer, 12(1):293, 2012.
[298] S. K S Sarada, P. Himadri, D. Ruma, S. K. Sharma, T. Pauline, and Mrinalini.
Selenium protects the hypoxia induced apoptosis in neuroblastoma cells through
upregulation of Bcl-2. Brain Research, 1209:29–39, 2008.
[299] Alessandra Bordoni, Pier Luigi Biagi, Cristina Angeloni, Emanuela Leoncini,
Francesca Danesi, and Silvana Hrelia. Susceptibility to hypoxia/reoxygenation of
aged rat cardiomyocytes and its modulation by selenium supplementation. Journal
of Agricultural and Food Chemistry, 53:490–494, 2005.
[300] Alessandra Bordoni, Pier L. Biagi, Cristina Angeloni, Emanuela Leoncini, Ivan
Muccinelli, and Silvana Hrelia. Selenium supplementation can protect cultured rat
cardiomyocytes from hypoxia/reoxygenation damage. Journal of Agricultural and
Food Chemistry, 51(6):1736–1740, 2003.
[301] Niels-Peter Becker, Janine Martitz, Kostja Renko, Mette Stoedter, Sandra Hybsier,
Thorsten Cramer, and Lutz Schomburg. Hypoxia reduces and redirects selenopro-
tein biosynthesis. Metallomics : integrated biometal science, 6:1079–86, 2014.
[302] Mahanama De Zoysa, Ilson Whang, Youngdeuk Lee, Sukkyoung Lee, Jae Seong Lee,
and Jehee Lee. Transcriptional analysis of antioxidant and immune defense genes
in disk abalone (Haliotis discus discus) during thermal, low-salinity and hypoxic
143
stress. Comparative Biochemistry and Physiology - B Biochemistry and Molecular
Biology, 154(4):387–395, 2009.
[303] Cheng Huang, Guangyu Ding, Chengyu Gu, Jian Zhou, Ming Kuang, Yuan Ji,
Yifeng He, Tadashi Kondo, and Jia Fan. Decreased selenium-binding protein 1
enhances glutathione peroxidase 1 activity and downregulates HIF-1a to promote
hepatocellular carcinoma invasiveness. Clinical Cancer Research, 18(11):3042–3053,
2012.
[304] Marzia Scortegagna, Rebecca J. Martin, Raleigh D. Kladney, Robert G. Neu-
mann, and Jeffrey M. Arbeit. Hypoxia-inducible factor-1alpha suppresses squamous
carcinogenic progression and epithelial-mesenchymal transition. Cancer research,
69(6):2638–46, mar 2009.
[305] Jee Yeong Jeong, Jin Rong Zhou, Chong Gao, Laurie Feldman, and Arthur J
Sytkowski. Human selenium binding protein-1 (hSP56) is a negative regulator of
HIF-1a and suppresses the malignant characteristics of prostate cancer cells. BMB
Reports, 47(7):411–416, 2014.
[306] Michael J Morgan and Zheng-gang Liu. Crosstalk of reactive oxygen species and
NF-κB signaling. Cell research, 21(1):103–15, 2011.
[307] R K Rao and L W Clayton. Regulation of protein phosphatase 2A by hydrogen
peroxide and glutathionylation. Biochem Biophys Res Commun, 293(1):610–616,
2002.
[308] Irfan Rahman, John Marwick, and Paul Kirkham. Redox modulation of chromatin
remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-
inflammatory gene expression. Biochemical pharmacology, 68(6):1255–67, sep 2004.
[309] K. Ito, T. Hanazawa, K. Tomita, P. J. Barnes, and I. M. Adcock. Oxidative
stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression:
Role of tyrosine nitration. Biochemical and Biophysical Research Communications,
315(1):240–245, 2004.
[310] Sandra Levrand, Benoˆıt Pesse, Franc¸ois Feihl, Bernard Waeber, Pal Pacher, Joe¨lle
Rolli, Marie Denise Schaller, and Lucas Liaudet. Peroxynitrite is a potent inhibitor
of NF-κB activation triggered by inflammatory stimuli in cardiac and endothelial
cell lines. Journal of Biological Chemistry, 280(41):34878–34887, 2005.
[311] S H Korn. Cytokine-induced Activation of Nuclear Factor-kappa B Is Inhibited by
Hydrogen Peroxide through Oxidative Inactivation of Ikappa B Kinase. Journal of
Biological Chemistry, 276(38):35693–35700, 2001.
144
[312] Tao Jiang, Fei Tian, Hongting Zheng, Samantha a Whitman, Yifeng Lin, Zhigang
Zhang, Nong Zhang, and Donna D Zhang. Nrf2 suppresses lupus nephritis through
inhibition of oxidative injury and the NF-κB-mediated inflammatory response. Kid-
ney international, 85(2):333–43, feb 2014.
[313] Antonio Cuadrado, Zaira Martin-Moldes, Jianping Ye, and Isabel Lastres-Becker.
Transcription factors NRF2 and nf-kb are coordinated effectors of the RHO family,
GTP binding protein rac1 during inflammation. The Journal of biological chemistry,
apr 2014.
[314] Narayanan Sriram, Srinivasan Kalayarasan, and Ganapasam Sudhandiran.
Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflamma-
tion during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1
signaling. Pulmonary Pharmacology and Therapeutics, 22:221–236, 2009.
[315] Asok R Karuri, Yong Huang, Sridevi Bodreddigari, Carrie Hayes Sutter, Bill D
Roebuck, Thomas W Kensler, and Thomas R Sutter. 3H-1,2-dithiole-3-thione tar-
gets nuclear factor kappaB to block expression of inducible nitric-oxide synthase,
prevents hypotension, and improves survival in endotoxemic rats. The Journal of
pharmacology and experimental therapeutics, 317:61–67, 2006.
[316] Rehan Ahmad, Deepak Raina, Colin Meyer, Surender Kharbanda, and Donald
Kufe. Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibi-
tion of IKKbeta on Cys-179. The Journal of biological chemistry, 281:35764–35769,
2006.
[317] Nobunao Wakabayashi, Stephen L Slocum, John J Skoko, Soona Shin, and
Thomas W Kensler. When NRF2 talks, who’s listening? Antioxidants & redox
signaling, 13:1649–1663, 2010.
[318] Edward Chaum, Jinggang Yin, Huaitao Yang, Fridtjof Thomas, and John C. Lang.
Quantitative AP-1 gene regulation by oxidative stress in the human retinal pigment
epithelium. Journal of Cellular Biochemistry, 108(6):1280–1291, 2009.
[319] Michael Karin and Eitan Shaulian. AP-1: linking hydrogen peroxide and oxidative
stress to the control of cell proliferation and death. IUBMB life, 52:17–24, 2001.
[320] Farhad Hafezi, Andreas Marti, Christian Grimm, Andreas Wenzel, and Charlotte E.
Reme´. Differential DNA binding activities of the transcription factors AP-1 and Oct-
1 during light-induced apoptosis of photoreceptors. Vision Research, 39(15):2511–
2518, 1999.
[321] H Konishi, T Fujiyoshi, Y Fukui, H Matsuzaki, Toshiyoshi Yamamoto, Yoshitaka
Ono, M Andjelkovic, Brian a Hemmings, and Ushio Kikkawa. Activation of protein
145
kinase B induced by H(2)O(2) and heat shock through distinct mechanisms depen-
dent and independent of phosphatidylinositol 3-kinase. Journal of biochemistry,
126(6):1136–43, dec 1999.
[322] Merrill J Christensen and Noel W. Pusey. Binding of nuclear proteins to transcrip-
tion regualtory elements in selenium deficiency. Biochimica et Biophysica Acta,
1225:338–341, 1994.
[323] Levente Jo´zsef and Ja´nos G. Filep. Selenium-containing compounds attenuate
peroxynitrite-mediated NF-κB and AP-1 activation and interleukin-8 gene and pro-
tein expression in human leukocytes. Free Radical Biology and Medicine, 35(9):1018–
1027, 2003.
[324] Vassili Makropoulos, T Bru¨ning, and K Schulze-Osthoff. Selenium-mediated inhibi-
tion of transcription factor NF-kappa B and HIV-1 LTR promoter activity. Archives
of toxicology, 70(5):277–83, 1996.
[325] Sonia Shalini and M. P. Bansal. Role of selenium in regulation of spermatogenesis:
Involvement of activator protein 1. BioFactors, 23(3):151–162, 2005.
[326] Sonia Shalini and Mohinder P. Bansal. Co-operative effect of glutathione depletion
and selenium induced oxidative stress on API and NFkB expression in testicular cells
in vitro: insights to regulation of spermatogenesis. Biological research, 40(3):307–
317, 2007.
[327] Sonia Shalini and Mohinder P. Bansal. Role of selenium in spermatogenesis: Dif-
ferential expression of cjun and cfos in tubular cells of mice testis. Molecular and
Cellular Biochemistry, 292(1-2):27–38, 2006.
[328] Mike Mu¨ller, Antje Banning, Regina Brigelius-Flohe´, and Anna Kipp. Nrf2 target
genes are induced under marginal selenium-deficiency. Genes & nutrition, 5(4):297–
307, dec 2010.
[329] Gregg L. Semenza. Hypoxia-Inducible Factors in Physiology and Medicine. Cell,
148(3):399–408, feb 2012.
[330] So´nia Moniz, John Biddlestone, and So´nia Rocha. Growl: the HIF system, energy
homeostasis and the cell cycle. Histology and histopathology, 29(5):589–600, may
2014.
[331] John Biddlestone, Daniel Bandarra, and Sonia Rocha. The role of hypoxia in in-
flammatory disease (Review). International Journal of Molecular Medicine, jan
2015.
146
[332] Carolyn Culver, Anders Sundqvist, Sharon Mudie, Andrew Melvin, Dimitris Xirodi-
mas, and Sonia Rocha. Mechanism of hypoxia-induced NF-kappaB. Molecular and
cellular biology, 30(20):4901–4921, 2010.
[333] Patrick van Uden, Niall S Kenneth, and Sonia Rocha. Regulation of hypoxia-
inducible factor-1alpha by NF-kappaB. The Biochemical journal, 412(3):477–84,
2008.
[334] P van Uden, N S Kenneth, R Webster, H A Muller, S Mudie, and S Rocha.
Evolutionary conserved regulation of HIF-1beta by NF-kappaB. PLoS genetics,
7(1):e1001285, 2011.
[335] Daniel Bandarra, John Biddlestone, Sharon Mudie, H-Arno J Mu¨ller, and Sonia
Rocha. HIF-1α restricts NF-κB-dependent gene expression to control innate immu-
nity signals. Disease models & mechanisms, 8(2):169–81, feb 2015.
[336] Xiang Xue, Sadeesh Ramakrishnan, Erik Anderson, Matthew Taylor, Ellen M. Zim-
mermann, Jason R. Spence, Sha Huang, Joel K. Greenson, and Yatrik M. Shah.
Endothelial PAS domain protein 1 activates the inflammatory response in the in-
testinal epithelium to promote colitis in mice. Gastroenterology, 145(4):831–841,
2013.
[337] J Fogh, J M Fogh, and T Orfeo. One hundred and twenty-seven cultured human
tumor cell lines producing tumors in nude mice. Journal of the National Cancer
Institute, 59(1):221–226, 1977.
[338] M Rousset. The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro
models for the study of intestinal differentiation. Biochimie, 68(9):1035–1040, 1986.
[339] Moise Pinto, Sylvie Robine-Leon, Marie-Dominique Appay, Miche`le Kedinger,
Nicole Triadou, Elisabeth Dussaulx, Brigitte Lacroix, Patricia Simon-Assmann,
Katy Haffen, Jorgen Fogh, and Alain Zweibaum. Enterocyte-like differentiation
and polarization of the human colon carcinoma cell line Caco-2 in culture. Biology
of the Cell, 47(323):323–330, 1983.
[340] R Hilgers, R Conradi, and P Burton. Caco-2 cell monolayers as a model for drug
transport across the intestinal mucosa. Pharmaceutical research, 7(9):902–10, sep
1990.
[341] John M. Mariadason, Kurt L. Rickard, David H. Barkla, Leonard H. Augenlicht,
and Peter R. Gibson. Divergent phenotypic patterns and commitment to apoptosis
of Caco-2 cells during spontaneous and butyrate-induced differentiation. Journal of
Cellular Physiology, 183(3):347–354, 2000.
147
[342] V. Meunier, M. Bourrie, Y. Berger, and G. Fabre. The human intestinal epithelial
cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biology
and Toxicology, 11:187–194, 1995.
[343] M. J. Engle, G. S. Goetz, and D. H. Alpers. Caco-2 cells express a combination of
colonocyte and enterocyte phenotypes. Journal of cellular physiology, 174(3):362–9,
mar 1998.
[344] Yula Sambuy, Isabella de Angelis, Giulia Ranaldi, Maria Laura Scarino, Annalaura
Stammati, and Flavia Zucco. The Caco-2 cell line as a model of the intestinal barrier:
Influence of cell and culture-related factors on Caco-2 cell functional characteristics.
Cell Biology and Toxicology, 21(1):1–26, 2005.
[345] G. Ou, V. Baranov, E. Lundmark, S. Hammarstro¨m, and M.-L. Hammarstro¨m.
Contribution of Intestinal Epithelial Cells to Innate Immunity of the Human Gut -
Studies on Polarized Monolayers of Colon Carcinoma Cells. Scandinavian Journal
of Immunology, 69(2):150–161, 2009.
[346] Miriam Bermudez-Brito, Sergio Mun˜oz-Quezada, Carolina Go´mez-Llorente, Esther
Matencio, Fernando Romero, and Angel Gil. Lactobacillus paracasei CNCM I-
4034 and its culture supernatant modulate Salmonella-induced inflammation in a
novel transwell co-culture of human intestinal-like dendritic and Caco-2 cells. BMC
Microbiology, 15(1), 2015.
[347] C C Grant, M E Konkel, W Cieplak, and L S Tompkins. Role of flagella in ad-
herence, internalization, and translocation of Campylobacter jejuni in nonpolarized
and polarized epithelial cell cultures. Infection and immunity, 61(5):1764–71, 1993.
[348] Sandra D K Kingma, Nan Li, Frank Sun, Ricardo B Valladares, Joe Neu, and Gra-
ciela L Lorca. Lactobacillus johnsonii N6.2 stimulates the innate immune response
through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell
number in biobreeding diabetes-prone rats. The Journal of nutrition, 141(6):1023–8,
jun 2011.
[349] Sushil Chandra Regmi, Su-Young Park, Sae Kwang Ku, and Jung-Ae Kim. Sero-
tonin regulates innate immune responses of colon epithelial cells through Nox2-
derived reactive oxygen species. Free Radical Biology and Medicine, 69:377–389,
2014.
[350] F Sierro, B Dubois, a Coste, D Kaiserlian, J P Kraehenbuhl, and J C Sirard.
Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration
of dendritic cells. Proceedings of the National Academy of Sciences of the United
States of America, 98(24):13722–7, nov 2001.
148
[351] Maria T Abreu. Toll-like receptor signalling in the intestinal epithelium: how bacte-
rial recognition shapes intestinal function. Nature reviews. Immunology, 10(2):131–
144, 2010.
[352] Jean-Christophe Bambou, Antoine Giraud, Sandrine Menard, Bernadette Begue,
Sabine Rakotobe, Martine Heyman, Franc¸ois Taddei, Nadine Cerf-Bensussan, and
Vale´rie Gaboriau-Routhiau. In vitro and ex vivo activation of the TLR5 signaling
pathway in intestinal epithelial cells by a commensal Escherichia coli strain. The
Journal of biological chemistry, 279(41):42984–42992, 2004.
[353] Alexey Larionov, Andreas Krause, and William Miller. A standard curve based
method for relative real time PCR data processing. BMC bioinformatics, 6:62, jan
2005.
[354] Nobuhiko Kamada, Sang-Uk Seo, Grace Y Chen, and Gabriel Nu´n˜ez. Role of the
gut microbiota in immunity and inflammatory disease. Nature reviews. Immunology,
13(5):321–35, may 2013.
[355] Hiutung Chu, Arya Khosravi, Indah P Kusumawardhani, Alice H K Kwon, Anil-
ton C Vasconcelos, Larissa D Cunha, Anne E Mayer, Yue Shen, Wei-Li Wu, Amal
Kambal, Stephan R Targan, Ramnik J Xavier, Peter B Ernst, Douglas R Green,
Dermot P B McGovern, Herbert W Virgin, and Sarkis K. Mazmanian. Gene-
microbiota interactions contribute to the pathogenesis of inflammatory bowel dis-
ease. Science (New York, N.Y.), 352(6289):1116–20, may 2016.
[356] Michael Graham Espey. Role of oxygen gradients in shaping redox relationships
between the human intestine and its microbiota. Free Radical Biology and Medicine,
55:130–140, 2013.
[357] Lindsey Albenberg, Tatiana V. Esipova, Colleen P. Judge, Kyle Bittinger, Jun
Chen, Alice Laughlin, Stephanie Grunberg, Robert N. Baldassano, James D. Lewis,
Hongzhe Li, Stephen R. Thom, Frederic D. Bushman, Sergei A. Vinogradov, and
Gary D. Wu. Correlation between intraluminal oxygen gradient and radial parti-
tioning of intestinal microbiota. Gastroenterology, 147(5):1055–1063.e8, 2014.
[358] Amber L Hartman, Denver M Lough, Dinesh K Barupal, Oliver Fiehn, Thomas
Fishbein, Michael Zasloff, and Jonathan a Eisen. Human gut microbiome adopts an
alternative state following small bowel transplantation. Proceedings of the National
Academy of Sciences of the United States of America, 106(40):17187–17192, 2009.
[359] Lionel Rigottier-Gois. Dysbiosis in inflammatory bowel diseases: the oxygen hy-
pothesis. The ISME journal, 7(7):1256–61, 2013.
149
[360] Luca Pastorelli, Carlo De Salvo, Joseph R. Mercado, Maurizio Vecchi, and
Theresa T. Pizarro. Central role of the gut epithelial barrier in the pathogene-
sis of chronic intestinal inflammation: Lessons learned from animal models and
human genetics. Frontiers in Immunology, 4(SEP):1–22, 2013.
[361] Christian Maaser, Jan Heidemann, Christof von Eiff, Andreas Lugering, Thomas W.
Spahn, David G. Binion, Wolfram Domschke, Norbert Lugering, and Torsten
Kucharzik. Human Intestinal Microvascular Endothelial Cells Express Toll-Like
Receptor 5: A Binding Partner for Bacterial Flagellin. The Journal of Immunology,
172(8):5056–5062, apr 2004.
[362] Yuan Lu and James R Swartz. Functional properties of flagellin as a stimulator of
innate immunity. Scientific reports, 6(January):18379, 2016.
[363] Michael J. Lodes, Yingzi Cong, Charles O. Elson, Raodoh Mohamath, Carol J.
Landers, Stephan R. Targan, Madeline Fort, and Robert M. Hershberg. Bacterial
flagellin is a dominant antigen in Crohn disease. Journal of Clinical Investigation,
113(9):1296–1306, 2004.
[364] Matam Vijay-Kumar and Andrew T. Gewirtz. Role of flagellin in Crohn’s disease:
Emblematic of the progress and enigmas in understanding inflammatory bowel dis-
ease. Inflammatory Bowel Diseases, 15(5):789–795, 2009.
[365] R S Esworthy, R Aranda, M G Mart´ın, J H Doroshow, S W Binder, and F F
Chu. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Ameri-
can journal of physiology. Gastrointestinal and liver physiology, 281(3):G848–G855,
2001.
[366] Caitlyn W. Barrett, Wei Ning, Xi Chen, Jesse Joshua Smith, Mary K. Washington,
Kristina E. Hill, Lori A. Coburn, Richard M. Peek, Rupesh Chaturvedi, Keith T.
Wilson, Raymond F. Burk, and Christopher S. Williams. Tumor suppressor function
of the plasma glutathione peroxidase Gpx3 in colitis-associated carcinoma. Cancer
Research, 73(3):1245–1255, feb 2013.
[367] Jacqueline M. Heilman, Tom J. Burke, Craig J. McClain, and Walter H. Watson.
Transactivation of gene expression by NF-κB is dependent on thioredoxin reductase
activity. Free Radical Biology and Medicine, 51(8):1533–1542, oct 2011.
[368] Merrill J Christensen, Edward T Nartey, Aimee L Hada, Russell L Legg, and Brett R
Barzee. High selenium reduces NF-kappaB-regulated gene expression in uninduced
human prostate cancer cells. Nutrition and cancer, 58(2):197–204, jan 2007.
[369] Simone Ju¨liger, Heidi Goenaga-Infante, T Andrew Lister, Jude Fitzgibbon, and
Simon P Joel. Chemosensitization of B-cell lymphomas by methylseleninic acid
150
involves nuclear factor-kappaB inhibition and the rapid generation of other selenium
species. Cancer research, 67(22):10984–92, nov 2007.
[370] Guan Min-chang, Tang Wei-hong, Xu Zhen, and Sun Jie. Effects of Selenium-
Enriched Protein from Ganoderma lucidum on the Levels of IL-1 β and TNF- α ,
Oxidative Stress, and NF- κ B Activation in Ovalbumin-Induced Asthmatic Mice.
Evidence-Based Complementary and Alternative Medicine, 2014:1–6, jan 2014.
[371] Wen Zhang, Runxiang Zhang, Tiancheng Wang, Haichao Jiang, Mengyao Guo, Er-
shun Zhou, Yong Sun, Zhengtao Yang, Shiwen Xu, Yongguo Cao, and Naisheng
Zhang. Selenium inhibits LPS-induced pro-inflammatory gene expression by mod-
ulating MAPK and NF-κB signaling pathways in mouse mammary epithelial cells
in primary culture. Inflammation, 37(2):478–85, apr 2014.
[372] J L Nano, D Czerucka, F Menguy, and P Rampal. Effect of selenium on the growth
of three human colon cancer cell lines. Biol Trace Elem Res, 20(1-2):31–43, 1989.
[373] Kirstin Wingler, Michael Bo¨cher, Leopold Flohe´, Heike Kollmus, and Regina
Brigelius-Flohe´. mRNA stability and selenocysteine insertion sequence efficiency
rank gastrointestinal glutathione peroxidase high in the hierarchy of selenoproteins.
European Journal of Biochemistry, 259(1-2):149–157, 1999.
[374] C D Davis, E O Uthus, and J W Finley. Dietary selenium and arsenic affect DNA
methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. The Journal
of nutrition, 130(12):2903–2909, 2000.
[375] B. A. Narayanan. Effects of a combination of docosahexaenoic acid and 1,4-
phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide
synthase and -catenin pathways in colon cancer cells. Carcinogenesis, 25(12):2443–
2449, jun 2004.
[376] Vasileios Pagmantidis, Giovanna Bermano, Stephane Villette, Iain Broom, John
Arthur, and John Hesketh. Effects of Se-depletion on glutathione peroxidase and
selenoprotein W gene expression in the colon. FEBS Letters, 579(3):792–796, 2005.
[377] H Zeng and J H Botnen. Selenium is critical for cancer-signaling gene expression
but not cell proliferation in human colon Caco-2 cells. Biofactors, 31(3-4):155–164,
2007.
[378] Huawei Zeng, James H. Botnen, and Luann K. Johnson. A selenium-deficient caco-2
cell model for assessing differential incorporation of chemical or food selenium into
glutathione peroxidase. Biological Trace Element Research, 123(1-3):98–108, 2008.
[379] Aye Aye Thant, Yanyuan Wu, Jane Lee, Dhruva Kumar Mishra, Heather Gar-
cia, H. Phillip Koeffler, and Jaydutt V. Vadgama. Role of caspases in 5-FU and
151
selenium-induced growth inhibition of colorectal cancer cells. Anticancer Research,
28(6 A):3579–3592, 2008.
[380] Eric Uthus, Adrienne Begaye, Sharon Ross, and Huawei Zeng. The von Hippel-
Lindau (VHL) tumor-suppressor gene is down-regulated by selenium deficiency in
Caco-2 cells and rat colon mucosa. Biological Trace Element Research, 142(2):223–
231, 2011.
[381] T Paukert, R Sailer, W S L Strauss, M Schubert-Zsilavecz, and A Zimmer.
Glutathione peroxidase isoenzymes in human tumor cell lines. Die Pharmazie,
66(11):894–8, nov 2011.
[382] Hannah Gautrey, Fergus Nicol, Alan A. Sneddon, Judith Hall, and John Hesketh.
A T/C polymorphism in the GPX4 3’UTR affects the selenoprotein expression
pattern and cell viability in transfected Caco-2 cells. Biochimica et biophysica acta,
1810(6):584–91, jun 2011.
[383] Anabel Maciel-Dominguez, Daniel Swan, Dianne Ford, and John Hesketh. Selenium
alters miRNA profile in an intestinal cell line: evidence that miR-185 regulates
expression of GPX2 and SEPSH2. Molecular nutrition & food research, 57(12):2195–
205, dec 2013.
[384] Lawrence N. Barrera, Ian T. Johnson, Yongping Bao, Aedin Cassidy, and Nigel J.
Belshaw. Colorectal cancer cells Caco-2 and HCT116 resist epigenetic effects of
isothiocyanates and selenium in vitro. European Journal of Nutrition, 52(4):1327–
1341, 2013.
[385] Bodo Speckmann, Kirsten Gerloff, Lisa Simms, Iulia Oancea, Wei Shi, Michael a
McGuckin, Graham Radford-Smith, and Kum Kum Khanna. Selenoprotein S is a
marker but not a regulator of endoplasmic reticulum stress in intestinal epithelial
cells. Free radical biology & medicine, 67:265–77, feb 2014.
[386] Ajay Goel, Florentine Fuerst, Erin Hotchkiss, and C. Richard Boland. Selenome-
thionine induces p53 mediated cell cycle arrest and apoptosis in human colon cancer
cells. Cancer Biology & Therapy, 5(5):529–535, 2014.
[387] Edyta Bajak, Marco Fabbri, Jessica Ponti, Sabrina Gioria, Isaac Ojea-Jime´nez,
Angelo Collotta, Valentina Mariani, Douglas Gilliland, Franc¸ois Rossi, and Laura
Gribaldo. Changes in Caco-2 cells transcriptome profiles upon exposure to gold
nanoparticles. Toxicology letters, 233(2):187–99, mar 2015.
[388] Linglin Fu, Xuxia Yan, Xinming Ruan, Junda Lin, and Yanbo Wang. Differential
protein expression of Caco-2 cells treated with selenium nanoparticles compared
with sodium selenite and selenomethionine. Nanoscale research letters, 9(1):589,
jan 2014.
152
[389] Silke De Spirt, Anna Eckers, Carina Wehrend, Mustafa Micoogullari, Helmut Sies,
Wilhelm Stahl, and Holger Steinbrenner. Interplay between the chalcone carda-
monin and selenium in the biosynthesis of Nrf2-regulated antioxidant enzymes in
intestinal Caco-2 cells. Free Radical Biology and Medicine, 91:164–171, 2016.
[390] G Leblondel, Y Mauras, A Cailleux, and P Allain. Transport measurements across
Caco-2 monolayers of different organic and inorganic selenium: influence of sulfur
compounds. Biological trace element research, 83(3):191–206, 2001.
[391] Giulia Ranaldi, Rosa Consalvo, Yula Sambuy, and Maria Laura Scarino. Perme-
ability characteristics of parental and clonal human intestinal Caco-2 cell lines dif-
ferentiated in serum-supplemented and serum-free media. Toxicology in Vitro, 17(5-
6):761–767, 2003.
[392] Flavia Zucco, Anne-Francoise Batto, Giovanna Bises, Jean Chambaz, Arianna Chiu-
solo, Rosa Consalvo, Heide Cross, Gianni Dal Negro, Isabella de Angelis, Gerard
Fabre, Francois Guillou, Sebastian Hoffman, Loic Laplanche, Etienne Morel, Mar-
tine Pincon-Raymond, Pilar Prieto, Laura Turco, Giulia Ranaldi, Monique Rousset,
Yula Sambuy, Maria Laura Scarino, Francois Torreilles, and Annalaura Stammati.
An inter-laboratory study to evaluate the effects of medium composition on the
differentiation and barrier function of Caco-2 cell lines. Alternatives to laboratory
animals : ATLA, 33(6):603–618, 2005.
[393] Shveta Taparia, James C. Fleet, Ji Bin Peng, Dong Wang Xiang, and Richard J.
Wood. 1,25-Dihydroxyvitamin D and 25-hydroxyvitamin D - Mediated regulation
of TRPV6 (a putative epithelial calcium channel) mRNA expression in Caco-2 cells.
European Journal of Nutrition, 45(4):196–204, 2006.
[394] Huawei Zeng, Matthew I Jackson, Wen-hsing hsing Cheng, and Jr Combs. Chemical
Form of Selenium Affects Its Uptake , Transport , and Glutathione Peroxidase
Activity in the Human Intestinal Caco-2 Cell Model. Biological Trace Element
Research, 143(2):1209–1218, 2011.
[395] Bodo Speckmann, Hans-Ju¨rgen Bidmon, Antonio Pinto, Martin Anlauf, Helmut
Sies, and Holger Steinbrenner. Induction of glutathione peroxidase 4 expres-
sion during enterocytic cell differentiation. The Journal of biological chemistry,
286(12):10764–72, mar 2011.
[396] Yanbo Wang and Linglin Fu. Forms of selenium affect its transport, Uptake and
glutathione peroxidase activity in the caco-2 cell model. Biological Trace Element
Research, 149(1):110–116, 2012.
[397] Bodo Speckmann, Hans-Ju¨rgen Ju¨rgen Bidmon, Andrea Borchardt, Helmut Sies,
and Holger Steinbrenner. Intestinal selenoprotein P in epithelial cells and in plasma
cells. Archives of biochemistry and biophysics, 541(October):1–7, oct 2013.
153
[398] Thorsten Buhrke, Imme Lengler, and Alfonso Lampen. Analysis of proteomic
changes induced upon cellular differentiation of the human intestinal cell line Caco-
2. Development, growth & differentiation, 53(3):411–26, 2011.
[399] Bruno Daniele Leoni, Manuela Natoli, Marta Nardella, Barbara Bucci, Flavia Zucco,
Igea D’Agnano, and Armando Felsani. Differentiation of Caco-2 cells requires
both transcriptional and post-translational down-regulation of Myc. Differentia-
tion, 83(3):116–127, 2012.
[400] Q Ding, Z Dong, and B M Evers. Enterocyte-like differentiation of the Caco-2
intestinal cell line is associated with increases in AP-1 protein binding. Life sciences,
64(3):175–82, 1999.
[401] Jacqueline Van De Walle, Aure´lie Hendrickx, Be´atrice Romier, Yvan Larondelle,
and Yves-Jacques Schneider. Inflammatory parameters in Caco-2 cells: effect of
stimuli nature, concentration, combination and cell differentiation. Toxicology in
vitro : an international journal published in association with BIBRA, 24(5):1441–9,
aug 2010.
[402] Sˇ. Jindrˇichova´, O. Nova´kova´, J. Bryndova´, E. Tvrzicka´, V. Lisa´, F. Nova´k, and
J. Pa´cha. Corticosteroid effect on Caco-2 cell lipids depends on cell differentiation.
The Journal of Steroid Biochemistry and Molecular Biology, 87(2-3):157–165, nov
2003.
[403] Veedamali S Subramanian, Abhisek Ghosal, Sandeep B Subramanya, Christian Ly-
tle, and Hamid M Said. Differentiation-dependent regulation of intestinal vitamin
B(2) uptake: studies utilizing human-derived intestinal epithelial Caco-2 cells and
native rat intestine. American journal of physiology. Gastrointestinal and liver phys-
iology, 304(8):G741–8, 2013.
[404] Cyrille Costa, J. F. Huneau, and Daniel Tome´. Characteristics of L-glutamine trans-
port during Caco-2 cell differentiation. Biochimica et Biophysica Acta - Biomem-
branes, 1509(1-2):95–102, 2000.
[405] He´le`ne Be´drine-Ferran, Nolwenn Le Meur, Isabelle Gicquel, Martine Le Cunff, Nico-
las Soriano, Isabelle Guisle, Ste´phanie Mottier, Annabelle Monnier, Raluca Teusan,
Patricia Fergelot, Jean Yves Le Gall, Jean Le´ger, and Jean Mosser. Transcriptome
variations in human CaCo-2 cells: A model for enterocyte differentiation and its
link to iron absorption. Genomics, 83(5):772–789, 2004.
[406] Christopher P Landowski, Pascale Anderle, Duxin Sun, Wolfgang Sadee, and Gor-
don L Amidon. Transporter and ion channel gene expression after Caco-2 cell dif-
ferentiation using 2 different microarray technologies. The AAPS journal, 6(3):e21,
2004.
154
[407] E. Scharmach, S. Hessel, B. Niemann, and A. Lampen. Glutathione S-transferase
expression and isoenzyme composition during cell differentiation of Caco-2 cells.
Toxicology, 265(3):122–126, 2009.
[408] Yvonne S Nkabyo, Thomas R Ziegler, Li H Gu, Walter H Watson, and Dean P
Jones. Glutathione and thioredoxin redox during differentiation in human colon
epithelial (Caco-2) cells. American journal of physiology. Gastrointestinal and liver
physiology, 283(6):G1352–9, 2002.
[409] Andre´s Garc´ıa-Lorenzo, Ana M. Rodr´ıguez-Pin˜eiro, Francisco J. Rodr´ıguez-
Berrocal, Mar´ıa Pa´ez de la Cadena, and Vicenta S. Mart´ınez-Zorzano. Changes
on the Caco-2 secretome through differentiation analyzed by 2-D differential in-gel
electrophoresis (DIGE). International Journal of Molecular Sciences, 13(11):14401–
14420, 2012.
[410] Claudia Piana, Michael Wirth, Stefan Gerbes, Helmut Viernstein, Franz Gabor, and
Stefan Toegel. Validation of reference genes for qPCR studies on Caco-2 cell differ-
entiation. European Journal of Pharmaceutics and Biopharmaceutics, 69(3):1187–
1192, 2008.
[411] Valentino Bezzerri, Monica Borgatti, Alessia Finotti, Anna Tamanini, Roberto
Gambari, and Giulio Cabrini. Mapping the transcriptional machinery of the IL-
8 gene in human bronchial epithelial cells. Journal of immunology (Baltimore, Md.
: 1950), 187(11):6069–81, dec 2011.
[412] Brian P Ashburner, Sandy D Westerheide, and A S Baldwin. The p65 (RelA)
subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors
HDAC1 and HDAC2 to negatively regulate gene expression. Molecular and cellular
biology, 21(20):7065–77, oct 2001.
[413] W Vanden Berghe, K De Bosscher, E Boone, S Plaisance, and G Haegeman. The
nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for
transcriptional activation of the interleukin-6 gene promoter. The Journal of bio-
logical chemistry, 274(45):32091–8, nov 1999.
[414] Robert F. Place, Emily J. Noonan, and Charles Giardina. HDAC inhibition prevents
NF-κB activation by suppressing proteasome activity: Down-regulation of protea-
some subunit expression stabilizes IκBα. Biochemical Pharmacology, 70(3):394–406,
aug 2005.
[415] Nong Xiang, Rui Zhao, Guoqing Song, and Weixiong Zhong. Selenite reactivates
silenced genes by modifying DNA methylation and histones in prostate cancer cells.
Carcinogenesis, 29(11):2175–2181, 2008.
155
[416] Margaret P Rayman, Peter Bode, and Christopher W.G Redman. Low selenium
status is associated with the occurrence of the pregnancy disease preeclampsia in
women from the United Kingdom. American Journal of Obstetrics and Gynecology,
189(5):1343–1349, nov 2003.
[417] Michael A. Lea, Chinwe Ibeh, Lydia Han, and Charles Desbordes. Inhibition of
growth and induction of differentiation markers by polyphenolic molecules and his-
tone deacetylase inhibitors in colon cancer cells. Anticancer Research, 30(2):311–318,
2010.
[418] Andrew J. Wilson, Do Sun Byun, Natalia Popova, Lucas B. Murray, Kaitlin
L’Italien, Yoshihiro Sowa, Diego Arango, Anna Velcich, Leonard H. Augenlicht, and
John M. Mariadason. Histone deacetylase 3 (HDAC3) and other class I HDACs reg-
ulate colon cell maturation and p21 expression and are deregulated in human colon
cancer. Journal of Biological Chemistry, 281(19):13548–13558, 2006.
[419] Michael P. Verzi, Hyunjin Shin, H. Hansen He, Rita Sulahian, Clifford A. Meyer,
Robert K. Montgomery, James C. Fleet, Myles Brown, X. Shirley Liu, and
Ramesh A. Shivdasani. Differentiation-Specific Histone Modifications Reveal Dy-
namic Chromatin Interactions and Partners for the Intestinal Transcription Factor
CDX2. Developmental Cell, 19(5):713–726, 2010.
[420] Michael A. Lea, Chinwe Ibeh, Neel Shah, and Mary P. Moyer. Induction of differenti-
ation of colon cancer cells by combined inhibition of kinases and histone deacetylase.
Anticancer Research, 27(2):741–748, 2007.
[421] Alireza Roostaee, Amel Guezguez, Marco Beause´jour, Aline Simoneau, Pierre H.
Vachon, Emile Levy, and Jean Franc¸ois Beaulieu. Histone Deacetylase Inhibition
Impairs Normal Intestinal Cell Proliferation and Promotes Specific Gene Expression.
Journal of Cellular Biochemistry, 116(11):2695–2708, 2015.
[422] Mahtab Nourbakhsh, Solveig Ka¨lble, Anneke Do¨rrie, Hansjo¨rg Hauser, Klaus Resch,
and Michael Kracht. The NF-κB Repressing Factor Is Involved in Basal Repression
and Interleukin (IL)-1-induced Activation of IL-8 Transcription by Binding to a
Conserved NF-κB-flanking Sequence Element. Journal of Biological Chemistry,
276(6):4501–4508, 2001.
[423] Elke Hoffmann, Oliver Dittrich-Breiholz, Helmut Holtmann, and Michael Kracht.
Multiple control of interleukin-8 gene expression. Journal of leukocyte biology,
72(November):847–855, 2002.
[424] F Hayashi, K D Smith, a Ozinsky, T R Hawn, E C Yi, D R Goodlett, J K Eng,
S Akira, D M Underhill, and a Aderem. The innate immune response to bacterial
flagellin is mediated by Toll-like receptor 5. Nature, 410(6832):1099–1103, 2001.
156
[425] Andrew T Gewirtz, Tony a Navas, Sean Lyons, Paul J Godowski, and James L
Madara. Cutting Edge: Bacterial Flagellin Activates Basolaterally Expressed TLR5
to Induce Epithelial Proinflammatory Gene Expression. The Journal of Immunol-
ogy, 167:1882–1885, 2001.
[426] Karim Jundi and Catherine M Greene. Transcription of Interleukin-8: How Altered
Regulation Can Affect Cystic Fibrosis Lung Disease. Biomolecules, 5(3):1386–1398,
2015.
[427] Helia B Schonthaler, Juan Guinea-Viniegra, and Erwin F Wagner. Targeting inflam-
mation by modulating the Jun/AP-1 pathway. Annals of the rheumatic diseases,
70 Suppl 1(Suppl 1):i109–12, 2011.
[428] Michael Karin, Zheng Gang Liu, and Ebrahim Zandi. AP-1 function and regulation.
Current Opinion in Cell Biology, 9(2):240–246, 1997.
[429] Erwin F Wagner and Angel R Nebreda. Signal integration by JNK and p38 MAPK
pathways in cancer development. Nature reviews. Cancer, 9:537–549, 2009.
[430] Andrea Krause, Helmut Holtmann, Solveig Eickemeier, Reinhard Winzen, Martha
Szamel, Klaus Resch, Jeremy Saklatvala, and Michael Kracht. Stress-activated
protein kinase/Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-
6 and IL-8 gene expression in the human epidermal carcinoma cell line KB. The
Journal of biological chemistry, 273(37):23681–9, sep 1998.
[431] Nadine Steubesand, Karlheinz Kiehne, Gabriele Brunke, Rene Pahl, Karina Reiss,
Karl-Heinz Herzig, Sabine Schubert, Stefan Schreiber, Ulrich R. Folsch, Philip
Rosenstiel, and Alexander Arlt. The expression of the beta-defensins hBD-2 and
hBD-3 is differentially regulated by NF-kappaB and MAPK/AP-1 pathways in an
in vitro model of Candida esophagitis. BMC Immunology, 10(1):36, 2009.
[432] P Vora, A Youdim, L S Thomas, M Fukata, S Y Tesfay, K Lukasek, K S Michelsen,
A Wada, T Hirayama, M Arditi, and M T Abreu. Beta-defensin-2 expression is
regulated by TLR signaling in intestinal epithelial cells. J.Immunol., 173(9):5398–
5405, 2004.
[433] Yi Fu, Keiko Kumura Ishii, Yasuhiko Munakata, Takako Saitoh, Mitsuo Kaku, and
Takeshi Sasaki. Regulation of tumor necrosis factor alpha promoter by human
parvovirus B19 NS1 through activation of AP-1 and AP-2. Journal of virology,
76(11):5395–403, 2002.
[434] Hee-sae Park, Eun Park, Mi-sung Kim, Kwangseog Ahn, Ick Young Kim, and Eui-
ju Choi. Selenite Inhibits the c-Jun N-terminal Kinase / Stress-activated Protein
Kinase ( JNK / SAPK ) through a Thiol Redox Mechanism. The journal of biological
chemistry, 275(4):2527–2531, 2000.
157
[435] M. Pazgier, D. M. Hoover, D. Yang, W. Lu, and J. Lubkowski. Human β-defensins.
Cellular and Molecular Life Sciences, 63(11):1294–1313, jun 2006.
[436] Jan Wehkamp, Ju¨rgen Harder, Kai Wehkamp, Birte Wehkamp-von Meissner,
Miriam Schlee, Corinne Enders, Ulrich Sonnenborn, Sabine Nuding, Stig Bengmark,
Klaus Fellermann, Jens Michael Schro¨der, and Eduard F Stange. NF-kappaB- and
AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by
Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infection and
immunity, 72(10):5750–8, oct 2004.
[437] M. Schlee, J. Harder, B. Ko¨ten, E. F. Stange, J. Wehkamp, and K. Fellermann.
Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2. Clinical & Exper-
imental Immunology, 151(3):528–535, jan 2008.
[438] Karlheinz Kiehne, Gabriele Brunke, Franziska Wegner, Tomas Banasiewicz, Ul-
rich R Folsch, and Karl-Heinz Herzig. Defensin expression in chronic pouchitis in
patients with ulcerative colitis or familial adenomatous polyposis coli. World journal
of gastroenterology : WJG, 12(7):1056–62, 2006.
[439] Su Ho Han, Young Eun Kim, Jeong A. Park, Jae Bong Park, Yong Sun Kim,
Younghee Lee, Ihn Geun Choi, and Hyung Joo Kwon. Expression of human β-
defensin-2 gene induced by CpG-DNA in human B cells. Biochemical and Biophys-
ical Research Communications, 389(3):443–448, 2009.
[440] F. C. Huang. The differential effects of 1,25-dihydroxyvitamin D3 on Salmonella-
induced interleukin-8 and human beta-defensin-2 in intestinal epithelial cells. Clin-
ical and Experimental Immunology, pages 98–106, 2016.
[441] Yuying Gan, Xuefan Cui, Ting Ma, Yanliang Liu, Amin Li, and Mao Huang.
Paeoniflorin Upregulates β-Defensin-2 Expression in Human Bronchial Epithelial
Cell Through the p38 MAPK, ERK, and NF-κB Signaling Pathways. Inflamma-
tion, 37(5):1468–1475, oct 2014.
[442] Fu-Chen Huang. Differential regulation of interleukin-8 and human beta-defensin 2
in Pseudomonas aeruginosa -infected intestinal epithelial cells. BMC microbiology,
14(1):275, 2014.
[443] D. Omagari, N. Takenouchi-Ohkubo, S. Endo, T. Ishigami, A. Sawada, I. Moro,
M. Asano, and K. Komiyama. Nuclear factor kappa B plays a pivotal role in
polyinosinic-polycytidylic acid-induced expression of human β-defensin 2 in intesti-
nal epithelial cells. Clinical & Experimental Immunology, 165(1):85–93, jul 2011.
[444] Kathryn E. Merriman, Mercedes F. Kweh, Jessica L. Powell, John D. Lippolis, and
Corwin D. Nelson. Multiple β-defensin genes are upregulated by the vitamin D
158
pathway in cattle. The Journal of Steroid Biochemistry and Molecular Biology,
154:120–129, 2015.
[445] Markus Schwab, Veerle Reynders, Stefan Loitsch, Dieter Steinhilber, Oliver
Schro¨der, and Ju¨rgen Stein. The dietary histone deacetylase inhibitor sul-
foraphane induces human beta-defensin-2 in intestinal epithelial cells. Immunology,
125(2):241–51, oct 2008.
[446] Sergei I Grivennikov, Dmitry V Kuprash, Zheng-Gang Liu, and Sergei A Ne-
dospasov. Intracellular signals and events activated by cytokines of the tumor
necrosis factor superfamily: From simple paradigms to complex mechanisms. Inter-
national review of cytology, 252:129–61, 2006.
[447] Bharat B Aggarwal. Signalling pathways of the TNF superfamily: a double-edged
sword. Nature reviews. Immunology, 3(9):745–56, sep 2003.
[448] Hongxia Z Imtiyaz and M Celeste Simon. Hypoxia-inducible factors as essential reg-
ulators of inflammation. Current topics in microbiology and immunology, 345:105–
20, jan 2010.
[449] Heiko Blaser, Catherine Dostert, Tak W. Mak, and Dirk Brenner. TNF and ROS
Crosstalk in Inflammation. Trends in Cell Biology, 26(4):249–261, apr 2016.
[450] Masataka Uchida, Eri Oyanagi, Noriaki Kawanishi, Motoyuki Iemitsu, Motohiko
Miyachi, Michael J Kremenik, Sho Onodera, and Hiromi Yano. Exhaustive exercise
increases the TNF-α production in response to flagellin via the upregulation of toll-
like receptor 5 in the large intestine in mice. Immunology letters, 158(1-2):151–8.
[451] Jill Tseng, Jiun Do, Jonathan H Widdicombe, and Terry E Machen. Innate immune
responses of human tracheal epithelium to Pseudomonas aeruginosa flagellin, TNF-
alpha, and IL-1beta. American journal of physiology. Cell physiology, 290(3):C678–
90, mar 2006.
[452] K L Rhoades, S H Golub, and J S Economou. The regulation of the human tumor
necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. The
Journal of biological chemistry, 267(31):22102–22107, 1992.
[453] J S Economou, K Rhoades, R Essner, W H McBride, J C Gasson, and D L Morton.
Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter re-
gion in a macrophage cell line. The Journal of experimental medicine, 170(1):321–6,
1989.
[454] J V Falvo, a M Uglialoro, B M Brinkman, M Merika, B S Parekh, E Y Tsai,
H C King, a D Morielli, E G Peralta, T Maniatis, D Thanos, and a E Goldfeld.
Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha
gene promoter. Molecular and cellular biology, 20(6):2239–2247, 2000.
159
[455] E Y Tsai, J V Falvo, a V Tsytsykova, a K Barczak, a M Reimold, L H Glimcher,
M J Fenton, D C Gordon, I F Dunn, and a E Goldfeld. A lipopolysaccharide-specific
enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300
is recruited to the tumor necrosis factor alpha promoter in vivo. Molecular and
cellular biology, 20(16):6084–6094, 2000.
[456] Robert Barthel, Alla V Tsytsykova, Amy K Barczak, Eunice Y Tsai, Christopher C
Dascher, Michael B Brenner, and Anne E Goldfeld. Regulation of tumor necrosis
factor alpha gene expression by mycobacteria involves the assembly of a unique
enhanceosome dependent on the coactivator proteins CBP/p300. Molecular and
cellular biology, 23(2):526–533, 2003.
[457] A N Shakhov, M A Collart, P Vassalli, S A Nedospasov, and C V Jongeneel. Kappa
B-type enhancers are involved in lipopolysaccharide-mediated transcriptional acti-
vation of the tumor necrosis factor alpha gene in primary macrophages. The Journal
of experimental medicine, 171(1):35–47, 1990.
[458] Anne E Goldfeld, Sean Doyle, and T Maniatis. Human tumor necrosis factor al-
pha gene regulation by virus and lipopolysaccharide. Proceedings of the National
Academy of Sciences of the United States of America, 87(24):9769–73, dec 1990.
[459] M A Collart, P Baeuerle, and P Vassalli. Regulation of tumor necrosis factor
alpha transcription in macrophages: involvement of four kappa B-like motifs and
of constitutive and inducible forms of NF-kappa B. Molecular and cellular biology,
10(4):1498–506, 1990.
[460] Josef Johann Schneider, Angela Unholzer, Martin Schaller, Monika Scha¨fer-Korting,
and Hans Christian Korting. Human defensins. Journal of Molecular Medicine,
83(8):587–595, aug 2005.
[461] D a O’Neil, E M Porter, D Elewaut, G M Anderson, L Eckmann, T Ganz, and
M F Kagnoff. Expression and regulation of the human beta-defensins hBD-1 and
hBD-2 in intestinal epithelium. Journal of immunology (Baltimore, Md. : 1950),
163:6718–6724, 1999.
[462] Kimberley Kallsen, Ellen Andresen, and Holger Heine. Histone Deacetylase (HDAC)
1 Controls the Expression of Beta Defensin 1 in Human Lung Epithelial Cells. PLoS
ONE, 7(11):1–8, 2012.
[463] Louise A Duits, Bep Ravensbergen, Mirjam Rademaker, Pieter S Hiemstra, and Pe-
ter H Nibbering. Expression of beta-defensin 1 and 2 mRNA by human monocytes,
macrophages and dendritic cells. Immunology, 106(4):517–25, 2002.
[464] Todd M Schaefer, John V Fahey, Jacqueline a Wright, and Charles R Wira. Innate
immunity in the human female reproductive tract: antiviral response of uterine
160
epithelial cells to the TLR3 agonist poly(I:C). Journal of immunology (Baltimore,
Md. : 1950), 174(2):992–1002, 2005.
[465] N Gao, G Sang Yoon, X Liu, X Mi, W Chen, T J Standiford, and F-SX Yu. Genome-
wide transcriptional analysis of differentially expressed genes in flagellin-pretreated
mouse corneal epithelial cells in response to Pseudomonas aeruginosa: involvement
of S100A8/A9. Mucosal Immunology, 6(5):993–1005, sep 2013.
[466] Soo-jin Ann, Ji Hyung Chung, Byung Hee Park, Soo Hyuk Kim, Jiyoung Jang,
Sungha Park, Seok-Min Kang, and Sang-Hak Lee. PPARα agonists inhibit inflam-
matory activation of macrophages through upregulation of β-defensin 1. Atheroscle-
rosis, 240(2):389–397, jun 2015.
[467] U. H. Gandhi, N. Kaushal, K. C. Ravindra, S. Hegde, S. M. Nelson, V. Narayan,
H. Vunta, R. F. Paulson, and K. S. Prabhu. Selenoprotein-dependent Up-regulation
of Hematopoietic Prostaglandin D2 Synthase in Macrophages Is Mediated through
the Activation of Peroxisome Proliferator-activated Receptor (PPAR). Journal of
Biological Chemistry, 286(31):27471–27482, aug 2011.
[468] Xuejiao Gao, Zecai Zhang, Ying Li, Xiaoyu Hu, Peng Shen, Yunhe Fu, Yongguo
Cao, and Naisheng Zhang. Selenium Deficiency Deteriorate the Inflammation of S.
aureus Infection via Regulating NF-κB and PPAR-γ in Mammary Gland of Mice.
Biological Trace Element Research, 172(1):140–147, jul 2016.
[469] Anze Zupanic, Catherine Meplan, Grazielle V B Huguenin, John E Hesketh, and
Daryl P Shanley. Modeling and gene knockdown to assess the contribution of
nonsense-mediated decay , premature termination , and selenocysteine insertion
to the selenoprotein hierarchy. RNA (New York, N.Y.), 22(7):1–9, jul 2016.
[470] Zahia Touat-Hamici, Yona Legrain, Anne-Laure Laure Bulteau, and Laurent Cha-
vatte. Selective Up-Regulation of Human Selenoproteins in Response to Oxidative
Stress. The Journal of biological chemistry, 289(21):14750–61, apr 2014.
[471] Yona Legrain, Zahia Touat-Hamici, and Laurent Chavatte. Interplay between se-
lenium levels, selenoprotein expression, and replicative senescence in WI-38 human
fibroblasts. Journal of Biological Chemistry, 289(9):6299–6310, 2014.
[472] Anna Patricia Kipp, Janna Frombach, Stefanie Deubel, and Regina Brigelius-Flohe´.
Selenoprotein w as biomarker for the efficacy of selenium compounds to act as source
for selenoprotein biosynthesis. Methods in enzymology, 527:87–112, jan 2013.
[473] K E Hill, G W McCollum, M E Boeglin, and R F Burk. Thioredoxin reduc-
tase activity is decreased by selenium deficiency. Biochem Biophys.Res Commun.,
19;234(2):293–295, 1997.
161
[474] Margareta M Berggren, Jose´ F Mangin, John R Gasdaska, and Garth Powis. Ef-
fect of selenium on rat thioredoxin reductase activity. Biochemical Pharmacology,
57(2):187–193, 1999.
[475] M Berggren, A Gallegos, J Gasdaska, and G Powis. Cellular thioredoxin reductase
activity is regulated by selenium. Anticancer research, 17(5A):3377–3380, 1997.
[476] Walter H. Watson, Jacqueline M. Heilman, Laura L. Hughes, and Jeanine C. Spiel-
berger. Thioredoxin reductase-1 knock down does not result in thioredoxin-1 ox-
idation. Biochemical and Biophysical Research Communications, 368(3):832–836,
2008.
[477] Xu Zhang, Yujuan Zheng, Levi E. Fried, Yatao Du, Sergio J. Montano, Allie Sohn,
Benjamin Lefkove, Lars Holmgren, Jack L. Arbiser, Arne Holmgren, and Jun Lu.
Disruption of the mitochondrial thioredoxin system as a cell death mechanism of
cationic triphenylmethanes. Free Radical Biology and Medicine, 50(7):811–820,
2011.
[478] Yatao Du, Huihui Zhang, Jun Lu, and Arne Holmgren. Glutathione and glutare-
doxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin
1 preventing cell death by aurothioglucose. Journal of Biological Chemistry,
287(45):38210–38219, 2012.
[479] Atsuko Sakurai, Kouji Yuasa, Yasuko Shoji, Seiichiro Himeno, Masafumi Tsuji-
moto, Manabu Kunimoto, Nobumasa Imura, and Shuntaro Hara. Overexpression
of thioredoxin reductase 1 regulates NF-kappa B activation. Journal of cellular
physiology, 198(1):22–30, 2004.
[480] Elke Heiss and Clarissa Gerha¨user. Time-dependent modulation of thioredoxin re-
ductase activity might contribute to sulforaphane-mediated inhibition of NF-kappaB
binding to DNA. Antioxidants & redox signaling, 7(11-12):1601–11, 2005.
[481] Hitoshi Ueno, Hitomi Kajihara, Hajime Nakamura, Junji Yodoi, and Katsuhiko
Nakamuro. Contribution of thioredoxin reductase to T-cell mitogenesis and NF-
kappaB DNA-binding promoted by selenite. Antioxidants & redox signaling,
9(1):115–21, jan 2007.
[482] R Harper, K Wu, M M Chang, K Yoneda, R Pan, S P Reddy, and R Wu. Activa-
tion of nuclear factor-kappa b transcriptional activity in airway epithelial cells by
thioredoxin but not by N-acetyl-cysteine and glutathione. Am J Respir Cell Mol
Biol, 25(2):178–185, 2001.
[483] J R Matthews, N Wakasugi, J L Virelizier, J Yodoi, and R T Hay. Thioredoxin
regulates the DNA binding activity of NF-kappa B by reduction of a disulphide
bond involving cysteine 62. Nucleic acids research, 20(15):3821–30, 1992.
162
[484] Shijun Li, Tao Yan, J Q Yang, T D Oberley, and L W Oberley. The role of cellular
glutathione peroxidase redox regulation in the suppression of tumor cell growth by
manganese superoxide dismutase. Cancer research, 60(14):3927–39, jul 2000.
[485] C Kretz-Remy and AP Arrigo. Selenium: a key element that controls NF-κB
activation and IκBα half life. Biofactors, 14:117–125, 2001.
[486] R Steven Esworthy, Lixin Yang, Paul H Frankel, and Fong-Fong Chu. Epithelium-
specific glutathione peroxidase, Gpx2, is involved in the prevention of intestinal
inflammation in selenium-deficient mice. The Journal of nutrition, 135(4):740–745,
2005.
[487] Fong Fong Chu, R. Steven Esworthy, Peiguo G. Chu, Jeffrey a. Longmate, Mark M.
Huycke, Sharon Wilczynski, and James H. Doroshow. Bacteria-Induced Intestinal
Cancer in Mice with Disrupted Gpx1 and Gpx2 Genes. Cancer Research, 64(3):962–
968, 2004.
[488] Antje Banning, Simone Florian, Stefanie Deubel, Sophie Thalmann, Katrin Mu¨ller-
Schmehl, Gisela Jacobasch, and Regina Brigelius-Flohe´. GPx2 Counteracts PGE2
Production by Dampening COX-2 and mPGES-1 Expression in Human Colon Can-
cer Cells. Antioxidants & Redox Signaling, 10(9):1491–1500, may 2008.
[489] Antje Banning, Anna Kipp, Stephanie Schmitmeier, Maria Lo¨winger, Simone
Florian, Susanne Krehl, Sophie Thalmann, Rene´ Thierbach, Pablo Steinberg,
and Regina Brigelius-Flohe´. Glutathione peroxidase 2 inhibits cyclooxygenase-2-
mediated migration and invasion of HT-29 adenocarcinoma cells but supports their
growth as tumors in nude mice. Cancer Research, 68(23):9746–9753, 2008.
[490] William D Landry and Thomas G Cotter. ROS signalling, NADPH oxidases and
cancer. Biochemical Society transactions, 42(4):934–8, 2014.
[491] Joseph B J Ward, Simon J Keely, and Stephen J Keely. Oxygen in the regulation of
intestinal epithelial transport. The Journal of physiology, 00(April):1–17, apr 2014.
[492] Qiang Ma. Role of nrf2 in oxidative stress and toxicity. Annual review of pharma-
cology and toxicology, 53:401–26, jan 2013.
[493] Mohinder Bansal and Naveen Kaushal. Introduction to Oxidative Stress. In Ox-
idative Stress Mechanisms and their Modulation, pages 1–18. Springer India, New
Delhi, 2014.
[494] Elmira Zolali, Hadi Hamishehkar, Nasrin Maleki-Dizaji, Naime Majidi Zolbanin,
Hamed Ghavimi, Maryam Kouhsoltani, and Parina Asgharian. Selenium effect on
oxidative stress factors in septic rats. Advanced pharmaceutical bulletin, 4(3):289–93,
jan 2014.
163
[495] Nilgu¨n Senol, Mustafa Nazırog˘lu, and Vehbi Yu¨ru¨ker. N-acetylcysteine and selenium
modulate oxidative stress, antioxidant vitamin and cytokine values in traumatic
brain injury-induced rats. Neurochemical research, 39(4):685–92, apr 2014.
[496] K Briviba, I Roussyn, V S Sharov, and H Sies. Attenuation of oxidation and
nitration reactions of peroxynitrite by selenomethionine, selenocystine and ebselen.
The Biochemical journal, 319 ( Pt 1:13–15, 1996.
[497] Thomas Nauser, Sindy Dockheer, Reinhard Kissner, and Willem H Koppenol. Catal-
ysis of electron transfer by selenocysteine. Biochemistry, 45:6038–6043, 2006.
[498] Aldwin Suryo Rahmanto and Michael J. Davies. Catalytic activity of selenomethio-
nine in removing amino acid, peptide, and protein hydroperoxides. Free Radical
Biology and Medicine, 51:2288–2299, 2011.
[499] Renee J. Krause and Adnan A. Elfarra. Reduction of l-methionine selenoxide to
seleno-l-methionine by endogenous thiols, ascorbic acid, or methimazole. Biochem-
ical Pharmacology, 77:134–140, 2009.
[500] Erin E Battin, Matthew T Zimmerman, Ria R Ramoutar, Carolyn E Quarles,
and Julia L Brumaghim. Preventing metal-mediated oxidative DNA damage with
selenium compounds. Metallomics : integrated biometal science, 3:503–512, 2011.
[501] Holger Blessing, Silke Kraus, Philipp Heindl, Wojciech Bal, and Andrea Hartwig.
Interaction of selenium compounds with zinc finger proteins involved in DNA repair.
European journal of biochemistry / FEBS, 271:3190–3199, 2004.
[502] Gregory V Kryukov, R Abhilash Kumar, Ahmet Koc, Zhaohui Sun, and Vadim N
Gladyshev. Selenoprotein R is a zinc-containing stereo-specific methionine sulfoxide
reductase. Proceedings of the National Academy of Sciences of the United States of
America, 99(7):4245–4250, 2002.
[503] Konstantin V. Korotkov, Easwari Kumaraswamy, You Zhou, Dolph L. Hatfield, and
Vadim N. Gladyshev. Association between the 15-kDa Selenoprotein and UDP-
glucose:Glycoprotein Glucosyltransferase in the Endoplasmic Reticulum of Mam-
malian Cells. Journal of Biological Chemistry, 276(18):15330–15336, 2001.
[504] Andrew D. Ferguson, Vyacheslav M. Labunskyy, Dmitri E. Fomenko, Demet Arac¸,
Yogarany Chelliah, Carlos A. Amezcua, Josep Rizo, Vadim N. Gladyshev, and
Johann Deisenhofer. NMR structures of the selenoproteins Sep15 and SelM reveal
redox activity of a new thioredoxin-like family. The Journal of biological chemistry,
281(6):3536–43, feb 2006.
[505] G. V. Kryukov, Valentin M Kryukov, and Vadim N Gladyshev. New Mammalian
Selenocysteine-containing Proteins Identified with an Algorithm That Searches
164
for Selenocysteine Insertion Sequence Elements. Journal of Biological Chemistry,
274(48):33888–33897, nov 1999.
[506] Marcus Cebula, Edward E Schmidt, and Elias S J Arne´r. TrxR1 as a potent regula-
tor of the Nrf2-Keap1 response system. Antioxidants & redox signaling, 23(10):823–
53, oct 2015.
[507] Gad Asher, Joseph Lotem, Rachel Kama, Leo Sachs, and Yosef Shaul. NQO1
stabilizes p53 through a distinct pathway. Proceedings of the National Academy of
Sciences of the United States of America, 99(5):3099–3104, 2002.
[508] Adil Anwar, Donna Dehn, David Siegel, Jadwiga K. Kepa, Luo Jia Tang, Jennifer a.
Pietenpol, and David Ross. Interaction of human NAD(P)H:Quinone oxidoreduc-
tase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems.
Journal of Biological Chemistry, 278(12):10368–10373, 2003.
[509] Kaiyu Liu, Bo Jin, Chenglin Wu, Jianming Yang, Xiangwen Zhan, Le Wang, Xi-
aomeng Shen, Jing Chen, Hao Chen, and Zebin Mao. NQO1 Stabilizes p53 in
Response to Oncogene-Induced Senescence. International Journal of Biological Sci-
ences, 11(7):762–771, 2015.
[510] Martin Belinsky and Anil K Jaiswal. NAD ( P ) H : Quinone oxidoreductase I (
DT-diaphorase ) expression in normal and tumor tissues. Cancer and Metastasis
Reviews, 1:103–117, 1993.
[511] Alvin M. Malkinson, David Siegel, Gerald L. Forrest, Adi F. Gazdar, Herbert K.
Oie, Daniel C. Chan, Paul a. Bunn, Mack Mabry, Donald J. Dykes, Steadman D.
Harrison, and David Ross. Elevated DT-diaphorase activity and messenger RNA
content in human non-small cell lung carcinoma: Relationship to the response of
lung tumor xenografts to mitomycin C. Cancer Research, 52(17):4752–4757, 1992.
[512] Yar´ı E Mar´ın, A Lo´pez de Cerain, E Hamilton, D Lewis, J M Martinez-Pen˜uela,
M Idoate, and J Bello. DT-diaphorase and cytochrome B5 reductase in human lung
and breast tumours. British journal of cancer, 76(7):923–9, 1997.
[513] Samantha M. Yeligar, Keigo Machida, and Vijay K. Kalra. Ethanol-induced HO-1
and NQO1 Are Differentially Regulated by HIF-1 and Nrf2 to Attenuate Inflamma-
tory Cytokine Expression. Journal of Biological Chemistry, 285(46):35359–35373,
nov 2010.
[514] Dinesh Thapa, Peng Meng, Roble G Bedolla, Robert L Reddick, Addanki P Ku-
mar, and Rita Ghosh. NQO1 suppresses NF-κB-p300 interaction to regulate in-
flammatory mediators associated with prostate tumorigenesis. Cancer research,
74(19):5644–5656, aug 2014.
165
[515] Y Li and A K Jaiswal. Regulation of human NAD(P)H:quinone oxidoreductase gene.
Role of AP1 binding site contained within human antioxidant response element. The
Journal of biological chemistry, 267(21):15097–104, jul 1992.
[516] John Wilkinson, Venugopal Radjendirane, Gordon R. Pfeiffer, Anil K. Jaiswal,
and Margie L. Clapper. Disruption of c-Fos Leads to Increased Expression of
NAD(P)H:Quinone Oxidoreductase1 and GlutathioneS-Transferase. Biochemical
and Biophysical Research Communications, 253(3):855–858, dec 1998.
[517] J Adler, N Reuven, C Kahana, and Y Shaul. c-Fos proteasomal degradation is acti-
vated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreduc-
tase 1 determines c-Fos serum response kinetics. Mol Cell Biol, 30(15):3767–3778,
2010.
[518] Gitte Ravn-Haren, Susanne Bu¨gel, Britta N Krath, Tien Hoac, Jan Stagsted, Karina
Jørgensen, June R Bresson, Erik H Larsen, and Lars O Dragsted. A short-term
intervention trial with selenate, selenium-enriched yeast and selenium-enriched milk:
effects on oxidative defence regulation. The British journal of nutrition, 99(4):883–
892, 2008.
[519] Gitte Ravn-Haren, Britta N Krath, Kim Overvad, Søren Cold, Sven Moesgaard,
Erik H Larsen, and Lars O Dragsted. Effect of long-term selenium yeast intervention
on activity and gene expression of antioxidant and xenobiotic metabolising enzymes
in healthy elderly volunteers from the Danish Prevention of Cancer by Intervention
by Selenium (PRECISE) pilot study. The British journal of nutrition, 99(6):1190–
1198, 2008.
[520] Edyta Reszka, Edyta Wieczorek, Ewa Jablonska, Beata Janasik, Wojciech Fendler,
and Wojciech Wasowicz. Association between plasma selenium level and NRF2
target genes expression in humans. Journal of trace elements in medicine and biology
: organ of the Society for Minerals and Trace Elements (GMS), 30:102–6, apr 2015.
[521] Melanie M Erzinger, Ce´dric Bovet, Anuli Uzozie, and Shana J Sturla. Induction of
Complementary Function Reductase Enzymes in Colon Cancer Cells by Dithiole-
3-thione versus Sodium Selenite. Journal of biochemical and molecular toxicology,
00(00):1–11, sep 2014.
[522] Anna M Raines and Roger A Sunde. Selenium toxicity but not deficient or super-
nutritional selenium status vastly alters the transcriptome in rodents. BMC ge-
nomics, 12:26, 2011.
[523] Roger A Sunde and Anna M Raines. Selenium regulation of the selenoprotein and
nonselenoprotein transcriptomes in rodents. Advances in nutrition (Bethesda, Md.),
2(2):138–50, mar 2011.
166
[524] Susanne Krehl, Maria Loewinger, Simone Florian, Anna P. Kipp, Antje Ban-
ning, Ludger A. Wessjohann, Martin N. Brauer, Renato Iori, Robert S. Esworthy,
Fong Fong Chu, and Regina Brigelius-Flohe´. Glutathione peroxidase-2 and selenium
decreased inflammation and tumors in a mouse model of inflammation-associated
carcinogenesis whereas sulforaphane effects differed with selenium supply. Carcino-
genesis, 33(3):620–628, 2012.
[525] Franziska Hiller, Lisa Oldorff, Karolin Besselt, and Anna Kipp. Differential Acute
Effects of Selenomethionine and Sodium Selenite on the Severity of Colitis. Nutri-
ents, 7(4):2687–2706, 2015.
[526] J Higdon, B Delage, D Williams, and R Dashwood. Cruciferous vegetables and
human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacological
Research, 55(3):224–236, mar 2007.
[527] Jana Jakub´ıkova´, Ja´n Sedla´k, Richard Mithen, and Yongping Bao. Role of
PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced
phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2
cells. Biochemical Pharmacology, 69(11):1543–1552, 2005.
[528] Leticia Mayor-Lo´pez, Elena Tristante, Mar Carballo-Santana, Estefan´ıa Carrasco-
Garc´ıa, Silvina Grasso, Pilar Garc´ıa-Morales, Miguel Saceda, Juan Luja´n, Jose´
Garc´ıa-Solano, Fernando Carballo, Carlos de Torre, and Isabel Mart´ınez-Lacaci.
Comparative Study of 17-AAG and NVP-AUY922 in Pancreatic and Colorectal
Cancer Cells: Are There Common Determinants of Sensitivity? Translational
Oncology, 7(5):590–604, oct 2014.
[529] Robert A M Vreeburg, Shanna Bastiaan-Net, and Jurriaan J Mes. Normalization
genes for quantitative RT-PCR in differentiated Caco-2 cells used for food exposure
studies. Food & function, 2(2):124–129, 2011.
[530] Korry J Hintze, Karl a Wald, Huawei Zeng, Elizabeth H Jeffery, and John W Fin-
ley. Thioredoxin reductase in human hepatoma cells is transcriptionally regulated
by sulforaphane and other electrophiles via an antioxidant response element. The
Journal of nutrition, 133(9):2721–2727, 2003.
[531] S. W. Ryter. Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Thera-
peutic Applications. Physiological Reviews, 86(2):583–650, apr 2006.
[532] Tzong-Shyuan Lee and Lee-Young Chau. Heme oxygenase-1 mediates the anti-
inflammatory effect of interleukin-10 in mice. Nature Medicine, 8(3):240–246, mar
2002.
[533] Leo E. Otterbein, Fritz H. Bach, Jawed Alam, Miguel Soares, Hong Tao Lu, Mark
Wysk, Roger J. Davis, Richard A. Flavell, and Augustine M.K. Choi. Carbon
167
monoxide has anti-inflammatory effects involving the mitogen-activated protein ki-
nase pathway. Nature medicine, 6(4):422–8, apr 2000.
[534] Judit K Sarady-Andrews, Fang Liu, David Gallo, Atsunori Nakao, Marcus Over-
haus, Robert Ollinger, Augustine M Choi, and Leo E Otterbein. Biliverdin admin-
istration protects against endotoxin-induced acute lung injury in rats. American
journal of physiology. Lung cellular and molecular physiology, 289(6):L1131–7, dec
2005.
[535] Marcus Overhaus, Beverley A Moore, Joel E Barbato, Florian F Behrendt, Julia G
Doering, and Anthony J Bauer. Biliverdin protects against polymicrobial sepsis by
modulating inflammatory mediators. American journal of physiology. Gastrointesti-
nal and liver physiology, 290(4):G695–703, apr 2006.
[536] Xiao Zhu, Wen-Guo Fan, Dong-Pei Li, Hsiangfu Kung, and Marie Cm Lin. Heme
oxygenase-1 system and gastrointestinal inflammation: a short review. World jour-
nal of gastroenterology : WJG, 17(38):4283–8, oct 2011.
[537] Antje Banning and Regina Brigelius-Flohe´. NF-kappaB, Nrf2, and HO-1 interplay
in redox-regulated VCAM-1 expression. Antioxidants & redox signaling, 7(7-8):889–
99.
[538] Halina Was, Jozef Dulak, and Alicja Jozkowicz. Heme oxygenase-1 in tumor biology
and therapy. Current drug targets, 11(12):1551–70, dec 2010.
[539] A Agarwal, F Shiraishi, G A Visner, and H S Nick. Linoleyl hydroperoxide tran-
scriptionally upregulates heme oxygenase-1 gene expression in human renal epithe-
lial and aortic endothelial cells. Journal of the American Society of Nephrology :
JASN, 9(11):1990–1997, 1998.
[540] A M Choi and Jawed Alam. Heme oxygenase-1: function, regulation, and impli-
cation of a novel stress-inducible protein in oxidant-induced lung injury. American
journal of respiratory cell and molecular biology, 15(1):9–19, jul 1996.
[541] W Durante, M H Kroll, N Christodoulides, K J Peyton, and A I Schafer. Nitric
oxide induces heme oxygenase-1 gene expression and carbon monoxide production
in vascular smooth muscle cells. Circulation research, 80(4):557–64, 1997.
[542] Sandra Fogg, Anupam Agarwal, Harry S. Nick, and Gary A. Visner. Iron regu-
lates hyperoxia-dependent human heme oxygenase 1 gene expression in pulmonary
endothelial cells. American Journal of Respiratory Cell and Molecular Biology,
20(4):797–804, 1999.
[543] R Eyssen-Hernandez, A Ladoux, and C Frelin. Differential regulation of cardiac
heme oxygenase-1 and vascular endothelial growth factor mRNA expressions by
168
hemin, heavy metals, heat shock and anoxia. FEBS letters, 382(3):229–33, mar
1996.
[544] M S Carraway, A J Ghio, J D Carter, and C A Piantadosi. Expression of heme
oxygenase-1 in the lung in chronic hypoxia. American journal of physiology. Lung
cellular and molecular physiology, 278(4):L806–12, apr 2000.
[545] P J Lee, B H Jiang, B Y Chin, N V Iyer, J Alam, G L Semenza, and A M
Choi. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme
oxygenase-1 gene in response to hypoxia. The Journal of biological chemistry,
272(9):5375–81, feb 1997.
[546] S M Keyse and R M Tyrrell. Both near ultraviolet radiation and the oxidizing agent
hydrogen peroxide induce a 32-kDa stress protein in normal human skin fibroblasts.
The Journal of biological chemistry, 262(30):14821–5, oct 1987.
[547] D Lautier, P Luscher, and R M Tyrrell. Endogenous glutathione levels modulate
both constitutive and UVA radiation/hydrogen peroxide inducible expression of the
human heme oxygenase gene. Carcinogenesis, 13(2):227–32, feb 1992.
[548] S L Camhi, J Alam, L Otterbein, S L Sylvester, and A M Choi. Induction of heme
oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation.
American journal of respiratory cell and molecular biology, 13(4):387–98, oct 1995.
[549] Xiaohan Zhai, Musen Lin, Feng Zhang, Yan Hu, Xiaomei Xu, Yubing Li, Kexin Liu,
Xiaochi Ma, Xiaofeng Tian, and Jihong Yao. Dietary flavonoid genistein induces
Nrf2 and phase II detoxification gene expression via ERKs and PKC pathways
and protects against oxidative stress in Caco-2 cells. Molecular Nutrition and Food
Research, 57(2):249–259, 2013.
[550] Sasitorn Aueviriyavit, Duangkamol Phummiratch, and Rawiwan Maniratanachote.
Mechanistic study on the biological effects of silver and gold nanoparticles in Caco-2
cells - Induction of the Nrf2/HO-1 pathway by high concentrations of silver nanopar-
ticles. Toxicology Letters, 224(1):73–83, 2014.
[551] Ananta Paine, Britta Eiz-Vesper, Rainer Blasczyk, and Stephan Immenschuh. Sig-
naling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Bio-
chemical Pharmacology, 80(12):1895–1903, 2010.
[552] Danielle Morse, Soeren E. Pischke, Zhihong Zhou, Roger J. Davis, Richard A.
Flavell, Torsten Loop, Sherrie L. Otterbein, Leo E. Otterbein, and Augustine M K
Choi. Suppression of inflammatory cytokine production by carbon monoxide in-
volves the JNK pathway and AP-1. Journal of Biological Chemistry, 278(39):36993–
36998, 2003.
169
[553] N M Inamdar, Y I Ahn, and J Alam. The heme-responsive element of the mouse
heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recog-
nition sequences for MAF and NF-E2 transcription factors. Biochemical and bio-
physical research communications, 221(3):570–576, 1996.
[554] Harumi Harada, Rika Sugimoto, Ayaka Watanabe, Shigeru Taketani, Kosuke
Okada, Eiji Warabi, Richard Siow, Ken Itoh, Masayuki Yamamoto, and Tetsuro
Ishii. Differential roles for Nrf2 and AP-1 in upregulation of HO-1 expression by
arsenite in murine embryonic fibroblasts. Free radical research, 42(4):297–304, 2008.
[555] Khatuna Gabunia, Stephen P. Ellison, Harrinder Singh, Prasun Datta, Sheri E.
Kelemen, Victor Rizzo, and Michael V. Autieri. Interleukin-19 (IL-19) induces Heme
Oxygenase-1 (HO-1) expression and decreases reactive oxygen species in human
vascular smooth muscle cells. Journal of Biological Chemistry, 287(4):2477–2484,
2012.
[556] L. Deferme, J.J. Briede´, S.M.H. Claessen, R. Cavill, and J.C.S. Kleinjans. Cell line-
specific oxidative stress in cellular toxicity: A toxicogenomics-based comparison
between liver and colon cell models. Toxicology in Vitro, 29(5):845–855, 2015.
[557] Huaqun Chen, Lijuan Wang, Tao Gong, Yang Yu, Chunhua Zhu, Fen Li, Li Wang,
and Chaojun Li. EGR-1 regulates Ho-1 expression induced by cigarette smoke.
Biochemical and Biophysical Research Communications, 396(2):388–393, 2010.
[558] Sharon L. Camhi, Jawed Alam, Gordon W. Wiegand, Beek Yoke Chin, and A M
Choi. Transcriptional activation of the HO-1 gene by lipopolysaccharide is mediated
by 5’ distal enhancers: role of reactive oxygen intermediates and AP-1. American
journal of respiratory cell and molecular biology, 18(2):226–34, feb 1998.
[559] S. L. Camhi, J. Alam, L. Otterbein, S. L. Sylvester, and A. M. Choi. Induction
of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1
activation. American journal of respiratory cell and molecular biology, 13(4):387–
398, 1995.
[560] Aodengqimuge, Shasha Liu, Sanyue Mai, Xiaoguang Li, Yi Li, Meiru Hu, Sheng-
tao Yuan, and Lun Song. AP-1 activation attenuates the arsenite-induced apop-
totic response in human bronchial epithelial cells by up-regulating HO-1 expression.
Biotechnology Letters, 36(10):1927–1936, 2014.
[561] Tetsuro Ishii, Ken Itoh, Satoru Takahashi, Hideyo Sato, Toru Yanagawa, Yasutake
Katoh, Shiro Bannai, and Masayuki Yamamoto. Transcription factor Nrf2 coordi-
nately regulates a group of oxidative stress-inducible genes in macrophages. Journal
of Biological Chemistry, 275(21):16023–16029, 2000.
170
[562] Arwa S Kathiria, Mackenzie a Butcher, Jason M Hansen, and Arianne L Theiss.
Nrf2 is not required for epithelial prohibitin-dependent attenuation of experimen-
tal colitis. American journal of physiology. Gastrointestinal and liver physiology,
304(10):G885–96, 2013.
[563] Regina Brigelius-Flohe´ and Anna Patricia Kipp. Selenium in the redox regulation
of the nrf2 and the wnt pathway. Methods in enzymology, 527:65–86, jan 2013.
[564] Yichong Wang, Christopher Dacosta, Wei Wang, Zhigang Zhou, Ming Liu, and
Yongping Bao. Synergy between sulforaphane and selenium in protection against
oxidative damage in colonic CCD841 cells. Nutrition Research, 35(7):610–617, 2015.
[565] Regina Brigelius-Flohe´. Selenium compounds and selenoproteins in cancer. Chem-
istry & biodiversity, 5(3):389–95, mar 2008.
[566] A L Furfaro, N Traverso, C Domenicotti, S Piras, L Moretta, U M Marinari, M A
Pronzato, and M Nitti. The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemore-
sistance. Oxidative medicine and cellular longevity, 2016:1958174, 2016.
[567] Agnieszka Loboda, Milena Damulewicz, Elzbieta Pyza, Alicja Jozkowicz, and Jozef
Dulak. Role of Nrf2/HO-1 system in development, oxidative stress response and dis-
eases: an evolutionarily conserved mechanism. Cellular and molecular life sciences
: CMLS, apr 2016.
[568] Dongbo Sun, Chunqiu Li, Jing Gao, Shu Li, and Hongbin Wang. Effects of Sele-
nium Deficiency on Principal Indexes of Chicken Kidney Function. Biological Trace
Element Research, 164(1):58–63, 2015.
[569] Jiu-li Zhang, Bo Xu, Xiao-dan Huang, Yu-hong Gao, Yu Chen, and An-shan Shan.
Selenium Deficiency Affects the mRNA Expression of Inflammatory Factors and
Selenoprotein Genes in the Kidneys of Broiler Chicks. Biological Trace Element
Research, 171(1):201–207, 2016.
[570] G.X. Sun, Y. Chen, C. P. Liu, S. Li, and J. Fu. Effect of Selenium Against Lead-
Induced Damage on the Gene Expression of Heat Shock Proteins and Inflammatory
Cytokines in Peripheral Blood Lymphocytes of Chickens. Biological Trace Element
Research, pages 474–480, 2016.
[571] Zhao Xu, Zhou Wang, Jian-jun Li, Chen Chen, Ping-chuan Zhang, Lu Dong, Jing-
hong Chen, Qun Chen, Xiao-tian Zhang, and Zhi-lun Wang. Protective effects of
selenium on oxidative damage and oxidative stress related gene expression in rat liver
under chronic poisoning of arsenic. Food and chemical toxicology : an international
journal published for the British Industrial Biological Research Association, 58:1–7,
2013.
171
[572] Wanli Xue, Zhilun Wang, Qun Chen, Jinghong Chen, Haojie Yang, and Senhai
Xue. High selenium status in individuals exposed to arsenic through coal-burning
in Shaanxi (PR of China) modulates antioxidant enzymes, heme oxygenase-1 and
DNA damage. Clinica Chimica Acta, 411(17-18):1312–1318, 2010.
[573] Benoˆıt D’Autre´aux and Michel B Toledano. ROS as signalling molecules: mecha-
nisms that generate specificity in ROS homeostasis. Nature reviews. Molecular cell
biology, 8(10):813–24, oct 2007.
[574] Irene Gan˜a´n-Go´mez, Yue Wei, Hui Yang, Mar´ıa Carmen Boyano-Ada´nez, and
Guillermo Garc´ıa-Manero. Oncogenic functions of the transcription factor Nrf2.
Free radical biology & medicine, 65:750–64, dec 2013.
[575] Joe M. McCord and Irwin Fridovich. Superoxide Dismutases: You’ve Come a Long
Way, Baby. Antioxidants & Redox Signaling, 20(10):1548–1549, 2014.
[576] Elizabeth a Hileman, Geetha Achanta, and Peng Huang. Superoxide dismutase:
an emerging target for cancer therapeutics. Expert opinion on therapeutic targets,
5(6):697–710, 2001.
[577] Anja Konzack and Thomas Kietzmann. Manganese superoxide dismutase in car-
cinogenesis: friend or foe? Biochemical Society Transactions, 42(4):1012–1016,
2014.
[578] D W Christianson. Structural chemistry and biology of manganese metalloenzymes.
Progress in biophysics and molecular biology, 67(2-3):217–52, 1997.
[579] M Akashi, M Hachiya, R L Paquette, Y Osawa, S Shimizu, and G Suzuki. Irradia-
tion increases manganese superoxide dismutase mRNA levels in human fibroblasts.
Possible mechanisms for its accumulation. The Journal of biological chemistry,
270(26):15864–9, jun 1995.
[580] Ye-Shih Ho, Renaud Vincent, Margaret S. Dey, Jan W. Slot, and James D.
Crapo. Transgenic Models for the Study of Lung Antioxidant Defense: Enhanced
Manganese-containing Superoxide Dismutase Activity Gives Partial Protection to
B6C3 Hybrid Mice Exposed to Hyperoxia. American Journal of Respiratory Cell
and Molecular Biology, 18(4):538–547, apr 1998.
[581] Lu Miao and Daret K. St. Clair. Regulation of superoxide dismutase genes: Impli-
cations in disease. Free Radical Biology and Medicine, 47(4):344–356, 2009.
[582] X S Wan, M N Devalaraja, and D K St Clair. Molecular structure and organiza-
tion of the human manganese superoxide dismutase gene. DNA and cell biology,
13(11):1127–36, nov 1994.
172
[583] Natarajan Aravindan, Rakhesh Madhusoodhanan, Salahuddin Ahmad, Daniel
Johnson, and Terence S Herman. Curcumin inhibits NFkappaB mediated radio-
protection and modulate apoptosis related genes in human neuroblastoma cells.
Cancer biology & therapy, 7(4):569–76, apr 2008.
[584] Y Xu, K K Kiningham, M N Devalaraja, C C Yeh, H Majima, E J Kasarskis, and
D K St Clair. An intronic NF-kappaB element is essential for induction of the
human manganese superoxide dismutase gene by tumor necrosis factor-alpha and
interleukin-1beta. DNA and cell biology, 18(9):709–22, sep 1999.
[585] Jamunarani Veeraraghavan, Mohan Natarajan, Terence S. Herman, and Natarajan
Aravindan. Low-dose γ-radiation-induced oxidative stress response in mouse brain
and gut: Regulation by NFκB–MnSOD cross-signaling. Mutation Research/Genetic
Toxicology and Environmental Mutagenesis, 718(1-2):44–55, jan 2011.
[586] K. Du, Y. Yu, D. Zhang, W. Luo, H. Huang, J. Chen, J. Gao, and C. Huang. NF
B1 (p50) suppresses SOD2 expression by inhibiting FoxO3a transactivation in a
miR190/PHLPP1/Akt-dependent axis. Molecular Biology of the Cell, 24(22):3577–
3583, nov 2013.
[587] Ishtiaq Qadri, Mieko Iwahashi, Juan M Capasso, Matthew W Hopken, Sonia Flores,
Jerome Schaack, and Francis R Simon. Induced oxidative stress and activated
expression of manganese superoxide dismutase during hepatitis C virus replication:
role of JNK, p38 MAPK and AP-1. The Biochemical journal, 378(Pt 3):919–28,
mar 2004.
[588] Shani Shilo, Michal Pardo, Michal Aharoni-Simon, Sagit Glibter, and Oren Tirosh.
Selenium supplementation increases liver MnSOD expression: Molecular mechanism
for hepato-protection. Journal of Inorganic Biochemistry, 102(1):110–118, 2008.
[589] Muhammad G. Kibriya, Farzana Jasmine, Maria Argos, Wendy J. Verret, Muham-
mad Rakibuz-Zaman, Alauddin Ahmed, Faruque Parvez, and Habibul Ahsan.
Changes in gene expression profiles in response to selenium supplementation among
individuals with arsenic-induced pre-malignant skin lesions. Toxicology Letters,
169(2):162–176, 2007.
[590] Raziye O¨ztu¨rk-U¨rek, Lu¨tfiye Arzu Bozkaya, and Leman Tarhan. The effects of
some antioxidant vitamin- and trace element-supplemented diets on activities of
SOD, CAT, GSH-Px and LPO levels in chicken tissues. Cell Biochemistry and
Function, 19(2):125–132, 2001.
[591] Shani Shilo, Michal Aharoni-Simon, and Oren Tirosh. Selenium attenuates ex-
pression of MnSOD and uncoupling protein 2 in J774.2 macrophages: molecular
mechanism for its cell-death and antiinflammatory activity. Antioxidants & redox
signaling, 7(1-2):276–86, 2005.
173
[592] Yun-Jeong Kim, Weon-Sup Lee, Clement Ip, Ho-Zoon Chae, Eun-Mi Park, and
Young-Mee Park. Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase
signaling in lung cancer cells through interaction with the glutathione S-transferase
Pi/c-Jun NH2-terminal kinase complex. Cancer research, 66(14):7136–42, jul 2006.
[593] Jason M Hansen, Siobhan Moriarty-Craige, and Dean P Jones. Nuclear and cy-
toplasmic peroxiredoxin-1 differentially regulate NF-kappaB activities. Free radical
biology & medicine, 43(2):282–8, jul 2007.
[594] D Y Jin, H Z Chae, S G Rhee, and K T Jeang. Regulatory role for a novel hu-
man thioredoxin peroxidase in NF-kappaB activation. The Journal of biological
chemistry, 272(49):30952–61, dec 1997.
[595] Min Zhang, Min Hou, Lihua Ge, Congcong Miao, Jianfei Zhang, Xinying Jing,
Ni Shi, Tong Chen, and Xiaofei Tang. Induction of Peroxiredoxin 1 by Hypoxia
Regulates Heme Oxygenase-1 via NF-κB in Oral Cancer. PloS one, 9(8):e105994,
jan 2014.
[596] Yun-Jeong Kim, Ji-Yeon Ahn, Ping Liang, Clement Ip, Yuesheng Zhang, and
Young-Mee Park. Human prx1 gene is a target of Nrf2 and is up-regulated by
hypoxia/reoxygenation: implication to tumor biology. Cancer research, 67(2):546–
54, jan 2007.
[597] Hwa-Jeong Lee, Jun Lee, Seung-Ki Min, Han-Young Guo, Sun-Kyung Lee, Hyung-
Ryong Kim, Hyun-Ock Pae, Hun-Taeg Chung, Seung-Heon Hong, Suk-Keun Lee,
and Eun-Cheol Kim. Differential induction of heme oxygenase-1 against nicotine-
induced cytotoxicity via the PI3K, MAPK, and NF-kappa B pathways in immortal-
ized and malignant human oral keratinocytes. Journal of oral pathology & medicine
: official publication of the International Association of Oral Pathologists and the
American Academy of Oral Pathology, 37(5):278–86, may 2008.
[598] Y Lavrovsky, C S Song, B Chatterjee, and A K Roy. Age-dependent increase of
heme oxygenase-1 gene expression in the liver mediated by NFkappaB. Mechanisms
of ageing and development, 114(1):49–60, feb 2000.
[599] Marcus E Allan and Kenneth B Storey. Expression of NF-κB and downstream
antioxidant genes in skeletal muscle of hibernating ground squirrels, Spermophilus
tridecemlineatus. Cell biochemistry and function, 30(2):166–74, mar 2012.
[600] Seung-Il Jeong, Byung-Min Choi, and Seon Il Jang. Sulforaphane suppresses
TARC/CCL17 and MDC/CCL22 expression through heme oxygenase-1 and NF-
κB in human keratinocytes. Archives of pharmacal research, 33(11):1867–76, nov
2010.
174
[601] B Coles and B Ketterer. The role of glutathione and glutathione transferases in
chemical carcinogenesis. Critical reviews in biochemistry and molecular biology,
25(1):47–70, 1990.
[602] Anders G. M. Sundberg, Robert Nilsson, Eeva-Liisa Appelkvist, and Gustav Dall-
ner. Immunohistochemical Localization of α and φ Class Glutathione Transferases
in Normal Human Tissues. Pharmacology & Toxicology, 72(4-5):321–331, apr 1993.
[603] I G Cowell, K H Dixon, S E Pemble, B Ketterer, and J B Taylor. The structure of the
human glutathione S-transferase pi gene. The Biochemical journal, 255(1):79–83,
oct 1988.
[604] C L Xia, I G Cowell, K H Dixon, S E Pemble, B Ketterer, and J B Taylor. Glu-
tathione transferase pi its minimal promoter and downstream cis-acting element.
Biochemical and biophysical research communications, 176(1):233–40, apr 1991.
[605] C Xia, J Hu, B Ketterer, and J B Taylor. The organization of the human GSTP1-
1 gene promoter and its response to retinoic acid and cellular redox status. The
Biochemical journal, 313 ( Pt 1:155–61, jan 1996.
[606] G J Moffat, A W McLaren, and C R Wolf. Involvement of Jun and Fos proteins in
regulating transcriptional activation of the human pi class glutathione S-transferase
gene in multidrug-resistant MCF7 breast cancer cells. The Journal of biological
chemistry, 269(23):16397–402, jun 1994.
[607] G. J. Moffat, A. W. McLaren, and C. R. Wolf. Functional Characterization of the
Transcription Silencer Element Located within the Human Pi Class Glutathione S-
Transferase Promoter. Journal of Biological Chemistry, 271(34):20740–20747, aug
1996.
[608] Charles S. Morrow, Merrill E. Goldsmith, and Kenneth H. Cowan. Regulation
of human glutathione S-transferase pi gene transcription: influence of 5’-flanking
sequences and trans-activating factors which recognize AP-1-binding sites. Gene,
88(2):215–25, apr 1990.
[609] Yuesheng Zhang, Veronica Gonzalez, and Min Jian Xu. Expression and regulation
of glutathione S-transferase P1-1 in cultured human epidermal cells. Journal of
dermatological science, 30(3):205–14, dec 2002.
[610] J B de Haan, Cecile Bladier, Peter Griffiths, Michael Kelner, Ross D. O’Shea,
Nam Sang Cheung, R. T. Bronson, Mary J. Silvestro, Steven Wild, Shao Shan
Zheng, Philip M. Beart, Paul J. Hertzog, and Ismail Kola. Mice with a homozygous
null mutation for the most abundant glutathione peroxidase, Gpx1, show increased
susceptibility to the oxidative stress-inducing agents paraquat and hydrogen perox-
ide. The Journal of biological chemistry, 273(35):22528–36, aug 1998.
175
[611] S. Perwez Hussain, Paul Amstad, Peijun He, Ana Robles, Shawn Lupold, Ichiro
Kaneko, Masato Ichimiya, Sagar Sengupta, Leah Mechanic, Shu Okamura, Lorne J.
Hofseth, Matthew Moake, Makoto Nagashima, Kathleen S. Forrester, and Curtis C.
Harris. p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases
Oxidative Stress and Apoptosis. Cancer Research, 64(7):2350–2356, 2004.
[612] L Z Zhou, A P Johnson, and T A Rando. NF kappa B and AP-1 mediate transcrip-
tional responses to oxidative stress in skeletal muscle cells. Free radical biology &
medicine, 31(11):1405–16, dec 2001.
[613] Eva Hernandez-Montes, Susan E. Pollard, David Vauzour, Laia Jofre-Montseny,
Cristina Rota, Gerald Rimbach, Peter D. Weinberg, and Jeremy P E Spencer. Ac-
tivation of glutathione peroxidase via Nrf1 mediates genistein’s protection against
oxidative endothelial cell injury. Biochemical and Biophysical Research Communi-
cations, 346(3):851–859, 2006.
[614] B. L. Emmink, J. Laoukili, a. P. Kipp, J. Koster, K. M. Govaert, S. Fatrai, a. Ver-
heem, E. J. a. Steller, R. Brigelius-Flohe, C. R. Jimenez, I. H. M. Borel Rinkes, and
O. Kranenburg. GPx2 Suppression of H2O2 Stress Links the Formation of Differen-
tiated Tumor Mass to Metastatic Capacity in Colorectal Cancer. Cancer Research,
74(22):6717–6730, 2014.
[615] John D Hayes and Albena T Dinkova-Kostova. The Nrf2 regulatory network pro-
vides an interface between redox and intermediary metabolism. Trends in biochem-
ical sciences, 39(4):1–20, mar 2014.
[616] Takaya Nakane, Kohtaro Asayama, Kohji Kodera, Hidemasa Hayashibe, Norihiko
Uchida, and Shinpei Nakazawa. Effect of selenium deficiency on cellular and extra-
cellular glutathione peroxidases: Immunochemical detection and mRNA analysis in
rat kidney and serum. Free Radical Biology and Medicine, 25(4-5):504–511, 1998.
[617] R Brigelius-Flohe´, K D Aumann, H Blo¨cker, Gerhard Gross, M Kiess, K D Klo¨ppel,
M Maiorino, A Roveri, R Schuckelt, and F Usani. Phospholipid-hydroperoxide
glutathione peroxidase. Genomic DNA, cDNA, and deduced amino acid sequence.
The Journal of biological chemistry, 269(10):7342–8, mar 1994.
[618] A. Borchert. The Role of Phospholipid Hydroperoxide Glutathione Peroxidase Iso-
forms in Murine Embryogenesis. Journal of Biological Chemistry, 281(28):19655–
19664, may 2006.
[619] X G Lei, J K Evenson, K M Thompson, and R a Sunde. Glutathione peroxidase
and phospholipid hydroperoxide glutathione peroxidase are differentially regulated
in rats by dietary selenium. The Journal of nutrition, 125(6):1438–1446, 1995.
176
[620] Lynda Latre`che, Ste´phane Duhieu, Zahia Touat-Hamici, Olivier Jean-Jean, and
Laurent Chavatte. The differential expression of glutathione peroxidase 1 and 4
depends on the nature of the SECIS element. RNA Biology, 9(5):681–690, 2012.
[621] J. Zhang. Synergy between sulforaphane and selenium in the induction of thiore-
doxin reductase 1 requires both transcriptional and translational modulation. Car-
cinogenesis, 24(3):497–503, mar 2003.
[622] Caitlyn W. Barrett, Sarah P. Short, and Christopher S. Williams. Selenoproteins
and oxidative stress-induced inflammatory tumorigenesis in the gut. Cellular and
molecular life sciences : CMLS, aug 2016.
[623] Yoshiro Saito, Takaaki Hayashi, Ayako Tanaka, Yasuko Watanabe, Masayo Suzuki,
Eiji Saito, and Kazuhiko Takahashi. Selenoprotein P in human plasma as an ex-
tracellular phospholipid hydroperoxide glutathione peroxidase: Isolation and enzy-
matic characterization of human selenoprotein P. Journal of Biological Chemistry,
274(5):2866–2871, 1999.
[624] Suguru Kurokawa, Sofi Eriksson, Kristie L Rose, Sen Wu, Amy K Motley, Salisha
Hill, Virginia P Winfrey, W Hayes McDonald, Mario R Capecchi, John F Atkins,
Elias S J Arne´r, Kristina E Hill, and Raymond F Burk. Sepp1(UF) forms are N-
terminal selenoprotein P truncations that have peroxidase activity when coupled
with thioredoxin reductase-1. Free radical biology & medicine, 69:67–76, apr 2014.
[625] Naveen Kaushal, Avinash K. Kudva, Andrew D. Patterson, Christopher Chiaro,
Mary J. Kennett, Dhimant Desai, Shantu Amin, Bradley A. Carlson, Margherita T.
Cantorna, and K. Sandeep Prabhu. Crucial role of macrophage selenoproteins in
experimental colitis. Journal of immunology (Baltimore, Md. : 1950), 193(7):3683–
92, oct 2014.
[626] Graziella Solinas, Silvia Schiarea, Manuela Liguori, Marco Fabbri, Samantha Pesce,
Luca Zammataro, Fabio Pasqualini, Manuela Nebuloni, Chiara Chiabrando, Alberto
Mantovani, and Paola Allavena. Tumor-conditioned macrophages secrete migration-
stimulating factor: a new marker for M2-polarization, influencing tumor cell motil-
ity. Journal of immunology (Baltimore, Md. : 1950), 185(1):642–52, 2010.
[627] Aude Carreau, Bouchra El Hafny-Rahbi, Agata Matejuk, Catherine Grillon, and
Claudine Kieda. Why is the partial oxygen pressure of human tissues a crucial pa-
rameter? Small molecules and hypoxia. Journal of Cellular and Molecular Medicine,
15(6):1239–1253, jun 2011.
[628] Steven M Dudek, Eddie T Chiang, Sara M Camp, Yurong Guo, Jing Zhao, Mary E
Brown, Patrick a Singleton, Lichun Wang, Anjali Desai, Fernando T Arce, Ratnesh
Lal, Jennifer E Van Eyk, Syed Z Imam, and Joe G N Garcia. Abl tyrosine kinase
177
phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier
function. Molecular biology of the cell, 21(22):4042–4056, 2010.
[629] Daniel J Bertges, So¨ren Berg, Mitchell P Fink, and Russell L Delude. Regulation
of hypoxia-inducible factor 1 in enterocytic cells. The Journal of surgical research,
106:157–165, 2002.
[630] Agnes Go¨rlach. Regulation of HIF-1alpha at the transcriptional level. Current
pharmaceutical design, 15(33):3844–52, 2009.
[631] Ulrike Bruning, Luca Cerone, Zoltan Neufeld, Susan F Fitzpatrick, Alex Cheong,
Carsten C Scholz, David a Simpson, Martin O Leonard, Murtaza M Tambuwala,
Eoin P Cummins, and Cormac T Taylor. MicroRNA-155 promotes resolution of
hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Molecular and
cellular biology, 31(19):4087–96, oct 2011.
[632] Florence Hazane-Puch, Josiane Arnaud, Candice Trocme´, Patrice Faure, Franc¸ois
Laporte, and Pierre Champelovier. Sodium Selenite Decreased HDAC Activity, Cell
Proliferation and Induced Apoptosis in Three Human Glioblastoma Cells. Anti-
Cancer Agents in Medicinal Chemistry, 16(4):490–500, feb 2016.
[633] Yang Yang, Hui Luo, Kaiyuan Hui, Yali Ci, Kejian Shi, Ge Chen, Lei Shi, and
Caimin Xu. Selenite-induced autophagy antagonizes apoptosis in colorectal cancer
cells in vitro and in vivo. Oncology Reports, dec 2015.
[634] H Zhong, K Chiles, D Feldser, E Laughner, C Hanrahan, M M Georgescu, J W Si-
mons, and G L Semenza. Modulation of hypoxia-inducible factor 1alpha expression
by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP
pathway in human prostate cancer cells: implications for tumor angiogenesis and
therapeutics. Cancer research, 60(6):1541–5, mar 2000.
[635] M A Maynard and M Ohh. The role of hypoxia-inducible factors in cancer. Cellular
and molecular life sciences : CMLS, 64(16):2170–80, aug 2007.
[636] E B Rankin and A J Giaccia. The role of hypoxia-inducible factors in tumorigenesis.
Cell death and differentiation, 15(4):678–85, apr 2008.
[637] Emmanual Unni, Dimpy Koul, Wai-Kwan Alfred Yung, and Raghu Sinha. Se-
methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mam-
mary epithelial tumor cells in vitro. Breast cancer research : BCR, 7(5):R699–707,
2005.
[638] Hongbo Hu, Cheng Jiang, Guangxun Li, and Junxuan Lu¨. PKB/AKT and ERK
regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate
cancer cells. Carcinogenesis, 26(8):1374–81, aug 2005.
178
[639] R K Bruick. Expression of the gene encoding the proapoptotic Nip3 protein is
induced by hypoxia. Proceedings of the National Academy of Sciences of the United
States of America, 97(16):9082–7, aug 2000.
[640] K Guo, G Searfoss, D Krolikowski, M Pagnoni, C Franks, K Clark, K T Yu, M Jaye,
and Y Ivashchenko. Hypoxia induces the expression of the pro-apoptotic gene
BNIP3. Cell death and differentiation, 8(4):367–76, apr 2001.
[641] James Shaw, Tong Zhang, Marek Rzeszutek, Natalia Yurkova, Delphine Baetz,
James R Davie, and Lorrie A Kirshenbaum. Transcriptional silencing of the death
gene BNIP3 by cooperative action of NF-kappaB and histone deacetylase 1 in ven-
tricular myocytes. Circulation research, 99(12):1347–54, dec 2006.
[642] R K Bruick and S L McKnight. A conserved family of prolyl-4-hydroxylases that
modify HIF. Science (New York, N.Y.), 294(5545):1337–40, nov 2001.
[643] Amandine Ginouve`s, Karine Ilc, Nuria Mac´ıas, Jacques Pouysse´gur, and Edurne
Berra. PHDs overactivation during chronic hypoxia ”desensitizes” HIFalpha and
protects cells from necrosis. Proceedings of the National Academy of Sciences of the
United States of America, 105(12):4745–50, mar 2008.
[644] D Hu¨ppe, M Tegenthoff, J Faig, F Brunke, S Depka, M Stuhldreier, G Micklefield,
A Gillissen, and B May. Esophageal dysfunction in diabetes mellitus: is there a rela-
tion to clinical manifestation of neuropathy? The Clinical investigator, 70(9):740–7,
sep 1992.
[645] Rebecca J Appelhoff, Ya-Min Tian, Raju R Raval, Helen Turley, Adrian L Har-
ris, Christopher W Pugh, Peter J Ratcliffe, and Jonathan M Gleadle. Differential
function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of
hypoxia-inducible factor. The Journal of biological chemistry, 279(37):38458–65,
sep 2004.
[646] Olga Aprelikova, Gadisetti V R Chandramouli, Matthew Wood, James R Vasselli,
Joseph Riss, Jodi K Maranchie, W Marston Linehan, and J Carl Barrett. Regu-
lation of HIF prolyl hydroxylases by hypoxia-inducible factors. Journal of cellular
biochemistry, 92(3):491–501, jun 2004.
[647] Terhi Jokilehto, Krista Rantanen, Marjaana Luukkaa, Pekka Heikkinen, Reidar
Grenman, Heikki Minn, Pauliina Kronqvist, and Panu M Jaakkola. Overexpression
and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in
head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Clinical cancer research : an official journal of the American Association for Cancer
Research, 12(4):1080–7, feb 2006.
179
[648] Ying Chen, Hai-Sheng Zhang, Guo-Hua Fong, Qiu-Lei Xi, Guo-Hao Wu, Chen-
Guang Bai, Zhi-Qiang Ling, Li Fan, Yi-Ming Xu, Yan-Qing Qin, Tang-Long Yuan,
Heng Sun, and Jing Fang. PHD3 Stabilizes the Tight Junction Protein Occludin
and Protects Intestinal Epithelial Barrier Function. Journal of Biological Chemistry,
290(33):20580–20589, aug 2015.
[649] Nuria Pescador, Yolanda Cuevas, Salvador Naranjo, Marisa Alcaide, Diego Villar,
Manuel O Landa´zuri, and Luis Del Peso. Identification of a functional hypoxia-
responsive element that regulates the expression of the egl nine homologue 3
(egln3/phd3) gene. The Biochemical journal, 390(Pt 1):189–97, aug 2005.
[650] Jian Fu, Keon Menzies, Robert S Freeman, and Mark B Taubman. EGLN3 prolyl
hydroxylase regulates skeletal muscle differentiation and myogenin protein stability.
The Journal of biological chemistry, 282(17):12410–8, apr 2007.
[651] Jian Fu and Mark B Taubman. Prolyl hydroxylase EGLN3 regulates skeletal my-
oblast differentiation through an NF-kappaB-dependent pathway. The Journal of
biological chemistry, 285(12):8927–35, mar 2010.
[652] John Goutsias and Seungchan Kim. A Nonlinear Discrete Dynamical Model for
Transcriptional Regulation: Construction and Properties. Biophysical Journal,
86(4):1922–1945, apr 2004.
[653] Till D. Frank, Miguel A. S. Cavadas, Lan K. Nguyen, and Alex Cheong. Non-
linear Dynamics in Transcriptional Regulation: Biological Logic Gates. In Nonlinear
Dynamics in Biological Systems, pages 43–62. Springer International Publishing,
2016.
[654] M. Nikinmaa. Redox state regulates HIF-1 and its DNA binding and phosphoryla-
tion in salmonid cells. Journal of Cell Science, 117(15):3201–3206, jul 2004.
[655] A C Koong, E Y Chen, and A J Giaccia. Hypoxia causes the activation of nuclear
factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues.
Cancer research, 54(6):1425–30, mar 1994.
[656] Cormac T. Taylor and Eoin P. Cummins. The Role of NF-κB in Hypoxia-Induced
Gene Expression. Annals of the New York Academy of Sciences, 1177(1):178–184,
oct 2009.
[657] Huaitao Yang, Xiuying Yang, John C. Lang, and Edward Chaum. Tissue culture
methods can strongly induce immediate early gene expression in retinal pigment
epithelial cells. Journal of Cellular Biochemistry, 98(6):1560–1569, 2006.
[658] Daniel Nickel, Martin Busch, Daniel Mayer, Benjamin Hagemann, Valeska Knoll,
and Steffen Stenger. Hypoxia triggers the expression of human β defensin 2 and
180
antimicrobial activity against Mycobacterium tuberculosis in human macrophages.
Journal of immunology (Baltimore, Md. : 1950), 188(8):4001–7, apr 2012.
[659] Niels-Peter Becker, Janine Martitz, Kostja Renko, Mette Stoedter, Sandra Hybsier,
Thorsten Cramer, and Lutz Schomburg. Hypoxia reduces and redirects selenopro-
tein biosynthesis. Metallomics, 2014.
[660] Yildiz Dincer, Yusuf Erzin, Solen Himmetoglu, Kezban Nur Gunes, Kadir Bal,
and Tu¨lay Akcay. Oxidative DNA damage and antioxidant activity in patients
with inflammatory bowel disease. Digestive Diseases and Sciences, 52(7):1636–1641,
2007.
[661] Hye-Kyung Na and Young-Joon Surh. Oncogenic potential of Nrf2 and its principal
target protein heme oxygenase-1. Free Radical Biology and Medicine, 67:353–365,
feb 2014.
[662] Louise E. Glover and Sean P. Colgan. Hypoxia and metabolic factors that influence
inflammatory bowel disease pathogenesis. Gastroenterology, 140(6):1748–1755, 2011.
[663] Hiroyuki Tamaki, Hajime Nakamura, Akiyoshi Nishio, Hiroshi Nakase, Satoru Ueno,
Norimitsu Uza, Masahiro Kido, Satoko Inoue, Sakae Mikami, Masanori Asada, Kei-
ichi Kiriya, Hiroshi Kitamura, Shinya Ohashi, Toshiro Fukui, Kimio Kawasaki,
Minoru Matsuura, Yasuyuki Ishii, Kazuichi Okazaki, Junji Yodoi, and Tsutomu
Chiba. Human thioredoxin-1 ameliorates experimental murine colitis in associa-
tion with suppressed macrophage inhibitory factor production. Gastroenterology,
131(4):1110–21, oct 2006.
[664] Daniel Bandarra, John Biddlestone, Sharon Mudie, H.-Arno J. Mu¨ller, and Sonia
Rocha. HIF-1α restricts NF-κB-dependent gene expression to control innate immu-
nity signals. Disease Models & Mechanisms, 8(2):169–181, feb 2015.
[665] G Bermano, J R Arthur, and J E Hesketh. Selective control of cytosolic glutathione
peroxidase and phospholipid hydroperoxide glutathione peroxidase mRNA stability
by selenium supply. FEBS letters, 387(2-3):157–60, jun 1996.
[666] Juliusz Bianga, Zahia Touat-Hamici, Katarzyna Bierla, Sandra Mounicou, Joanna
Szpunar, Laurent Chavatte, and Ryszard Lobinski. Speciation analysis for trace
levels of selenoproteins in cultured human cells. Journal of proteomics, 108:316–
324, jun 2014.
181
